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Abstract 
In the following chapters new methods in organocatalysis are described. The design 
of new catalysts is explored starting from the synthesis and the study of ion tagged 
prolines to their applications and recycle, then moving to the synthesis of new bicyclic 
diarylprolinol silyl ethers and their use in organocatalytic transformations.  
The study of new organocatalytic reaction is also investigated, in particular 
bifunctional thioureas are employed to catalyse the conjugate addition of nitro 
compounds to 3-yilidene oxindoles in sequential and domino reactions. 
Finally, preliminary results on photochemical organocatalytic atom transfer radical 
addition to alkenes are discussed in the last chapter. 
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Chapter 1 
Asymmetric Organocatalysis 
1. Introduction 
In organic chemistry the ‘‘value’’ of a product is directly related to purity; in most 
instances, when the molecule is chiral, this implies that it must be present only one 
enantiomer. In recent years the number of methods available for high-yielding and 
enantioselective transformations of organic compounds has increased tremendously 
and new concepts and methods are emerging continuously.  
Amongst the different ways of creating enantiomerically enriched products, 
catalytic methods are considered as the most appealing ones as they provide better 
atom economy. Enantioselective catalysis needs to be efficient, facile, reliable and 
economic if it has to be used widely in particular for pharmaceutical synthesis. 
Between the extremes of transition metal catalysis and enzymatic transformations, 
a third general approach to the catalytic production of enantiomerically pure organic 
compounds has emerged, that is asymmetric organocatalysis.1,2 The principle of 
organocatalysis is that small organic molecules (without metal elements) could 
function as efficient and selective catalysts for a large variety of enantioselective 
transformations. It is now widely accepted that organocatalysis is one of the main 
branches of enantioselective synthesis, complementary to the organometallic and bio-
catalysis. 
                                                     
1 Books on organocatalysis: (a) Berkessel A., Gröger H., Asymmetric Organocatalysis – From Biomimetic 
Concepts to Applications in Asymmetric Synthesis (2005), Wiley-VCH; (b) Dalko P. I., Enantioselective 
Organocatalysis – Reactions and Experimental Procedures (2007), Wiley-VCH. 
2 Reviews on organocatalysis: (a) MacMillan D. W. C., Nature 2008, 455, 304-308; (b) Gaunt M. J., Johansson C. 
C. C., McNally A., Vo N. T., Drug Discovery Today 2007, 12, 8-27; (c) Seayad J., List B., Org. Biomol. Chem. 2005, 
3, 719-724; (d) Dalko P. I., Moisan L., Angew. Chem. Int. Ed. 2004, 43, 5138-5175. 
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The use of small organic molecules as catalysts has been known for more than a 
century. But only in the past decade organocatalysis has become a thriving area of 
general concepts and widely applicable asymmetric reactions. 
In fact, the historic roots of organocatalysis date back to the first half of the 20th 
century when the attempts to use low-molecular weight organic compounds were 
focused to both understand and mimic the catalytic activity and selectivity of enzymes. 
Isolated examples of enantioselective organocatalytic processes were reported 
from the 1960s to the 1980s, for example the alkaloid-catalysed addition of alcohols to 
prochiral ketenes by Pracejus et al.,3 the Hajos–Parrish–Eder–Sauer–Wiechert 
reaction,4 the hydrocyanantion of aldehydes using the Inoue catalyst,5 or the Juliá–
Colonna epoxidation,6 but these chemical studies were viewed more as unique 
chemical reactions than as integral parts of a larger, interconnected field. 
It was not until 2000, however, that the field of organocatalysis was effectively 
launched, by two publications that appeared almost simultaneously: one from Carlos 
Barbas III, Richard Lerner and Benjamin List,7 on enamine catalysis, and the other from 
MacMillan group,8 on iminium catalysis. 
The work of Barbas, Lerner and List was significant because it showed that the 
underlying mechanism of the Hajos–Parrish reaction could be extended and applied to 
transformations that have a broader applicability (specifically, the intermolecular aldol 
reaction). Moreover, this work showed that small organic molecules (such as proline) 
could catalyse the same chemical reactions as much larger organic molecules 
(enzymes) by using similar mechanisms. Meanwhile, the report of iminium catalysis 
conceptualized “organocatalysis” in three important ways: by delineating how 
organocatalysts could provide economic, environmental and scientific benefits; by 
describing a general activation strategy for organocatalysis that could be applied to a 
                                                     
3 (a) Pracejus H., Justus Liebigs Ann. Chem. 1960, 634, 9-22; (b) Pracejus H., Mäthe H., J. Prakt. Chem. 1964, 24, 
195-205. 
4 (a) Eder U., Sauer G., Wiechert R., Angew. Chem. Int. Ed. 1971, 10, 496-497; (b) Hajos Z. G., Parrish D. R., J. Org. 
Chem. 1974, 39, 1615-1621. 
5 (a) Oku J., Inoue S., J. Chem. Soc., Chem. Commun. 1981, 229-230; (b) Oku J., Ito N., Inoue S., Macromol. Chem. 
1982, 183, 579-589. 
6 (a) Juliá S., Guixer J., Masana J., Rocas J., Colonna S., Annuziata R., Molinari H., J. Chem. Soc., Perkin Trans. 1 
1982, 1317-1324; (b) Juliá S., Masana J., Vega J. C., Angew. Chem. Int. Ed. 1980, 19, 929-931. 
7 List B., Lerner R. A., Barbas III C. F., J. Am. Chem. Soc. 2000, 122, 2395-2396. 
8 Ahrendt K. A., Borths C. J., MacMillan D. W. C., J. Am. Chem. Soc. 2000, 122, 4243-4244. 
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broad range of reaction classes and by introducing the term organocatalysis to the 
chemical literature. 
Organocatalysis has several significant advantages over conventional metal 
catalysis: organocatalysts are usually robust, inexpensive and generally readily 
available in both enantiomeric forms. Because of their stability toward moisture and 
oxygen, demanding reaction conditions like inert atmosphere, low temperatures, 
absolute solvents, etc., are usually not required. Organocatalysts are mostly 
inexpensive indeed they are chiral-pool compounds themselves, or they are derived 
from these readily available sources of chirality by means of few synthetic steps. They 
are bench-stable compounds which are incomparably more robust than enzymes or 
other bioorganic catalysts. Some “privileged” organocatalysts are shown in Figure 1. 
 
Figure 1 
Because of the absence of transition metals, organocatalytic methods seem to be 
especially attractive for the preparation of compounds that do not tolerate metal 
contamination, e.g. pharmaceutical products. Organocatalysts are typically less toxic 
than metal-based catalysts (although little is known about the toxicity of many organic 
catalysts), can be tolerated to a large extent in waste streams and are more easily 
removed from waste streams, again mitigating the cost of high catalyst loadings. 
The operational simplicity, ready availability of catalysts and low toxicity associated 
with organocatalysis make it an attractive method to synthesise complex structures 
and give it a great potential in discovery chemistry. 
Chapter 1 
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Together with the ease and low cost of carrying out organocatalytic reactions in the 
laboratory, most crucial to the success of organocatalysis has been the invention or 
identification of generic modes of catalyst activation, induction and reactivity. A 
generic activation mode describes a reactive species, whose formation allow the 
reaction to proceed. This reactive species can participate in many reaction types 
providing, in many istances, high enantioselectivity. Such reactive species arise from 
the interaction of the substrate with a single chiral catalyst, owning a determined 
functional group, in a highly organized and predictable manner. The value of generic 
activation modes is that, after they have been established, it is relatively 
straightforward to use them as a platform for designing new enantioselective 
reactions. 
2. Covalent organocatalysis 
Covalent catalysis involves the formation of a covalent adduct between catalyst and 
substrate within the catalytic cycle. 
Between the various types of organocatalysis belonging to this category, the most 
widespread and best known is without any doubt the aminocatalysis.9 
In aminocatalysis is possible to distinguish different activation modes: enamine, 
iminium ion, SOMO (Singly Occupied Molecular Orbital) and photoredox catalysis. 
Enamine catalysis10 (Scheme 1) was first introduced in 2000 by List, Barbas and 
Lerner;7 it is based on the HOMO (Highest Occupied Molecular Orbital) activation of 
carbonyl compounds with the corresponding increase of electron density at the 
reaction centre allowing their α-functionalization. The reaction can take place with a 
diverse array of electrophiles making possible reactions like aldol, Mannich and 
conjugate additions, α-oxygenation, amination, chlorination, fluorination, etc.. 
                                                     
9 Melchiorre P., Marigo M., Carlone A., Bartoli G., Angew. Chem. Int. Ed. 2008, 47, 6138-6171. 
10 Mukherjee S., Yang J. W., Hoffmann S., List B., Chem. Rev. 2007, 107, 5471-5569. 
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Scheme 1 
Meanwhile MacMillan’s group presented the concept of asymmetric iminium 
catalysis8,11 (Scheme 2). It is based on the capacity of chiral amines to work as 
enantioselective catalysts for several transformations that traditionally use Lewis acid 
catalysts. The reversible formation of iminium ions from α,β-unsaturated aldehydes or 
ketones and chiral amines might emulate the equilibrium dynamics and π-orbital 
electronics involved in Lewis acid catalysis. This LUMO (Lowest Unoccupied Molecular 
Orbital) lowering activates the intermediate toward the attack from a wide variety of 
nucleophiles to afford β-substituted carbonyl compounds or toward pericyclic 
reactions. 
 
Scheme 2 
MacMillan’s group extended the versatility of traditional enamine chemistry 
through the establishment of two novel, radical-based activation modes.  
The first one is SOMO catalysis12 (Scheme 3), based on one-electron oxidation of the 
enamine that generates a reactive radical cation with 3π-electrons. This intermediate 
can react readily with a variety of π-nucleophiles (SOMOphiles) at the α-carbon of the 
parent enamine, resulting in formal alkylation products. The alkylation in α-position of 
carbonyl compounds is not possible with simple enamine catalysis thus making SOMO 
catalysis a complementary way of α-functionalization. 
                                                     
11 Erkkilä A., Majander I., Pihko P. M., Chem. Rev. 2007, 107, 5416-5470. 
12 Beeson T. D., Mastracchio A., Hong J., Ashton K., MacMillan D. W. C., Science 2007, 316, 582-585. 
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Scheme 3 
The last activation mode is organo-photoredox catalysis13 (Scheme 4). In this case 
the reactive radical intermediate is generated in a photochemical manner and 
represents the electrophile that reacts with the enamine. Organocatalysis and 
photocatalysis are merged together to afford α-alkylated aldehydes. 
 
Scheme 4 
Recently aminocatalysis evolved to the use of primary amines14 as catalysts too and 
to the remote functionalization meeting the vinylogy principle.15 
3. Non-covalent organocatalysis 
Non-covalent organocatalysed processes rely on interactions such as hydrogen 
bonding16 or the formation of ion pairs.17 
Hydrogen bonding to an electrophile decreases its electron density (LUMO 
decreases in energy), activating it toward nucleophilic attack. This principle is 
                                                     
13 Nicewicz D. A., MacMillan D. W. C., Science 2008, 322, 77-80. 
14 Melchiorre P., Angew. Chem. Int. Ed. 2012, 51, 9748-9770. 
15 (a) Jurberga I. D., Chatterjeea I., Tannerta R., Melchiorre P., Chem. Commun. 2013, 49, 4869-4883; (b) Jianga 
H, Albrechtab Ł., Jørgensen K. A., Chem. Sci. 2013, 4, 2287-2300; (c) Bertelsen S., Jørgensen K. A., Chem. Soc. 
Rev. 2009, 38, 2178-2189. 
16 (a) Doyle A. G., Jacobsen E. N., Chem. Rev. 2007, 107, 5713-5743; (b) Taylor M. S., Jacobsen E. N., Angew. 
Chem. Int. Ed. 2006, 45, 1520-1543. 
17 (a) Brak K., Jacobsen E. N., Angew. Chem. Int. Ed. 2013, 52, 534-561; (b) Brière J., Oudeyer S., Dallab V., 
Levacher V., Chem. Soc. Rev. 2012, 41, 1696-1707. 
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employed frequently by enzymes for the acceleration of a variety of chemical 
processes. Taking example from nature also organic chemists have started to exploit 
hydrogen bonding as a mechanism for electrophile activation; in particular, chiral 
hydrogen bond donors (like for example thioureas, BINOL and TADDOL derivatives, 
etc…) have emerged as a broadly applicable class of organocatalysts for 
enantioselective synthesis. 
Most of chemical reactions proceed via charged intermediates or transition states; 
such reactions can be influenced by the counterion, especially if conducted in apolar 
organic solvents, where ion pairs are inefficiently separated by the solvent. 
The use of ion pairing in asymmetric catalysis has been realized in enantioselective 
phase-transfer catalysis (PTC), which is well-established for reactions proceeding via 
anionic intermediates.18 The underlying idea is that these intermediates are necessarily 
paired to a cation and, if this cation is chiral and a sufficient association can be 
achieved, reactions can proceed enantioselectively. The use of chiral non racemic salts, 
like ammonium or phosphonium, as effective phase-transfer catalysts has been 
intensively studied for the enantioselective carbon-carbon and carbon-heteroatom 
bond formation under mild biphasic conditions. The rational design of catalysts for 
targeted reaction is crucial because the generation of a well-defined chiral ion pair is 
necessary for electrophiles to react in a highly efficient and stereoselective manner. 
The advantages of this catalysis are its simple experimental procedures, versatility, 
mild reaction conditions, inexpensive and environmentally benign reagents and 
solvents, and the possibility of conducting large-scale preparations. 
Recently, the use of enantiomerically pure counteranions for the induction of 
asymmetry in reactions proceeding through cationic intermediates has emerged as a 
new concept, which has been termed asymmetric counteranion-directed catalysis 
(ACDC).19 This catalysis refers to the induction of enantioselectivity in a reaction by 
means of ion pairing with a chiral, enantiomerically pure anion provided by the 
catalyst. Examples of PTC and ACDC catalysts are shown in Figure 2. 
                                                     
18 Ooi T., Maruoka K., Angew. Chem. Int. Ed. 2007, 46, 4222-4266. 
19 Mahlau M., List B., Angew. Chem. Int. Ed. 2013, 52, 518-533. 
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Figure 2 
“An ion pair is defined to exist when cation and anion are close enough in space 
that the energy associated with their electrostatic attraction is larger than the thermal 
energy (rt) available to separate them. This means that the ions stay associated longer 
than the time required for Brownian motion to separate non-interacting species.”20 
Hydrogen bonds can be discussed as a special case of ion pairing between the 
dipoles of a donor bond and an acceptor atom. This shows that the borders between 
ion pairing and other interactions are not so clean-cut. 
Let’s consider for example Brønsted acid organocatalysis where BINOL-derived 
phosphoric acids are amongst the most widely used motifs.21 Regarding the activation 
of reactive electrophiles like imines, the formation of a chiral contact ion pair between 
the chiral acid and the substrate is generally assumed. In the case of carbonyl 
activation, the existence of a contact ion pair is less probable because of the low 
basicity of the oxygen atom; here a sort of equilibrium between the formation of a 
hydrogen bonding interaction and a contact ion pair complex is more likely. The pKa 
difference between the Brønsted acid catalyst and the carbonyl function determines 
which activation mode is more populated in the equilibrium of these two activated 
species (Scheme 5). 
 
Scheme 5 
                                                     
20 Anslyn E. V., Dougherty D. A., Modern Physical Organic Chemistry (2006), University Science Books, Sausalito. 
21 Rueping M., Kuenkel A., Atodiresei I., Chem. Soc. Rev. 2011, 40, 4539-4549. 
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Thioureas (this family of organocatalysts is described in details in Chapter 4) are 
widely used organocatalysts thanks to their ability to activate neutral electrophiles 
through hydrogen bonding; furthermore, these catalysts can be used also for anion-
binding catalysis (Scheme 6). In this last case is difficult to have a smooth distinction 
between hydrogen bonding and ion pair catalysis; in fact, the reaction is not 
proceeding via ion-pairing with a charged chiral catalyst, but through hydrogen 
bonding to the intermediate ion pair by a chiral neutral catalyst. 
 
Scheme 6 
In particular when a bifunctional catalyst, like Takemoto or Soós thioureas, is used 
hydrogen bonding interactions are present, but also the basic site can deprotonate one 
of the reactant thus forming an ion pair (Figure 3 ‒ enantioselective addition of 
acetylacetone to trans-β-nitrostyrene). 
 
Figure 3 
Finally, in the case of non-covalent organocatalysis the activation modes are not so 
clear-cut as for the covalent one and most of the cases are borderline involving 
somehow both hydrogen bonding and ion-pairing activation. 
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Chapter 2 
Ion-Tagged Prolines 
1. Introduction on proline catalysts 
L-Proline is perhaps the most well-known and cheap organocatalyst. Although the 
natural L-form is normally used, proline is available in both enantiomeric forms, 
providing an advantage compared to enzymatic catalysis. Proline is the only natural 
amino acid to own a secondary amine functionality, featuring an enhanced 
nucleophilicity compared to the other amino acids. Hence, proline is able to act as a 
nucleophile, in particular with carbonyl compounds or Michael acceptors, to form 
either an enamine or an iminium ion. In these reactions, the carboxylic function of the 
amino acid acts as a Brønsted acid binding the acceptor by hydrogen bonding and 
rendering the proline a bifunctional catalyst.22 
The high enantioselectivity of proline-mediated reactions can be rationalized by the 
ability of the molecule to provide highly organized transition states by an extensive 
hydrogen-bonding network. In all proline-mediated reactions, proton-transfer from 
the amine or the carboxylic group of proline to the forming alkoxide or imide is 
essential for charge stabilization and to facilitate C-C bond formation in the transition 
state.23  
Since most of the steps in the catalytic cycle of proline catalysed reactions are in 
equilibrium, the enhanced nucleophilicity of the catalyst can entail a number of 
equilibrated reactions with the electrophiles present, resulting in a low turnover 
number.  
                                                     
22 (a) Sharma K., Sunoj R. B., Angew. Chem. Int. Ed. 2010, 49, 6373-6377; (b) Schmid M. B., Zeitler K., Gschwind 
R. M., Angew. Chem. Int. Ed. 2010, 49, 4997-5003; (c) Ajitha M. J., Suresh C. H., J. Mol. Catal. A-Chem. 2011, 345, 
37-43; (d) Schmid M. B., Zeitler K., Gschwind R. M., J. Org. Chem. 2011, 76, 3005-3015. 
23 (a) Bahmanyar S., Houk K. N., Org. Lett. 2003, 5, 1249-1251; (b) Bahmanyar S., Houk K. N., Martin H. J., List 
B., J. Am. Chem. Soc. 2003, 125, 2475-2479; (c) Hoang L., Bahmanyar S., Houk K. N., List B., J. Am. Chem. Soc. 
2003, 125, 16-17; (d) Bahmanyar S., Houk K. N., J. Am. Chem. Soc. 2001, 123, 12911-12912; (e) Bahmanyar S., 
Houk K. N., J. Am. Chem. Soc. 2001, 123, 11273-11283. 
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Also the choice of the solvent is very limited for solubility reasons. Problems of 
solubility and poor turn-over number, forced people to use high reaction times and/or 
high catalyst loading. 
Synthetic drawbacks related to proline are also present. For example, in the 
dimerization or oligomerization of α-unbranched aldehydes, it is difficult to avoid 
competing pathways. Reactions with acetaldehyde or acetophenone afford generally 
low yields and selectivity in aldol reactions. 
Although proline continues to play a central role in aminocatalysis, new synthetic 
analogues and more complex oligopeptides were developed to improve proline 
catalytic performances. Over the last 12 years, an outstanding number of new catalysts 
were synthesised by modifying proline skeleton, many of these successful efforts were 
directed to increase catalyst solubility in organic solvents by incorporating lipophilic 
substituents on proline structure. Skeleton modifications were generally accomplished 
by adding supplementary groups on the proline carboxylic function or on the hydroxyl 
group of trans or cis-4-hydroxy proline.24 With similar purposes, the hydroxy group of 
4-hydroxyproline has been successfully used as a joint to bind proline to soluble 
polymers25 and solid matrices.26 
The first asymmetric organocatalysed reaction using proline as the catalyst was the 
aldol addition7 (Scheme 7). It has become the benchmark reaction to test new proline 
derivatives and demonstrate their efficiency as catalysts,24 able to provide improved 
performances. 
                                                     
24 (a) Aratake S., Itoh T., Okano T., Nagae N., Sumiya T., Shoji M., Hayashi Y., Chem. Eur. J. 2007, 13, 10246-
10256; (b) Gu L. Q., Yu M. L., Wu X. Y., Zhang Y. Z., Zhao G., Adv. Synth. Catal. 2006, 348, 2223-2228; (c) 
Giacalone F., Gruttadauria M., Agrigento P., Lo Meo P., Noto R., Eur. J. Org. Chem. 2010, 5696-5704; (d) Guizzetti 
S., Benaglia M., Pignataro L., Puglisi A., Tetrahedron: Asymmetry 2006, 17, 2754-2760; (e) Chen X. H., Luo S. W., 
Tang Z., Cun L. F., Mi A. Q., Jiang Y. Z., Gong L. Z., Chem. Eur. J. 2007, 13, 689-701; (f) Maya V., Raj M., Singh V. K., 
Org. Lett. 2007, 9, 2593-2595; (g) Cobb A. J. A., Shaw D. M., Longbottom D. A., Gold J. B., Ley S. V., Org. Biomol. 
Chem. 2005, 3 , 84-96; (h) Giacalone F., Gruttadauria M., Lo Meo P., Riela S., Noto R., Adv. Synth. Catal. 2008, 
350, 2747-2760; (i) Notz W., Tanaka F., Barbas III C. F., Acc. Chem. Res. 2004, 37, 580-591; (j) Bellis E., Kokotos 
G., Tetrahedron 2005, 61, 8669-8676; (k) Hayashi Y., Sumiya T., Takahashi J., Gotoh H., Urushima T., Shoji M., 
Angew. Chem. 2006, 118, 972-975; (l) List B., Pojarliev P., Castello C., Org. Lett. 2001, 3, 573-575; (m) Huang J., 
Zhang X., Armstrong D. W., Angew. Chem. Int. Ed. 2007, 46, 9073-9077. 
25 Benaglia M., Cinquini M., Cozzi F., Puglisi A., Celentano G., Adv. Synth. Catal. 2002, 344, 533-542. 
26 (a) Gruttadauria M., Salvo A. M. P., Giacalone F., Agrigento P., Noto R., Eur. J. Org. Chem. 2009, 5437-5444; (b) 
Gruttadauria M., Giacalone F., Noto R., Chem. Soc. Rev. 2008, 37, 1666-1688; (c) Kehat T., Portnoy M., Chem. 
Commun. 2007, 2823-2825; (d) Font D., Jimeno C., Pericas M. A., Org. Lett. 2006, 8, 4653-4655. 
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Scheme 7 
2. Electrosteric activation 
Ion tagged catalysts own an ionic-tag connected to the catalytic centre through a 
spacer (Figure 4). The cation is commonly covalently bounded to the catalytic centre 
and the anion is the counterion. 
 
Figure 4 
The presence of the counterion is of great importance to determine the solubility 
profile of  the catalyst. Because of their ionic character, ion-tagged catalysts are usually 
insoluble in non-polar organic solvents, such as hexane or diethyl ether. Conversely, 
they are usually soluble in polar organic solvents, like for example acetonitrile, 
dimethylformamide, methanol, and in halogenated solvents, like chloroform or 
dichloromethane. The solubility in water depends on the nature of the tag: 
hydrophobicity can be achieved using cations bearing long alkyl chains or using 
hydrophobic counterions, like hexafluorophosphate (PF6
-) or 
bis(trifluoromethylsulfonyl)imide (NTf2
-).  
Ammonium and phosphonium ions are the most common choice for the cation, 
while halogenated anions such as tetrafluoroborate (BF4
-), PF6
- or NTf2
- are often 
Chapter 2 
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chosen as counterions. Among the ammonium ions, imidazolium and pyridinium  are 
the most widely used, because of their  stability in many chemical transformations.  
The nature of the spacer is fundamental as well, since it must be stable in the 
reaction conditions. Moreover, the spacer length and flexibility should be properly 
designed to achieve the best catalytic performances.  
The use of an ion-tag as a catalyst recovery strategy displays several attractive 
advantages: the careful choice  of  the cation and anion structure enables fine tuning 
of the solubility, so that immobilization on the supporting phase can be optimized and 
catalyst leaching reduced. In addition, ion-tags can be employed with common organic 
solvents, water and ILs, which are commonly addressed as benign solvents from an 
environmental point of view.27 
Finally, due to the presence of a charged group, ion-tagged catalysts may display 
improved catalytic performance compared to their analogous untagged counterparts, 
when similar experimental conditions are applied.28 The ionic group can stabilize the 
transition state, lowering the activation energy of the process thus enhancing the 
reaction rate.   In fact, if the tag ion pair can approach charges that develop along the 
reaction coordinate with minimal distortion of bond angles and distances, it can lower 
the free-energy barrier by complementing charge separation in the dipolar transition 
state (Figure 5). As a consequence, the catalyst loading can be reduced compared to 
the reference homogeneous catalyst.  
                                                     
27 Huo C., Chan T. H., Chem. Soc. Rev. 2010, 39, 2977-3006. 
28 Lombardo M., Trombini C., ChemCatChem 2010, 2, 135-145. 
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Figure 5 
Since organocatalysis mechanistically mimics enzymes with small organic molecules, 
the electrostatic stabilization of a transition state by an ion tag can be considered a 
simplified version of the electrostatic activation provided in enzymatic reactions by 
protein cationic and anionic residues oriented towards the charges of a dipolar 
transition state. Moreover the presence of the ion pair also determines new steric 
interactions. Since the overall effect is the result of electrostatic and steric 
interactions, we defined it as “electrosteric stabilization” of the transition state by the 
ionic tag, or “electrosteric activation” of the catalytic process. 
Provided that interactions between the ionic group and the transition state take 
place, it is conceivable that the stereochemical outcome of the reaction might be 
affected as well. Indeed, if parallel reaction pathways leading to stereoisomeric 
products are accessible, electrosteric interactions may affect competitive transition 
states to a different extent. However, predicting the effect of the ion-tag on reactivity 
and selectivity is an extremely challenging issue, since it depends on several factors:  
the ion covalently bounded to the catalyst,  the nature of the potentially exchangeable 
counter ion, the length and flexibility of the spacer, which must ensure the best charge 
approach with minimal strain energy. In addition, also the interaction of the solvent 
with the polar transition state and the ionic group should be taken into account, 
particularly when polar and highly structured solvents, like water and ILs, are 
employed. 
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3. Electrosteric activation by using ion-tagged prolines: a combined 
experimental and computational investigation 
The rate-determining steps in catalytic cycles of proline-catalyzed aldol reactions 
have been demonstrated to correlate well with those characteristic of class I aldolases, 
which activate substrates through an iminium ion formation step, followed by 
conversion to an enamine.29 The amazing substrate-, site-, and stereo-selectivities 
characterizing enzymatic catalysis are the result of multiple bonds of the substrate to 
the active site through hydrogen bonding, hydrophobic, van der Waals, π-stacking, 
ion–ion and ion–dipole electrostatic interactions, to form the enzyme–substrate 
complex. This multiple binding is enabled by the presence of aminoacidic residues in 
the catalytic site of the enzyme that take part in the chemical reaction.30 
The aim of introducing structural modifications on the proline, exploiting the  use of 
4-hydroxyproline as starting material for the synthesis of the catalyst, is to provide 
further interactions, for example extra hydrophobic and van der Waals or new 
hydrogen-bonding opportunities, in the transition state of the rate-limiting addition of 
enamine to the acceptor aldehyde.  
The synthetic strategy of inserting an ionic group onto the proline original catalyst is 
aimed to improve its catalytic performance exploiting supplementary electrostatic 
interactions. The electrostatic stabilization of a transition state by an ion tag could be 
considered a simplified version of the electrostatic activation of enzymatic reactions, in 
which cationic and anionic residues are oriented towards the charges of a dipolar 
transition state.31 Of course, also new steric interactions have to be considered 
together with the possibility of the ion tag to affect the stereochemical outcome of the 
reaction.  
In order to study the electrosteric activation we designed a combined experimental 
and computational investigation on aldol reaction comparing the use of ion-tagged and 
tag-free prolines as catalysts (Scheme 8). This reaction was promoted, under the same 
conditions, by two diastereomeric ion-tagged prolines (trans- and cis-1) and by the 
                                                     
29 (a) Mase N., Barbas III C. F., Org. Biomol. Chem. 2010, 8, 4043-4050; (b) Barbas III C. F., Heine A., Zhong G., 
Hoffmann T., Gramatikova S., Bjçrnestedt R., List B., Anderson J., Stura E. A., Wilson I. A., Lerner R. A., Science 
1997, 278, 2085-2092. 
30 Bartlett G. J., Porter C. T., Borkakoti N., Thornton J. M., J. Mol. Biol. 2002, 324, 105-121. 
31 Warshel A., Sharma P. K., Kato M., Xiang Y., Liu H., Olsson M. H. M., Chem. Rev. 2006, 106, 3210-3235. 
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corresponding phenylacetic esters (trans- and cis-2). Catalysts 2 are isoster analogues 
of the N-methylimidazolium-tagged 1. 
 
Scheme 8 
The use of an imidazolium ion as the tag was investigated, owing to its well-known 
ability to favour supramolecular organization by electrostatic, hydrogen-bonding, 
and/or aromatic-stacking interactions. It may simulate the role of a catalytic residue in 
enzyme catalysis through the promotion of supplementary interactions between the 
reacting species in the transition state.32 
The reaction conditions for the selected benchmark reaction were identified in the 
solvent-free protocol previously developed for 1,33 in which 5 equivalents of 
cyclohexanone were used  in the presence of an almost stoichiometric amount of 
water. The role of water in organocatalyzed aldol reactions was discussed recently by 
Gruttadauria and co-workers34 and rationalized by Armstrong and Blackmond.35  
To better evaluate reactivity differences, we decided to use a low loading of the 
four catalysts cis- and trans-1 and cis- and trans-2 (2 mol%) and a moderately reactive 
aldehyde such as benzaldehyde. 
                                                     
32 Noujeim N., Leclercq L., Schmitzer A. R., Curr. Org. Chem. 2010, 14, 1500-1516. 
33 (a) Lombardo M., Easwar S., Pasi F., Trombini C., Adv. Synth. Catal. 2009, 351, 276-282; (b) Lombardo M., 
Pasi F., Easwar S., Trombini C., Synlett 2008, 2471-2474. 
34 Gruttadauria M., Giacalone F., Noto R., Adv. Synth. Catal. 2009, 351, 33-57. 
35 Zotova N., Franzke A., Armstrong A., Blackmond D. G., J. Am. Chem. Soc. 2007, 129, 15100-15101. 
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The reaction was checked in each case by taking samples at different times (after 30 
minutes and 1, 2, 3, 4, 7, 8 hours) and analyzing them by reversed-phase HPLC. 
Conversions were calculated based on the ratio of anti-3 and benzaldehyde peak 
areas, having previously determined their corresponding response factors by 
calibration curves on purified samples. The resulting analysis of the conversion during 
the reaction time is reported in Figure 6.  
 
Figure 6 
Catalyst cis-1 showed a far superior activity compared to both its tagged analogue 
trans-1 and the untagged catalysts 2. In all cases here examined, enantioselectivities 
were almost complete (ee>99%) and diastereomeric ratios were in the 90:10–95:5 
range in favor of the anti-3 compound. 
To understand in detail the origin of the catalytic effect and stereochemical 
outcome, in collaboration with the group of Prof. Bottoni and Dr. Miscione, we 
performed a computational DFT investigation on the reaction reported in Scheme 8 
that focused on the rate-limiting step, i.e. the addition of the resulting enamine to the 
acceptor aldehyde. To this purpose, we considered two different model systems: one 
to emulate the ion-tagged systems (trans-1 and cis-1) and the other for untagged ones 
(trans-2 and cis-2). 
In addition to electrostatic and steric interactions, given the nature of the ion tag 
and the counterion, other interactions played important roles in stabilizing the 
transition state of the rate-limiting step, in particular hydrogen bonds and π-stacking 
interactions. We analyzed in detail the interactions responsible for the superior activity 
0,0
10,0
20,0
30,0
40,0
50,0
60,0
70,0
0 1 2 3 4 5 6 7 8 9
C
o
n
ve
rs
io
n
 (
%
) 
Time (h) 
Catalyst trans-2
Catalyst cis-2
Catalyst trans-1
Catalyst cis-1
Chapter 2 
19 
 
of cis-1 compared to a simple proline, where the above-mentioned interactions were 
lacking, and compared to its isomer trans-1 and the species cis-2 and trans-2 with 
similar steric biases but lacking a neat charge on the substituent at C-4 of the proline 
ring system. 
The strong stabilization of the transition state with cis-1 is the result of a complex 
interplay of hydrogen bonds, in particular those involving the NTf2
- oxygen atoms and 
the hydrogen atoms of the ionic tag. In catalyst cis-1 stabilizing π-stacking interactions 
between the NTf2
- π oxygen lone pairs and the π electron cloud of benzaldehyde 
phenyl ring exist. A further stabilization owes to π-stacking interactions between the 
imidazole ring and the proline carboxyl group. Furthermore, during its migration the 
hydrogen atom interacts with the proline nitrogen, so this nitrogen atom can be 
thought to behave like a proton shuttle that “assists” the hydrogen atom transfer from 
the carboxyl group of the proline to the oxygen of the benzaldehyde, by stabilizing the 
corresponding transition state. These interactions are possible only if the system can 
achieve a suitable folded arrangement of the ionic tag, the spacer, and proline carboxyl 
group; this is due to the presence of the ion tag in cis geometry respect to the carboxyl 
function of the proline (Figure 7). 
 
Figure 7 
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The poorer catalytic effect observed experimentally for catalysts 2 is due to the 
absence in the tag-free case of the folded enamine structure providing an activation 
barrier which is larger than the one computed for the ion-tagged system along the cis 
pathway. The folded enamine structure brings the ionic tag and the proline carboxyl 
group closer and activates stabilizing π-stacking interactions between the two 
fragments. If a benzene ring replaces the imidazolium group these interactions 
disappear and are replaced by others between the C-H bond of the aldehyde phenyl 
ring and the π electron cloud of the benzene ring bonded to proline, which are active 
only in the preliminary complex and not in the following transition state. Hence, the 
resulting barrier for the untagged system increases significantly. 
This study computationally proved the superior reactivity of cis-1 and, in all the 
cases examined, was in agreement with the stereochemical outcome of the reaction. 
4. A new robust and efficient ion-tagged proline catalyst 
A limit in the use of catalysts cis- and trans-1 is given by the sensitivity of the ester 
spacer to hydrolysis. For example, when they were exposed to hydrogenation 
conditions in methanol, transesterification reactions occured and methanol had to be 
replaced with ethyl acetate to avoid this problem. Moreover, chromatographic 
purification was not possible and time-consuming crystallizations at low temperature 
were needed. A reduced storability (not more than 1 month under argon) was also a 
consequence of the sensitivity to hydrolysis of the ester linkage. The synthesis of a 
new, highly efficient cis-ion-tagged catalyst (8), possessing a robust amide linkage 
between the imidazolium tag and the proline ring, was developed (Scheme 9). 
 
Scheme 9 
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When exposed to hydrogenolytic conditions (H2 1 atm, Pd/C) in methanol, 
compounds 7a-c were deprotected to 8a-c with no trace of side reactions, confirming 
the stability towards hydrolysis of 8. Moreover all precursors 6 and 7a-c could be 
efficiently purified by chromatography on neutral alumina using CH2Cl2/MeOH 
mixtures (98:2 to 95:5 v/v). Furthermore, catalyst 8a has been stored unaltered for six 
months without any precautions. 
To compare the counterions and establish which was the best one, we tested 
catalysts 8a-c in the aldol reaction between 4-chlorobenzadehyde and cyclohexanone  
in two different protocols: protocol A in ionic liquids and protocol B in solvent-free 
conditions in the presence of water (Table 1). In protocol B we used 5 equivalents of 
cyclohexanone which acted also as the reaction medium homogenizing the reaction 
mixture. This is an essential task when solid catalysts (like 8) and solid acceptors are 
employed. 
Table 1: Aldol reaction between 4-chlorobenzadehyde and cyclohexanone in two different protocols.
a 
 
Entry Protocol Catalyst Solvent Time (h) Yieldb (%) anti/sync ee (%)d 
1 A 8a [bmim][NTf2] 18 63 83:17 89 
2 A 8b [bmim][BF4] 18 37 71:29 73 
3 A 8c [bmim][PF6] 23 47 75:25 83 
4 B 8a - 18 91 97:3 99 
5 B 8b - 18 0 - - 
6 B 8c - 23 60 92:8 95 
a
 Reaction conditions protocol A: 4-chlorobenzaldehyde (0.5 mmol), cyclohexanone (1 mmol), catalyst (5 
mol%), solvent (0.3 mL), rt; Reaction conditions protocol B: 4-chlorobenzaldehyde (0.5 mmol), 
cyclohexanone (2.5 mmol), catalyst (5 mol%), H2O (0.6 mmol), rt. 
b
 Yield of the isolated product after 
flash-chromatography. 
c
 Determined by 
1
H NMR of the crude mixture. 
d
 Determined for the anti product 
by CSP-HPLC. 
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The ionic liquid used in protocol A was a 1-butyl-3-methylimidazolium ([bmim]) salt, 
carrying the same counterion of the selected catalyst. The 8a/[bmim][NTf2] system 
revealed to be the best catalyst/solvent pair compared to the analogous with PF6 and 
BF4 (entries 1-3). 
Catalyst 8a was superior to 8c also in protocol B (entries 4, 6), while hydrophilic 
catalyst 8b failed to react (entry 5) for its lack of solubility in the reaction mixture. 
The results reported in entries 1-6 prompted us to choose catalyst 8a for the aldol 
reaction. 
In the aldol reaction catalysed by prolines 4-nitrobenzaldehyde shows a higher 
reactivity with respect to 4-chlorobenzaldehyde, the former providing a quantitative 
yield with a lower catalyst loading in a shorter reaction time.  
To verify the effect of the amount of water on the reaction we performed some 
experiments both employing protocol A and B (Table 2).  
Table 2: Study of the effect of water amount.
a 
 
Entry H2O Time (h) Yield (%)
b anti/sync ee (%)d 
1 - 8 20 70:30 98 
2 1.2 3 99 98:2 >99 
3 12 8 5 97:3 97 
4 excesse 24 45 96:4 58 
5f - 18 91 75:25 85 
6f 1.2 16 99 94:6 94 
a
 Reaction conditions protocol B: 4-nitrobenzaldehyde (0.5 mmol), 
cyclohexanone (2.5 mmol), catalyst (2 mol%), H2O, rt; 
b
 Yield of the isolated 
product after flash-chromatography. 
c
 Determined by 
1
H NMR of the crude 
mixture. 
d
 Determined for the anti product by CSP-HPLC. 
e
 Under emulsion 
conditions using 0.8 mL of water, under efficient stirring. 
f
 Protocol A: 4-
nitrobenzaldehyde (0.5 mmol), cyclohexanone (1 mmol), [bmim][NTf2] (0.3 
mL), catalyst (2 mol%), H2O, rt. 
In protocol B without the addition of water (entry 1) a 20% yield was obtained after 
8 hours using 8a (2 mol%), accompanied by a poor diastereocontrol, while under the 
same conditions in the presence of 1.2 equivalents of water, yield, diastereo- and 
enantio-selectivity reached remarkable values (entry 2). Increasing the amount of 
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water (entry 3) or adopting an “on water” protocol (entry 4), that means generating in 
water microdroplets of the concentrated organic phase consisting of the reactants and 
the catalyst, had deleterious effects on conversions and enantiocontrol. 
The presence of a nearly stoichiometric amount of water was also significant when 
protocol A was emplyed, not only in terms of an improved yield, but particularly in 
terms of a remarkable increase of the anti-diastereoselectivity and enantiocontrol 
(entries 5, 6). 
The efficiency of catalyst 8a was also compared to the one of the ester analogues 
cis-1 and trans-1, using protocol B and benzaldehyde (Table 3). We chose 
benzaldehyde because it is less reactive than 4-nitrobenzaldehyde and allowed a more 
accurate evaluation of reactivity diversity. 
Table 3: Comparison between catalytic performances of catalysts 8a and cis-/trans-1 in aldol reaction.
a 
 
Entry Catalyst Time (h) Yield (%)b anti/sync ee (%)d 
1 8a 24 82 95:5 >99 
2 trans-1 24 66 93:7 94 
3 cis-1 19 86 92:8 >99 
a
 Reaction conditions: benzaldehyde (0.5 mmol), cyclohexanone (2.5 mmol), 
catalyst (5 mol%), H2O (0.6 mmol), rt. 
b
 Yield of the isolated product after 
flash-chromatography. 
c
 Determined by 
1
H NMR of the crude mixture. 
d
 
Determined for the anti product by CSP-HPLC. 
After 19-24 hours we analysed the crude reaction mixtures for conversions, dr and 
ee. Catalyst cis-8a gave results similar to cis-1, providing a slightly lower yield, an 
higher dr and the same ee. In short, reactivity of 8a locates very close to that of cis-1, 
while trans-1 was less active and stereoselective under these conditions. 
To study in detail the activity of these catalysts, we checked the conversion of the 
reaction during the time obtaining the curves shown in Figure 8. 
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Figure 8 
Finally, we explored the scope of the reaction, testing a few different combinations 
of donor and acceptor carbonyl compounds that included reactive and known poorly 
reactive substrates (Table 4). 
Table 4: Scope of the aldol reaction using catalyst 8a.
a 
 
Entry Aldehyde Ketone 
8a 
(mol%) 
Time 
(h) 
Yield 
(%)b 
anti/sync 
ee 
(%)d 
1 C6F5CHO cyclohexanone 5 1.5 99 >99:1 99 
2 C6F5CHO cyclohexanone 2 24 88 98:2 >99 
3 C6F5CHO cyclohexanone 0.1 24 64 98:2 97 
4e 4-MeOC6H4CHO cyclohexanone 5 60 35 80:20 98 
5f n-pentanal cyclohexanone 10 50 80 >99:1 >99 
6f isobutanal cyclohexanone 10 60 75 >99:1 >99 
7 isobutanal hydroxyacetone 10 24 60 88:12 99 
8 4-NO2C6H4CHO cyclopentanone 1 3 97 83:17 97 
9 4-NO2C6H4 CHO cycloheptanone 5 60 35 56:44 54 
10 ethyl glyoxalate cyclopentanone 5 4 99 70:30 77 
11 4-NO2C6H4CHO acetone 2 24 91 - 35 
12 4-NO2C6H4CHO hydroxyacetone 10 23 70 70:30 84 
a
 Reaction conditions: aldehyde (0.5 mmol), ketone (2.5 mmol), catalyst, H2O (0.6 mmol), rt. 
b
 Yield of the isolated 
product after flash-chromatography. 
c
 Determined by 
1
H NMR and HPLC of the crude mixture. 
d
 Determined for the 
anti product by CSP-HPLC. 
e
 After 8 hours the conversion was 35%. 
f
 H2O (0.65 mmol). 
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The reaction using pentafluorobenzaldehyde showed an high rate allowing us to 
decrease the catalyst loading up to 0.1 mol% (entries 1-3). While the result obtained 
with 4-methoxybenzaldehyde (entry 4), confirmed that electron-poor aldehydes are 
the preferred acceptors in the aldol reaction catalysed by proline derivatives. 
Aliphatic aldehydes, even though less reactive, ensured an excellent anti-
diastereoselection and a complete enantioselectivity when reacted with either 
cyclohexanone or hydroxy-acetone (entries 5-7). 
Among cycloalkanones, cyclopentanone is the most reactive one (entries 8, 10) 
allowing us to reduce to 1 mol% the catalyst loading in the reaction with 4-
nitrobenzaldehyde with an almost complete conversion in only 3 hours. 
In terms of stereochemical control, cycloheptanone and acetone (entries 9 and 11) 
didn’t afford good results.  
As far as diastereoselection is concerned, hydroxyacetone presented its known 
irregular behaviour. Indeed 8a provided anti-adducts (entries 7 and 12) with proline 
itself,36 as well as other proline derivatives like C2-symmetrical bis-prolinamides
37 and 
small N-terminal prolyl peptides.38 Conversely, a variety of structurally different chiral 
amines are known to favour the formation of syn adducts using hydroxyacetone as 
donor in aldol reactions.39 
5. Ion-tagged proline catalyst recycling by using a silica gel bound 
multilayered ionic liquid phase 
A major challenge over the last two decades has been to heterogenize intrinsically 
homogeneous catalysts by anchoring them on a solid support to allow a simple 
catalyst–product separation and the recycling of structurally complex and expensive 
species. However, a decrease in catalyst activity is generally associated with 
immobilization: the presence of mass transfer limitations, heat transfer, possible lack 
of homogeneity of the solid support, and other factors make the reaction kinetics very 
                                                     
36 Notz W., List B., J. Am. Chem. Soc. 2000, 122, 7386-7387. 
37 Samanta S., Liu J., Dodda R., Zhao C., Org. Lett. 2005, 7, 5321-5323. 
38 Tang Z., Yang Z., Cun L., Gong L., Mi A., Jiang Y., Org. Lett. 2004, 6, 2285-2287. 
39 (a) Kumar A., Singh S., Kumar V., Chimni S. S., Org. Biomol. Chem. 2011, 9, 2731-2742; (b) Czarnecki P., 
Plutecka A., Gawroński J., Kacprzak K., Green Chem. 2011, 13, 1280-1287; (c) Demuynck A. L. W., Peng L., de 
Clippel F., Vanderleyden J., Jacobs P. A., Selsa B. F., Adv. Synth. Catal. 2011, 353, 725-732; (d) Paradowska J., 
Rogozińska M., Mlynarski J., Tetrahedron Lett. 2009, 50, 1639-1641; (e). Xu X., Wang Y., Gong L., Org. Lett. 
2007, 9, 4247-4249. 
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complex.40 Moreover, the weakening of the catalyst support bonds ascribable to the 
stress of repeated cycles results in the unavoidable leaching of the catalyst.41 
Liquid–liquid homogeneous conditions are an attractive alternative strategy for 
combining the advantages of homogeneous and heterogeneous catalysis. These 
include superlative activities and selectivities under mild homogeneous conditions, 
simple operations for product-catalyst separation with minimum cross-contamination, 
and catalyst recycling.42 A biphasic system consisting of two mutually insoluble 
solvents is proposed. In one phase the reaction takes place and the solvent entraps the 
catalyst; in the other phase, reactants and products can be removed from the catalyst-
containing solvent. High degrees of dispersion can be obtained through emulsification 
and the two phases can be separated by conventional means. The main limitation of 
this approach is the identification of a solvent pair that enables a perfectly 
complementary catalyst and product partition, which is essential to limit final cross-
contamination and ensure efficient catalyst recycling. The advantages are those typical 
of homogeneous processes, namely faster reactions with higher selectivities, followed 
by a simple physical operation such as decantation, after which the catalyst-containing 
phase can be reused directly. Several technical solutions have been proposed for 
liquid–liquid biphasic homogeneous catalysis.43 Water, fluorous phases, supercritical 
fluids, and ionic liquids are possible components of the liquid–liquid biphase. 
The main problem with these reactions is to magnify the affinity of the catalyst for 
one of the two phases. Generally, this is done by the installation of a solvent-
recognition element on the structure of the catalyst. For example, if an organic solvent 
is used in combination with an immiscible ionic liquid, an ion pair can be installed onto 
the catalyst frame to magnify its solubility into the ionic liquid. One ionic group is 
covalently bonded to the catalyst, whereas the exchangeable counterion allows the 
control of the catalyst solubility profile.44 Literature on the physico-chemical properties 
                                                     
40 (a) Buchmeiser M. R., Chem. Rev. 2009, 109, 303-321; (b) Fraile J. M., García J. I., Mayoral J. A., Chem. Rev. 
2009, 109, 360-417; (c) Trindade A. F., Gois P. M. P., Afonso C. A. M., Chem. Rev. 2009, 109, 418-514; (d) Lu J., 
Toy P. H., Chem. Rev. 2009, 109, 815-838; (e) Shylesh S., Schünemann V., Thiel W. R., Angew. Chem. Int. Ed. 
2010, 49, 3428-3459; (f) Collis E. A. C., Horváth I. T., Catal. Sci. Technol. 2011, 1, 912-919. 
41 Mayr M., Mayr B., Buchmeiser M. R., Angew. Chem. Int. Ed. 2001, 40, 3839-3842. 
42 Lombardo M., Quintavalla A., Chiarucci M., Trombini C., Synlett 2010, 1746-1765. 
43 (a) Keim W., Chem. Ing. Tech. 1984, 56, 850-853; (b) Keim W., Green Chem. 2003, 5, 105-111. 
44 (a) Chiappe C., Pieraccini D., J. Phys. Org. Chem. 2005, 18, 275-297; (b) Weingärtner H., Angew. Chem. Int. Ed. 
2008, 47, 654-670; (c) Marciniak A., Int. J. Mol. Sci. 2010, 11, 1973-1990; (d) Werner S., Haumann M., 
Wasserscheid P., Annu. Rev. Chem. Biomol. Eng. 2010, 1, 203-230. 
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of ionic liquids has found that the use of Tf2N
- brings a dramatic decrease of solubility 
in water. 
A major limitation in traditional biphasic ionic liquid-organic solvent systems is the 
need for relatively large amounts of ionic liquids, which are expensive solvents. In 
addition, the high viscosity of ionic liquids compared to classical organic solvents can 
induce mass transfer limitations. Both these drawbacks can be circumvented by 
immobilizing a thin film of ionic liquid onto a high surface area support.45 Supported 
ionic liquid phases (SILP) on porous support material have been prepared by covalent 
bonding of the ionic liquid to the support or by physisorption, which exploits van der 
Waals and dipole forces. IL immobilization by covalent bonding is much more robust 
and the ionic liquid film is not easily leached from the support to polar solvents. 
Covalently bonded aromatic ionic liquids offered the best results in terms of 
reaction performance and recyclability. Notably, the SILP preparation strategy affects 
the nature of the liquid microlayer. Indeed, the SILP is present as a monolayer if there 
is covalent bonding to the surface, whereas it appears as a multilayer if the IL is 
adsorbed.  
To overcome this problem, Gruttadauria et al. proposed an innovative approach to 
prepare a multilayered covalently bonded supported ionic liquids phases (mlc-SILP). 
This method is shown in Scheme 10, representing the mlc-SILP we used to recycle our 
catalyst 8a. 
 
Scheme 10 
This approach offers all of the desirable features of a click reaction: high efficiency, 
simplicity, no side products, relatively fast reaction, and high yield. The reaction led to 
                                                     
45 (a) Mehnert C. P., Chem. Eur. J. 2005, 11, 50-56; (b) Shi F., Zhang Q., Li D., Deng Y., Chem. Eur. J. 2005, 11, 
5279-5288; (c) Riisager A., Fhermann R., Haumann M., Wasserscheid P., Top. Catal. 2006, 40, 91-102; (d) 
Sievers C., Jimenez O., Müller T. E., Steuernagel S., Lercher J. A., J. Am. Chem. Soc. 2006, 128, 13990-13991; (e) 
Burguete M. I., Galindo F., Garcia-Verdugo E., Karbass N., Luis S. V., Chem. Commun. 2007, 3086-3088; (f) 
Mikkola J. T., Virtanen P. P., Kordás K., Karhu H., Salmi T. O., Appl. Catal. A 2007, 328, 68-76. 
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the near-quantitative anchoring of the employed salt on the surface of the support to 
yield the mlc-SILP material 11. As the bisvinylimidazolium salt 10 is added in excess 
relative to the amount of thiol groups (3.62 molsalt/molthiol group), the formation of 
imidazolium cross-linked networks through self-addition reaction of the double bonds 
is expected. The multilayered ionic liquid phase is generated through this 
oligomerization. The obtained material showed a surface area of 128 m2/g and a 
cumulative pore volume of 0.2 cm3/g. Anion metathesis was accomplished to give the 
supported ionic liquid material 12 with the correct counterion. 
The repeated use of a catalyst recycling may give decomposition of it over time, so 
we chose the cis-ion-tagged proline 8a catalyst since it’s characterized by a robust 
amide linkage between the catalytically active site and the imidazolium tag, with 
bistriflimide as the counterion. We speculated that the structural similarity between 
the imidazolium motif and the counterion between mlc-SILP 12 and catalyst 8a should 
optimize their mutual interactions, and, hence, the solubility of 8a in 12. The 
absorption of 8a was accomplished simply by stirring the mlc-SILP 12 with a methanol 
solution of 8a and then removing the solvent under reduced pressure. The white 
powder obtained (13) was prepared with a catalyst loading of 13.8 wt% (Scheme 11). 
 
Scheme 11 
Given the excellent catalytic performances of 8a in aldol addition, we decided to 
recycle it exploiting its adsobtion on 12 and chosing 4-nitrobenzaldehyde and 
cyclohexanone as the partners of aldol reaction. 
Catalyst 8a was tested in aldol reaction using the previously described protocol B. 
For the development of the recycling procedure we used the same reaction conditions 
replacing pure 8a with the catalytic material 13. 
The process is split into a reaction and a separation stage (Figure 9). In the reaction 
stage, 13 was first soaked with cyclohexanone and water. The aldehyde was added and 
the mixture stirred at room temperature for the required time, monitoring the 
reaction by TLC.  
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Figure 9 
In this first stage, the composite material 13 acts as a catalyst reservoir that delivers 
8a to the cyclohexanone phase, allowing a homogeneous reaction to take place. To 
better understand the partitioning of catalyst 8a between the mlc-SILP/cyclohexanone 
system in this stage, we stirred material 13 (193 mg, 0.05 mmol of 8a) with 
cyclohexanone (5 mmol) for 2.5 hours at room temperature. The mixture was then 
filtered, and the cyclohexanone was evaporated at reduced pressure. Waiting the 
crude residue and recording a 1H NMR we found out that approximately 50% of 
catalyst 8a was extracted by cyclohexanone from mlc-SILP 12. In the separation stage, 
cyclohexanone is removed under vacuum and the resulting solid residue is extracted 
with anhydrous diethylether, which is a catalyst antisolvent. Here, 12 acts as a catalyst 
sponge redissolving 8a in its multilayer film and restoring 13, which can be reused. 
Product extraction is extremely selective: no trace of catalyst was detected in the 
product containing phase.  
The first experiments reported in Table 5 were aimed to determine the 
performances achievable with different catalyst loadings. 
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Table 5: Aldol reaction with different catalyst loadings.
a
 
 
Entry 13 (mg) 8a (%) Time (h) Yield (%)b anti/sync ee (%)d 
1 386 10 2 99 94:6 >99 
2 193 5 2 96 96:4 >99 
3 77 2 3 99 96:4 99 
4 39 1 17 99 97:3 99 
5 19 0.5 19 97 98:2 99 
a
 Reaction conditions: 4-nitrobenzaldehyde (1 mmol), cyclohexanone (5 mmol), 13, H2O 
(1.2 mmol), rt. 
b
 Yield of the isolated product. 
c
 Determined by 
1
H NMR and HPLC of the 
crude mixture. 
d
 Determined for the anti product by CSP-HPLC. 
The reaction proceeded slower decreasing the catalyst loading, but it still worked 
well using only 0.5 mol% of catalyst. The reactivity recorded using this procedure were 
the same as in homogeneous conditions. 
We performed the recycling procedure of 13 in the model reaction first using 1 
mol% of catalyst (Table 6). 
Table 6: Recycle of 13 with 1 mol% of catalyst.
a
 
 
Cycle 13 (mg) 8a (%) Time (h) Yield (%)b anti/sync ee (%)d 
1 39 1 17 99 97:3 99 
2 39 1 17 99 98:2 99 
3 39 1 17 99 95:5 98 
4 39 1 17 97 95:5 97 
5 39 1 17 89 94:6 96 
6 39 1 17 40 93:7 92 
a
 Reaction conditions: 4-nitrobenzaldehyde (1 mmol), cyclohexanone (5 mmol), 13 (39 
mg, 8a 1 mol%), H2O (1.2 mmol), rt. 
b
 Yield of the isolated product. 
c
 Determined by 
1
H 
NMR and HPLC of the crude mixture. 
d
 Determined for the anti product by CSP-HPLC. 
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In these conditions we were able to recycle the catalyst, recording a consistent drop 
of yield only in the 6th cycle.  
We performed the same recycling experiment lowering to 0.5 mol% the amount of 
8a (Table 7). 
Table 7: Recycle of 13 with 0.5 mol% of catalyst.
a
 
 
Cycle 13 (mg) 8a (%) Time (h) Yield (%)b anti/sync ee (%)d 
1 19 0.5 19 97 98:2 99 
2 19 0.5 19 87 96:4 97 
3 19 0.5 19 34 96:4 95 
a
 Reaction conditions: 4-nitrobenzaldehyde (1 mmol), cyclohexanone (5 mmol), 13 (19 
mg, 8a 0.5 mol%), H2O (1.2 mmol), rt. 
b
 Yield of the isolated product. 
c
 Determined by 
1
H 
NMR and HPLC of the crude mixture. 
d
 Determined for the anti product by CSP-HPLC 
In this case we were able to reuse the catalytic material 13 two times, recording in 
the 3rd cycle a lowering of the yield. Given the relatively small amount of 13 used, we 
probably lost some catalytic material during the extaction of the product. 
The cumulative productivity Pn and the averaged enantiomeric excess [EE]n after n 
cycles, which were performed by using the same molar amount of limiting aldehyde 
and the same excess of ketone in each run, were calculated by using Equations (1) and 
(2), as reported by Mandoli et al.,46 in which yi is the yield and eei the enantiomeric 
excess of the ith recycle. 
   
               
               
 
∑      
 
   
   
             (1) 
      
∑          
 
   
∑      
 
   
                               (2) 
The calculated values for the recycling experiments in Table 6 that used 1 mol% of 
the catalyst were remarkably high, with P6=523 and [EE]6=97% and, to the best of our 
knowledge, unprecedented in this benchmark organocatalysed aldol reaction. 
Although use of 0.5 mol% of the catalyst resulted in a low yield and stereoselectivity in 
                                                     
46 Cancogni D., Mandoli A., Jumde R. P., Pini D., Eur. J. Org. Chem. 2012, 1336-1345. 
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the third recycle (Table 7), the productivity and the averaged enantiomeric excess 
remained high, with P3=436 and [EE]3=98%. 
Experiments collected in Table 8 were aimed to demonstrate the robustness of the 
mlc-SILP 12. By using methanol, we washed out 8a from the sample of 13 used for the 
previously reported experiments. Freed solid material 12 was then reloaded with fresh 
8a at a loading of 13.8 wt%, to give a regenerated sample of 13. This material was then 
subjected to a longer series of recycling experiments using 5 mol% of catalyst, to allow 
the use of less-reactive aldehydes. 
Table 8: Recycle of 13 with 5 mol% of catalyst changing the aldehyde.
a 
 
 
  
a 
Reaction conditions: aldehyde (1 mmol), cyclohexanone (5 mmol), 13 (193 mg, 
8a 5 mol%), H2O (1.2 mmol), rt. 
b
 Yield of the isolated product. 
c
 Determined by 
1
H NMR and HPLC of the crude mixture. 
d
 Determined for the anti product by 
CSP-HPLC. 
Besides the robustness of mlc-SILP 12, which can be regenerated and reused for 15 
cycles, these experiments showed the efficiency of the reaction workup, which 
Cycle Aldehyde Time (h) Yield (%)b anti/sync ee (%)d 
1 4-NO2C6H4CHO 2.5 99 94:6 98% 
2 4-NO2C6H4CHO 2.5 99 93:7 97% 
3 4-NO2C6H4CHO 2.5 99 94:6 97% 
4 4-NO2C6H4CHO 2.5 99 93:7 94% 
5 4-NO2C6H4CHO 2.5 99 93:7 96% 
6 4-ClC6H4CHO 18 92 97:3 99% 
7 4-BrC6H4CHO 18 95 97:3 97% 
8 4-CNC6H4CHO 7 99 93:7 92% 
9 4-NO2C6H4CHO 2.5 98 93:7 94% 
10 Ph-CHO 24 94 90:10 96% 
11 4-NO2C6H4CHO 2.5 95 93:7 92% 
12 4-NO2C6H4CHO 2.5 89 92:8 89% 
13 4-NO2C6H4CHO 2.5 90 90:10 87% 
14 4-NO2C6H4CHO 2.5 81 90:10 88% 
15 4-NO2C6H4CHO 2.5 81 89:11 91% 
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ensured a very effective catalyst recovery and a quantitative product extraction, as 
confirmed by the absence of cross-contamination when different aldehydes were used 
in consecutive runs. 
In the long term, iminium intermediates may irreversibly decompose, namely by 
decarboxylation or oxidation, or they may epimerize with a detrimental effect on 
maximum turnover numbers or in preservation of stereocontrol with longer reaction 
times. This may explain the worsening of catalytic performances after 15 cycles, 
together with a loss of catalytic material. 
The role of material 12 in this process revealed to be very important. Indeed, we 
studied amorphous and C18 silica gels as surrogates of the mlc-SILP in recycling 
experiments, but they didn’t provide the same good resuts. Both silicas were charged 
with catalyst 8a at a loading of 13.8 wt% with a methanol solution, followed by 
stripping of the solvent under vacuum. Applying the same conditions of entry 2 (Table 
5) to amorphous silica gel loaded with 8a, the aldol product was recovered in 36% yield 
after 2.5 hours with an anti/syn diastereomeric ratio of 80:20. The use of C18 silica gel 
charged with 8a was more effective. The first reaction in the same conditions delivered 
the product in 87% yield after 2.5 hours, with an anti/syn diastereomeric ratio of 97:3 
and ee (anti)>99%. However, in the second run, the yield decreased to 73 %, indicating 
that the aliphatic monolayer of this reverse silica gel phase was much less efficient 
than 12 as a catalyst trap. Conversely to these disappointing resuts, the use of 12 do 
not show any significant change in catalytic activity and stereocontrol as previously 
reported, thus demonstrating its importance and efficiency as a catalyst trap. A series 
of reactions were set up also simply using catalyst 8a in the absence of mlc-SILP and 
adopting exactly the same experimental protocol reported in entry 3 in Table 5. The 
results obtained with 4-nitrobenzaldehyde are reported in Table 9.  
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Table 9: Recycle of 8a with 2 mol% of catalyst loading 
a
 
 
Cycle Yield (%)b anti/sync ee (%)d 
1 99 98:2 >99 
2 99 98:2 >99 
3 76 98:2 >99 
a
 Reaction conditions: aldehyde (1 mmol), 
cyclohexanone (5 mmol), 8a (2 mol%), H2O (1.2 
mmol), 16 h, rt; 
b
 Yield of the isolated product. 
c
 
Determined by 
1
H NMR and HPLC of the crude 
mixture. 
d
 Determined for the anti product by CSP-
HPLC 
In the absence of mlc-SILP 12, a drastic drop in the yield of the aldol product was 
observed already in the third cycle, although high values of diastereo- and 
enantioselectivity were retained. This was probably due to the loss of catalyst during 
the work up and confirmed the importance of 12 in the catalyst recycling.  
6. Conclusions 
We studied the concept of electrosteric activation through a combined 
compuational and experimental investigation analysing the aldol reaction catalysed by 
ion-tagged and ion-free prolines. From these studies we found out that the better 
performances of the ion-tagged proline cis-1 were due to the presence of the ionic tag 
on the same side of the carboxyl group of the proline, thus enabling stabilizing 
hydrogen bonding and π-stacking interactions in the transition state. 
Knowing now the importance of the cis geometry for the ion-tagged proline 
catalysts and the instability of catalyst cis-1 toward hydrolytic conditions, we 
developed a new ion-tagged catalyst with a robust amide linkage between the 
imidazolium ion and the proline ring (8a). This made the catalyst highly stable to acidic, 
hydrolytic and reductive conditions. Catalyst 8a was prepared in a 4-step sequence in 
50% total yield from 4 on a multigram scale and, using the reaction protocol “in the 
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presence of water”, 8a can be considered equal to cis-1 in terms of overall 
performance. 
The robustness of 8a and its catalytic performances prompted us to develop a 
recycling procedure of this catalyst in the aldol reaction. We used material mlc-SILP 12, 
produced for the first time in Gruttadauria’s lab, to charge it with catalyst 8a; the 
resulting composite material 13 played a dual role, depending on the nature of the 
second solvent it was in combination with. For the reaction we used a molar excess of 
cyclohexanone as partner solvent, while for the work-up we used anhydrous diethyl 
ether as antisolvent. In these conditions the recycle of the catalytic material 13 was 
very efficient and productivities above 400–500 were achieved easily using 0.5 or 1 
mol% of catalyst 8a. The robustness of 12, 8a and the overall reaction procedure was 
confirmed further by the 15 cycle for which a regenerated 13 was employed, without 
any detectable cross-contamination when different aldehydes were used in 
consecutive runs.  
7. Experimental section 
General Information:  
Chemicals and solvents were purchased from commercial suppliers or purified by 
standard techniques. For thin-layer chromatography (TLC), silica gel plates (Merck 60 
F254) were used and compounds were visualized by irradiation with UV light and/or by 
treatment with a soluition KMnO4 followed by heating. Flash chromatography was 
performed using silica gel Merck grade Type 9385 230-400, 60 Å purchased from 
Sigma-Aldrich. 1H and 13C NMR spectra were recorded on a Varian Mercury 400 and on 
a Varian Gemini 200. Chemical shifts are reported in d relative to tetramethylsilane 
(TMS); the coupling constants J are given in Hz. Chiral HPLC studies were carried out on 
a Hewlett-Packard series 1090 instrument. 
Preparation of catalysts Catalysts cis-1, trans-1 and trans-2 were prepared according 
to literatureprocedures.33,47 
cis-2: A solution of diethyl azodicarboxylate (DEAD) (0.824 mL, 1.8 mmol) in anhydrous 
THF (3 mL) was added dropwise to an icecold solution of triphenylphosphine (0.432 g, 
1.65 mmol), phenylacetic acid (0.215 g, 1.58 mmol), and N-benzyloxycarbonyl-(2S,4R)-
                                                     
47 Giacalone F., Gruttadauria M., Lo Meo P., Riela S., Noto R., Adv. Synth. Catal. 2008, 350, 2747-2760. 
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4-hydroxyproline benzyl ester (0.533 g, 1.5 mmol) in anhydrous THF (8 mL). The 
reaction mixture was allowed to warm to room temperature and stirred for a further 
24 h. Concentration of the reaction mixture in vacuo followed by silica-gel column 
chromatographic purification of the residue (cyclohexane/ethyl acetate 90:10) 
furnished quantitatively the cis-phenyl acetate. *α+D
20 =-39.9° (c=0.90, CHCl3); 
1H NMR 
(400 MHz, CDCl3, two conformational isomers 1:1) δ=2.31–2.38 (m, 2 H), 2.39–2.53 (m, 
2 H), 3.29–3.41 (m, 4H), 3.58–3.53 (m, 2H), 3.76–3.87 (m, 2H), 4.55 (dd, J=2.1, 9.4 Hz, 1 
H), 4.64 (dd, J=2.2, 9.3 Hz, 1 H), 5.00–5.08 (m, 2 H), 5.08–5.13 (m, 2 H), 5.13–5.18 (m, 
2H), 5.18–5.23 (m, 2H), 5.23–5.30 (m, 2 H), 7.15–7.21 (m, 4H), 7.22–7.41 ppm (m, 
26H); 13C NMR (100 MHz, CDCl3, two conformational isomers 1:1) δ=171.3, 171.0, 
170.97, 170.87, 154.7, 154.3, 136.4, 135.7, 135.6, 133.4, 129.29, 129.27, 128.65, 
128.56, 128.51, 128.45, 128.4, 128.21, 128.16, 128.10, 128.04, 127.96, 127.2, 73.2, 
72.2, 67.4, 67.3, 67.0, 66.9, 58.1, 57.8, 52.7, 52.4, 40.9, 36.4, 35.4 ppm; elemental 
analysis calcd for C28H27NO6 (473.52): C, 71.02; H, 5.75; N, 2.96; found: C, 71.69; H, 
5.69; N, 2.95. 
The intermediate cis-phenyl acetate was dissolved in MeOH, 10% palladium on 
charcoal (0.160 g, 0.15 mmol) was added and the mixture stirred under hydrogen at 
room temperature under atmospheric pressure for 24 h. It was then filtered on Celite 
by washing 5 times with CH3CN (5 mL). The organic phase was evaporated in vacuo to 
provide the catalyst cis-2 as a solid (0.334 g, 89% yield). [α]D
20 = -16.4° (c=0.61, CH3OH); 
1H NMR (400 MHz, CD3OD) δ=2.43–2.54 (m, 1H), 2.54–2.64 (m, 1 H), 3.43–3.53 (m, 1 
H), 3.53–3.61 (m, 1 H), 3.64 (s, 2 H), 4.13 (dd, J=3.6, 9.9 Hz, 1 H), 5.27–5.33 (m, 2H), 
7.21–7.36 ppm (m, 5H); 13C NMR (100 MHz, CD3OD) δ= 172.59, 172.55, 135.1, 130.5, 
129.5, 128.1, 74.2, 65.6, 52.0, 41.5, 36.1 ppm; elemental analysis calcd for C13H15NO4 
(249.26): C, 62.64; H, 6.07; N, 5.62; found: C, 62.32; H, 6.15; N, 5.57. 
Aldol reaction 
General procedure: Cyclohexanone (0.52 mL, 5 mmol), water (0.022 mL, 1.2 mmol) and 
benzaldehyde (0.102 mL, 1 mmol) were added to the appropriate catalyst (0.02 mmol) 
and the mixture was stirred at room temperature. The reaction mixture was quenched 
by charging it directly onto a silica-gel column and the pure aldol was obtained upon 
elution with cyclohexane/ethyl acetate 8:2. The ee values were determined by using 
chiral HPLC with a CHIRALCEL OJ column (n-hexane/2-propanol 90:10, flow rate=0.5 
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mL/min, λ=220 nm, T=40°C); tR anti (major)=15.57 min, tR syn=16.50 min, tR anti=18.81 
min, tR syn (major)=21.03 min.
 33a 
Determination of reaction conversion 
A sample of the reaction mixture (10 μL) was diluted in 3 mL of CH3CN and 5 μL of the 
resulting solution was injected on HPLC. The retention time for benzaldehyde was 13.6 
min and the retention time for the product anti-3 was 22.9 min. HPLC conditions: 
Eclipse XDB-C18 5 μm column (4.6 mm x 150 mm) with CH3CN/H2O 30:70 as the mobile 
phase and detection at 210 nm, flow rate=0.5 mL/min, T=30°C.  
Computational Methods 
All computations reported in the paper were performed with the Gaussian09 series of 
programs. As aryl groups and extended π systems were present on both the aldehyde 
and the catalyst, a functional capable of describing interactions involving π system was 
required. It is well-known that this class of interaction (in which medium-range 
correlation effects are dominant) are not described properly by most popular DFT 
functionals, for example, B3LYP. However, during the last decade new functionals have 
been recommended that are capable of treating medium-range correlation effects. 
Within this family of innovative functionals, we have chosen that recently proposed by 
Truhlar and Zhao, known as M06-2X, which has been demonstrated to provide a good 
estimate of π–π interactions and reaction energetics. All atoms have been described by 
the DZVP basis, which is a local spin densityoptimized basis set of double-zeta quality 
including polarization functions. The geometries of the various critical points on the 
potential surface were optimized fully by using the gradient method available in 
Gaussian 09 and harmonic vibrational frequencies were computed to evaluate the 
nature of all critical points. 
 
All reagents were purified by distillation or recrystallization before use. (2S,4S)-N-
benzyloxycarbonyl-4-aminoproline benzyl ester was prepared following a known 
literature procedure: M. Tamaki, G. Han, V. J. Hruby, J. Org. Chem. 2001, 66, 1038-
1042. 
N-Benzyloxycarbonyl-(2S,4S)-4-(2-chloroacetamido)-proline Benzyl Ester (5) 
2-Chloroacetyl chloride (0.83 mL, 10.2 mmol) was added dropwise at -20°C to a 
solution of (2S,4S)-N-benzyloxycarbonyl-4-aminoproline benzyl ester 4 (3.0 g. 8.47 
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mmol) and triethylamine (1.53 mL, 11.0 mmol) in anhydrous CH2Cl2 (15 mL). The 
reaction mixture was stirred at this temperature for 3 h after which it was diluted with 
CH2Cl2 (5 mL) and washed with water (10 mL). The organic phase was dried over 
Na2SO4. Concentration of the solvent under vacuum gave an oily residue which was 
purified by flash chromatography on silica gel (cyclohexane/ethyl acetate 1:1). The 
product was obtained as a colourless oil; yield: 3.14 g (7.29 mmol, 86%); *α]D
20: -26.38° 
(c=0.95, CHCl3). 
1H NMR (400 MHz, CDCl3, two conformational isomers): δ=1.92–2.07 
(m, 1H), 2.43–2.58 (m, 1H), 3.54–3.81 (m, 2H), 3.82–4.03 (m, 2H), 4.41–4.56 (ddd, 
J=29.7, 9.8, 2.0 Hz, 1H), 4.61–4.76 (m, 1H), 4.93–5.40 (m, 4H), 7.20–7.42 (m, 10H), 
7.42–7.58 (m, 1H); 13C NMR (100 MHz, CDCl3, two conformational isomers): δ=35.47, 
36.51, 42.3, 48.0, 49.0, 53.0, 53.4, 57.7, 58.1, 67.41, 67.43, 67.46, 67.49, 127.8, 1, 
128.07, 128.14, 128.25, 128.34, 128.42, 128.44, 128.47, 128.55, 128.57, 134.9, 135.1, 
136.0, 153.9, 154.5, 165.5, 173.5; anal. calcd. for C22H23ClN2O5 (430.88): C 61.32, H 
5.38, N 6.50; found: C 61.22, H 5.34, N 6.53. 
Imidazolium Chloride Salt (6) 
1-Methylimidazole (0.64 mL, 8.1 mmol) was added to a solution of the 
chloroacetamide 5 (2.9 g, 6.7 mmol) in anhydrous CH3CN (12 mL) and the reaction 
mixture was heated at 50°C for 16 h. The organic solvent was removed under reduced 
pressure, the crude hygroscopic product was washed with anhydrous ether (5 x 5 mL) 
and vacuum dried. The title imidazolium chloride salt was obtained as a low-melting 
solid after purification by flash-chromatography on neutral alumina, eluting with 
CH2Cl2/methanol 95:5; yield: 2.24 g (4.4 mmol, 65%); [α]D
20: -17.48° (c=0.28, CHCl3). 
1H 
NMR (400 MHz, CDCl3, two conformational isomers): δ=2.04–2.25 (m, 1H), 2.46–2.59 
(m, 1H), 3.28–3.47 (m, 1H), 3.77–3.95 (m, 4H), 4.15–4.45 (m, 2H), 4.81–5.33 (m, 6H), 
7.03–7.11 (m, 1H), 7.11–7.33 (m, 10H), 7.39–7.49 (m, 1H), 9.39–9.51 (t, J=7.1 Hz, 1H), 
9.74 (s, 1H); 13C NMR (100 MHz, CDCl3, two conformational isomers): δ=34.4, 35.3, 
36.5, 48.3, 49.0, 50.7, 51.1, 51.5, 57.7, 58.0, 67.10, 67.13, 67.2, 122.20, 122.23, 123.61, 
123.66, 127.73, 127.99, 128.04, 128.08, 128.14, 128.20, 128.26, 128.39, 128.48, 
128.52, 135.4, 135.6, 136.2, 136.3, 138.2, 153.9, 154.6, 164.9, 171.9, 172.1; anal. calcd. 
for C26H29ClN4O5 (512.99): C 60.87, H 5.70, N 10.92; found: C 61.41, H 5.72, N 10.33. 
Imidazolium Bis(trifluoromethanesulfonyl)imide Salt (7a) 
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Lithium bis(trifluoromethanesulfonyl)imide (1.23 g, 4.3 mmol) was added to a solution 
of the imidazolium chloride salt 6 (2.0 g, 3.6 mmol) in CH2Cl2 (15 mL). The reaction 
mixture was stirred overnight at room temperature, then it was diluted with CH2Cl2 (30 
mL) and washed with water (5 x 10 mL). The organic layer was dried (Na2SO4) and 
concentred under vacuum to give the title compound 7a as a gummy solid; yield: 2.72 
g (3.9 mmol, 92%); [α]D
20: -11.98° (c=0.70, CHCl3). 
1H NMR (400 MHz, CDCl3, two 
conformational isomers): δ=1.97–2.15 (m, 1H), 2.45–2.64 (m, 1H), 3.38–3.52 (m, 1H), 
3.75–3.87 (m, 4H), 4.30–4.51 (m, 2H), 4.71–4.90 (m, 2H), 4.92–5.24 (m, 4H), 7.13–7.39 
(m, 12H), 7.70–7.86 (d, J=7.0 Hz, 1H), 8.62–8.74 (s, 1H); 13C NMR (100 MHz, CDCl3, two 
conformational isomers): δ=33.2, 34.5, 35.5, 36.2, 48.2, 49.0, 50.8, 51.4, 51.7, 57.6, 
58.0, 67.18, 67.24, 114.9, 118.0, 121.2, 122.8, 123.7, 124.4, 127.6, 127.7, 127.8, 127.9, 
128.05, 128.07, 128.11, 128.2, 128.37, 128.40, 128.44, 128.5, 135.1, 135.3, 136.0, 
136.1, 137.1, 154.0, 154.6, 163.8, 172.7, 172.8; anal. calcd. for C28H29F6N5O9S2 
(757.68): C 44.39, H 3.86, N 9.24; found: C 44.24, H 3.83, N 9.35. 
Imidazolium Tetrafluoroborate Salt (7b) 
Following the same procedure reported for 7a, 6 (0.14 g, 0.28 mmol) was reacted with 
sodium tetrafluoroborate (0.037 g, 0.34 mmol) to afford 7b as a solid; yield: 0.15 g 
(0.27 mmol, 95%); *α]D
20: -9.48 (c=0.58, CHCl3). 
1H NMR (200 MHz, CDCl3): δ=1.87–2.16 
(m, 1H), 2.31–2.64 (m, 1H), 3.18–3.50 (m, 1H), 3.57–3.91 (m, 4H), 4.19–4.47 (m, 2H), 
4.63–4.88 (s, 2H), 4.89–5.24 (m, 4H), 7.08–7.57 (m, 12H), 8.45–8.64 (s, 1H); 13C NMR 
(100 MHz, CDCl3): δ= 34.5, 35.4, 36.2, 48.1, 49.0, 50.8, 51.4, 51.6, 53.4, 57.7, 58.0, 
67.2, 67.3, 122.78, 122.81, 123.6, 127.7, 127.91, 127.95, 128.00, 128.05, 128.11, 128.2, 
128.3, 128.4, 128.5, 128.6, 135.3, 135.5, 136.2, 136.3, 137.4, 154.0, 154.6, 164.5, 
164.5, 172.5, 172.7; anal. calcd. for C26H29BF4N4O5 (564.34): C 55.34, H 5.18, N 9.93; 
found: C 55.43, H 5.21, N 9.97. 
Imidazolium Hexafluorophosphate Salt (7c) 
Following the same procedure reported for 7a, 6 (0.11 g, 0.21 mmol) was reacted with 
potassium hexafluorophosphate (0.047 g, 0.26 mmol) to afford 7c as a solid; yield: 0.13 
g (0.20 mmol, 97%); *α]D
20: -7.78 (c=0.67, CHCl3). 
1H NMR (400 MHz, CDCl3, two 
conformational isomers): δ=2.00–2.15 (m, 1H), 2.40–2.60 (m, 1H), 3.40–3.58 (m, 1H), 
3.72–3.85 (m, 4H), 4.30–4.54 (m, 2H), 4.59–4.78 (m, 2H), 4.96–5.26 (m, 4H), 7.03–7.15 
(m, 2H), 7.17–7.41 (m, 10H), 8.39–8.47 (s, 1H); 13C NMR (100 MHz, CDCl3): δ= 29.7, 
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33.9, 34.6, 35.4, 36.1, 48.1, 49.0, 50.8, 51.6, 51.8, 57.7, 58.0, 67.26, 67.30, 122.9, 
123.6, 127.7, 127.9, 128.0, 128.07, 128.11, 128.24, 128.26, 128.38, 128.44, 128.5, 
128.6, 135.3, 135.5, 136.2, 136.3, 137.1, 154.0, 154.7, 164.1, 172.8, 172.9; anal. calcd. 
for C26H29F6N4O5P (622.50): C 50.17, H 4.70, N 9.00; found: C 55.33, H 4.72, N, 8.94. 
Imidazolium Bis(trifluoromethylsulfonyl)imide Catalyst (8a) 
10% palladium on charcoal (0.19 g, 0.18 mmol) was added to a solution of 7a (2.7 g, 
3.6 mmol) in anhydrous CH3OH (10 mL). The mixture was stirred under hydrogen at 
atmospheric pressure overnight. The reaction mixture was then filtered and washed 
with CH3OH (10 mL). The organic layer was evaporated under vacuum to provide the 
catalyst as a solid; yield: 1.83 g (3.56 mmol, 96%); [α]D
20: -20.48 (c=0.80, CH3OH). 
1H 
NMR (400 MHz, CD3OD): δ=2.24 (dt, J= 13.7, 6.0 Hz, 1H), 2.63 (ddd, J=13.8, 9.2, 7.0 Hz, 
1H), 3.41 (dd, J=12.2, 4.9 Hz, 1H), 3.54 (dd, J=12.2, 6.7 Hz, 1H), 4.09 (dd, J=9.1, 6.5 Hz, 
1H), 4.44 (ddd, J=11.8, 6.7, 5.1 Hz, 1H), 4.99 (s, 2H), 7.52–7.65 (m, 2H), 8.90 (s, 1H); 1H 
NMR (400 MHz, DMSO-d6): δ=1.84–1.96 (dt, J=13.2, 7.4 Hz, 1H), 2.36–2.53 (m, 1H), 
3.00–3.10 (dd, J=11.6, 6.5 Hz, 1H), 3.26–3.36 (dd, J=11.6, 7.0 Hz, 1H), 3.78–3.86 (t, 
J=8.3 Hz, 1H), 3.86–3.93 (s, 3H), 4.22–4.35 (m, 1H), 4.90–5.02 (d, J= 3.5 Hz, 2 H), 7.65–
7.72 (m, 2H), 8.88–8.95 (d, J=6.5 Hz, 1H), 9.04–9.11 (s, 1H); 13C NMR (100 MHz, DMSO-
d6): δ= 34.0, 35.8, 48.6, 48.9, 50.5, 59.4, 123.0, 123.7, 137.7, 165.0, 169.6; anal. calcd. 
for C13H17F6N5O7S2 (533.42): C 29.27, H 3.21, N 13.13; found: C 29.04, H 3.19, N, 13.14. 
Imidazolium Tetrafluoroborate Catalyst (8b) 
Following the same procedure reported for 8a, 8b was obtained as a solid; yield: 96%; 
*α]D
20: -15.38 (c=0.36, H2O). 
1H NMR (400 MHz, D2O): δ=2.18–2.34 (dt, J=14.2, 6.2 Hz, 
1H), 2.65–2.83 (ddd, J=14.1, 9.1, 7.0 Hz, 1H), 3.43–3.55 (dd, J=12.5, 5.0 Hz, 1H), 3.62–
3.73 (dd, J=12.6, 6.9 Hz, 1H), 3.90–4.02 (s, 3 H), 4.21–4.36 (dd, J=9.1, 6.8 Hz, 1H), 4.44–
4.62 (ddd, J=12.2, 6.8, 5.4 Hz, 1H), 5.00–5.13 (s, 2H), 7.47–7.51 (s, 1H), 7.51–7.54 (s, 
1H), 8.74–8.86 (s, 1H); 13C NMR (50 MHz, CD3OD): δ=35.2, 36.6, 50.6, 50.7, 51.8, 61.4, 
124.5, 125.0, 139.3, 167.2, 173.3; anal. calcd. For C11H17BF4N4O3 (340.08): C 38.85, H 
5.04, N 16.47; found: C 38.64, H 5.07, N 16.49. 
Imidazolium Hexafluorophosphate Catalyst (8c) 
Following the same procedure reported for 8a, 8c was obtained as a solid; yield: 68%; 
[α]D
20: -14.28 (c=0.32, H2O). 
1H NMR (400 MHz, CD3OD): δ=2.17–2.29 (dt, J=13.0, 6.0 
Hz, 1H), 2.56–2.73 (m, 1H), 3.37–3.46 (dd, J=12.2, 4.9 Hz, 1H), 3.47–3.58 (dd, J=12.2, 
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6.7 Hz, 1H), 3.91–4.01 (s, 3H), 4.01–4.13 (dd, J=9.0, 6.7 Hz, 1H), 4.36–4.52 (m, 1H), 
4.93–5.11 (s, 2H), 7.52–7.62 (s, 2H), 8.79–8.94 (s, 1H); 13C NMR (100 MHz, CD3OD): 
δ=35.4, 36.5, 50.75, 50.77, 51.8, 61.6, 124.4, 125.0, 138.5, 167.1, 173.6; anal. calcd. for 
C11H17F6N4O3P (398.24): C 33.18, H 4.30, N 14.07; found: C 33.14, H 4.33, N 14.02.  
Typical Procedure using Protocol A (Table 1, Entry 14) 
Cyclohexanone (0.10 mL, 1 mmol) was added to a solution of catalyst 8a (5.3 mg, 0.01 
mmol) in [bmim] [NTf2] (0.3 mL) and the mixture was allowed to stir for 10 min at 
room temperature. 4-Nitrobenzaldehyde (0.075 g, 0.5 mmol) was then added and the 
reaction mixture was stirred at room temperature for 18 h. The product was extracted 
from ionic liquid with diethyl ether (8 x 2 mL). The combined organic phases were 
dried (Na2SO4) and evaporated to dryness. The pure aldol product was obtained by 
flash-chromatography on silica gel eluting with cyclohexane/ethyl acetate (7:3); yield: 
0.113 g (0.46 mmol, 91%). The ee was determined by chiral HPLC (CHIRALPAK AD 
column, n-hexane/2-propanol=85:15, flow rate: 0.8 mL/min, λ=254 nm): tR syn=11.1 
min, tR syn=13.6 min, tR anti (minor)=14.6 min, tR anti (major)=18.8 min. 
Typical Procedure using Protocol B (Table 2, Entry 7) 
Cyclopentanone (0.22 mL, 2.5 mmol) and water (0.011 mL, 0.6 mmol) were added to 
the catalyst 8a (2.7 mg, 0.005 mmol) and the mixture was allowed to stir for 10 min at 
room temperature. 4-Nitrobenzaldehyde (0.076 g, 0.5 mmol) was then added and the 
reaction mixture was stirred at room temperature for 3 h. The reaction mixture was 
quenched by addition of CH2Cl2 (1.0 mL) and saturated aqueous NH4Cl solution (0.5 
mL). The aqueous layer was extracted with CH2Cl2 (3 x 5 mL) and the combined organic 
phases were dried (Na2SO4) and evaporated to dryness. The pure aldol was obtained 
by flash-chromatography on silica gel upon eluting with cyclohexane/ethyl acetate 
mixtures. The ee was determined by chiral HPLC (CHIRALPAK OF column, n-hexane/2-
propanol=80:20, flow rate: 1.0 mL/min, λ=254 nm): tR syn=11.3 min, tR syn=14.9 min, tR 
anti (major)=22.3 min, tR anti (minor)=26.1 min. 
2-hydroxy(4-nitrophenyl)methyl)cyclohexanone:33a Daicel Chiralpak AD column, n-
hexane/2-propanol = 85:15, flow rate: 0.8 mL/min, λ = 214 nm, tR (syn, major) = 16.09 
min, tR (syn, minor) = 17.31 min, tR (anti, minor) = 18.08 min, tR (anti, major) = 22.66 
min. 
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2-hydroxy(pentafluorophenyl)methyl)cyclohexanone:33a Daicel Chiralcel OJ column, 
n-hexane/2-propanol = 99:1, flow rate: 0.7 mL/min, λ = 210 nm, tR (anti, major) = 12.42 
min, tR (anti, minor) = 15.40 min, tR (syn) = 28.76 min, tR (syn) = 30.30 min. 
2-hydroxy(4-chlorophenyl)methyl)cyclohexanone:33a Daicel Chiralcel OJ column, n-
hexane/2-propanol = 93:7, flow rate: 0.5 mL/min, λ = 210 nm, tR (anti, major) = 17.82 
min, tR (syn) = 18.90 min, tR (anti, minor) = 20.37 min, tR (syn) = 23.99 min. 
2-hydroxy(4-methoxyphenyl)methyl)cyclohexanone:33a Daicel Chiralcel OD column, n-
hexane/2-propanol = 95:05, flow rate: 1.0 mL/min, λ = 214 nm, tR (syn) = 9.92 min, tR 
(syn) = 10.12 min, tR (anti, major) = 11.97 min, tR (anti, minor) = 14.70 min. 
4-hydroxy-4-(4-nitrophenyl)butan-2-one:33a Daicel Chiralcel OJ column, n-hexane/2-
propanol = 90:10, flow rate:1.0 mL/min, λ = 214 nm, tR (major) = 24.27 min, tR (minor) 
= 27.16 min. 
2-(hydroxy(4-nitrophenyl)methyl)cycloheptanone:33a Daicel Chiralcel OJ column, n-
hexane/2-propanol = 95:05, flow rate: 1.0 mL/min, λ = 214 nm, tR (syn, minor) = 24.04 
min, tR (syn, major) = 28.74 min, tR (anti, major) = 31.04 min, tR (anti, minor) = 32.84 
min. 
2-(hydroxy(4-nitrophenyl)methyl)cyclopentanone:33a Daicel Chiralcel OF column, n-
hexane/2-propanol = 80:20, flow rate: 1.0 mL/min, λ = 214 nm, tR (syn) = 11.25 min, tR 
(syn) = 14.90 min, tR (anti, major) = 22.31 min, tR (anti, minor) = 26.07 min. 
2-(1-hydroxy-2-methylpropyl)cyclohexanone:33b Daicel Chiralcel OJ column, n-
hexane/2-propanol = 99:01, flow rate: 0.4 mL/min, λ = 214 nm, tR (anti, major) = 12.49 
min, tR (anti, minor) = 13.61 min. 
2-(1-hydroxypentyl)cyclohexanone: Daicel Chiralcel OJ column, n-hexane/2-propanol 
= 95:05 for 20 min, then 90:10, 85:15 and 80:20 in 5 min intervals, flow rate: 0.5 
mL/min, λ = 214 nm, tR (anti, major) = 7.95 min, tR (anti, minor) = 10.10 min. 
Ethyl 2-hydroxy-2-(2-oxocyclopentyl)acetate:48 Daicel Chiralpak AD column, n-
hexane/2-propanol = 98:02, flow: 0.7 mL/min, λ = 214 nm, tR (syn) = 36.65 min, tR (syn) 
= 45.89 min, tR (anti, minor) = 56.37 min, tR (anti, major) = 58.40 min. 
3,4-dihydroxy-4-(4-nitrophenyl)butan-2-one:39c Daicel Chiralpak AD column, n-
hexane/2-propanol = 80:20, flow rate: 0.9 mL/min, λ = 210 nm, tR (syn) = 8.28 min, tR 
(syn) = 9.02 min, tR (anti, major) = 10.50 min, tR (anti, minor) = 12.81 min. 
                                                     
48 Tsuboi S., Nishiyama E., Furutani H., Utaka M., Takeda A., J. Org. Chem. 1987, 52, 1359-1362. 
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3,4-dihydroxy-5-methylhexan-2-one:39e Daicel Chiralpak AS-H column, n-hexane/2-
propanol = 85:15, flow rate: 0.5 mL/min, λ = 214 nm, tR (anti, major) = 11.75 min, tR 
(anti, minor) = 13.82 min, tR (syn) = 13.82 min, tR (syn) = 18.60 min. 
 
Synthesis of bis-vinylimidazolium salt 10:  
A solution of 1,3-dibromopropane (0.01 mol) and 1-vinylimidazole (0.021 mol) in 
toluene (10 mL) was heated at reflux for 24 h in an oil bath at 90°C with magnetic 
stirring. After cooling at room temperature, the mixture was filtered and washed 
several times with diethyl ether and the resulting solid was dried at 40°C to give a 
white solid. Yield: 83%; 1H NMR (300 MHz, CD3OD): δ=2.67–262 (m, 2H), 4.51–4.46 (m, 
4H), 5.48 (dd, J=8.7, 2.7 Hz, 2H), 5.98 (dd, J=15.6,2.7 Hz, 2H), 7.31 (dd, J= 15.6, 8.7 Hz, 
2H), 7.89 (d, J=1.8 Hz, 2H), 8.07 (d, J=1.8 Hz, 2H), 9.51 ppm (s, 2H); 13C NMR (CD3OD): 
δ=31.1, 47.9, 110.2, 120.9, 124.4, 129.8 ppm; elemental analysis calcd (%) for 
C13H18Br2N4 (390.12): C 40.0, H 4.5, Br 41.4, N 14.3; found: C 40.0, H 4.7, Br 41.5, N 
14.4. 
Synthesis of mlc-SILP materials 11 and 12:  
The mercaptopropylmodified silica 9 (1.2 mmol/g), the bis-vinylimidazolium salt 10 
(3.62 eq.), AIBN (60 mg), and ethanol (130 mM) were placed in a three-necked, round-
bottom flask. The suspension was degassed by bubbling argon for 10 min and the 
reaction mixture was magnetically stirred under argon. The flask was heated to 78°C to 
favour the dissolution of the bis-vinylimidazolium salt and the mixture was stirred for 
20 h. After cooling to room temperature, the solid was filtered and washed with hot 
methanol and diethyl ether and then dried at 40°C overnight. Material 11 (1.00 g) was 
suspended in water (20 mL) and LiNTf2 (1.4 g, 1.5 eq.) was added. The mixture was 
stirred for 48 h, then filtered and washed with water, methanol, and diethyl ether and 
dried at 40°C overnight to provide 12. 
Asymmetric aldol reaction, typical procedure (Table 3, run 1): Cyclohexanone (0.516 
mL, 5 mmol, 5 eq.) and water (0.022 mL, 1.2 mmol, 1.2 eq.) were added to 13 (193 mg, 
13.8 wt% 8a, 0.05 mmol, 5 mol%) in a centrifuge tube and the heterogeneous mixture 
was magnetically stirred until a semi-transparent gel was obtained (5–10 min). p-
Nitrobenzaldehyde (0.151 g, 1 mmol) was then added and the mixture stirred at room 
temperature for 2.5 h, during which the conversion was monitored by TLC. After the 
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reaction was complete, cyclohexanone was removed under reduced pressure (≈0.1 
mmHg, 1 h) and 2 mL of anhydrous diethyl ether were added. The two phases were 
separated by using a centrifuge (2000 rpm, 1 min), and diethyl ether was removed and 
collected. Extractions were repeated 4–6 times until TLC evidenced the complete 
disappearance of product and unreacted reagents, if present. The combined organic 
phases were evaporated at reduced pressure and the residue was purified by silica gel 
chromatography with a cyclohexane/ethyl acetate (7:3) eluent. ee was determined by 
chiral HPLC using a Chiralpak AD column (n-hexane/2-propanol= 85:15, flow rate=0.8 
mL/min, λ =230 nm); tR (syn)=13.5 min, tR (syn)=16.8 min, tR (anti, minor)=18.0 min, tR 
(anti, major)=23.4 min. The catalytically active material 13 was dried under vacuum 
(≈10 mmHg, 1 h, rt), then charged with the reactants and water using the same 
reaction and workup conditions described previously. 
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Chapter 3 
A New Family of Bicyclic Diarylprolinol 
Silyl Ethers as Organocatalysts 
1. Introduction 
A long-standing goal in the development of new catalytic systems is the discovery of 
general catalysts, able to promote a large number of enantioselective reactions, via 
multiple activation modes, with good substrate tolerance and high stereoselectivity. 
Relevant examples are the amino acid proline 1 and MacMillan’s imidazolidinones 2 
(Figure 10), which have often been described as fairly general and efficient amine-
based catalysts.  
 
Figure 10 
Enamine catalysis using 1 has been applied to both intermolecular and 
intramolecular nucleophilic addition reactions with a variety of electrophiles.49 In these 
processes the configuration of the final adducts is generally controlled by a hydrogen-
bond interaction between the acidic proton of proline and the incoming electrophile. 
Thus, this interaction, whilst activating the electrophile, guides its approach from the 
upper face of the enamine. A similar pattern is generally followed by catalysts bearing 
a hydrogen-bond donor at the α position of the pyrrolidine nitrogen.49d,e 
                                                     
49 (a) List B., Tetrahedron 2002, 58, 5573-5590; (b) List B., Acc. Chem. Res. 2004, 37, 548-557; (c) List B., Chem. 
Commun. 2006, 819-824; (d) Marigo M., Jørgensen K. A., Chem. Commun. 2006, 2001-2011; (e) Guillena G., 
Ramón D. J., Tetrahedron: Asymmetry 2006, 17, 1465-1492. 
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MacMillan's imidazolidinone-based catalysts are even more general,50 but although 
applicable to a variety of reactions, a fine-tuning of the substituents is often required 
to reach the desired selectivities. 
Recently, other pyrrolidine derivatives and diarylprolinol have emerged as 
potentially general organocatalysts. Although (S)-2,2-diphenylprolinol may promote 
reactions with a good level of stereocontrol, the processes are characterized by low 
catalyst turnover. This fact has been mainly ascribed to the formation of the relatively 
stable and unreactive hemiaminal species, which removes a significant amount of the 
catalyst from the catalytic cycle. To avoid the hemiaminal formation, trimethylsilyl 
(TMS) ethers 3 have been developed (Figure 11). 
 
Figure 11 
The α,α-L-diaryl prolinol silyl ethers 3a and 3b, originally developed by Hayashi’s51 
and Jørgensen’s52 groups, can be considered the most important and employed ones, 
since they are able to promote several functionalizations of carbonyl compounds with 
excellent stereocontrol.53 Moreover, the absolute configuration of the newly formed 
stereogenic centres is predictable on the basis of the steric shielding exerted by the O-
protecting group on one face of the conformationally preferred enamine or iminium 
ion formed during the process. Hence the electrophile approach takes place at the 
lower face of the enamine, thus affording products of opposite configuration 
compared to those obtained with L-proline as catalyst.  
Based on the diarylprolinol silyl ether system, several studies on enamine-mediated 
transformations of saturated carbonyl compounds were able to provide the 
introduction of different functionalities into the α-position in a highly stereoselective 
manner. This activation mode was later extended to α,β-unsaturated aldehydes, which 
after condensation with the aminocatalyst generate a dienamine species able to give 
                                                     
50 Lelais G., MacMillan D. W. C., Aldrichimica Acta 2006, 39, 79-87. 
51 Hayashi Y., Gotoh H., Hayashi T., Shoji M., Angew. Chem. Int. Ed. 2005, 44, 4212-4215. 
52 Marigo M., Wabnitz T. C., Fielenbach D., Jørgensen K. A., Angew. Chem. Int. Ed. 2005, 44, 794-797. 
53 (a) Jensen K. L., Dickmeiss G., Jiang H., Albrecht Ł., Jørgensen K. A., Acc. Chem. Res. 2012, 45, 248-264; (b) 
Palomo C., Mielgo A., Angew. Chem. Int. Ed. 2006, 45, 7876-7880; (c) Palomo C., Mielgo A., Chem. Asian J. 2008, 
3, 922-948; (d) Meninno S., Lattanzi A., Chem. Commun. 2013, 49, 3821-3832. 
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stereoselective Diels-Alder reactions and provide an effective functionalization of the 
γ-position. Recently, this activation principle was further developed to include 2,4-
dienals, which form trienamine intermediates upon condensation with the 
aminocatalyst, which effectively react with carbon-centered dienophiles. Because of 
the concerted nature of the reaction and the efficient catalyst shielding of the β-
position, the stereoinduction is achieved at the remote ε-position of the original 
aldehyde. 
Complementary to the enamine-mediated activations, α,β-unsaturated aldehydes 
can also be efficiently functionalized by applying the diarylprolinol silyl ether systems 
in the conjugate addition through iminium ion mediated processes. In such reactions, 
the aminocatalyst not only effectively shields one of the enantiotopic faces of the enal, 
but it also ensures excellent chemoselectivity, affording only 1,4-adducts. Several 
different carbon and heteroatom nucleophiles can be added in a highly stereoselective 
fashion.  
The ability of these catalysts to participate in various enamine and iminium ion 
mediated processes also makes them ideal for the sequential addition of nucleophiles 
and electrophiles in a cascade manner.  
Due to the ease of their preparation, the wide versatility of their applications and 
the almost invariable high stereochemical efficiency, Jørgensen-Hayashi’s diarylprolinol 
silyl ethers certainly play a central role when iminium/enamine-based reactivity is 
considered. 
2. Synthesis and applications of conformationally constrained bicyclic 
diarylprolinol silyl ethers as organocatalysts 
We rationally designed a new family of bicyclic diarylprolinol silyl ethers 8a–d 
characterised by a 2,4-dioxa-3-sila-7-azabicyclo[4.2.1]nonane scaffold, which were 
easily obtained in good yields from commercially available N-Cbz-trans-4-L-
hydroxyproline 4 in a four synthetic steps (Scheme 12). 
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Scheme 12 
Catalysts 8a–d are bench-stable solids that can be stored for long time at room 
temperature in a simple vial, without noticeable decomposition, whereas commercially 
purchased catalysts 3 may contain up to 10–15% of their deprotected analogues. 
Zeitler and Gschwind quantitatively assessed the entity of the desilylation reaction of 
3. They recorded different 1H NMR spectra of 3 in the presence of PhCOOH as additive 
(100 mol%, 50 mM) in DMSO-d6 at different times.54 They found out that, when 
catalyst 3a was subjected to these experimental conditions, 50% of the desilylated 
compound was observed after only about 45 minutes and an almost complete (nearly 
90%) desilylation reaction occurred within 5 hours. Conversely, in the same conditions 
we did not observe any trace of the desilylated product deriving from 8a, even after 
more than 48 hours, as shown in the 1H NMR spectra reported in Figure 12. 
                                                     
54 Haindl M. H., Schmid M. B., Zeitler K., Gschwind R. M., RSC Advances 2012, 2, 5941-5943. 
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Figure 12 
The bicyclic structure of these catalysts prevent the free rotation around the 
exocylic C(2)-C(1’) bond, therefore directing an aromatic ring, and not the O-protected 
group as in the case of catalysts 3, towards one face of the reacting intermediate. The 
effect of the substituents on the aromantic ring responsible of shielding one face of 
the reacting intermediate has already been studied by Mayr and Gilmour for 
MacMillan catalysts.55 They demonstated that the rational modulation of this 
substitution pattern can improve the catalytic performances. Hence, also in our case it 
is possible in principle to fine tune the efficiency and the selectivity of these catalysts 
by changing nature, number and position of the substituents on the aromatic rings. 
This bridge between the C-2 and C-4 carbon atoms blocks also the ring puckering of 
the pyrrolidine, forcing the ring in the “down”56 envelope conformation and thus 
exposing the less hindered convex bottom face to the attack of the reaction partner. 
The B3LYP/6-31G(d) optimised geometry for the cinnamoylidene imminium adduct of 
catalyst 8d is reported in Figure 13. 
                                                     
55 Holland M. C., Paul S., Schweizer W. B., Bergander K., Mück-Lichtenfeld C., Lakhdar S., Mayr H., Gilmour R., 
Angew. Chem. Int. Ed. 2013, 52, 7967-7971. 
56 Schmid M. B., Zeitler K., Gschwind R. M., Chem. Sci. 2011, 2, 1793-1803. 
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Figure 13 
We tested our new catalysts in different transformations in which Jørgensen–
Hayashi catalysts 3 were reported to afford excellent results.  
We first examined the cyclopropanation reaction of 4-nitrocynnamaldehyde with 
dimethyl bromomalonate in the conditions recently reported by Wang and co-
workers.57 This reaction allowes the formation of two new C-C bonds, two new 
stereogenic centers and one quaternary carbon atom. 
The results obtained with this reaction protocol are reported in Table 10. 
Table 10: Organocatalytic cyclopropanation reaction of trans-4-nitrocinnamaldehyde with dimethyl 
bromomalonate.
a 
 
 
 
Entry Catalyst Time (h) Conv. (%)b Yield (%)c dr (anti/syn)b ee (%)d 
1 
3a 
4 74 
73 >30:1 91 
2 6 82 
                                                     
57 Xie H., Zu L., Li H., Wang J., Wang W., J. Am. Chem. Soc. 2007, 129, 10886-10894. 
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Entry Catalyst Time (h) Conv. (%)b Yield (%)c dr (anti/syn)b ee (%)d 
3 
8a 
4 84 
76 >30:1 94 
4 6 86 
5 
8b 
3 0 
18 >30:1 80 6 24 10 
7 51 24 
8 
8c 
5 73 
74 >30:1 92 
9 6 80 
10 
8d 
4 84 
83 >30:1 95 
11 6 89 
a
 Reaction conditions: dimethyl bromomalonate (0.12 mmol), 4-nitrocinnamaldehyde (0.14 mmol), 
2,6-lutidine (0.13 mmol), catalyst (10 mol%), dichloromethane (DCM, 0.5 mL), rt. 
b
 Determined by 
1
H NMR of the crude mixture. Conversions calculated with respect to dimethyl bromomalonate. 
c
 
Yield of the isolated product after flash-chromatography.
 d
 Determined by CSP-HPLC. 
Catalyst 8c afforded more or less the same activity and selectivity as 3a (entries 8 
and 9), while catalysts 8a and 8d proved to be slightly better, providing both higher 
conversions and ees in the same reaction time (entries 3, 4, 10, and 11). Catalyst 8b 
afforded lower ees and also showed an evident decrease of reactivity (entries 5-7). 
Also Wang et al. reporting the use of catalyst 3b in the cyclopropanation reaction, 
using TEA as the base obtained a very low yield (<20%) and thus the ee was not 
determined. It is noteworthy that both 3b and 8b possess two CF3 groups in the meta 
positions of the phenyl rings; these are probably reasponsible of this decrease of 
efficiency. 
We investigated the performances of our catalysts also in the conjugate addition of 
nitromethane to (E)-cinnamaldehyde. This reaction was reported by many groups 
using Jørgensen-Hayashi catalysts 3 in rather different reaction conditions.58 We chose 
the conditions reported by Ye and co-workers, involving the use of 5 mol% of catalyst, 
                                                     
58 (a) Hayashi Y., Itoh T., Ishikawa H., Angew. Chem. Int. Ed. 2011, 50, 3920-3924; (b) Ghosh S. K., Zheng Z., Ni 
B., Adv. Synth. Catal. 2010, 352, 2378-2382; (c) Mager I., Zeitler K., Org. Lett. 2010, 12, 1480-1483; (d) Wang Y., 
Li P., Liang X., Zhang T. Y., Ye J., Chem. Commun. 2008, 1232-1234; (e) Zu L., Xie H., Li H., Wang J., Wang W., Adv. 
Synth. Catal. 2007, 349, 2660-2664; (f) Palomo C., Landa A., Mielgo A., Oiarbide M., Puente A., Vera S., Angew. 
Chem. Int. Ed. 2007, 46, 8431-8435. 
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catalytic amounts of NaOAc (30 mol%) in a 9:1 mixture of DCM and methanol as the 
solvent.58d The results obtained are collected in Table 11. 
Table 11: Organocatalytic Michael addition of nitromethane to (E)-cinnamaldehyde.
a
 
 
Entry Catalyst Yield (%)b ee (%)c 
1 3a 76 97 
2 8a 40 96 
3 8b 16 94 
4 8c 44 96 
5 8d 70 98 
a
 Reaction conditions: cinnamaldehyde (0.3 
mmol), nitromethane (0.9 mmol), sodium acetate 
(30 mol%), catalyst (5 mol%), DCM/MeOH (9:1, 
0.6 mL), rt. 
b
 Yield of the isolated product after 
flash-chromatography.
 c
 Determined by CSP-HPLC. 
Again catalyst 8b revealed to be the least reactive one, even if in this reaction it 
afforded a very good enantiocontrol (entry 3). The other three catalysts (8a, c, d) 
provided ees  comparable with catalyst 3a (entries 2, 4 and 5), but only 8d gave similar 
reactivity. Since catalyst 8b furnished poor results and catalysts 8a and 8c showed so 
far almost the same stereoselectivity and reactivity, we decided to continue the 
screening of catalysts performances using only 8a and 8d. 
These catalysts were used in some recent Diels–Alder reactions based on 
trienamine activation mode.59 First we analysed the organocatalytic Diels-Alder 
reaction between (2E,4E)-hexadienal and 3-ylidene oxindole 9, which afforded the  
spirocyclic oxidole 10 as a single diastereoisomer (Table 12). 
                                                     
59 Jia Z., Jiang H., Li J., Gschwend B., Li Q., Yin X., Grouleff J., Chen Y., Jørgensen K. A., J. Am. Chem. Soc. 2011, 133, 
5053-5061. 
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Table 12: Organocatalytic Diels–Alder reaction of (2E,4E)-hexadienal with 3-yilidene oxindole 9.
a
 
 
Entry Catalyst Acid Time  (h) Conv. (%)b Yield (%)c ee (%)d 
1 3ce OFBA 4 99 92 98 
2 8a OFBA 24 32 28 93 
3 8d OFBA 48 45 38 96 
4 8a CA 4 76 64 94 
5 8a CA 24 99 84 94 
6 8a MNBA 9 85 73 94 
7 8a DFPA 9 99 86 95 
8 8d DFPA 9 99 87 96 
a
 Reaction conditions: 3-yilidene oxindole 9 (0.1 mmol), (2E,4E)-hexadienal (0.15 mmol), acid 
(20 mol%), catalyst (20 mol%), chloroform (1 mL), rt. 
b
 Determined by 
1
H NMR of the crude 
mixture. Conversions calculated with respect to 9. 
c
 Yield of the isolated product after flash-
chromatography.
 d
 Determined by CSP-HPLC. 
e
 3 wih Ar=Ph and TES group instead of TMS 
group. 
The best results obtained by Jørgensen and co-workers in this reaction were 
achieved in the presence of 20 mol% o-fluorobenzoic acid (OFBA) as the additive and 
installing triethyl silyl group instead of trimethyl silyl group on the diphenylprolinol 3c 
(entry 1). 
In the same reaction conditions 8a and 8d displayed a slightly diminished 
stereoselectivity compared to the catalyst used by Jørgensen and co-workers, but also 
remarkable reduced reactivities (entries 1-3). 
Acid additives play a central role in secondary amine organocatalysts activity. 
Seebach and Hayashi recently demonstrated that the acid additive may play many 
different roles in the organocatalytic cycle and that a strong relationship exists 
between acid strength and catalyst activity.60 So we tested the former Diels–Alder 
                                                     
60 Patora-Komisarska K., Benohoud M., Ishikawaa H., Seebach D., Hayashi Y., Helv. Chim. Acta 2011, 94, 719-
745. 
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reaction in the presence of different acid additives. In particular we increased the 
acidity of the additive trying chloroacetic acid (CA), 4-methyl-2-nitrobenzoic acid 
(MNBA) and α,α-difluorophenylacetic acid (DFPA). Using 8a we found an apparent 
direct relationship between catalyst activity and acid additive pKa, obtaining higher 
conversions in shorter reaction times when stronger acids were used (entries 2, 4–7). 
With α,α-difluorophenylacetic acid we obtained quantitative conversions and very high 
stereoselectivities for both 8a and 8d, although these results are still slightly lower 
than those provided by 3c (entries 1, 7 and 8). 
We used 8d in a second Diels–Alder addition between (2E,4E)-hexadienal and the 
ethyl (E)-2-cyano-3-phenylacrylate 11 (Table 13). This reaction, reported by Jørgensen, 
required a much more encumbered organocatalyst 3d (Ar=4-OMe-3,5-(di-tBu)C6H2 and 
TES instead of TMS) and higher temperatures to give good conversions and acceptable 
ees.59 
Table 13: Organocatalytic Diels–Alder reaction of (2E,4E)-hexadienal with ethyl (E)-2-cyano-3-phenylacrylate 11.
a
 
 
Entry Catalyst Additive Yield (%)b ee (%)c drd 
1 3de OFBA 87 86 80:20 
2 8d OFBA 83 89 80:20 
3 8d CA 58 92 80:20 
a
 Reaction conditions: ethyl (E)-2-cyano-3-phenylacrylate 11 (0.1 mmol), 
(2E,4E)-hexadienal (0.2 mmol), acid (20 mol%), catalyst (20 mol%), 
chloroform (0.5 mL), 50°C. 
b
 Yield of the isolated product after flash-
chromatography.
 c
 Determined by CSP-HPLC. 
d
 Determined by 
1
H NMR of 
the crude mixture. 
e
 3 with Ar=4-OMe-3,5-(di-tBu)C6H2 and TES instead of 
TMS. 
In this case the use of OFBA was sufficient for 8d to afford a comparable conversion 
and better stereochemical control with respect to those obtained with 3d (entries 1, 
2). Conversely, CA afforded this time a much lower yield, but still a very good ee value 
(entry 3). 
Among the reactions in which we tested our bicyclic diaryl prolinol silyl ethers, the 
cyclopropanation was the one that provided us the best results (Table 10). These 
performances together with the stability of our catalysts prompted us to carry out the 
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reaction in the same conditions, but lowering the catalyst loading. First we used 5 
mol% of catalyst 8a, chosen for these experiments, and we obtained a complete 
conversion, determined by 1H NMR of the crude mixture, after 21 hours. Then, we 
decreased the amount of catalyst to 1 mol% and we recorded 91% of conversion in 21 
hours. Encouraged by these results we performed the reaction using only 0.1 mol% of 
8a and we checked the conversion during the reaction time. We also carried out the 
reaction in the same conditions and catalytic loading using Hayashi’s catalyst 3a in 
order to compare the activity of the two systems. The results obtained are shown in 
Figure 14. 
 
 
Figure 14 
It is noteworthy that after 11 days catalyst 8a provided 81% of conversion, while 
catalyst 3a didn’t reach 50%, thus demonstrating the major reactivity of our catalyst 
and confirming its stability. 
3. Conclusions 
These new bicyclic diarylprolinol silyl ethers are easily accessible in good yields 
using simple synthetic procedures. They are much more stable to hydrolytic conditions 
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and so more easily stored and handled compared to Jørgensen-Hayashi catalysts 
maintaining comparable activity and selectivity.  
Using these new catalysts the stereochemical outcomes of the reactions mainly 
depend on the nature of the aromatic rings and not on the bulky O-protected 
diarylmethanol group; this opens up the possibility to further modulate their efficacy 
and activity by varying the nature and the substitution pattern of the aromatic rings.  
The cyclopropanation reaction performed using only 0.1 mol% of catalyst proved 
that this family of organocatalysts may be successfully employed in organocatalytic 
transformations with a very low catalyst loading. These performances are possible 
thanks to the reactivity and stability of these new catalysts. Further studies on these 
low loading organocatalytic reactions are still in progress. 
The stability and reactivity of these new catalysts, together with their structural 
modulability make them possible alernatives to widen the choice of catalysts available 
for asymmetric organocatalytic transformations. 
4. Experimental section 
General information 
1H and 13C NMR were recorded on a Varian Inova 400 and on a Varian Gemini 200; 
chemical shifts (δ) are reported in ppm relative to TMS. Chiral HPLC studies were 
carried out on a Agilent Technologies Series 1200 instrument. HPLC-MS were recorded 
using a Agilent Technologies HP1100 instrument (column ZOBRAX-Eclipse XDB-C8 
Agilent Technologies, mobile phase: H2O/CH3CN, gradient from 30% to 80% of CH3CN 
in 8 min, 80% of CH3CN until 25 min, 0.4 mL/min) coupled with Agilent Technologies 
MSD1100 single-quadrupole mass spectrometer (full-scan mode from m/z 50 to m/z 
2600, scan time 0.1 s in positive ion mode, ESI spray voltage 4500 V, nitrogen gas 35 
psi, drying gas flow 11.5 mL/min, fragmentor voltage 20 V). Optical rotations were 
measured with a Perkin-Elmer 343 polarimeter. Reactions were monitored by TLC 
(Merck 60 F254). Flash-chromatography was carried out using Merck silica gel 60 (230-
400 mesh particle size). All reagents were commercially available and were used 
without further purification, unless otherwise stated. 
Synthesis of the catalysts 
(1S,4S)-benzyl 3-oxo-2-oxa-5 -azabicyclo[2.2.1]heptane-5-carboxylate (5) 
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A solution of DEAD 40% in toluene (5.5 mL, 12 mmol) was added dropwise at 0°C to a 
solution of Z-Hyp-OH (2.65 g, 10 mmol) and triphenylphosphine (3.16 g, 12.06 mmol) 
in anhydrous THF (40 mL) under argon atmosphere. The reaction was stirred at room 
temperature for 5 h. The solvent was removed under reduced pressure and then 
diethyl ether (20 mL) was added to the residue in order to precipitate 
triphenylphosphine oxide that was filtered away. The solution was concentred under 
reduced pressure and the residue was purified by flash-chromatogaphy on silica gel 
(diethyl ether/DCM 95:5). The product was obtained as a white solid (1.65 g, 6.67 
mmol, 67%). 1H NMR (400 MHz, CDCl3) δ 7.45 – 7.28 (m, 5H), 5.28 – 5.03 (m, 3H), 4.67 
(bs, 1H), 3.62 (dd, J = 10.9, 1.3 Hz, 1H), 3.54 (d, J = 11.1 Hz, 1H), 2.25 (ddt, J = 10.8, 2.6, 
1.3 Hz, 1H), 2.04 (d, J = 11.2 Hz, 1H). 13C NMR (100 MHz, CDCl3) δ 38.9, 49.9, 57.3, 
67.4, 78.2, 127.8, 128.1, 128.4, 135.8, 154.2, 170.6. HPLC-MS: [M+Na]+ =270.2 m/z. 
Anal. Calcd for C13H13NO4 (247.25): C, 63.15; H, 5.30; N, 5.67. Found: C, 63.59; H, 5.28; 
N, 5.70. 
(2S,4S)-benzyl 4-hydroxy-2-(hydroxydiphenylmethyl)pyrrolidine-1-carboxylate (6a,c) 
Compound 5 (0.52 g, 2.1 mmol) was dissolved in 13 mL of anhydrous THF under argon 
atmosphere and a 3 M solution of phenylmagnusium bromide in diethyl ether (2.1 mL, 
6.3 mmol) was added dropwise over 30 minutes at 0°C. The reaction was allowed to 
reach room temperature. After stirring for 8 h the reaction was quenched with a 
saturated solution of ammonium chloride (20 mL) and extracted with diethyl ether (15 
mL). The organic phase was dried over sodium sulphate, then filtered and the solvent 
was removed under reduced pressure. The residue was purified by flash-
chromatography on silica gel (cyclohexane/ethyl acetate 1:1). The product was 
obtained as a white solid (0.6 g, 1.5 mmol, 70%). *α+D
20 = 95.8° (c = 0.95, CHCl3). 
1H 
NMR (400 MHz, CDCl3) δ 7.61 – 7.02 (m, 15H), 5.04 (d, J = 8.9 Hz, 1H), 4.93 (d, J = 12.3 
Hz, 1H), 4.52 – 4.38 (m, 1H), 4.18 – 4.06 (m, 1H), 3.47 (d, J = 11.2 Hz, 1H), 2.45 – 2.25 
(m, 1H), 1.91 (d, J = 14.7 Hz, 1H). 13C NMR (50 MHz, CDCl3) δ 38.2, 57.3, 64.9, 66.9, 
69.9, 81.2, 126.8, 127.1, 127.2, 127.7, 127.8, 127.9, 128.3, 136.4, 144.6, 144.7, 155.3. 
HPLCMS: [M-OH-]+ =386.3 m/z; [M+Na]+ =426.4 m/z. Anal. Calcd for C25H25NO4 
(403.47): C, 74.42; H, 6.25; N, 3.47. Found: C, 74.18; H, 6.21; N, 3.44. 
(1S,6S)-benzyl 3,3-dimethyl-5,5-diphenyl-2,4-dioxa-7-aza-3-silabicyclo[4.2.1]nonane-
7-carboxylate (7a) 
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To a solution of compound 6a,c (0.3 g, 0.74 mmol) and imidazole (0.12 g, 1.78 mmol) in 
anhydrous DMF (3 mL) under argon atmosphere was added dichlorodimethylsilane 
(0.11 mL, 0.89 mmol) dropwise at 0°C. The reaction was stirred at room temperature 
for 19 h, then quenched with a phosphate buffer pH=7 (5 mL) and extracted with ethyl 
acetate (8 mL). The organic phase was washed with a 5% aqueous solution of lithium 
chloride (5 mL × 3). The organic phase was dried over sodium sulphate, then filtered 
and the solvent was removed under reduced pressure. The residue was purified by 
flash chromatography on silica gel (cyclohexane/ethyl acetate 9:1). The product was 
obtained as a gummy white solid (0.24 g, 0.52 mmol, 70%). *α+D
20 = 139.8° (c = 1.00, 
CHCl3). 
1H NMR (400 MHz, CDCl3) δ 7.60 – 7.01 (m, 15H), 5.21 (bs, 1H), 4.89 (d, J = 12.3 
Hz, 1H), 4.68 (t, J = 5.8 Hz, 1H), 3.96 (dd, J = 13.1, 6.5 Hz, 1H), 3.68 (d, J = 12.7 Hz, 1H), 
2.57 – 2.46 (m, 1H), 2.34 (d, J = 14.8 Hz, 1H), 0.35 (s, 3H), -0.27 (s, 3H). 13C NMR (100 
MHz, CDCl3) δ 0.9, 1.6, 39.0, 58.3, 64.9, 66.6, 72.7, 84.6, 126.4, 126.9, 127.1, 127.4, 
127.6, 127.8, 127.9, 128.0, 128.2, 136.7, 144.9, 155.1. HPLC-MS: [M+H]+ =460.4 m/z. 
Anal. Calcd for C27H29NO4Si (459.61): C, 70.56; H, 6.36; N, 3.05. Found: C, 70.36; H, 
6.41; N, 3.03. 
(1S,6S)-3,3-dimethyl-5,5-diphenyl-2,4-dioxa-7-aza-3-silabicyclo[4.2.1]nonane (8a) 
Compound 7a (0.18 g, 0.4 mmol) was dissolved in a mixture of anhydrous THF and 
methanol 1:1 (4 mL). Then palladium on charcoal 10% (0.043 g, 0.040 mmol) was 
added to the solution and the reaction was stirred under hydrogen at atmospheric 
pressure for 36 h. The reaction mixture was then filtered and washed with ethyl 
acetate (15 mL). The organic layer was evaporated under vacuum and the residue was 
purified by flash chromatography on silica gel (cyclohexane/ethyl acetate 7:3). The 
product was obtained as a white solid (0.11 g, 0.34 mmol, 85%). *α+D
20 = -67.6° (c = 
0.96, CHCl3). 
1H NMR (400 MHz, CDCl3) δ 7.64 – 7.45 (m, 4H), 7.36 – 7.22 (m, 4H), 7.21 
– 7.09 (m, 2H), 4.61 (dd, J = 8.0, 4.0 Hz, 1H), 4.43 – 4.35 (m, 1H), 3.05 (d, J = 9.4 Hz, 1H), 
2.91 (dd, J = 9.4, 2.3 Hz, 1H), 1.93 – 1.87 (m, 2H), 1.71 (bs, 1H), 0.23 (s, 3H), 0.18 (s, 
3H). 13C NMR (100 MHz, CDCl3) δ 1.5, 2.9, 36.3, 54.5, 62.4, 73.9, 84.3, 125.6, 125.9, 
126.27, 126.31, 128.0, 128.1, 146.6, 146.8. HPLC-MS: [M+H]+ =326.1 m/z. Anal. Calcd 
for C19H23NO2Si (325.48): C, 69.94; H, 7.14; N, 4.33. Found: C, 70.36; H, 6.41; N, 3.03. 
(2S,4S)-benzyl 2-(bis(3,5-bis(trifluoromethyl)phenyl)(hydroxy)methyl)-4-
hydroxypyrrolidine-1-carboxylate (6b) 
Chapter 3 
59 
 
Bromo-3,5-bis(trifluoromethyl)benzene (1.0 mL, 6 mmol) in 4 mL of anhydrous THF 
was added dropwise to a suspension of magnesium (0.15 g, 6.3 mmol) in anhydrous 
THF (2 mL) under argon atmosphere. The reaction was refluxed for 30 minutes. After 
cooling to room temperature the reaction mixture was added dropwise to a solution of 
compound 5 (0.5 g, 2 mmol) in anhydrous THF (4 mL) at 0°C under argon atmosphere. 
The reaction was left to reach room temperature and stirred for 17 h. The reaction was 
quenched with a saturated solution of ammonium chloride (15 mL) and extracted with 
diethyl ether (10 mL). The organic phase was dried over sodium sulphate, then filtered 
and the solvent was removed under reduced pressure. The residue was purified by 
flash-chromatography on silica gel (cyclohexane/ethyl acetate 8:2). The product 
obtained was obtained as a white solid (0.69 g, 1.0 mmol, 50%). *α+D
20 = 83.0° (c = 0.95, 
CHCl3). 
1H NMR (400 MHz, CDCl3) δ 8.10 (s, 2H), 7.91 (s, 2H), 7.88 (s, 1H), 7.71 (s, 1H), 
7.36 – 7.28 (m, 3H), 7.14 (s, 2H), 6.33-6.28 (m, 1H), 5.17 (d, J = 9.1 Hz, 1H), 4.82 (d, J = 
11.9 Hz, 1H), 4.65-4.55 (m, 1H), 4.08-3.96 (m, 1H), 3.62 (d, J = 12.9 Hz, 1H), 3.03 (bs, 
1H), 2.41 (ddd, J = 15.3, 9.4, 6.3 Hz, 1H), 1.82 (d, J = 14.9 Hz, 1H). 13C NMR (100 MHz, 
CDCl3) δ 37.4, 57.1, 65.0, 67.5, 70.1, 79.1, 119.1, 119.3, 121.21, 121.25, 121.29, 121.32, 
121.78, 121.81, 121.85, 121.89, 121.93, 121.96, 124.49, 124.67, 126.80, 126.84, 
127.02, 127.20, 127.38, 127.98, 128.12, 128.26, 128.33, 128.36, 128.42, 128.44, 
128.47, 128.51, 131.0 (q, J = 33.2 Hz), 132.1 (q, J = 33.5 Hz), 135.7, 146.2, 147.8, 155.3. 
HPLC-MS: [M+OH-]+ =658.3 m/z. Anal. Calcd for C29H21F12NO4 (675.46): C, 51.57; H, 
3.13; N, 2.07. Found: C, 69.90; H, 6.42; N, 3.01. 
(1S,6S)-benzyl 5,5-bis(3,5-bis(trifluoromethyl)phenyl)-3,3-dimethyl-2,4-dioxa-7-aza-3-
sila bicyclo[4.2.1]nonane-7-carboxylate (7b) 
To a solution of compound 6b (0.69 g, 1.0 mmol) and imidazole (0.17 g, 2.5 mmol) in 
anhydrous DMF (4 mL) under argon atmosphere was added dichlorodimethylsilane 
(0.15 mL, 1.2 mmol) dropwise at 0°C. The reaction was stirred at room temperature for 
19 h, then quenched with a phosphate buffer pH=7 (5 mL) and extracted with ethyl 
acetate (8 mL). The organic phase was washed with a 5% aqueous solution of lithium 
chloride (5 mL × 3). The organic phase was dried over sodium sulphate, then filtered 
and the solvent was removed under reduced pressure. The residue was purified by 
flash chromatography on silica gel (cyclohexane/ethyl acetate 9:1). The product was 
obtained as a gummy white solid (0.49 g, 0.67 mmol, 65%). *α+D
20 = 138.8° (c = 1.05, 
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CHCl3). 
1H NMR (400 MHz, CDCl3) δ 7.97 (s, 2H), 7.92 (s, 1H), 7.72 (s, 3H), 7.40 – 7.29 
(m, 3H), 7.22 – 7.11 (m, 2H), 5.26 (d, J = 9.1 Hz, 1H), 4.78 (d, J = 11.6 Hz, 1H), 4.68 (t, J = 
5.4 Hz, 1H), 3.88 – 3.75 (m, 1H), 3.72 (d, J = 12.5 Hz, 1H), 2.59 – 2.46 (m, 1H), 2.10 (d, J 
= 14.8 Hz, 1H), 0.46 (s, 3H), -0.09 (s, 3H). 13C NMR (100 MHz, CDCl3) δ 1.0, 1.2, 38.4, 
58.2, 65.0, 67.4, 73.0, 83.8, 118.9, 119.2, 121.29, 121.33, 121.37, 121.40, 121.44, 
121.64, 121.95, 122.12, 122.16, 122.20, 122.23, 122.27, 124.35, 124.66, 126.90, 
126.94, 126.98, 127.02, 127.06, 127.24, 127.27, 127.31, 127.36, 128.06, 128.17, 
128.20, 128.28, 128.41, 128.42, 128.45, 128.47, 132.1 (q, J = 33.6), 130.9 (q, J = 33.3), 
136.0, 146.6, 146.7, 155.8. HPLC-MS: [M+H]+ =732.3 m/z. Anal. Calcd for 
C31H25F12NO4Si (731.60): C, 50.89; H, 3.44; N, 1.91. Found: C, 51.23; H, 3.47; N, 1.92. 
(1S,6S)-5,5-bis(3,5-bis(trifluoromethyl)phenyl)-3,3-dimethyl-2,4-dioxa-7-aza-3-
silabicyclo[4.2.1]nonane (8b) 
Compound 7b (0.49 g, 0.67 mmol) was dissolved in a mixture of anhydrous THF and 
methanol 1:3 (4 mL). Then palladium on charcoal 10% (0.071 g, 0.067 mmol) was 
added to the solution and the reaction was stirred under hydrogen at atmospheric 
pressure for 24 h. The reaction mixture was then filtered and washed with ethyl 
acetate (15 mL). The organic layer was evaporated under vacuum and the residue was 
purified by flash chromatography on silica gel (cyclohexane/ethyl acetate 8:2). The 
product was obtained as a white solid (0.22 g, 0.37 mmol, 55%). *α+D20 = -35° (c = 0.91, 
CHCl3). 
1H NMR (400 MHz, CDCl3) δ 8.01 (s, 2H), 7.99 (s, 2H), 7.79 (s, 1H), 7.77 (s, 1H), 
4.70 (dd, J = 10.2, 1.6 Hz, 1H), 4.51 – 4.41 (m, 1H), 3.10 (dd, J = 9.4, 2.2 Hz, 1H), 3.00 
(dd, J = 9.4, 2.4 Hz, 1H), 2.04 (ddd, J = 14.2, 10.2, 3.9 Hz, 1H), 1.80 – 1.70 (m, 1H), 1.65 
(bs, 1H), 0.32 (s, 3H), 0.24 (s, 3H). 13C NMR (100 MHz, CDCl3) δ 1.1, 2.7, 36.6, 54.4, 62.5, 
73.5, 83.9, 119.09, 119.11, 121.17, 121.21, 121.25, 121.28, 121.34, 121.38, 121.42, 
121.46, 121.49, 121.80, 121.82, 124.50, 124.53, 125.75, 125.79, 125.83, 126.05, 
126.09, 127.21, 127.24, 131.48, 131.50, 131.81, 131.83, 132.15, 132.16, 132.47, 
132.49, 147.7, 148.2. HPLC-MS: [M+H]+ =598.1 m/z. Anal. Calcd for C23H19F12NO2Si 
(597.47): C, 46.24; H, 3.21; N, 2.34. Found: C, 46.28; H, 3.18; N, 2.36. 
(1S,6S)-benzyl 3,3,5,5-tetraphenyl-2,4-dioxa-7-aza-3-silabicyclo[4.2.1]nonane-7-
carboxylate (7c) 
Dichlorodiphenylsilane (0.088 mL, 0.43 mmol) was added dropwise at 0°C to a solution 
of compound 6a,c (0.14 g, 0.36 mmol) and imidazole (0.058 g, 0.85 mmol) in 
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anhydrous DMF (3 mL) under argon atmosphere. The reaction was stirred at room 
temperature for 21 h, then quenched with a phosphate buffer pH=7 (5 mL) and 
extracted with ethyl acetate (8 mL). The organic phase was washed with a 5% aqueous 
solution of lithium chloride (5 mL × 3). The organic phase was dried over sodium 
sulphate, then filtered and the solvent was removed under reduced pressure. The 
residue was purified by flash chromatography on silica gel (cyclohexane/ethyl acetate 
9:1). The product was obtained as a gummy white solid (0.18 g, 0.31 mmol, 87%) that 
was characterized by HPLC-MS and used directly in the next reaction. HPLC-MS: [M+H]+ 
=584.2 m/z.  
(1S,6S)-3,3,5,5-tetraphenyl-2,4-dioxa-7-aza-3-silabicyclo[4.2.1]nonane (8c) 
Compound 7c (0.25 g, 0.42 mmol) was dissolved in a mixture of anhydrous THF and 
methanol 1:1 (4 mL). Then palladium on charcoal 10% (0.045 g, 0.042 mmol) was 
added to the solution and the reaction was stirred under hydrogen at atmospheric 
pressure for 18 h. The reaction mixture was then filtered and washed with ethyl 
acetate (15 mL). The organic layer was evaporated under vacuum and the residue was 
purified by flash chromatography on silica gel (cyclohexane/ethyl acetate 9:1). The 
product was obtained as a white solid (0.12 g, 0.27 mmol, 63%). *α+D
20 = -88.8° (c = 
0.81, CHCl3). 
1H NMR (400 MHz, CDCl3) δ 7.76 – 7.05 (m, 20H), 4.67 (dd, J = 7.9, 4.4 Hz, 
1H), 4.58 – 4.53 (m, 1H), 3.04 (d, J = 9.3Hz, 1H), 2.81 (dd, J = 9.4, 1.9 Hz, 1H), 2.09 – 
1.89 (m, 2H). 13C NMR (50 MHz, CDCl3) δ 37.1, 53.6, 60.7, 73.7, 85.1, 125.5, 126.4, 
126.8, 127.1, 127.5, 127.8, 127.9, 128.1, 128.2, 128.4, 129.0, 130.3, 133.0, 134.3, 
134.4, 134.5, 134.6, 138.5, 139.5, 146.5, 146.6. HPLC-MS: [M+H]+ =450.2 m/z. Anal. 
Calcd for C29H27NO2Si (449.62): C, 77.47; H, 6.05; N, 3.12. Found: C, 77.17; H, 6.09; N, 
3.09. 
(2S,4S)-benzyl 4-hydroxy-2-(hydroxydi(naphthalen-2-yl)methyl)pyrrolidine-1-
carboxylate (6d) 
2-Bromonaphtalene (0.62 g, 3.0 mmol) in 4 mL of anhydrous THF was added dropwise 
to a suspension of magnesium (0.077 g, 3.15 mmol) in anhydrous THF (2 mL) under 
argon atmosphere. The reaction was refluxed for 45 minutes. After cooling to room 
temperature the reaction mixture was added dropwise to a solution of compound 5 
(0.25 g, 1.0 mmol) in anhydrous THF (4 mL) at 0°C under argon atmosphere. The 
reaction was left to raise to room temperature and stirred for 3 h. The reaction was 
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quenched with a saturated solution of ammonium chloride (10 mL) and extracted with 
diethyl ether (10 mL). The organic phase was dried over sodium sulphate, then filtered 
and the solvent was removed under reduced pressure. The residue was purified by 
flash-chromatography on silica gel (cyclohexane/ethyl acetate 7:3). The product was 
obtained as a gummy white solid (0.43 g, 0.85 mmol, 85%). *α+D
20 = 132.1° (c = 1.28, 
CHCl3). 
1H NMR (400 MHz, CDCl3) δ 8.04 (s, 1H), 7.93 – 7.78 (m, 4H), 7.78 – 7.66 (m, 
2H), 7.65 – 7.59 (m, 2H), 7.58 – 7.47 (m, 3H), 7.47 – 7.36 (m, 2H), 7.25 – 7.10 (m, 3H), 
6.85 (s, 2H), 5.24 (d, J = 8.7 Hz, 1H), 4.73 (d, J = 11.6 Hz, 1H), 4.40 – 4.29 (m, 1H), 4.04 
(dd, J = 12.6, 7.1 Hz, 1H), 3.55 (d, J = 13.0 Hz, 1H), 2.34 (ddd, J = 14.5, 9.2, 7.2 Hz, 1H), 
1.97 (d, J = 14.6 Hz, 1H). 13C NMR (100 MHz, CDCl3) δ 38.3, 57.3, 64.9, 66.8, 69.9, 81.3, 
125.2, 125.4, 125.5, 125.8, 125.9, 126.2, 126.3, 127.1, 127.3, 127.5, 127.7, 127.8, 
128.0, 128.1, 128.3, 128.4, 132.3, 132.4, 132.7, 132.9, 136.1, 142.2, 142.3, 155.3. 
HPLC-MS: [M+OH-]+ =486.4 m/z. Anal. Calcd for C33H29NO4 (503.59): C, 78.71; H, 5.80; 
N, 2.78. Found: C, 79.08; H, 5.81; N, 2.80. 
(1S,6S)-benzyl 3,3-dimethyl-5,5-di(naphthalen-2-yl)-2,4-dioxa-7-aza-3-
silabicyclo[4.2.1]nonane-7-carboxylate (7d) 
Dichlorodimethylsilane (0.11 mL, 0.94 mmol) was added dropwise at 0°C to a solution 
of compound 6d (0.34 g, 0.78 mmol) and imidazole (0.13 g, 1.87 mmol) in anhydrous 
DMF (2 mL) under argon atmosphere. The reaction was stirred at room temperature 
for 21 h, then quenched with a phosphate buffer pH=7 (5 mL) and extracted with ethyl 
acetate (8 mL). The organic phase was washed with a 5% aqueous solution of lithium 
chloride (5 mL × 3). The organic phase was dried over sodium sulphate, then filtered 
and the solvent was removed under reduced pressure. The residue was purified by 
flash chromatography on silica gel (cyclohexane/ethyl acetate 7:3). The product was 
obtained as a gummy white solid (0.32 g, 0.58 mmol, 74%). *α+D
20 = 309.5° (c = 1.66, 
CHCl3). 
1H NMR (200 MHz, CDCl3) δ 8.06 – 7.65 (m, 7H), 7.64 – 7.29 (m, 8H), 7.23 – 7.08 
(m, 2H), 6.96 – 6.76 (m, 2H), 5.47 (bs, 1H), 4.83 – 4.55 (m, 2H), 4.02 (dd, J = 12.9, 6.4 
Hz, 1H), 3.76 (d, J = 12.4 Hz, 1H), 2.79 – 2.41 (m, 2H), 0.44 (s, 3H), -0.30 (s, 3H). 13C 
NMR (50 MHz, CDCl3) δ 1.0, 1.6, 39.1, 58.4, 64.8, 66.5, 72.8, 84.9, 125.3, 125.56, 
125.62, 126.0, 126.3, 126.4, 126.5, 126.9, 127.4, 127.6, 127.7, 127.8, 128.1, 128.2, 
128.3, 128.5, 132.3, 132.5, 132.6, 132.8, 136.5, 142.3, 143.3, 155.2. HPLC-MS: [M+H]+ 
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=560.5 m/z. Anal. Calcd for C35H33NO4Si (559.73): C, 75.10; H, 5.94; N, 2.50. Found: C, 
75.22; H, 5.92; N, 2.51. 
(1S,6S)-3,3-dimethyl-5,5-di(naphthalen-2-yl)-2,4-dioxa-7-aza-3-
silabicyclo[4.2.1]nonane (8d) 
Compound 7d (0.29 g, 0.52 mmol) was dissolved in a mixture of anhydrous THF and 
methanol 1:1 (4 mL). Then palladium on charcoal 10% (0.056 g, 0.052 mmol) was 
added to the solution and the reaction was stirred under hydrogen at atmospheric 
pressure for 26 h. The reaction mixture was then filtered and washed with ethyl 
acetate (15 mL). The organic layer was evaporated under vacuum and the residue was 
purified by flash chromatography on silica gel (cyclohexane/ethyl acetate 8:2). The 
product was obtained as a white solid (0.17 g, 0.4 mmol, 76%). *α+D
20 = -69.8° (c = 0.64, 
CHCl3). 
1H NMR (200 MHz, CDCl3) δ 8.15 (s, 2H), 8.06 – 7.60 (m, 8H), 7.60 – 7.34 (m, 
4H), 4.86 (dd, J = 8.5, 3.1 Hz, 1H), 4.58 – 4.34 (m, 1H), 3.10 (d, J = 9.3 Hz, 1H), 2.96 (d, J 
= 9.4 Hz, 1H), 2.20 – 1.76 (m, 2H), 0.39 (s, 3H), 0.29 (s, 3H). 13C NMR (50 MHz, CDCl3) δ 
1.6, 2.9, 36.6, 54.7, 62.3, 73.9, 84.7, 124.2, 124.6, 124.9, 125.7, 125.9, 126.0, 127.4, 
127.5, 127.7, 128.0, 128.2, 128.3, 132.2, 133.2, 143.8, 144.0. HPLC-MS: [M+H]+ =426.4 
m/z. Anal. Calcd for C27H27NO2Si (425.59): C, 76.20; H, 6.39; N, 3.29. Found: C, 76.40; H, 
6.39; N, 3.32. 
Organocatalytic Cyclopropanation Reaction of trans-4-Nitrocinnamaldehyde with 
Dimethyl α-Bromomalonate (Table 10) 
To a solution of catalyst (10 mol%) in DCM (0.5 mL) was added dimethyl 
bromomalonate (0.12 mmol, 0.018 mL), 2,6-lutidine (0.13 mmol, 0.015 mL) and finally 
4-nitrocinnamaldehyde (0.14 mmol, 0.025 mg). The reaction was stirred at room 
temperature for the specified time. The product was purified by flash-cromatography 
on silica gel (cyclohexane/ethyl acetate 8:2). 1H NMR (400 MHz, CDCl3): δ=9.59 (d, J= 
3.8 Hz, 1H), 8.19 (d, J=8.8 Hz, 2H), 7.44 (d, J=8.2 Hz, 2H), 3.88–3.83 (m, 4H), 3.54 (s, 
3H), 3.47 (dd, J=7.6, 3.8 Hz, 1H). Conversions were determined by 1H NMR using the 
doublet at 8.19 ppm of the product and the singlet at 4.87 ppm of the dimethyl 
bromomalonate. The racemic product was synthesised under the same conditions with 
racemic proline (10 mol%). The enantiomeric excess was determined after 
derivatisation of the product with Ph3P=CHCOOEt. Separation conditions in chiral 
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HPLC: AD 90:10 n-Hex/IPA for 15 min then 80:20 in 10 min, 0.7 mL/min, 40°C, λ=230 
nm, tr (major) = 25.0 min , tr (minor) = 26.8 min.  
Organocatalytic Enantioselective Michael Addition of Nitromethane to (E)-
Cinnamaldehyde (Table 11) 
To a solution of catalyst (5 mol%) in a DCM/MeOH mixture (9:1, 0.6 mL) was added 
cinnamaldehyde (0.3 mmol, 0.038 mL), nitromethane (0.9 mmol, 0.048 mL) and finally 
sodium acetate (30 mol%, 7.4 mg). The reaction was stirred at room temperature for 
22 h. The mixture was diluted with DCM and extracted with water. The water was 
washed two times with DCM and the organic phases were collected, dried over 
anhydrous Na2SO4, filtered and the solvent was evaporated under reduced pressure. 
The residue was purified by flash-cromatography on silica gel (cyclohexane/ethyl 
acetate 9:1). 1H NMR (CDCl3, 400 MHz): δ=9.69 (s, 1H), 7.22–7.35 (m, 5H), 4.60–4.69 
(m, 2H), 4.06–4.08 (m, 1H), 2.94 (d, J=3.5 Hz, 2H). Conversions were determined by 1H 
NMR using the doublet at 2.94 ppm of the product and the dd at 6.69 ppm of 
cinnamaldehyde. The racemic product was synthesised under the same conditions 
with racemic Jørgensen–Hayashi catalyst (20 mol%). The enantiomeric excess was 
determined after reduction of the product with NaBH4 in ethanol. Separation 
conditions in chiral HPLC: IB 90:10 n-Hex/IPA, 0.5 mL/min, 40°C, λ=230 nm, tr (minor) = 
25.0 min , tr (major) = 27.5 min. 
Organocatalytic Diels–Alder Reaction of (2E,4E)-Hexadienal with 3-Ylidene Oxindole  
(Table 12) 
To a solution of catalyst (20 mol%) and acid (20 mol%) in CHCl3 (1 mL) were added the 
dienophile (0.1 mmol, 0.032 g) and the aldehyde (0.15 mmol, 0.017 mL). The reaction 
was stirred at room temperature for the specified time. The product was purified by 
flash-cromatography on silica gel (cyclohexane/ethyl acetate from 9:1 to 8:2). 1H NMR 
(400 MHz, CDCl3): δ=9.69 (s, 1H), 7.89 (d, J=8.2 Hz, 1H), 7.33–7.28 (m, 1H), 7.26–7.21 
(m, 1H), 7.10–7.03 (m, 1H), 6.02–5.95 (m, 1H), 5.80–5.71 (m, 1H), 3.93 (q, J=7.2 Hz, 
2H), 3.32–3.19 (m, 2H), 3.02–2.93 (m, 1H), 2.86–2.73 (m, 1H), 2.63–2.51 (m, 1H), 2.41 
(dd, J=18.5, 5.0 Hz, 1H), 1.64 (s, 9H), 1.05 (t, J=7.1 Hz, 3H). The conversions were 
determined by 1H NMR using the multiplet at 5.83–5.70 ppm of the product and the 
doublet at 8.69 ppm of the isatin derivative. The racemic product was synthesised 
under the same conditions with pyrrolidine (20 mol%). The enantiomeric excess was 
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determined after derivatisation of the product with Ph3P=CHCOOEt. Separation 
conditions in chiral HPLC: AD 95:5 n-Hex/IPA, 1 mL/min, 40°C, λ=230 nm, tr (minor) = 
6.6 min , tr (major) = 8.0 min. 
Organocatalytic Diels–Alder Reaction of (2E,4E)-Hexadienal with (E)-Ethyl 2-Cyano-3-
phenylacrylate (Table 13) 
To a solution of catalyst (20 mol%) and acid (20 mol%) in CHCl3 (0.5 mL) were added 
the dienophile (0.1 mmol, 0.020 g) and the aldehyde (0.2 mmol, 0.022 mL). The 
reaction was stirred at 50°C for the specified time. The product was purified by flash-
cromatography on silica gel (cyclohexane/ethyl acetate from 9:1 to 8:2). 1H NMR (400 
MHz, CDCl3): δ=9.68 (s, 1H), 7.51–7.22 (m, 5H), 6.01–5.92 (m, 1H), 5.77–5.70 (m, 1H), 
3.97–3.85 (m, 2H), 3.65–3.57 (m, 1H), 3.26 (dd, J= 11.3, 5.5 Hz, 1H), 3.15 (dd, J=19.0, 
8.5 Hz, 1H), 2.72–2.63 (m, 1H), 2.59 (dd, J=18.8, 4.7 Hz, 1H), 2.51–2.40 (m, 1H), 1.00 (t, 
J=7.1 Hz, 3H). Conversions were determined by 1H NMR using the multiplets at 5.77–
5.70 ppm and 5.58–5.53 ppm of the two diastereoisomers of the product and the 
singolet at 8.27 ppm of the ethyl cyanophenylacrylate. The dr was determined by 1H 
NMR using the multiplets at 5.77–5.70 ppm and 5.58–5.53 ppm of the two 
diastereoisomers of the product. The racemic product was synthesised under the same 
conditions with pyrrolidine (20 mol%). The enantiomeric excess was determined after 
derivatisation of the product with Ph3P=CHCOCH3. Separation conditions in chiral 
HPLC: OD 80:20 n-Hex/IPA for 11 min at 0.7 mL/min then to 1 mL/min in 1 min, 40 °C, λ 
= 230 nm, tr (minor) = 9.3 min , tr (major) = 11.6 min. 
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Chapter 4 
Conjugate Addition of Nitrocompounds 
to 3-Ylidene Oxindoles: Sequential and 
Domino Reactions 
1. Thiourea-based bifunctional catalysis 
Ureas and thioureas are able to donate two hydrogen bonds thus accelerating 
reactions by giving LUMO-lowering of electrophiles or stabilising developing negative 
charges at heteroatoms in the transition state.  
In 1998, Sigman and Jacobsen disclosed that chiral urea or thiourea derivatives 
(Figure 15) could efficiently transfer stereochemical information promoting highly 
enantioselective Strecker reactions of N-allyl aldimines.61 
Schreiner et al. were the first to show how profoundly catalyst activity can be tuned 
by simply varying the N-aryl substituent. They introduced the N-trifluoromethylphenyl 
substituent which increased both the solubility and N–H acidity, i.e. hydrogen-bond 
donating ability, of these compounds62 (Figure 15). 
In 2003, Takemoto and co-workers introduced the 1,2-trans-cyclohexyldiamine- 
derived thiourea catalyst (Figure 15). This molecule represents a logical extension of 
Jacobsen’s and Schreiner’s ideas, with the advantage of double functionality,63 
including both a Brønsted base that activate the nucleophile and a hydrogen bond 
donor for the activation of the electrophile. The authors demonstrated the catalyst 
                                                     
61 Sigman M. S., Jacobsen E. N., J. Am. Chem. Soc. 1998, 120, 4901-4902. 
62 (a) Schreiner P. R., Wittkopp A., Org. Lett. 2002, 4, 217-220; (b) Schreiner P. R., Wittkopp A., Chem. Eur. J. 
2003, 9, 407-414. 
63 (a) Siau W., Wang J., Catal. Sci. Technol. 2011, 1, 1298-1310; (b) Ting A., Goss J. M., McDougal N. T., Schaus S. 
E., “Brønsted Base Catalysts”, Topics in Current Chemistry, 2010, Springer, 145-200. 
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operates via a bifunctional mechanism in the enantioselective Michael addition of 
dimethylmalonate to nitroalkenes at room temperature.64  
 
Figure 15 
The first catalytic enantioselective conjugate addition was documented in 
Wynberg’s65 seminal work on Cinchona alkaloid catalysed addition of cyclic β-
ketoesters to methyl vinyl ketone. Cinchona alkaloids possess relatively rigid structures 
in which the basicity of the quinuclidine nitrogen combined with the Brønsted acidic 
C(9)–OH, confers them a bifunctional catalytic property (Figure 16). Acting as 
bifunctional organocatalysts or ligands, Cinchona alkaloids are very useful in 
asymmetric transformations.  
The Cinchona alkaloids are provided by nature in pseudoenantiomeric pairs that can 
be employed to generate either enantiomer of chiral product. The absolute 
configuration of the alcohol can be readily inverted if required, this way the influence 
of the relative stereochemistry at the Lewis basic and Lewis acidic groups can change 
both activity and selectivity. 
Also cupreine and cupreidine are pseudoenantiomers of Cinchona alkaloids in which 
the quinoline C(6’)–OCH3 is replaced with an OH–group. The result is the availability of 
an additional hydrogen-bonding moiety. 
                                                     
64 Okino T., Hoashi Y., Takemoto Y., J. Am. Chem. Soc. 2003, 125, 12672-12673. 
65 Wynberg H., Heider R., Tetrahedron Lett. 1975, 16, 4057-4060. 
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Figure 16 
After the introduction of Takemoto’s bifunctional catalyst and given the wide 
applicability of Cinchona alkaloids, the development of Cinchona derived thiourea 
catalysts (Figure 17) was the next step.66  
 
Figure 17 
The C-9 secondary alcohol can readily be transformed into a urea or thiourea 
derivative via the corresponding primary amine. Thus four research groups began 
working independently with these new catalytic systems and reported their results 
with half a year of distance between each other. The first report came from Chen and 
                                                     
66 Connon S. J., Chem. Commun. 2008, 2499-2510. 
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co-workers,67 then Soós and co-workers68 and finally, a short time later, Connon’s and 
then Dixon’s groups.69 
Thiourea-based bifunctional catalysis has been applied in a variety of different 
reactions like for example Michael addition for C-C, C-O, C-N and C-S bond formation, 
1,2 addition, Morita-Baylis-Hillman reaction and Diels-Alder reaction. These catalysts 
were used also in cascade transformations, dynamic kinetic resolutions and 
desymmetrization reactions. 
2. Oxindole derivatives 
Oxindoles are aromatic heterocyclic organic compounds with a bicyclic structure. A 
2-oxindole molecule consists of a six-membered benzene ring fused to a five-
membered ring containing nitrogen. Its structure is based on the indoline frame where 
a carbonyl is situated at the 2-position of the five-membered ring. Isatin (or 1H-indole-
2,3-dione) is an indole derivative (Figure 18). 
 
Figure 18 
A variety of biological activities are associated with isatins like for instance 
analgesic, anticonvulsant, antidepressant, antiinflammatory, antimicrobial, etc. Also 
oxindoles have a wide range of applications and are reported to exhibit many 
biological effects which include the antiviral, antifungal, antibacterial, antiproliferative, 
                                                     
67 Li B., Jiang L., Liu M., Chen Y., Ding L., Wu Y., Synlett 2005, 603-606. 
68 Vakulya B., Varga S., Csámpai A., Soós T., Org. Lett. 2005, 7, 1967-1969. 
69 (a) McCooey S. H., Connon S. J., Angew. Chem. Int. Ed. 2005, 44, 6367-6370; (b) Ye J., Dixon D. J., Hynes P. S., 
Chem. Commun. 2005, 4481-4483. 
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anticancer, antiinflammatory, antihypertensive, anticonvulsant and antimalaric 
activities70 (Figure 19).  
Since the chemistry of oxindoles is very interesting and they show biological activity, 
these compounds became very important in synthetic organic and medicinal 
chemistry. Indeed, some of the most important spirocycles isolated from natural 
sources are spirooxindole and spiroindoline alkaloids. These natural products were the 
target of total syntheses from several groups71, particularly because several of them 
possess interesting biological activities, furthermore spirocycles still remain a 
challenging motif for synthetic chemists. 
                                                     
70 (a) Millemaggi A., Taylor R. J. K., Eur. J. Org. Chem. 2010, 4527-4547; (b) Bhrigu B., Pathak, D., Siddiqui N., 
Alam M. S., Ahsan, W., Int. J. Pharm. Sci. Drug Res. 2010, 2, 229-235; (c) Fensome A., Adams W. R., Adams A. L., 
Berrodin T. J., Cohen J., Huselton C., Illenberger A., Kern J. C., Hudak V. A., Marella M. A., Melenski E. G., 
McComas C. C., Mugford C. A., Slayden O. D., Yudt M., Zhang Z., Zhang P., Zhu Y., Winneker R. C., Wrobel J. E., J. 
Med. Chem. 2008, 51, 1861-1873; (d) Canner J., Sobo M., Ball S., Hutzen B., DeAngelis S., Willis W., Studebaker 
A. W., Ding K., Wang S., Yang D., Lin J., Br. J. Cancer 2009, 101, 774-781; (e) Shangary S., Qin D., McEachern D., 
Liu M., Miller R. S., Qiu S., Nikolovska-Coleska Z., Ding K., Wang G., Chen J., Bernard D., Zhang J., Lu Y., Gu Q., 
Shah R. B., Pienta K. J., Ling X., Kang S., Guo M., Sun Y., Yang D., Wang S., Proc. Natl. Acad. Sci. U. S. A. 2008, 105, 
3933-3938; (f) Rottmann M., McNamara C., Yeung B. K. S., Lee M. C. S., Zou B., Russell B., Seitz P., Plouffe D. M., 
Dharia N. V., Tan J., Cohen S. B., Spencer K. R., Gonza lez-Pa ez G. E., Lakshminarayana  . B., Goh A.,  uwanarusk 
R., Jegla T., Schmitt E. K., Beck H., Brun R., Nosten F., Renia L., Dartois V., Keller T. H., Fidock D. A., Winzeler E. A., 
Diagana T. T., Science 2010, 329, 1175-1180. 
71 (a) Albrecht B. K., Williams R. M., Org. Lett. 2003, 5, 197-200; (b) Lin H., Danishefsky S. J., Angew. Chem. Int. 
Ed. 2003, 42, 36-51; (c) Greshock T. J., Grubbs A. W., Jiao P., Wicklow D. T., Gloer J. B., Williams R. M., Angew. 
Chem. Int. Ed. 2008, 47, 3573-3577; (d) Reisman S. E., Ready J. M., Weiss M. M., Hasuoka A., Hirata M., Tamaki 
K., Ovaska T. V., Smith C. J., Wood J. L., J. Am. Chem. Soc. 2008, 130, 2087-2100; (e) Galliford C. V., Scheidt K. A., 
Angew. Chem. Int. Ed. 2007, 46, 8748-8758; (f) Marti C., Carreira E. M., Eur. J. Org. Chem. 2003, 2209-2219; (g) 
Trost B. M., Brennan M. K., Synthesis 2009, 18, 3003-3025. 
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Figure 19 
The importance of enantiopure compounds with oxindole scaffold gave birth to the 
development of different asymmetric approaches both metal-72 and organo-73 
catalysed. There has been significant focus on the synthesis of 3,3’-disubstituted 
oxindoles (often as spirocycles) particularly because their biological properties make 
them good targets for drug candidates and clinical pharmaceuticals. These 
                                                     
72 (a) Ma S., Han X., Krishnan S., Virgil S. C., Stoltz B. M., Angew. Chem. Int. Ed. 2009, 48, 8037-8041; (b) Trost, B. 
M., Zhang Y., Chem. Eur. J. 2011, 17, 2916-2922; (c) Trost B. M., Cramer N., Silverman S. M., J. Am. Chem. Soc. 
2007, 129, 12396-12397; (d) Kato Y., Furutachi M., Chen Z., Mitsunuma H., Matsunaga S., Shibasaki M., J. Am. 
Chem. Soc. 2009, 131, 9168-9169; (e) Antonchick A. P., Gerding-Reimers C., Catarinella M.,  chu rmann M., 
Preut H., Ziegler S., Rauh D., Waldmann H., Nat. Chem. 2010, 2, 735-740. 
73 (a) Dalpozzo R., Bartoli G., Bencivenni G., Chem. Soc. Rev. 2012, 41, 7247-7290; (b) Ball-Jones N. R., Badillo J. 
J., Franz A. K., Org. Biomol. Chem. 2012, 10, 5165-5181; (c) Singh G. S., Desta Z. Y., Chem. Rev. 2012, 112, 6104-
6155; (d) Hong L., Wang R., Adv. Synth. Catal. 2013, 355, 1023-1052; (e) Zhou F., Liu Y., Zhou J., Adv. Synth. 
Catal. 2010, 352, 1381-1407. 
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compounds, together with the quaternary stereocenter74 in the oxindole 3-position, 
often have a sequence of contiguous stereocenters. These synthetic challenging 
features caught the attention of many organic chemists who started to exploit achiral 
or racemic oxindole derivatives as starting materials for asymmetric transformations 
generating complex structures, often making use of consecutive, one-pot, multi-
component or domino reactions. 
3. Reaction design: sequential transformations 
Among all the organocatalysed asymmetric transformations involving oxindole 
derivatives, we focused our attention on the ones involving bifunctional thioureas as 
catalyst, in particular we decided to study the reaction concerning the addition of 
nitroalkanes. 
Even if nitrocompounds are commonly used in organocatalysis,75 in the literature 
there were only two papers in which a bifunctional thiourea catalysed attack of 
nitroalkanes to 3-ylidene oxindole derivatives is described. In the first case76 (Scheme 
13) the nitroalkane attacks the oxindole compound in a 1,4 addition respect to the 
cyano and ester groups.  
 
Scheme 13 
In the second work the nitrocyclopropanation of oxindoles achieved via domino 
reaction is discussed77 (Scheme 14). 
                                                     
74 (a) Corey E. J., Guzman-Perez A., Angew. Chem. Int. Ed. 1998, 37, 388-401; (b) Douglas C. J., Overman L. E., 
Proc. Natl. Acad. Sci. U.S.A. 2004, 101, 5363-5367; (c) Peterson E. A., Overman L. E., Proc. Natl. Acad. Sci. U.S.A. 
2004, 101, 11943-11948; (d) Trost B. M., Jiang C., Synthesis 2006, 3, 369-396; (e) Bella M., Gasperi T., Synthesis 
2009, 10, 1583-1614. 
75 Aitken L.  ., Arezki N. R., Dell’Isola A., Cobb A. J. A., Synthesis 2013, 45, 2627-2648. 
76 Liu L., Wu D., Zheng S., Li T., Li X., Wang S., Li J., Li H., Wang W., Org. Lett. 2012, 14, 134-137. 
77 Pesciaioli F., Righi P., Mazzanti A., Bartoli G., Bencivenni G., Chem. Eur. J. 2011, 17, 2842-2845. 
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Scheme 14 
Also the Henry reaction to isatin is described,78 but in these cases bifunctional 
thioureas are not the catalysts of choice. 
In order to introduce a nitro group in the β-position of oxindole using bifunctional 
thiourea catalysis, only reactions with oxindoles as nucleophiles and nitrostyrenes as 
electrophiles were known79 (Scheme 15). 
 
Scheme 15 
Since the reactions of nitroalkanes with oxindole derivatives were not particularly 
explored, we decided to study the Michael addition of these nitrocompounds to 3-
ylidene oxindoles mediated by thiourea-based bifunctional organocatalysts (Scheme 
16). In this reaction we observed a different regioselectivity compared to the work 
reported by Wang et al.76 because of the highest electron-withdrawing power of the 
oxindole compared to the ester on the β terminus of the double bond. 
 
Scheme 16 
                                                     
78 (a) Liu L., Zhang S., Xue F., Lou G., Zhang H., Ma S., Duan W., Wang W., Chem. Eur. J. 2011, 17, 7791-7795; (b) 
Zhang Y., Li Z. J., Xu H. S., Zhang Y., Wang W., RSC Advances 2011, 1, 389-392; (c) Li M., Zhang J., Huang X., Wu 
B., Liu Z., Chen J., Li X., Wang X., Eur. J. Org. Chem. 2011, 5237-5241; (d) Prathima P. S., Srinivas K., Balaswamy 
K., Arundhathi R., Reddy G. N., Sridhar B., Rao M. M., Likhar P. R., Tetrahedron: Asymmetry 2011, 22, 2099-
2103. 
79 (a) Chen X., Zhu W., Qian W., Feng E., Zhou Y., Wang J., Jiang H., Yao Z., Liu H., Adv. Synth. Catal. 2012, 354, 
2151-2156; (b) Retini M., Bergonzini G., Melchiorre P., Chem. Commun. 2012, 48, 3336-3338; (c) Li X., Zhang B., 
Xi Z., Luo S., Cheng J., Adv. Synth. Catal. 2010, 352, 416-424; (d) Bui T., Syed S., Barbas III C. F., J. Am. Chem. Soc. 
2009, 131, 8758-8759; (e) Cui B., Han W., Wu Z., Zhang X., Yuan W., J. Org. Chem. 2013, 78, 8833-8839. 
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There are very few studies on organocatalytic asymmetric intermolecular additions 
to the β-carbon of 3-ylidene oxindoles. Xiao and co-workers80 reported the conjugate 
addition of acetylacetone to 3-ylidene oxindoles recording excellent 
enantioselectivities, but moderate diastereomeric ratios. In one reaction they tested 
also nitromethane as Michael donor: the expected product was obtained in high yield 
and enantiocontrol at C-α, but the two diastereoisomers were formed in almost 
identical amounts due to lack of control at C-3. 
We took advantage of the stereolability problem of oxindole C-3 exploiting its 
nucleophilicity for a further functionalization81 generating an all-carbon quaternary 
stereocenter (Scheme 17).  
 
Scheme 17 
The most frequently exploited approach present in literature to solve this 
stereolability problem is spirocyclization, treated in details in paragraph 5 of this 
chapter. 
4. Organocatalytic conjugate addition of nitroalkanes to 3-ylidene 
oxindoles: a stereocontrolled diversity oriented route to oxindole 
derivatives 
Protecting groups screening 
We decided to start the study of the addition of nitroalkane to 3-yilidene-oxindoles 
performing the reaction between nitromethane (1a) and differently N-substituted (E)-
ethyl 2-(2-oxoindolin-3-ylidene)acetates (2a-c). We choose a bifunctional thiourea 
derived from Cinchona alkaloid as organocatalyst. 
                                                     
80 Duan S., Lu H., Zhang F., Xuan J., Chen J., Xiao W., Synthesis 2011, 12, 1847-1852. 
81 For some examples of C-3 acting as nucleophile, see: (a) Ohmatsu K., Kiyokawa M., Ooi T., J. Am. Chem. Soc. 
2011, 133, 1307-1309; (b) Ogawa S., Shibata N., Inagaki J., Nakamura S., Toru T., Shiro M., Angew. Chem. Int. Ed. 
2007, 46, 8666-8669; (c) Jiang K., Peng J., Cui H., Chen Y., Chem. Commun. 2009, 3955-3957; (d) Tian X., Jiang 
K., Peng J., Du W., Chen Y., Org. Lett. 2008, 10, 3583-3586; (e) He R., Ding C., Maruoka K., Angew. Chem. Int. Ed. 
2009, 48, 4559-4561; (f) Li X., Luo S., Cheng J., Chem. Eur. J. 2010, 16, 14290-14294; (g) Zhang T., Cheng L., 
Hameed S., Liu L., Wang D., Chen Y., Chem. Commun. 2011, 47, 6644-6646. 
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Since many reactions with oxindole derivatives catalysed by bifunctional thioureas 
are strongly dependent on the protecting group, we first focused our attention on 
their screening (Table 14).   
Table 14. N-protecting groups screening in the organocatalysed asymmetric conjugate addition of 1a to 3-ylidene 
oxindoles (2a-c).
a
 
 
Entry Substrate Time (h) Conv. (%)b drb ee (%)c 
1 2a 1.5 92 51:49 93/92 
2 2b 1.75 99 49:51 92/93 
3 2c 1 99 55:45 99/>99 
a
 Reaction conditions: 2 (0.1 mmol), 1a (1 mmol), catalyst (10 mol%), 
dichloromethane (DCM, 0.15 mL), rt. 
b
 Determined by 
1
H NMR of the crude 
mixture. Conversion calculated with respect to 2. 
c
 Determined by CSP-HPLC 
of 3, isolated as mixture of two C-3 epimers; ee values refer to the two C-3 
epimers. 
 
The reaction gave good reactivity (better than in Xiao’s conditions:80 90% yield after 
15 hours) and enantioselectivity with every substituent we tested. As expected, the 
two diastereoisomers were formed in almost the same amount providing very poor 
diastereomeric ratios, this is due to the stereolability of C-3 in the reaction conditions. 
We were very pleased to see that also the unprotected starting material (2a) 
provided very good reactivity and enantioselectivity (entry 1), indeed most of the 
reactions reported in literature work well only on N-protected substrates. 
The best enantioselectivity was obtained for N-Boc substrate 2c (entry 3), so further 
optimizations were performed on it. 
Catalysts screening 
Other bifunctional organocatalysts were tested in the model reaction between 1a 
and 2c (Table 15). 
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Table 15: Catalysts screening in the organocatalysed asymmetric conjugate addition of 1a to 2c.
a
 
 
 
 
Entry Catalyst Time (h) Conv. (%)b drb ee (%)c 
1 I 1 99 55:45 99/>99 
2 II 1.5 91 48:52 97/98d 
3 III 1.75 99 48:52 95/96 
4 IV 1.5 99 55:45 97/97d 
5 V 1.5 99 57:43 98/98 
6 VI 1 99 52:48 99/>99 
7 VII 1.5 99 54:46 59/64 
8 VIII 1.5 99 55:45 82/86 
9 IX 2 99 53:47 83/86d 
a
 Reaction conditions: 2c (0.1 mmol), 1a (1 mmol), catalyst (10 mol%), 
dichloromethane (DCM, 0.15 mL), rt. 
b
 Determined by 
1
H NMR of the crude 
mixture. Conversion calculated with respect to 2c. 
c
 Determined by CSP-HPLC 
of 3c, isolated as mixture of two C-3 epimers; ee values refer to the two C-3 
epimers. 
d
 Opposite enantiomers were formed. 
High conversions in short reaction times were invariably observed (entries 2-9), 
while diastereo- and enantioselectivities did not undergo significant changes when 
Cinchona-derived thioureas (II-V) and Takemoto’s thiourea (VI) were used (entries 2-
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6). Conversely significant lower ees were recorded employing Cinchona alkaloids VIII 
and IX (entries 8 and 9) and, particularly, the Jacobsen’s thiourea VII (entry 7). The best 
results in terms of reaction rate and stereocontrol were obtained with catalysts I and 
VI, thus we chose Takemoto’s thiourea VI (TUC) as the catalyst for the reaction since it 
is low cost commercially available.  
Optimization of the reaction conditions 
A short screening of solvents was carried out (Table 16) confirming 
dichloromethane as the solvent of choice, even if all the solvents tested afforded good 
results.  
Table 16: Solvents screening in the organocatalysed asymmetric conjugate addition of 1a to 2c.
a
 
 
Entry Solvent Time (h) Conv. (%)b drb ee (%)c 
1 DCM 1.5 99 52:48 99/>99 
2 THF 1.5 99 49:51 99/>99 
3 Toluene 1.5 99 50:50 99/99 
4 MeOH 1.5 99 53:47 97/97 
5 MeCN 1.5 99 52:48 98/98 
a
 Reaction conditions: 2c (0.1 mmol), 1a (1 mmol), catalyst VI (2.5 mol%), 
solvent (0.15 mL), rt. 
b
 Determined by 
1
H NMR of the crude mixture. 
Conversion calculated with respect to 2c. 
c
 Determined by CSP-HPLC of 3c, 
isolated as mixture of two C-3 epimers; ee values refer to the two C-3 
epimers. 
Also other reaction conditions were deeply investigated in order to verify the 
effects of the decrease of nitromethane equivalents, catalyst loading and temperature 
on both  rate and stereoselection (Table 17). 
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Table 17: Optimization of the reaction conditions for the organocatalysed asymmetric conjugate addition of 1a to 
2c.
a 
 
Entry 1a (eq.) VI (mol %) T (°C) Time (h) Conv. (%)b drb ee (%)c 
1 2.5 10 rt 1 99 57:43 97/>99 
2 10 1 rt 1.5 99 52:48 >99/99 
3 5 5 rt 1 99 53:47 99/99 
4 2.5 2.5 rt 2 99 52:48 98/98 
5 2 1 rt 5.5 72 52:48 95/95 
6 5 5 0 1.5 99 49:51 >99/>99 
7 5 5 -20 120 72 47:53 >99/>99 
a
 Reaction conditions: 2c (0.1 mmol), catalyst VI, DCM (0.15 mL). 
b
 Determined by 
1
H NMR of the crude 
mixture. Conversion calculated with respect to 2c. 
c
 Determined by CSP-HPLC of 3c, isolated as mixture 
of two C-3 epimers; ee values refer to the two C-3 epimers. 
When nitromethane amount (entry 1) and catalyst loading (entry 2) were 
individually lowered, and also when they were simultaneously decreased up to 2.5 
equivalents of 1a and 2.5 mol % of VI (entries 3 and 4) we still got excellent results. The 
reaction time increased (only up to 5.5 hours) using 2 equivalents of 1a and only 1 mol 
% of catalyst (entry 5). Finally we lowered the temperature (entries 6 and 7) in order to 
have an improvement of diastereoselectivity, but it remained unchanged. From these 
results we can infer that our reaction system did not allow a stereoselective C-3 
protonation. Indeed the C(3)-H acidity of 3-alkyl substituted oxindoles might be 
significantly influenced by the N-protecting group.82 Electron-withdrawing protecting 
groups increase the acidity of the C-3 position, for instance the pKa of N-acetyloxindole 
is around 13. Hence the N-Boc protection could favor a C-3 epimerization in our 
reaction conditions. The temperature effect on the diastereoselectivity was 
investigated also on substrate 2b: when the model reaction was performed at −20°C, 
the conversion was complete in 14 hours but the dr was still 1/1. The same reaction at 
−40°C did not proceed. 
                                                     
82
 Bordwell F. G., Fried H. E., J. Org. Chem. 1991, 56, 4218-4223. 
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Scope of the reaction 
To expand the reaction scope, we employed the reaction conditions that provided 
the best balance between reaction rate and stereocontrol for the different substrates; 
these were identified in 5 equivalents of 1a and 5 mol % of catalyst VI. We applied our 
protocol to a variety of 3-ylidene oxindoles (2c-n) and we were delighted to find that 
the process well tolerated different substitution patterns (Table 18).  
Table 18: Organocatalysed asymmetric conjugate addition of 1a to 3-ylidene oxindoles 2c-n.
a
 
 
Entry Substrate R1 R2 R3 Product 
Time 
(h) 
Yield 
(%)b 
drc ee (%)d 
1 2c H CO2Et H 3c 1 80 53:47 99/99 
2 2d 5-Cl CO2Et H 3d 3.5 83 60:40 >99/>99 
3 2e 5-Br CO2Et H 3e 3.5 72 53:47 >99/>99 
4 2f 6-Cl CO2Et H 3f 1.5 92 56:44 98/98 
5 2g 7-Br CO2Et H 3g 1 82 59:41 95/94 
6 2h 5-OMe CO2Et H 3h 1 89 55:45 >99/>99 
7 2i H CO2Bn H 3i 2 72 55:45 >99/>99 
8 2j H CO2tBu H 3j 2 99 57:43 >99/>99 
9 2k H Ph H 3k 2 52 59:41 60/64 
10 2l H pNO2Ph H 3l 2 98 60:40 31/33 
11 2m H tBu H 3m 26 62 69:31 26/29 
12 2n H CO2Et Me 3n 2 57 60:40 94/92 
a
 Reaction conditions: 2 (0.1 mmol), 1a (0.5 mmol), catalyst VI (5 mol%), DCM (0.15 mL), rt. 
b
 Yield of the isolated 
product after flash-chromatography. 
c
 Determined by 
1
H NMR of the crude mixture. 
d
 Determined by CSP-HPLC of 
products 3, isolated as mixture of two C-3 epimers; ee values refer to the two C-3 epimers. 
The reaction was not affected by the presence of substituents, both electron-
withdrawing (entries 2-5) and electron-donating (entry 6), on the aromatic ring 
proceeding in short reaction times and with excellent enantiocontrol. Also the 
substituent position on the ring did not significantly affect the efficiency of the process 
(cf. entries 2 and 4, entries 3 and 5). The ethyl ester could be replaced with benzyl- 
(entry 7) and tert-butyl (entry 8) esters preserving complete enantioselectivity. 
Chapter 4 
81 
 
Significant changes, mainly in the enantiocontrol, were observed when, instead of 
the ester function, aromatic or aliphatic groups were located at the exocyclic double 
bond. For the phenyl derivative 3k the ee dropped to 60% (entry 9) and the addition of 
an electron-withdrawing substituent on the phenyl ring provided even worse results 
(entry 10). The last attempt was conducted introducing an aliphatic group on the 
double bond, however obtaining very poor ees and longer reaction times (entry 11). 
The latter data suggested that a crucial role for the enantioselectivity was played by 
the presence of an ester on the 3-ylidene oxindole. According to the dual activation 
model83 proposed by Takemoto, Deng and theoretical calculations performed by Pápai, 
the bifunctional organocatalyst should simultaneously activate both Michael donor 
and acceptor, thus controlling the approach of the nitroalkane to the 3-ylidene 
oxindole. The oxindole reasonably interacts with the thiourea moiety via multiple 
hydrogen bonds, enhancing the electrophilicity of the reacting carbon center. 
Concurrently, the nitro compound coordinates to the tertiary amine group. The poor 
enantiocontrol observed when the methyleneindolinone was directly connected to an 
aryl or alkyl group may suggest that the ester moiety can affect the coordination 
between catalyst and substrate, enabling a high enantiocontrol. On the other hand, 
the interaction between the N-Boc carboxyl group and the catalyst in our system 
seems to be present but not strictly necessary, as evidenced by the small differences in 
enantioselectivity recorded for substrates 2a, 2b and 2c (Table 14).  
The substrate scope was also extended to the challenging construction of a 
quaternary stereocenter on the C-α position applying our protocol to substrate 2n, 
characterized by a tetrasubstituted exocyclic double bond (Table 18, entry 12). Once 
again the reaction quickly provided the desired product with high ees for both the 
diastereoisomers. 
The next step in our investigation was to explore the use of other nitroalkanes 
(Table 19), with the aim to introduce a further stereocenter. 
                                                     
83 (a) Okino T., Hoashi Y., Furukawa T., Xu X., Takemoto Y., J. Am. Chem. Soc. 2005, 127, 119-125; (b) Li H., 
Wang Y., Tang L., Wu F., Liu X., Guo C., Foxman B. M., Deng L., Angew. Chem. Int. Ed. 2005,   ,    -     (c) 
Hamza A.,  chubert G.,  oo s  ., Pa pai I., J. Am. Chem. Soc. 2006, 128, 13151-13160. 
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Table 19: Organocatalysed asymmetric conjugate addition of nitroalkanes 1a-f to 2c.
a
 
 
Entry R4 Product Time (h) Yield (%)b anti/sync ee anti (%)d 
1e 1a = MeNO2 3c 1 80 - 99/99 
2e Me (1b) 4b 2 78 76:24 97/98 
3f Me (1b) 4b 48 73 99:1 >99/>99 
4 Me (1b) 4b 3 71 95:5 >99/>99 
5 Et (1c) 4c 7 76 92:8 >99/>99 
6 (CH2)2CO2Me (1d) 4d 4 83 91:9 >99/>99 
7 CH2Ph (1e) 4e 4 72 90:10 >99/>99 
8 1f = iPrNO2 4f 144 traces - - 
a
 Reaction conditions: 2c (0.1 mmol), 1 (0.5 mmol), catalyst VI (10 mol%), DCM (0.15 mL), 0°C. 
b 
Yield of the 
isolated product after flash-chromatography. 
c
 Determined by CSP-HPLC of the crude mixture; stereochemical 
notation anti:syn refers to the Cα-Cβ relationship. 
d
 Determined by CSP-HPLC of the products, isolated as 
mixture of two C-3 epimers; ee values refer to the two C-3 epimers. 
e
 Reaction performed at rt with 5 mol % of 
VI. 
f
 Reaction performed at -10°C. 
We first applied the conditions optimized for nitromethane 1a (entry 1). 
Nitroethane 1b quickly provided the desired product 4b in good yield and excellent 
stereocontrol at C-α, but with modest control of the C-β stereochemistry (entry 2). We 
tried to improve the anti/syn ratio (relative to the Cα-Cβ relationship) by lowering the 
temperature; performing the reaction at -10°C the diastereocontrol was almost 
complete (entry 3). However, the reaction time was much longer, so that the best 
trade-off between reactivity and stereoselectivity was reached employing 10 mol% of 
catalyst at 0°C. In these conditions, after 3 hours 4b was obtained in good yield, high 
diastereomeric ratio and excellent ees (entry 4). The protocol was successfully applied 
to nitroalkanes 1c-e (entries 5-7), while the isopropyl derivative 1f did not afford the 
corresponding product (entry 8), probably because of the steric hindrance at the α-
nitro position. With this protocol the configurations of the two stereocenters directly 
generated in the conjugate addition were highly defined, while the C-3 configuration 
was, as usual, out of control. With the aim to introduce a quaternary and two tertiary 
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contiguous stereocenters on the oxindole scaffold, we extended the addition of 
nitroethane 1b to substrate 2n (Scheme 18). 
 
Scheme 18 
The product 5 was obtained in good yield and high ee. In this case the two C-3 
epimers were not equally present (dr = 85:15), probably because the steric crowding 
and the substituents distribution on the adjacent stereocenters partially affect the C-3 
configuration. 
Concluding this first part, we developed an asymmetric organocatalytic protocol for 
the conjugate addition of nitroalkanes to 3-ylidene oxindoles, which proceeds with 
good yields and excellent enantioselectivities. 
Further functionalization: all-carbon C-3 quaternary stereocenter construction 
Although it was not possible to control the absolute configuration of the C-3 
stereocenter, this limitation can become an opportunity of an all-carbon quaternary 
stereocenter construction by reacting the β-nitro oxindole 4 with an electrophile, thus 
increasing the structural complexity. The β-nitro indolin-2-one scaffold 4 could 
represent a useful precursor for the asymmetric synthesis of 3,3’-disubstituted 
oxindoles with more substitution variants. 
The first attempts were made using N-phenylmaleimide,84 1,1-bis(benzenesulfonyl)-
ethylene85 and trans-β-nitrostyrene86,79c,d as electrophiles, in the presence of the same 
thiourea-catalyst used for the preliminary Michael addition (Scheme 19).  
                                                     
84 Liao Y., Liu X., Wu Z., Cun L., Zhang X., Yuan W., Org. Lett. 2010, 12, 2896-2899. 
85 (a) Zhu Q., Lu Y., Angew. Chem. Int. Ed. 2010, 49, 7753-7756; (b) Lee H. J., Kang S. H., Kim D. Y., Synlett 2011, 
1559-1562. 
86 (a) Li X., Li Y., Peng F., Wu S., Li Z., Sun Z., Zhang H., Shao Z., Org. Lett. 2011, 13, 6160-6163; (b) Ding M., Zhou 
F., Liu Y. L., Wang C., Zhao X., Zhou J., Chem. Sci. 2011, 2, 2035-2039; (c) Liu X., Wu Z., Du X., Zhang X., Yuan W., J. 
Org. Chem. 2011, 76, 4008-4017. 
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Scheme 19 
The reaction with N-phenylmaleimide smoothly proceeded, affording product 6 as 
single stereoisomer in good yield. In this one pot three-component tandem reaction 
four contiguous stereocenters, including the desired C-3 all-carbon quaternary one, 
were enantioselectively generated. 
To introduce structural diversity, the reactivity of 4b was also tested in the Michael 
addition to 1,1-bis(benzenesulfonyl)-ethylene. Compound 7, containing three adjacent 
stereocenters, was efficiently isolated with excellent stereoenrichment. The 
organocatalysed conjugate addition of 3-substituted racemic oxindole derivatives to 
vinyl sulfones is known to proceed with good stereocontrol if an aryl substituent on C-
3 is present, while 3-alkyl oxindoles generally afford the corresponding adducts in low 
yields and poor enantioselectivity; for this reason, Lu and co-workers85a and Kim and 
co-workers85b were forced to develop specifically modified organocatalysts. In our 
case, thanks to the matched induction of pre-existing stereocenters and catalyst, the 
asymmetric Michael reaction smoothly proceeded on 3-alkyl oxindole 4b employing 
the readily available Takemoto’s catalyst VI.  
The last application of the hydrogen-bonding catalysis involved the addition of 4b to 
trans-β-nitrostyrene, further confirming the versatility of the β-nitro indolin-2-one 
scaffold as synthetic precursor of optically active 3,3’-disubstituted oxindoles. 
One of the advantages of the proposed one-pot tandem reactions was that a single 
catalyst sequentially promoted two different transformations, so that the addition of 
other catalysts was not necessary. 
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To further expand the opportunities of structural diversification, we explored a 
second activation mode employing covalent amino-catalysis for the reaction of 4b with 
2-cyclohexen-1-one87 and with crotonaldehyde88 (Scheme 20). Catalyst VI was easily 
removed by means of an acidic work up, allowing to carry out the subsequent Michael 
reaction directly on the crude reaction mixture containing 4b. 
 
Scheme 20 
Primary amine X and secondary amine XI were used, respectively, for the α,β-
unsaturated ketone and the α,β-unsaturated aldehyde, affording the corresponding 
products 9 and 10 in good yields. Once again 3,3’-disubstituted oxindoles bearing four 
contiguous stereocenters were obtained with good to excellent stereocontrol.  
A notable synthetic application of the β-nitro oxindole scaffold lies in its easy 
conversion to the corresponding β-amino derivative, present in many bioactive 
compounds. The reduction with Raney Nickel of 4b quantitatively provided the 
expected β-amino indolin-2-one 11 (Scheme 21). 
We tried also to carry out the reduction with palladium on carbon and, surprisingly, 
the couple of products observed was different from the one obtained using Raney 
                                                     
87 (a) Pesciaioli F., Tian X., Bencivenni G., Bartoli G., Melchiorre P., Synlett 2010, 11, 1704-1708; (b) Wang L., 
Peng L., Bai J., Huang Q., Xu X., Wang L., Chem. Commun. 2010, 46, 8064-8066. 
88 (a) Bencivenni G., Wu L., Mazzanti A., Giannichi B., Pesciaioli F., Song M., Bartoli G., Melchiorre P., Angew. 
Chem. Int. Ed. 2009, 48, 7200-7203; (b) Jiang K., Jia Z., Chen S., Wu L., Chen Y., Chem. Eur. J. 2010, 16, 2852-
2856; (c) Jiang K., Jia Z., Yin X., Wu L., Chen Y., Org. Lett. 2010, 12, 2766-2769; (d) Galzerano P., Bencivenni G., 
Pesciaioli F., Mazzanti A., Giannichi B., Sambri L., Bartoli G., Melchiorre P., Chem. Eur. J. 2009, 15, 7846-7849; 
(e) Companyo  X., Zea A., Alba A. R., Mazzanti A., Moyano A., Rios R., Chem. Commun. 2010,   ,     -      (f) 
Noole A., Ose ka M., Pehk  ., O eren M., Ja rving I., Elsegood M. R. J., Malkov A.  ., Lopp M., Kanger T., Adv. Synth. 
Catal. 2013, 355, 829-835. 
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Nickel. A careful analysis of the HPLC-MS and NMR spectra allowed us to establish that 
the palladium catalyst reduced the β-nitro oxindole 4b only partially, providing the 
corresponding β-hydroxylamino oxindole 12. As expected, the β-amino and the β-
hydroxylamino derivatives were both isolated as mixture of two C-3 epimers (11a,b 
and 12a,b respectively), but, when subjected to basic conditions, both compound 11 
and 12 converged to a single stereoisomer (Scheme 21). As previously mentioned 
about compound 5, the C-3 configuration could be affected by the stereochemical 
features and the ability to form specific interactions of the substituents on C-α and C-
β. In this case, probably the higher thermodynamic stability of 11a and 12a acts as 
driving force in the base-promoted stereoconvergent C-3 epimerization. 
 
Scheme 21 
Finally, the optically active conjugate adduct anti-4b (>99% ee) was first reduced 
and then cyclized to compound 13, featured by a core structure similar to those of 
many important natural products with biological activity (Scheme 22). The possibility 
to obtain stereochemically different scaffolds starting from the same substrate could 
be synthetically very useful, providing the opportunity to obtain a platform of 
diastereomeric derivatives to better evaluate the effect of relative stereochemistry on 
bioactivity. With this aim, exploiting the acidity on the C-β position, we subjected anti-
4b to basic conditions (1,5-diazabiciclo[5.4.0]undec-5-ene, DBU, 30 mol %) and syn-4b 
was isolated in good yield without compromising the optical purity. The previously 
described reductive protocol allowed us to obtain product 14, characterized by a 
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different relative stereochemistry from that of compound 13. The C-, whose absolute 
configuration is controlled by the chiral thiourea during the conjugate addition, is the 
only stereocenter that remains unchanged, while the stereochemistry at the other 
centres can be manipulated by means of stereoconvergent transformations, 
depending on the desired target molecule. 
 
Scheme 22 
1D NOESY experiments on compounds 13 and 14 allowed us to establish the 
relative configuration of the three stereocenters. The more relevant and diagnostic 
nOe signals are represented in Figure 20. 
 
Figure 20 
The absolute configuration of compound 13 has been determined by theoretical 
calculation of its electronic circular dichroism (ECD) spectrum and of its optical rotation 
(OR), using TD-DFT method. 
5. Reaction design: domino spirocyclization 
The usual procedure for the synthesis of organic compounds is the stepwise 
formation of the individual bonds in the target molecule. However, a process in which 
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several bonds are formed in one sequence without isolating the intermediates, 
changing the reaction conditions, or adding reagents would be much more efficient. 
A domino reaction89 involves two or more bond-forming transformations which 
take place under the same reaction conditions without adding additional reagents and 
catalysts, and in which the subsequent reactions result as a consequence of the 
functionality formed in the previous step. 
This type of reactions, compared to stepwise reactions, allow the minimization of 
waste, of the amount of solvents, reagents, adsorbents, work and energy. Thus, these 
reactions would allow a more ecologically and economically favourable production. 
These domino reactions dramatically increase the structural complexity in only one 
process. 
A significant advantage of many organocatalysts is the capability of promoting 
several types of reactions through different activation modes, this ability makes an 
organocatalyst ideal for application in domino reactions.90 Organocatalytic domino 
reactions are highly efficient and somehow biomimetic, since the same principles are 
often found in the biosynthesis of natural products. Domino reactions avoid time-
consuming and costly protection/deprotection steps as well as the purification of 
intermediates; furthermore they often proceed with excellent stereoselectivities. For 
all these reasons organocatalytic domino reactions are used also in total synthesis.91 
Of particular interest is the use of organocatalytic domino reactions for the 
synthesis of 3,3’-spirocyclic oxindoles.92 As already mentioned, after the conjugate 
addition of a nucleophile to 3-ylidene oxindoles, the C-3 stereocenter is labile and can 
act as a nucleophile; so introducing on the same reacting molecule both a nucleophile 
which reacts for first in the 1,4 addition with the oxindole derivative, and an 
electrophile which reacts in a second time, is possible to have spirocyclization (Scheme 
23). 
                                                     
89 Tietze L. F., Chem. Rev. 1996, 96, 115-136. 
90 For reviews on organocatalytic domino reactions, see: (a) Enders D., Grondal C., Hüttl M. R. M., Angew. Chem. 
Int. Ed. 2007, 46, 1570-1581; (b) Pellissier H., Adv. Synth. Catal. 2012, 354, 237-294. 
91 Grondal C., Jeanty M., Enders D., Nat. Chem. 2010, 2, 167-178. 
92 Honga L., Wang R., Adv. Synth. Catal. 2013, 355, 1023-1052. 
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Scheme 23 
Another target that caught the attention in the field of organocatalytic domino 
reactions is the enantioselective synthesis of six-membered carbocycles.93  
We decided to merge together these fields for the synthesis of 3,3’-
spirocyclohexane oxindoles. In order to do this we decided to expand the study of the 
addition of nitroalkane to 3-ylidene oxindoles adding to the nitrocompound structure 
an electrophile. We got inspired by a previous project developed in our group94 for the 
choice of an α,β-unsaturated ester as the electrophile for our domino spirocyclization. 
Later two new reactions using nitro-α,β-unsaturated ester were reported by Cobb and 
co-workers 95 (Scheme 24).  
 
Scheme 24 
Using ε-nitro-α,β-unsaturated ester is possible to obtain a 3,3’-spirocyclohexane 
oxindole (Scheme 25, eq. 1), while using δ-nitro-α,β-unsaturated ester a 3,3’-
spirocyclopentane oxindole is provided (Scheme 25, eq. 2). 
                                                     
93 Goudedranche S., Raimondi W., Bugaut X., Constantieux T., Bonne D., Rodriguez J., Synthesis 2013, 45, 1909-
1930. 
94 Quintavalla A., Lombardo M., Sanap S. P., Trombini C., Adv. Synth. Catal. 2013, 355, 938-946. 
95 (a) Rajkumar S., Shankland K., Brown G. D., Cobb A. J. A., Chem. Sci. 2012, 3, 584-588; (b) Rajkumar S., 
Shankland K., Goodman J. M., Cobb A. J. A., Org. Lett. 2013, 15, 1386-1389. 
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Scheme 25 
Spirocyclohexane oxindoles with a nitro group in β-position are present in 
literature, but they are synthesised in completely different ways, always using Hayashi 
catalyst and conjugated nitroolefins like nitrostyrene.96 
Spirocyclopentane oxindoles with a nitro group in β-position are also present in 
literature, but obtained with different catalytic systems and still employing conjugated 
nitroolefins as source for nitro group.97 There is only one recent example in which a 
bifunctional thiourea catalyst is used with nitroalkanes (Scheme 26), but the 
electrophilic group that provides the spirocyclization is a ketone.98 
 
Scheme 26 
The method we designed for bifunctional thiourea catalysed spirocyclization 
between 3-ylidene-oxindole and nitro-α,β-unsaturated ester is the only one known in 
literature able to provide both spirocyclohexane- and spirocyclopentane- oxindoles. 
                                                     
96 (a) Zhou B., Yang Y., Shi J., Luo Z., Li Y., J. Org. Chem. 2013, 78, 2897-2907; (b) Jiang K., Jia Z., Yin X., Wu L., 
Chen Y., Org. Lett. 2010, 12, 2766-2769; (c) Jiang K., Jia Z., Chen S., Wu L., Chen Y., Chem. Eur. J. 2010, 16, 2852-
2856. 
97 (a) Albertshofer K., Tan B., Barbas III C. F., Org. Lett. 2012, 14, 1834-1837; (b) Li Y., Li X., Peng F., Li Z., Wu S., 
Sun Z., Zhang H., Shao Z., Org. Lett. 2011, 13, 6200-6203; (c) Chandler B. D., Roland J. T., Li Y., Sorensen E. J., 
Org. Lett. 2010, 12, 2746-2749. 
98 Noole A., Ilmarinen K., Ja rving I., Lopp M., Kanger T., J. Org. Chem. 2013, 78, 8117-8122. 
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6. Asymmetric synthesis of spiro-oxindoles via bifunctional thiourea 
catalysed domino reaction 
We first focused on the study of the bifunctional thiourea catalysed asymmetric 
synthesis of 3,3’-spirocyclohexane oxindoles using 3-ylidene oxindole and ε-nitro-α,β-
unsaturated carboxyl compounds as reaction partners. 
Protecting groups screening 
We first carried out the N-protecting groups screening (Table 20) using Takemoto’s 
catalyst (VI), since it was the catalyst of choice for the previously described addition of 
nitroalkanes to 3-ylidene oxindoles. 
Table 20: N-protecting groups screening for the organocatalysed domino reaction between 15a and 3-ylidene 
oxindoles (2a-c,o).
a 
The stereochemistry of the product is not specified because it still has to be determined. 
 
Entry Substrate Time (d) Conv. (%)b ee (%)c 
1 2a 4 tracesd - 
2 2b 7 60 80 
3 2c 3 90 97 
4 2o 7 48 55 
a
 Reaction conditions: 2 (0.1 mmol), 15a (0.12 mmol), catalyst VI 
(10 mol%), dichloromethane (DCM, 0.15 mL), rt. 
b
 Determined by 
1
H NMR of the crude mixture. Calculated with respect to the 
open intermediate. 
c
 Determined for the major diastereoisomer 
formed, by CSP-HPLC. 
d
 Only the first attack took place giving only 
traces of the spirocyclization product. 
While for the addition of nitroalkanes to 3-ylidene-oxindoles the differences in 
reactivity and selectivity between the differently N-substituted oxindoles were really 
small, in this domino transformation the nature of the N-protecting group plays a 
crucial role. The unprotected substrate 2a gave only traces of the desired product, 
while the insertion of a substituent on the nitrogen of the oxindole provided an 
increase of reactivity allowing the formation of the product as a single 
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diastereoisomer. However, only Boc-protected oxindole 2c gave excellent 
enantioselectivity and good reactivity, so we decided to carry out the study of the 
reaction using Boc-oxindole derivatives. 
In this reaction, first the nitronate is formed and attacks the 3-ylidene-oxindole 
forming the first bond in few hours and generating two stereocenters with excellent 
enantiocontrol. Also the labile C-3 stereocenter is formed and exploited for the second 
bond formation that requires longer reaction time providing the stereodefinition of C-3 
and the formation of another stereocenter. In this process only one diastereoisomer is 
observed in the 1H NMR spectrum of the crude mixture and  it is produced with high 
enantiomeric values. 
Catalysts screening 
We tested other different bifunctional organocatalysts like Jacobsen’s thiourea, 
Cinchona alkaloids and their thiourea derivatives (Table 21).  
Table 21: Catalysts screening for the organocatalysed domino reaction between 15a and 2c.
a
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Entry Catalyst Time (d) Conv. (%)b ee (%)c 
1 I 7 49 96 
2 II 7 54 96d 
3 IV 7 60 96d 
4 V 7 54 97 
5 VI 3 90 97 
6 VII 7 60 63 
7 VIII 7 59 73 
8 XII 7 52 66 
9 XIII 7 61 86 
10 XIV 7 46 95d 
11 XV 7 56 95 
12 XVI 7 47 86 
a
 Reaction conditions: 2c (0.1 mmol), 15a (0.12 mmol), catalyst 
(10 mol%), dichloromethane (DCM, 0.15 mL), rt. 
b
 Determined by 
1
H NMR of the crude mixture. Calculated with respect to the 
open intermediate. 
c
 Determined for the major diastereoisomer 
formed, by CSP-HPLC. 
d
 Opposite enantiomers were formed. 
Cinchonidine VIII and quinine XII (entries 7-8) were tested as bifunctional catalysts 
providing only modest enantioselectivity, probably because the hydroxyl group is not 
able to furnish an appropriate hydrogen-bonding with the substrate. 
All the bifunctional thioureas tested gave very good results in terms of 
enantiocontrol (entries 1-5, 9-12) except of Jacobsen’s catalyst VII (entry 6). 
Catalyst VI was the one that gave the best reactivity, providing 90% of conversion in 
3 days, together with excellent stereoselectivity (only one diastereoisomer formed 
with 97% ee). 
Optimization of the reaction conditions 
The reaction was performed in different solvents using catalyst VI checking in all 
cases the stereocontrol and the reactivity (Table 22). 
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Table 22: Solvents screening for the organocatalysed domino reaction between 15a and 2c.
a
 
 
Entry Solvent Time (d) Conv. (%)b ee (%)c 
1 DCM 3 90 97 
2 Toluene 3 70 >99 
3 CH3CN 4 62 96 
4 DMF 3 76 81 
5 H2O 2 72 94 
6 THF 4 73 98 
7 n-hexane 3 90 94 
8 Et2O 3 90 97 
a
 Reaction conditions: 2c (0.1 mmol), 15a (0.12 mmol), catalyst VI (10 
mol%), solvent (0.15 mL), rt. 
b
 Determined by 
1
H NMR of the crude 
mixture. Calculated with respect to the open intermediate. 
c
 
Determined for the major diastereoisomer formed, by CSP-HPLC. 
The domino transformation showed excellent ee values in all the solvents except of 
dimethylformamide (DMF, entry 4) which probably partially compete with the 
substrate for the hydrogen-bonding to the catalyst. Even if toluene (entry 2) gave 
complete stereocontrol, the reaction rate was not so satisfying, so we chose DCM 
(entry 1) as the solvent for the reaction since, together with the more toxic diethyl 
ether (entry 8), provided the best trade-off between reactivity and selectivity. 
Noteworthy are also the reaction performances in water (entry 5). 
Even if the reaction times were already pretty long, we tried the same to decrease 
the catalyst loading (Table 23) in order to improve the reaction conditions employed 
until now and already quite satisfactory: only 1.2 equivalents of nitrocompound, room 
temperature and 10 mol% of catalyst. 
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Table 23: Optimization of the reaction conditions for the organocatalysed domino reaction between 15a and 2c.
a
 
 
Entry Solvent Catalyst VI Time (d) Conv. (%)b ee (%)c 
1 DCM 10 mol% 3 90 97 
2 DCM   5 mol% 4 61 98 
3 H2O 10 mol% 2 72 94 
4 H2O   5 mol% 2 66 90 
a
 Reaction conditions: 2c (0.1 mmol), 15a (0.12 mmol), catalyst VI, solvent (0.15 
mL), rt. 
b
 Determined by 
1
H NMR of the crude mixture. Calculated with respect to 
the open intermediate. 
c
 Determined for the major diastereoisomer formed, by 
CSP-HPLC.  
We tried to decrease the catalyst loading to 5 mol% both in DCM and in water, but 
as expected, we had a clear increase of the reaction times; therefore we decided to 
study the scope of the reaction still using 10 mol% of TUC.  
Scope of the reaction 
We applied our protocol to different ethyl (E)-2-(2-oxoindolin-3-ylidene)acetate 
Boc-protected (Table 24). 
Table 24: Organocatalysed domino reaction between 15a and 2(c,d,f,h,p-r).a 
 
Entry Substrate R Product Time (d) Y (%)b ee (%)c 
1 2c H 16c,a 3 73 97 
2 2d 5-Cl 16d,a 2 82 96 
3 2f 6-Cl 16f,a 1 63 97 
4 2p 7-Cl 16p,a 2 42 83 
5 2h 5-OMe 16h,a 2 76 95 
6 2q 5-Me 16q,a 5 77 97 
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Entry Substrate R Product Time (d) Y (%)b ee (%)c 
7 2r 5-OCF3 16r,a 3 78 94 
a
 Reaction conditions: 2 (0.1 mmol), 15a (0.12 mmol), catalyst VI (10 mol%), 
dichloromethane (0.15 mL), rt. 
b
 Yield of the product after flash-chromatography. 
c
 
Determined for the major diastereoisomer formed, by CSP-HPLC. 
The model reaction (entry 1) provided only one diastereoisomer in good yield and 
excellent enantiocontrol. The substituents on the aromatic ring of the oxindole 
derivative tested were all tolerated by the process. Only the chloro in position 7 
seemed to be problematic giving an enantiomeric excess of 83% and moderate yield 
(entry 4), while the chloro in 5 and 6 positions provided excellent stereocontrol and 
good yields (entries 2, 3). All the other substrates tested, holding electron donating 
groups, provided excellent enantioselectivities and good yields (entries 5-7). The 
reaction times varied from 1 to 5 days without a particular connection with the nature 
and the position of the substituents. The yields were not as high as the conversion 
values (entries 1 Table 23 and Table 24). The reason is that while the conversion in the 
product was calculated with respect to the open intermediate, the yield was obviously 
calculated with respect to the limiting starting material. During the reaction the 
oxindolic starting material or the intermediate probably partially decomposes giving 
the difference between conversion and yield. In fact from the 1H NMR spectrum of the 
crude mixture we could see that an excess higher then 0.2 equivalents of 
nitrocompound remains unreacted. Despite of this probable decomposition we didn’t 
observe any other byproduct, but studies are still in progress. 
Also variations on the substituents of the exocyclic double bond were analysed 
(Table 25).  
Table 25: Organocatalysed domino reaction between 15a and 2(i,l,n,t-w).
a 
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Entry Substrate R1 R2 Product Time (d) Y (%)b ee (%)c 
1 2i COOBn H 16i,a 1 74 97 
2 2t COPh H 16t,a 1 19 90 
3 2l p-NO2Ph H 16l,a 2 83 56 
4 2u CN H 16u,a 1 47 23 
5 2n COOEt Me 16n,a 2 21 94 
6d 2v Me COOEt 16n,a 2 38 94 
7 2w NHBoc COOMe 16w,a 7 - - 
a
 Reaction conditions: 2 (0.1 mmol), 15a (0.12 mmol), catalyst VI (10 mol%), dichloromethane (0.15 
mL), rt. 
b
 Yield of product after flash-chromatography. 
c
 Determined for the major diastereoisomer 
formed, by CSP-HPLC. 
d
 15a (2 eq.), catalyst VI (20 mol%). 
As in the addition of nitroalkanes to 3-ylidene oxindoles, also in this asymmetric 
organocatalytic domino spirocyclization the presence of an ester on the exocyclic 
double bond revealed to be essential. In fact when the ethyl ester was replaced with a 
benzyl ester (entry 1) the reaction preserved its efficiency with good yield and 
excellent ee; but when a ketone, an aromatic ring or a cyano group were present 
instead of the ester moiety the process was no more effective (entries 2-4). The ketone 
functional group seemed not to be tolerated giving low yield caused by the formation 
of a number of byproducts, but it still preserved high enantioselectivity in the 
formation of the desired 3,3’-spirocyclohexane oxindole. Conversely the presence of 
the p-NO2-phenyl ring or of the cyano group provided poor enantiocontrol. 
The geometry of the exocyclic double bond of 3-ylidene oxindole didn’t seem to 
affect the product formation providing in both cases the same diastereoisomer with 
high enantiocontrol (entries 5, 6); to this purpose mechanistic investigations are still in 
progress. When also a methyl was present on the exocyclic double bond the reaction 
was less efficient; replacing the methyl with a much more hindered and electron 
donating substituent like NHBoc (entry 7) not even the first attack took place. 
The scope of the nitrocompounds was explored and it is shown in Table 26.  
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Table 26: Organocatalysed domino reaction between 15(a-k) and 2c.
a
 
 
Entry Substrate R1 R2 Product Time (d) Y (%)b ee (%)c 
1 15a COOEt H 16c,a 3 73 97 
2d 15b H COOEt 16c,b 1 79 97 
3 15c COOEt Me 16c,c 4 19 98 
4e 15c COOEt Me 16c,c 4 40 96 
5f 15c COOEt Me 16c,c 7 18 98 
6e 15d Me COOEt 16c,c 13 32 96 
7 15e COPh H 16c,e 16h Mixture of products 
8 15f COOBn H 16c,f 1 59 >99 
9d 15g H COOBn 16c,g 1 75 98 
10 15h CN H 16c,h 2 90g 99:91:>99:75 
11 15i H CN 16c,i 2 83 95 
12 15j COOEt F 16c,j 3 -h - 
13 15k F COOEt 16c,k 6 -h - 
a
 Reaction conditions: 2c (0.1 mmol), 15a-k (0.12 mmol), catalyst VI (10 mol%), dichloromethane (0.15 mL), 
rt. 
b
 Yield of product after flash-chromatography. 
c
 Determined for the major diastereoisomer formed, by 
CSP-HPLC. 
d
 A different diastereoisomer is obtained. 
e
 Catalyst VI (20 mol%). 
f
 15c (0.2 mmol). 
g
 4 
diastereoisomers formed in 22:35:27:16 ratio. 
h
 Only the first attack took place without giving 
spirocyclization.  
Changing the geometry of the double bond in the ε-nitro-α,β-unsaturated ester we 
obtained a different diastereoisomeric product. With both the geometry only one 
diastereoisomer was formed with excellent enantiomeric excess and good yield 
(entries 1-2, 8-9).  
The ketone was not tolerated also when it was installed on the nitro compound 
providing a complicated mixture of different products (entry 7). 
When the double bond is trisubstituted, adding a methyl, the reaction became 
much slower (entry 3), so we tried to speed it up increasing both the catalyst loading 
(entry 4) and the excess of nitrocompound (entry 5). With 20 mol% of catalyst we 
obtained 40% yield in 4 days; in these conditions we tested also the Z isomer of the 
Chapter 4 
99 
 
nitro compound which slowly provided the same major diastereoisomer produced 
using the E isomer with high ee (entry 6). 
Conversely to the result presented in entry 4 Table 25 the cyano group can replace 
the ester moiety in this reaction partner (entries 10, 11). Using the Z isomer the 
reaction provided good yield and excellent enantioselectivity for the only 
diastereoisomer formed, while the E isomer provided 4 diastereoisomers in 
22:35:27:16 ratio, being the minor isomer the only one provided by the reaction of the 
corresponding Z nitrocompound. The enantiomeric excesses of these diasteroisomers 
were very high except for the minor one that had only a moderate 75% ee. 
We tested also E and Z isomers of the trisubstituted double bond with a fluoro in 
the α position, but in both cases the reaction provided only the first attack and not the 
spirocyclization (entries 12, 13). 
In order to clarify the role of the double bond geometry of the nitrocompound 
further mechanistic studies are expected. 
We performed the reaction also using compound 15l, but only the first conjugate 
addition took place (Scheme 27). 
 
Scheme 27 
Preliminary studies on the bifunctional thiourea catalysed asymmetric synthesis of 3,3’-
spirocyclopentane oxindoles 
Encouraged by the results obtained for the synthesis of 3,3’-spirocyclohexane 
oxindoles, we expanded our study to the formation of 3,3’-spirocyclopentane 
oxindoles. 
First, we performed the reaction with 10 mol% of catalyst VI (entry 1, Table 27) and 
we observed the complete conversion of the oxindolic starting material in only 5 hours 
into two products 19A and 19B. The reaction that produced the 5-membered ring was 
much faster than the one producing the 6-membered one. In the case of 
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spirocyclopentane we studied the reaction at different times via 1H NMR and the 
intermediates (18) were never visible in the crude, since they react very fast.  
Table 27: Preliminary study on the synthesis of 3,3’-spirocyclopentane-oxindoles.
a 
The stereochemistry of the 
product is not specified because it still has to be determined. 
 
Entry Cat (%) T(°C) Time Y (%)b 19 (A:B)c ee A (%)d ee B (%)d 
1e VI (10%) rt 5h 66 60:40 >99 92 
2 VI (5%) rt 3d 82 60:40 >99 96 
3 VI (10%) -10 2d 49 65:35 >99 >99 
a
 Reaction conditions: 2c (0.1 mmol), 17 (0.12 mmol), catalyst, DCM (0.15 mL). 
b
 Yield of product 
after flash-chromatography. 
c
 Determined by 
1
H NMR of the crude mixture. 
d
 Determined by CSP-
HPLC. 
e
 17 (0.2 mmol). 
In order to exclude a possible epimerizarion of the C-β stereocenter due to the 
catalyst acting as a base, thus changing the relative configuration between C-α and C-β 
and enabling the elimination, we performed the reaction decreasing the catalyst 
loading. This should slower the elimination rate and change the ratio between 19A and 
19B, but also with 5 mol% of catalyst the ratio between the two products remained 
unchanged (entry 2). We could infer that 19B probably was not formed from 19A; this 
was confirmed by isolating 19A and reacting it with the catalyst; after 21 hours the 
formation of 19B was not observed. Probably the reaction produced two different 
diastereoisomers and one of them was able to give elimination providing the 
unsaturated 19B.  
We also performed the reaction lowering the temperature to -10°C (entry 3). In 
these conditions we were able to observe the diastereoisomer from wich 19B derives. 
Unfortunately, also at this temperature the final ratio between 19A and 19B didn’t 
improve and further studies on the reaction are still in progress. 
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7. Conclusions 
Even though asymmetric processes applied to indoles, oxindoles and isatins seem to 
represent a mature field in organocatalysis, we demonstrated that still a number of 
useful reactions and applications can be disclosed. 
In the first part of this study, we developed a new asymmetric organocatalytic 
protocol for the conjugate addition of nitroalkanes to 3-ylidene oxindoles, which 
efficiently provided substituted β-nitro indolin-2-ones with good yields and excellent 
enantioselectivities. Indeed, up to three stereocenters were generated one-pot, two of 
them, C-α and C-β, with high stereocontrol. In our reaction conditions we had no 
chance to stereodefine the C-3 position, but, when the generated intermediate 
enolate was trapped with a second Michael acceptor, an all carbon quaternary 
stereocenter was formed in a perfectly defined configuration.  
Furthermore, the conversion of the β-nitro oxindole adduct into the corresponding 
β-amino derivative disclosed intriguing and synthetically useful transformations, such 
as stereoconvergent processes and stereoselective base-promoted isomerizations.  
In the second part we focused on the asymmetric domino spirocyclization catalysed 
by Takemoto’s bifunctional thiourea. Spirocyclohexane oxindoles were generated as a 
single diastereoisomer owning up to five stereocenters with excellent enantiocontrol. 
In the same conditions also spirocyclopentane oxindoles could be generated with 
complete enantiocontrol and further studies are ongoing in the research group. To the 
best of our knowledge our reaction conditions are the only ones present in literature 
able to provide both 3,3’-spirocyclohexane oxindoles and 3,3’-spirocyclopentane 
oxindoles with high enantioselectivity and good yields. 
At last we remark the usefulness of the asymmetric organocatalytic processes 
reported here in the synthesis of enantioenriched oxindole and indoline derivatives, 
potentially useful in drug discovery. 
8. Experimental section 
Materials. All of the chemicals were used as received. Catalysts I-V were known and 
prepared according to the literature procedures.68 Compounds 2a,99 2b-c,100 2d-f,h,101 
                                                     
99 Malhotra S., Balwani S., Dhawan A., Singh B. K., Kumar S., Thimmulappa R., Biswal S., Olsen C. E., Van der 
Eycken E., Prasad A. K., Ghosh B., Parmar V. S., Med. Chem. Commun. 2011, 2, 743-751. 
100 Cao S., Zhang X., Wei Y., Shi M., Eur. J. Org. Chem. 2011, 2668-2672. 
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2i,102 2j-k,103 2l,104 2o,105 2t,u,106 1e,107 15a,c,k108 were known and prepared according 
to the literature procedures.  
Characterization of compounds. 1H and 13C NMR spectra were recorded on a 200 or 
400 NMR instrument with a 5 mm probe. All chemical shifts have been quoted relative 
to deuterated solvent signals, chemical shifts (δ) are reported in ppm and coupling 
constants (J) are reported in Hz. HPLC-MS analysis was performed using an HPLC 
system coupled with a single-quadrupole mass spectrometer. A ZOBRAX-Eclipse XDB-
C8 column was employed for the chromatographic separation; mobile phase: 
H2O/CH3CN, gradient from 30% to 80% of CH3CN in 8 min, 80% of CH3CN until 25 min, 
0.4 mL min-1. Mass spectrometric detection was performed in full-scan mode from m/z 
50 to m/z 2600, scan time 0.1 s in positive ion mode, ESI spray voltage 4500 V, nitrogen 
gas 35 psi, drying gas flow 11.5 mL min-1, fragmentor voltage 20 V. CSP-HPLC analyses 
were performed using hexane/2-propanol mixtures. Flash-chromatography was carried 
out using Merck silica gel 60 (230-400 mesh particle size). Thin-layer chromatography 
was performed on Merck 60 F254. The *α+D
25 values and the major enantiomers in the 
following characterization have been defined with respect to the products obtained 
with catalyst VI.  
Synthesis of (E)-tert-butyl 7-bromo-3-(2-ethoxy-2-oxoethylidene)-2-oxoindoline-1-
carboxylate (2g). Ethyl 2-(triphenylphosphoranylidene)acetate (1.2 mmol) was added 
to a solution of 7-bromoindoline-2,3-dione (1 mmol, 226 mg) in DCM (4 mL). The 
reaction was stirred at rt overnight. After the reaction was complete, the solvent was 
removed under reduced pressure. The crude mixture was dissolved in THF (5 mL), 
DMAP (4-dimethylaminopyridine, 5 mol%) was added to the solution and, finally, 
Boc2O (di-tert-butyl dicarbonate, 1.1 mmol) was added. The reaction was stirred at rt 
for 1 h. Then the solvent was removed under reduced pressure and the product was 
                                                                                                                                                           
101 Sun W., Zhu G., Wu C., Hong L., Wang R., Chem. Eur. J. 2012, 18, 6737-6741. 
102  an B., Herna ndez-Torres G., Barbas  III C. F., J. Am. Chem. Soc. 2011, 133, 12354-12357. 
103 (a) Jia Z., Jiang H., Li J., Gschwend B., Li Q.-Z., Yin X., Grouleff J., Chen Y., Jørgensen K. A., J. Am. Chem. Soc. 
2011, 133, 5053-5061; (b) Tan B., Candeias N. R., Barbas III C. F., J. Am. Chem. Soc. 2011, 133, 4672-4675. 
104 Liu Y., Nappi M., Arceo E., Vera S., Melchiorre P., J. Am. Chem. Soc. 2011, 133, 15212-15218. 
105 Tan B., Zeng X., Leong W. W. Y., Shi Z., Barbas III C. F., Zhong G., Chem. Eur. J. 2012, 18, 63-67. 
106 Halskov K. S., Johansen T. K., Davis R. L., Steurer M., Jensen F., Jørgensen K. A., J. Am. Chem. Soc. 2012, 134, 
12943-12946. 
107 Kodukulla R. P. K., Trivedi G. K., Vora J. D., Mathur H. H., Synth. Commun. 1994, 24, 819-832. 
108 Rajkumar S., Shankland K., Brown G. D., Cobb A. J. A., Chem. Sci. 2012, 3, 584-588. 
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purified by flash-chromatography on silica gel (cyclohexane/ethyl acetate 9/1). 95% 
yield (376 mg), crystalline solid (mp = 73-77°C). 1H NMR (400 MHz, CDCl3) δ = 8.66 (dd, 
J = 7.9, 1.1 Hz, 1H), 7.59 (dd, J = 8.1, 1.1 Hz, 1H), 7.08 (t, J = 8.0 Hz, 1H), 6.94 (s, 1H), 
4.34 (q, J = 7.1 Hz, 2H), 1.66 (s, 9H), 1.38 (t, J = 7.1 Hz, 3H). 13C NMR (100 MHz, CDCl3) δ 
= 14.1, 27.7, 61.5, 85.8, 106.7, 123.4, 124.6, 125.6, 127.5, 136.2, 137.1, 140.8, 147.6, 
164.9, 166.3. HPLC-MS (ESI): tr = 12.7 min. [M+Na]
+ = 418.2 m/z, [2M+Na]+ = 813.2 
m/z, 817.2 m/z. Anal. Calcd for C17H18BrNO5 (395.04): C, 51.53; H, 4.58; N, 3.53. Found: 
C, 51.37; H, 4.56; N, 3.54. 
Synthesis of (E)-tert-butyl 3-(2,2-dimethylpropylidene)-2-oxoindoline-1-carboxylate 
(2m). Pivalaldehyde (1.2 mmol) was added to a solution of indolin-2-one (1 mmol, 133 
mg) in EtOH (5 mL), finally piperidine (10 mol%) was added. The reaction was refluxed 
for 1.5 h, then it was cooled to room temperature and the solvent was removed under 
reduced pressure. The product was purified by flash-chromatography on silica gel 
(cyclohexane/ethyl acetate 8/2). (E)-3-(2,2-dimethylpropylidene)indolin-2-one was 
dissolved in THF (5 mL), then DMAP (5 mol%) was added and finally Boc2O (1.1 mmol). 
The reaction was stirred at room temperature for 1 h. After the reaction was complete, 
the solvent was removed under reduced pressure and the product was purified by 
flash-chromatography on silica gel (cyclohexane/ethyl acetate 9/1). 97% yield (292 
mg), crystalline solid (mp = 82-86°C). 1H NMR (400 MHz, CDCl3) δ = 7.94 (d, J = 7.8 Hz, 
1H), 7.78 – 7.71 (m, 1H), 7.36 – 7.29 (m, 1H), 7.25 (s, 1H), 7.17 (td, J = 7.7, 1.2 Hz, 1H), 
1.65 (s, 9H), 1.39 (s, 9H). 13C NMR (100 MHz, CDCl3) δ = 28.1, 29.1, 32.7, 84.0, 115.0, 
120.9, 123.5, 125.5, 126.0, 128.9, 140.0, 149.3, 154.3, 167.0. HPLC-MS (ESI): tr = 13.4 
min; [2M+Na]+ = 625.4 m/z. Anal. Calcd for C18H23NO3 (301.17): C, 71.73; H, 7.69; N, 
4.65. Found: C, 71.61; H, 7.71; N, 4.65. 
Synthesis of (E)-tert-butyl 3-(1-ethoxy-1-oxopropan-2-ylidene)-2-oxoindoline-1-
carboxylate (2n). DMAP (5 mol%) was added to a solution of indoline-2,3-dione (1 
mmol, 147 mg) in THF (5 mL), finally Boc2O (1.1 mmol) was added. The reaction was 
stirred at room temperature for 1 h. After the reaction was complete, the solvent was 
removed under reduced pressure. The crude mixture was dissolved in DCM (4 mL) and 
ethyl 2-(triphenylphosphoranylidene)propanoate (1.2 mmol) was added. The reaction 
was stirred at room temperature overnight. Then the solvent was removed under 
reduced pressure and the product was purified by flash-chromatography on silica gel 
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(cyclohexane/ethyl acetate 9/1). 50% yield (166 mg), gum. 1H NMR (400 MHz, CDCl3) δ 
= 7.87 (d, J = 8.7 Hz, 1H), 7.36 – 7.29 (m, 2H), 7.09 (t, J = 7.7 Hz, 1H), 4.43 (q, J = 7.1 Hz, 
2H), 2.63 (s, 3H), 1.66 (s, 9H), 1.39 (t, J = 7.1 Hz, 3H). 13C NMR (100 MHz, CDCl3) δ = 
14.0, 17.1, 28.1, 30.9, 62.0, 84.4, 114.9, 120.7, 122.0, 123.4, 123.9, 129.9, 138.8, 141.8, 
149.2, 165.7, 169.2. HPLC-MS (ESI): tr = 11.7 min; [M+Na]
+ = 354.2 m/z, [2M+Na]+ = 
685.5 m/z. Anal. Calcd for C18H21NO5 (331.14): C, 65.24; H, 6.39; N, 4.23. Found: C, 
65.22; H, 6.37; N, 4.22.  
Synthesis of (E)-tert-butyl 7-chloro-3-(2-ethoxy-2-oxoethylidene)-2-oxoindoline-1-
carboxylate (2p). 
Same procedure used for 2n. Yield = 12%. 
1H NMR (400 MHz, CDCl3) δ 8.62 (d, J = 7.8 Hz, 1H), 7.42 (d, J = 8.2 Hz, 1H), 7.14 (t, J = 
8.0 Hz, 1H), 6.96 (s, 1H), 4.34 (q, J = 7.2 Hz, 2H), 1.65 (s, 9H), 1.38 (t, J = 7.2 Hz, 3H). 13C 
NMR (100 MHz, CDCl3) δ 166.2, 165.0, 149.1, 147.6, 136.1, 134.0, 133.8, 127.1, 126.9, 
123.0, 118.9, 85.8, 61.6, 27.7, 14.0. HPLC-MS  (ESI) tr = 13.1 min; [M+Na]
+ = 374.0 m/z, 
[2M+Na]+ = 725.2 m/z. 
Synthesis of (E)-tert-butyl 3-(2-ethoxy-2-oxoethylidene)-5-methyl-2-oxoindoline-1-
carboxylate (2q). 
Same procedure used for 2n. Yield = 71%. 
1H NMR (200 MHz, CDCl3) δ 8.46 (s, 1H), 7.75 (dd, J = 8.4, 2.3 Hz, 1H), 7.21 (d, J = 8.4 
Hz, 1H), 6.85 (d, J = 2.3 Hz, 1H), 4.32 (q, J = 7.1 Hz, 2H), 2.36 (s, 3H), 1.63 (s, 9H), 1.37 (t, 
J = 7.1 Hz, 3H). 13C NMR (50 MHz, CDCl3) δ 165.8, 165.3, 148.7, 139.6, 136.5, 134.1, 
133.2, 128.6, 122.6, 120.0, 114.6, 84.4, 61.2, 28.0, 21.0, 14.1. HPLC-MS  (ESI) tr = 13.5 
min; [M+Na]+ = 354.2 m/z, [2M+Na]+ = 685.2 m/z. 
Synthesis of (E)-tert-butyl 3-(2-ethoxy-2-oxoethylidene)-2-oxo-5-
(trifluoromethoxy)indoline-1-carboxylate (2r). 
Same procedure used for 2n. Yield = 96%. 
1H NMR (200 MHz, CDCl3) δ 8.66 (s, 1H), 7.97 (d, J = 8.9 Hz, 1H), 7.29 (d, J = 9.6 Hz, 1H), 
6.97 (s, 1H), 4.35 (q, J = 7.1 Hz, 2H), 1.65 (s, 9H), 1.38 (t, J = 7.1 Hz, 3H). 13C NMR (50 
MHz, CDCl3) δ 165.2, 165.1, 148.7, 145.7, 140.3, 135.5, 125.3, 125.1, 121.5, 121.2, 
120.5 (q, J = 256 Hz), 116.0, 85.1, 61.6, 27.8, 13.9. HPLC-MS  (ESI) tr = 14.9 min; 
[M+Na]+ = 424.0 m/z, [2M+Na]+ = 825.2 m/z. 
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Synthesis of (Z)-tert-butyl 3-(1-ethoxy-1-oxopropan-2-ylidene)-2-oxoindoline-1-
carboxylate (2v). 
Compound 3c (58 mg, 0.18 mmol) was dissolved in 1 mL of DCM and DBU (0.031 mL, 
0.2 mmol) was added. The reaction was stirred for 6 h at room temperature, then 
quenched with a saturated solution of NH4Cl and extracted 3 times with DCM. The 
organic phases were collected, dried over Na2SO4, filtered and concentrated under 
reduced pressure. The purification by column chromatography on silica gel (diethyl 
ether/cyclohexane 5:95) provided the desired product in 19% yield. 
1H NMR (400 MHz, CDCl3) δ 7.89 (d, J = 8.1 Hz, 1H), 7.59 (d, J = 7.7 Hz, 1H), 7.36 (t, J = 
8.0 Hz, 1H), 7.19 (t, J = 7.6 Hz, 1H), 4.42 (q, J = 7.2 Hz, 2H), 2.45 (s, 3H), 1.64 (s, 9H), 
1.38 (t, J = 7.1 Hz, 3H). HPLC-MS  (ESI) tr = 11.1 min; [M+Na]
+ = 354.2 m/z, [2M+Na]+ = 
685.2 m/z. 
Synthesis of tert-butyl (E)-3-(1-((tert-butoxycarbonyl)amino)-2-methoxy-2-
oxoethylidene)-2-oxoindoline-1-carboxylate (2w). 
DMAP (5 mol%) was added to a solution of indoline-2,3-dione (1 mmol, 147 mg) in THF 
(5 mL), finally Boc2O (1.1 mmol) was added. The reaction was stirred at room 
temperature for 1 h. After the reaction was complete, the solvent was removed under 
reduced pressure.  
A solution of  (±)-trimethyl-Boc-α-phosphonoglycinate (1.2 mmol) in anhydrous THF (6 
mL) was added dropwise to a suspension of NaH (60%, 1.2 mmol, 48 mg) in anhydrous 
THF (6 mL) at 0° C, then the reaction was stirred at this temperature for 15 min. Now, 
the crude of Boc-isatin (1 mmol) in 4 ml of THF was added slowly into the reaction 
mixture at 0°C, then the reaction was stirred at room temperature overnight. It was 
then quenched with a saturated solution of NH4Cl and the aqueous phase was 
extracted 3 times with diethyl ether. The combined organic layers were dried over 
Na2SO4 and concentrated. Purification by column chromatography on silica gel 
(cyclohexane/ethyl acetate 9:1) afforded the title compound (362.1 mg, 87%, 0.87 
mmol). 
1H NMR (400 MHz, CDCl3) δ 10.90 (s, 1H), 7.88 (d, J = 8.3 Hz, 1H), 7.31 – 7.22 (m, 1H), 
7.20 – 7.06 (m, 2H), 4.06 (s, 3H), 1.68 (s, 9H), 1.51 (s, 9H). 
Synthesis of ethyl (Z)-6-nitrohex-2-enoate (15b). 
Obtained as the minor isomer from the synthesis of 15a.108 Yield = 13%. 
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1H NMR (400 MHz, CDCl3) δ 6.25 – 6.12 (m, 1H), 5.88 (d, J = 11.6 Hz, 1H), 4.42 (t, J = 7.2 
Hz, 2H), 4.18 (q, J = 7.1 Hz, 2H), 2.78 (q, J = 7.7 Hz, 2H), 2.19 (p, J = 7.3 Hz, 2H), 1.30 (t, J 
= 7.2 Hz, 3H). 13C NMR (100 MHz, CDCl3) δ 166.0, 146.3, 121.9, 74.7, 60.1, 26.4, 25.4, 
14.1. HPLC-MS  (ESI) tr = 7.5 min; [M+H]
+ = 188.0 m/z, [M+Na]+ = 210.0 m/z. 
Synthesis of ethyl (Z)-2-methyl-6-nitrohex-2-enoate (15d). 
KHMDS (2 mmol, 4 mL, 0.5 M in toluene) was added dropwise to a solution of triethyl 
2-phosphonopropionate (2 mmol, 0.438 mL) and 18-crown-6 (3.6 mmol, 950 mg) in 
anhydrous THF (18 mL) at -78°C and the reaction was stirred for 20 min at this 
temperature. Then a solution of 4-bromobutanal108 (2 mmol, 302 mg) in anhydrous 
THF (4.5 mL) was added dropwise and the reaction was stirred 1 h at -78°C, then 1 h at 
room temperature. The reaction was quenched with a saturated solution of NH4Cl and 
extracted 3 times with diethyl ether. The organic phases were collected, dried over 
Na2SO4, then filtered and concentrated under reduced pressure. Both E and Z isomer 
1:3.3 of the product were produced and purification by column chromatography on 
silica gel (ethyl acetate/cyclohexane 1:9) afforded the title compound (322 mg, 69%, 
1.37 mmol). The obtained ethyl 6-bromo-2-methylhex-2-enoate was dissolved in 
anhydrous DMF (13 mL) and NaNO2 (2.06 mmol, 141.7 mg) was added. The reaction 
was stirred overnight at room temperature. Cold water was added to the reaction and 
the water phase was extracted 3 times with diethy ether. The organic phases were 
collected, dried over Na2SO4, then filtered and concentrated under reduced pressure. 
Purification by column chromatography on silica gel (diethyl ether/cyclohexane 5:95) 
allowed the separation of E and Z isomers affording the products as colorless oils. A 
35% yield of Z product (95.7 mg, 0.48 mmol) and 58% total yield (161 mg, 0.8 mmol) 
were obtained.  
1H NMR (400 MHz, CDCl3) δ 5.86 (t, J = 7.5 Hz, 1H), 4.39 (t, J = 7.1 Hz, 2H), 4.19 (q, J = 
7.3 Hz, 2H), 2.55 (q, J = 7.6 Hz, 2H), 2.14 (p, J = 7.1 Hz, 2H), 1.91 (s, 3H), 1.29 (t, J = 7.3 
Hz, 3H). 13C NMR (100 MHz, CDCl3) δ 167.5, 138.9, 129.7, 74.8, 60.3, 26.8, 26.0, 20.6, 
14.3. HPLC-MS  (ESI) tr = 8.6 min; [M+Na]
+ = 224.0 m/z. 
Synthesis of (E)-6-nitro-1-phenylhex-2-en-1-one (15e). 
Same procedure used for 15c. Yield = 39% 
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1H NMR (400 MHz, CDCl3) δ 7.94 (d, J = 7.0 Hz, 2H), 7.63 – 7.54 (m, 1H), 7.54 – 7.38 (m, 
2H), 6.94 (d, J = 11.6 Hz, 1H), 6.31 (td, J = 11.6, 7.7 Hz, 1H), 4.46 (t, J = 7.2 Hz, 2H), 2.75 
(q, J = 7.3 Hz, 2H), 2.26 (p, J = 7.3 Hz, 2H). 
Synthesis of benzyl (E)-6-nitrohex-2-enoate (15f). 
Same procedure used for 15c. Yield = 74%. 
1H NMR (400 MHz, CDCl3) δ 7.46 – 7.29 (m, 5H), 6.95 (td, J = 15.6, 6.9 Hz, 1H), 5.95 (td, 
J = 15.7, 1.6 Hz, 1H), 5.20 (s, 2H), 4.41 (t, J = 6.8 Hz, 2H), 2.42 – 2.29 (m, 2H), 2.26 – 
2.13 (m, 2H). 13C NMR (50 MHz, CDCl3) δ 165.7, 146.0, 135.8, 128.5, 128.14, 128.11, 
122.8, 74.3, 66.1, 28.5, 25.4. HPLC-MS  (ESI) tr = 9.4 min; [M+Na]
+ = 272.0 m/z. 
Synthesis of benzyl (Z)-6-nitrohex-2-enoate (15g). 
Obtained as the minor isomer from the synthesis of 15f. Yield = 8.8%. 
1H NMR (200 MHz, CDCl3) δ 7.61 – 7.22 (m, 5H), 6.36 – 6.09 (m, 1H), 5.93 (d, J = 11.2 
Hz, 1H), 5.17 (s, 2H), 4.39 (t, J = 7.1 Hz, 2H), 2.79 (q, J = 7.8 Hz, 2H), 2.19 (p, J = 7.1 Hz, 
2H). HPLC-MS  (ESI) tr = 9.7 min; [M+Na]
+ = 272.0 m/z. 
Synthesis of 6-nitrohex-2-enenitrileate (15h,i). 
To a solution of (cyanomethyl)triphenylphosphonium chloride (2.4 mmol, 853.4 mg) in 
THF (10 mL) at 0° C was added NaH (2.4 mmol, 96 mg) and stirred at this temperature 
for 15 min. At this temperature 4-bromobutanal (302 mg, 2 mmol) in 10 mL of THF was 
added slowly into the reaction mixture. Then, the reaction was left stirring at room 
temperature overnight. It was then quenched with a saturated solution of NH4Cl and 
the aqueous phase was extracted 3 times with diethyl ether. The combined organic 
layers were dried over Na2SO4, filtered and concentrated. The reaction afforded both E 
and Z isomer (2:1) of the product. The mixture was purified by column 
chromatography on silica gel (diethyl ether/ cyclohexane 1:9) providing a colorless oil 
in quantitative yield. The two isomers were not separated and were dissolved in 20 mL 
of anhydrous DMF. Then, NaNO2 (3 mmol, 207 mg) was added and the reaction was 
stirred at room temperature for 22 h. Cold water was added to the reaction and the 
water phase was extracted 3 times with diethy ether. The organic phases were 
collected, dried over Na2SO4, then filtered and concentrated under reduced pressure. 
Purification by column chromatography on silica gel (diethyl ether/cyclohexane from 
1:9 to 3:7) allowed the separation of E and Z isomers and afforded the title compounds 
as colorless oils (89.1 mg, 32%, 0.64 mmol). 
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15h: Yield = 26%. 1H NMR (400 MHz, CDCl3) δ 6.82 – 6.52 (m, 1H), 5.44 (d, J = 16.4 Hz, 
1H), 4.42 (t, J = 6.7 Hz, 2H), 2.38 (q, J = 7.2 Hz, 2H), 2.29 – 2.06 (m, 2H). 13C NMR (100 
MHz, CDCl3) δ 152.1, 116.7, 102.0, 74.1, 29.8, 25.2. HPLC-MS  (ESI) tr = 4.7 min; [M+H]
+ 
= 141.0 m/z, [M+Na]+ = 163.0 m/z. 
15i: Yield = 6.6%. 1H NMR (400 MHz, CDCl3) δ 6.57 – 6.38 (m, 1H), 5.45 (d, J = 10.8 Hz, 
1H), 4.44 (t, J = 7.0 Hz, 2H), 2.57 (q, J = 7.7 Hz, 2H), 2.23 (p, J = 7.4 Hz, 2H). 13C NMR (50 
MHz, CDCl3) δ 151.3, 115.2, 101.9, 74.3, 28.5, 25.7. HPLC-MS  (ESI) tr = 4.5 min; [M+H]
+ 
= 141.0 m/z, [M+Na]+ = 163.0 m/z. 
Synthesis of ethyl (Z)-2-fluoro-6-nitrohex-2-enoate (15j). 
Obtained as the minor isomer from the synthesis of 15k. Yield = 15% 
1H NMR (400 MHz, CDCl3) δ 6.10 (td, J = 32.2, 7.8 Hz, 1H), 4.42 (t, J = 7.0 Hz, 2H), 4.30 
(q, J = 7.2 Hz, 2H), 2.38 (q, J = 7.6 Hz, 2H), 2.19 (p, J = 7.0 Hz, 2H), 1.35 (t, J = 6.7 Hz, 
3H). 
Synthesis of ethyl (E)-5,5-dimethyl-6-nitrohex-2-enoate (15l). 
Nitromethane (6.25 mmol, 0.339 mL)  and methyl 3-methylbut-2-enoate (2.5 mmol, 
0.327 mL) were dissolved in acetonitrile (5 mL) and DBU (1.25 mmol, 0.185 mL) was 
added. The reaction was stirred overnight at room temperature, then the solvent was 
evaporated and the product was purified by column chromatography on silica gel 
(cyclohexane/ethyl acetate 9:1). The product was obtained as a colourless oil (0.47 
mmol, 19%, 83.1 mg). The obtained methyl 3,3-dimethyl-4-nitrobutanoate was 
dissolved in anhydrous DCM (5 mL) and DIBAL-H (1M in DCM, 0.52 mmol, 0.52 mL) was 
added at -78°C. The reaction was stirred at this temperature for 1 h, then quenched 
with 1 mL of methanol and extracted with a saturated solution of potassium sodium 
tartrate. The organic phase was dried over Na2SO4, filtered and concentrated under 
reduced pressure. The 3,3-dimethyl-4-nitrobutanal was directly used without further 
purifications. It was dissolved in DCM (1 mL) and ethyl 
(triphenylphosphoranylidene)acetate (0.56 mmol, 185.8 mg) was added. The reaction 
was stirred at room temperature for 6 h, then the solvent was evaporated and the 
product was purified by column chromatography on silica gel (cyclohexane/ethyl 
acetate 95:5). The product was obtained as a colourless oil (0.45 mmol, 95%, 95.9 mg). 
1H NMR (400 MHz, CDCl3) δ 6.94 (dt, J = 16.1, 8.0 Hz, 1H), 5.94 (d, J = 15.5 Hz, 1H), 4.30 
– 4.15 (m, 4H), 2.31 (d, J = 8.0 Hz, 2H), 1.31 (t, J = 7.2 Hz, 3H), 1.12 (s, 6H). 
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Synthesis of ethyl (E)-5-nitropent-2-enoate (17). 
Synthesised from 3-nitropropanal (produced according to literature procedure109 and 
not purified) using the same procedure of 15c. Yield = 37%. 
1H NMR (400 MHz, CDCl3) δ 6.86 (td, J = 15.6, 6.9 Hz, 1H), 5.95 (td, J = 15.7, 1.5 Hz, 1H), 
4.52 (t, J = 6.9 Hz, 2H), 4.20 (q, J = 7.2 Hz, 2H), 2.92 (q, J = 6.9 Hz, 2H), 1.30 (t, J = 7.1 Hz, 
3H). 13C NMR (100 MHz, CDCl3) δ 165.5, 140.9, 125.0, 73.3, 60.6, 29.4, 14.2. HPLC-MS  
(ESI) tr = 6.0 min; [M+H]
+ = 174.0 m/z. 
General procedure for the organocatalysed Michael addition of nitroalkanes (1) to 3-
ylidene oxindoles (2). The 3-ylidene oxindole (0.1 mmol) was added to a solution of 
catalyst (5 or 10 mol%) in DCM (0.15 mL), then nitroalkane (0.5 mmol) was added at 
room temperature or at 0°C. The mixture was stirred at the same temperature and the 
conversion was monitored by TLC and 1H-NMR. The crude mixture of the reactions 
performed at room temperature was directly purified by flash chromatography on 
silica gel (cyclohexane/ethyl acetate 85/15). The crude mixture of the reactions 
performed at 0°C was quenched at the same temperature with 2 mL of HCl (1N) and 
extracted with DCM (3 X 2 mL). The organic phases were collected, dried over Na2SO4, 
the solvent was evaporated under reduced pressure without heating and the product 
was purified by flash-chromatography on silica gel (cyclohexane/ethyl acetate 85/15). 
Before CSP-HPLC analysis, the purified product (0.04 mmol) (and, when necessary, the 
crude reaction mixture) was deprotected using 18 equivalents of trifluoroacetic acid 
(TFA) in 0.4 mL of DCM. After 45 minutes the reaction was quenched with 2 mL of a 0.1 
M solution of phosphate buffer (pH = 7) and the aqueous phase was extracted with 
DCM (2 X 2 mL). The organic phases were collected and dried over Na2SO4. The solvent 
was evaporated under reduced pressure and the corresponding N-deprotected β-nitro 
oxindole was obtained pure and directly injected into CSP-HPLC.  
3-((R)-1-ethoxy-3-nitro-1-oxopropan-2-yl)-2-oxoindoline (3a): mixture of two 
diastereoisomers. 85% yield (24 mg), oil. 1H NMR (400 MHz, CDCl3) δ = 7.93 (bs, 2H), 
7.34 – 7.20 (m, 3H), 7.17 (d, J = 7.5 Hz, 1H), 7.12 – 7.01 (m, 2H), 6.91 (d, J = 7.8 Hz, 2H), 
4.99 (dd, J = 14.5, 9.4 Hz, 1H), 4.78 (dd, J = 14.8, 8.9 Hz, 1H), 4.46 (m, 2H), 4.29 – 4.14 
(m, 4H), 4.14 – 4.07 (m, 1H), 4.04 (m, 1H), 3.99 – 3.91 (m, 2H), 1.23 (t, J = 7.1 Hz, 3H), 
1.17 (t, J = 7.2 Hz, 3H). 13C NMR (100 MHz, CDCl3) δ = 13.8, 13.9, 43.0, 43.3, 45.0, 45.1, 
                                                     
109 Griesser H., Öhrlein R., Schwab W., Ehrler R., Jäger V., Org. Synth. 2000, 77, 236. 
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62.1, 62.2, 72.0, 72.3, 110.3, 122.9, 123.0, 124.3, 124.4, 124.8, 125.0, 129.2, 129.3, 
141.3, 141.6, 169.1, 169.8, 176.5, 176.8. HPLC-MS (ESI): tr = 6.4 min, 6.8 min; [M+H]
+ = 
279.2 m/z, [M+Na]+ = 301.2 m/z. Anal. Calcd for C13H14N2O5 (278.09): C, 56.11; H, 5.07; 
N, 10.07. Found: C, 55.91; H, 5.09; N, 10.04. CSP-HPLC: OJ 90:10 n-Hex/IPA for 10 min, 
then up to 80:20 in 20 min, 80:20 up to 60 min; flow rate = 0.5 mL/min at 40°C. λ=214 
nm. tr(isomer A) = 38.5 min (major), 44.8 min (minor); tr(isomer B) = 42.7 min (major), 
53.8 min (minor). 
(2R)-Ethyl 2-(1-benzyl-2-oxoindolin-3-yl)-3-nitropropanoate (3b): mixture of two 
diastereoisomers. 86% yield (32 mg), gum. 1H NMR (400 MHz, CDCl3) δ = 7.39 – 7.16 
(m, 14H), 7.10 – 7.01 (m, 2H), 6.84 – 6.72 (m, 2H), 5.03 – 4.88 (m, 5H), 4.80 (dd, J = 
14.8, 8.9 Hz, 1H), 4.52 – 4.37 (m, 2H), 4.24 – 4.04 (m, 6H), 4.01 (d, J = 3.7 Hz, 2H), 1.17 
(t, J = 7.1 Hz, 3H), 1.08 (t, J = 7.1 Hz, 3H). 13C NMR (100 MHz, CDCl3) δ = 13.7, 13.8, 43.2, 
43.4, 44.09, 44.11, 44.5, 44.6, 62.0, 62.1, 72.10, 72.41, 109.5, 122.9, 123.0, 124.0, 
124.1, 124.3, 124.5, 127.4, 127.5, 127.88, 127.91, 128.86, 128.87, 129.0, 129.2, 135.40, 
135.42, 143.4, 143.6, 169.2, 169.7, 174.4, 174.6. HPLC-MS (ESI): tr = 9.5 min, 9.8 min; 
[M+H]+ = 369.2 m/z, [M+Na]+ = 391.2 m/z. Anal. Calcd for C20H20N2O5 (368.14): C, 
65.21; H, 5.47; N, 7.60. Found: C, 65.06; H, 5.47; N, 7.61. CSP-HPLC: IC 90:10 n-Hex/IPA 
for 10 min, then up to 85:15 in 5 min, 85:15 up to 80 min; flow rate = 0.5 mL/min at rt. 
λ=254 nm. tr(isomer A) = 56.1 min (major), 71.0 min (minor); tr(isomer B) = 61.2 min 
(major), 73.6 min (minor).  
Tert-butyl 3-((R)-1-ethoxy-3-nitro-1-oxopropan-2-yl)-2-oxoindoline-1-carboxylate 
(3c): mixture of two diastereoisomers. 80% yield (30 mg), oil. 1H NMR (400 MHz, CDCl3) 
δ = 7.87 (dd, J = 8.4, 2.8 Hz, 2H), 7.41 – 7.33 (m, 2H), 7.29 – 7.14 (m, 4H), 5.01 (dd, J = 
14.4, 9.3 Hz, 1H), 4.84 (dd, J = 14.9, 8.1 Hz, 1H), 4.64 (dd, J = 14.8, 5.8 Hz, 1H), 4.40 (dd, 
J = 14.4, 5.0 Hz, 1H), 4.23 – 4.06 (m, 6H), 4.04 (d, J = 3.8 Hz, 1H), 3.99 (d, J = 3.1 Hz, 1H), 
1.65 (s, 18H), 1.18 (t, J = 7.1 Hz, 3H), 1.13 (t, J = 7.2 Hz, 3H). 13C NMR (100 MHz, CDCl3) 
δ = 13.6, 13.8, 28.0, 43.7, 43.9, 45.0, 45.4, 62.2, 62.3, 72.3, 72.4, 84.9, 85.0, 115.3, 
115.4, 123.2, 123.5, 123.6, 123.7, 124.7, 124.8, 129.2, 129.5, 140.3, 140.6, 148.77, 
148.76, 168.7, 169.2, 172.7, 173.4. HPLC-MS (ESI): tr = 9.9 min, 10.0 min; [M+Na]
+ = 
401.3 m/z. Anal. Calcd for C18H22N2O7 (378.14): C, 57.14; H, 5.86; N, 7.40. Found: C, 
57.02; H, 5.85; N, 7.39.  
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3-((R)-1-ethoxy-3-nitro-1-oxopropan-2-yl)-2-oxoindoline: mixture of two 
diastereoisomers. CSP-HPLC: OJ 90:10 n-Hex/IPA for 10 min, then up to 80:20 in 20 
min, 80:20 up to 70 min; flow rate = 0.5 mL/min at rt. λ=214 nm. tr(isomer A) = 43.2 
min (major), 51.8 min (minor); tr(isomer B) = 49.5 min (major), 63.9 min (minor). 
Tert-butyl 5-chloro-3-((R)-1-ethoxy-3-nitro-1-oxopropan-2-yl)-2-oxoindoline-1-
carboxylate (3d): mixture of two diastereoisomers. 83% yield (34 mg), oil. 1H NMR (400 
MHz, CDCl3) δ = 7.85 (d, J = 5.1 Hz, 1H), 7.83 (d, J = 5.2 Hz, 1H), 7.38 – 7.31 (m, 2H), 
7.24 – 7.20 (m, 2H), 5.00 (dd, J = 14.4, 9.0 Hz, 1H), 4.91 (dd, J = 14.8, 7.3 Hz, 1H), 4.78 
(dd, J = 14.8, 6.6 Hz, 1H), 4.46 (dd, J = 14.4, 5.2 Hz, 1H), 4.22 – 4.03 (m, 6H), 4.00 (d, J = 
4.3 Hz, 1H), 3.93 (d, J = 3.0 Hz, 1H), 1.64 (s, 18H), 1.22 – 1.09 (m, 6H). 13C NMR (50 
MHz, CDCl3) δ = 13.68, 13.73, 28.0, 43.7, 44.0, 44.7, 45.2, 62.4, 62.5, 72.2, 72.6, 85.2, 
85.3, 116.6, 116.7, 123.7, 123.9, 125.1, 125.8, 129.2, 129.5, 130.2, 130.3, 138.9, 139.1, 
148.6, 168.4, 168.6, 171.9, 172.8. HPLC-MS (ESI): tr = 10.7 min; [M+Na]
+ = 435.2, 437.3 
m/z, [M+K]+ = 451.2 m/z, [2M+Na]+ = 847.4 m/z. Anal. Calcd for C18H21ClN2O7 (412.10): 
C, 52.37; H, 5.13; N, 6.79. Found: C, 52.21; H, 5.14; N, 6.78.  
5-chloro-3-((R)-1-ethoxy-3-nitro-1-oxopropan-2-yl)-2-oxoindoline: mixture of two 
diastereoisomers, gum. 1H NMR (400 MHz, CDCl3) δ = 7.96 (bs, 2H), 7.52 – 7.48 (m, 1H), 
7.33 – 7.16 (m, 3H), 6.92 – 6.76 (m, 2H), 4.99 (dd, J = 14.4, 9.0 Hz, 1H), 4.84 (dd, J = 
14.7, 8.2 Hz, 1H), 4.65 – 4.55 (m, 1H), 4.52 (dd, J = 14.5, 4.9 Hz, 1H), 4.40 (m, 1H), 4.27 
– 4.16 (m, 3H), 4.12 – 4.05 (m, 2H), 4.02 – 3.87 (m, 2H), 1.31 – 1.15 (m, 6H). 13C NMR 
(100 MHz, CDCl3) δ = 13.8, 13.9, 43.1, 43.3, 44.8, 44.9, 62.3, 62.4, 72.1, 72.2, 111.0, 
111.1, 124.5, 124.7, 124.9, 124.9, 126.8, 128.0, 128.4, 129.1, 129.3, 129.5, 139.7, 
139.9, 168.9, 169.3, 176.0. HPLC-MS (ESI): tr= 7.5 min, 7.6 min; [M+H]
+= 313.1 m/z, 
[M+Na]+= 335.1 m/z. Anal. Calcd for C13H13ClN2O5 (312.05): C, 49.93; H, 4.19; N, 8.96. 
Found: C, 49.89; H, 4.20; N, 8.94. CSP-HPLC: IC 90:10 n-Hex/IPA up to 50 min; flow rate 
= 0.6 mL/min at rt. λ=214 nm. tr(isomer A) = 31.4 min (major), 39.7 min (minor); 
tr(isomer B) = 44.2 min (minor), 45.9 min (major). 
Tert-butyl 5-bromo-3-((R)-1-ethoxy-3-nitro-1-oxopropan-2-yl)-2-oxoindoline-1-
carboxylate (3e): mixture of two diastereoisomers. 72% yield (33 mg), oil. 1H NMR (400 
MHz, CDCl3) δ = 7.82 – 7.76 (m, 2H), 7.53 – 7.45 (m, 2H), 7.40 – 7.32 (m, 2H), 5.00 (dd, J 
= 14.4, 9.0 Hz, 1H), 4.91 (dd, J = 14.8, 7.3 Hz, 1H), 4.80 (dd, J = 14.8, 6.6 Hz, 1H), 4.46 
(dd, J = 14.5, 5.1 Hz, 1H), 4.24 – 4.02 (m, 6H), 4.00 (d, J = 4.3 Hz, 1H), 3.93 (d, J = 3.0 Hz, 
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1H), 1.64 (s, 18H), 1.22 – 1.09 (m, 6H). 13C NMR (100 MHz, CDCl3) δ = 13.7, 13.7, 28.0, 
43.8, 44.1, 44.7, 45.1, 62.4, 62.5, 72.2, 72.6, 85.2, 85.4, 117.0, 117.0, 117.6, 117.7, 
125.5, 126.2, 126.5, 126.7, 132.1, 132.5, 139.4, 139.6, 148.6, 168.4, 168.6, 171.8, 
172.7. HPLC-MS (ESI): tr= 10.9 min; [M+Na]
+= 479.2, 481.1 m/z. Anal. Calcd for 
C18H21BrN2O7 (456.05): C, 47.28; H, 4.63; N, 6.13. Found: C, 47.13; H, 4.61; N, 6.11.  
5-bromo-3-((R)-1-ethoxy-3-nitro-1-oxopropan-2-yl)-2-oxoindoline: mixture of two 
diastereoisomers, gum. 1H NMR (400 MHz, CDCl3) δ = 7.79 (bs, 2H), 7.45 – 7.38 (m, 2H), 
7.38 – 7.29 (m, 2H), 6.84 – 6.76 (m, 2H), 4.99 (dd, J = 14.5, 8.8 Hz, 1H), 4.84 (dd, J = 
14.8, 8.1 Hz, 1H), 4.62 (dd, J = 14.8, 5.7 Hz, 1H), 4.52 (dd, J = 14.5, 4.8 Hz, 1H), 4.26 – 
4.18 (m, 4H), 4.12 – 4.04 (m, 1H), 4.00 – 3.89 (m, 3H), 1.31 – 1.14 (m, 6H). 13C NMR 
(100 MHz, CDCl3) δ = 13.8, 13.9, 43.2, 43.3, 44.7, 44.8, 62.3, 62.4, 72.17, 72.23, 111.4, 
111.5, 115.5, 127.2, 127.3, 127.6, 127.7, 132.0, 132.2, 140.2, 140.4, 168.9, 169.2, 
175.2, 175.7. HPLC-MS (ESI): tr= 7.7 min; [M+H]
+= 357.1, 359.1 m/z, [M+Na]+= 379.1, 
381.0 m/z. Anal. Calcd for C13H13BrN2O5 (356.00): C, 43.72; H, 3.67; N, 7.84. Found: C, 
43.69; H, 3.68; N, 7.83. CSP-HPLC: IC 90:10 n-Hex/IPA for 10 min, then up to 80:20 in 
10 min, 80:20 for 15 min, then up to 75:25 in 15 min, 75:25 up to 40 min; flow rate = 
0.5 mL/min at rt. λ=214 nm. tr(isomer A) = 27.7 min (major), 31.3 min (minor); 
tr(isomer B) = 32.4 min (major), 33.0 min (minor). 
Tert-butyl 6-chloro-3-((R)-1-ethoxy-3-nitro-1-oxopropan-2-yl)-2-oxoindoline-1-
carboxylate (3f): mixture of two diastereoisomers. 92% yield (38 mg), oil. 1H NMR (400 
MHz, CDCl3) δ = 7.98 – 7.92 (m, 2H), 7.22 – 7.12 (m, 4H), 5.00 (dd, J = 14.3, 9.0 Hz, 1H), 
4.87 (dd, J = 14.8, 7.5 Hz, 1H), 4.74 (dd, J = 14.8, 6.4 Hz, 1H), 4.44 (dd, J = 14.4, 5.3 Hz, 
1H), 4.21 – 4.04 (m, 6H), 3.98 (d, J = 3.9 Hz, 1H), 3.92 (d, J = 2.7 Hz, 1H), 1.65 (s, 18H), 
1.22 – 1.11 (m, 6H). 13C NMR (50 MHz, CDCl3) δ = 13.7, 13.8, 28.0, 43.8, 44.0, 44.6, 
45.0, 62.3, 62.4, 72.3, 72.5, 85.4, 85.5, 116.16, 116.23, 121.7, 122.3, 124.3, 124.5, 
124.7, 124.8, 135.1, 135.4, 141.3, 141.5, 148.5, 168.4, 168.8, 172.2, 173.0. HPLC-MS 
(ESI): tr= 10.9 min; [M+Na]
+= 435.2 m/z, [2M+Na]+= 847.4 m/z. Anal. Calcd for 
C18H21ClN2O7 (412.10): C, 52.37; H, 5.13; N, 6.79. Found: C, 52.16; H, 5.13; N, 6.78.  
6-chloro-3-((R)-1-ethoxy-3-nitro-1-oxopropan-2-yl)-2-oxoindoline: mixture of two 
diastereoisomers, gum. 1H NMR (400 MHz, CDCl3) δ = 8.33 (bs, 2H), 7.19 – 7.02 (m, 4H), 
6.95 (s, 2H), 4.99 (dd, J = 14.4, 9.0 Hz, 1H), 4.81 (dd, J = 14.7, 8.3 Hz, 1H), 4.57 (dd, J = 
14.7, 5.5 Hz, 1H), 4.49 (dd, J = 14.4, 5.1 Hz, 1H), 4.26 – 4.11 (m, 4H), 4.08 (ddd, J = 8.6, 
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5.5, 3.4 Hz, 1H), 4.01 (m, 1H), 3.93 – 3.87 (m, 2H), 1.23 (t, J = 7.1 Hz, 3H), 1.18 (t, J = 7.2 
Hz, 3H). 13C NMR (50 MHz, CDCl3) δ = 13.8, 13.9, 43.1, 43.3, 44.5, 44.6, 62.26, 62.34, 
72.1, 72.3, 110.9, 122.9, 123.0, 123.37, 123.42, 125.28, 125.32, 135.0, 135.2, 142.4, 
168.9, 169.5, 176.4, 176.7. HPLC-MS (ESI): tr= 7.3 min, 7.7 min; [M+Na]
+= 335.1 m/z. 
Anal. Calcd for C13H13ClN2O5 (312.05): C, 49.93; H, 4.19; N, 8.96. Found: C, 49.77; H, 
4.18; N, 8.93. CSP-HPLC: IC 90:10 n-Hex/IPA for 35 min, then up to 80:20 in 15 min, 
80:20 for 10 min, then up to 70:30 in 5 min, 70:30 for 5 min, then up to 1:1 in 2 min, 
1:1 up to 73 min; flow rate = 0.6 mL/min at rt. λ=254 nm. tr(isomer A) = 33.4 min 
(major), 52.7 min (minor); tr(isomer B) = 44.1 min (minor), 68.4 min (major). 
Tert-butyl 7-bromo-3-((R)-1-ethoxy-3-nitro-1-oxopropan-2-yl)-2-oxoindoline-1-
carboxylate (3g): mixture of two diastereoisomers. 82% yield (37 mg), oil. 1H NMR (400 
MHz, CDCl3) δ = 7.56 – 7.47 (m, 2H), 7.22 – 7.16 (m, 2H), 7.05 (t, J = 7.8 Hz, 2H), 5.01 
(dd, J = 14.4, 9.0 Hz, 1H), 4.88 (dd, J = 14.9, 7.5 Hz, 1H), 4.74 (dd, J = 14.9, 6.4 Hz, 1H), 
4.44 (dd, J = 14.4, 5.1 Hz, 1H), 4.20 – 4.05 (m, 6H), 4.04 (d, J = 3.9 Hz, 1H), 3.99 (d, J = 
3.2 Hz, 1H), 1.66 (s, 9H), 1.65 (s, 9H), 1.15 (t, J = 7.6 Hz, 3H), 1.12 (t, J = 7.6 Hz, 3H). 13C 
NMR (50 MHz, CDCl3) δ = 13.6, 13.7, 27.7, 43.7, 44.0, 45.2, 45.6, 62.5, 72.3, 72.4, 86.0, 
86.1, 106.5, 106.6, 122.6, 122.8, 125.49, 125.54, 127.0, 127.6, 134.0, 134.3, 139.3, 
139.5, 147.5, 168.4, 168.6, 173.0, 173.7. HPLC-MS (ESI): tr= 10.5 min; [M+Na]
+= 479.1, 
481.2 m/z. Anal. Calcd for C18H21BrN2O7 (456.05): C, 47.28; H, 4.63; N, 6.13. Found: C, 
47.13; H, 4.64; N, 6.14.  
7-bromo-3-((R)-1-ethoxy-3-nitro-1-oxopropan-2-yl)-2-oxoindoline: mixture of two 
diastereoisomers, gum. 1H NMR (400 MHz, CDCl3) δ = 8.07 (bs, 2H), 7.43 (d, J = 3.7 Hz, 
1H), 7.41 (d, J = 3.7 Hz, 1H), 7.17 (d, J = 7.4 Hz, 1H), 7.13 (d, J = 7.7 Hz, 1H), 7.00 – 6.93 
(m, 2H), 5.01 (dd, J = 14.4, 9.0 Hz, 1H), 4.81 (dd, J = 14.8, 8.4 Hz, 1H), 4.60 (dd, J = 14.8, 
5.5 Hz, 1H), 4.49 (dd, J = 14.5, 4.6 Hz, 1H), 4.26 – 3.99 (m, 8H), 1.21 (t, J = 7.1 Hz, 3H), 
1.15 (t, J = 7.1 Hz, 3H). 13C NMR (50 MHz, CDCl3) δ = 13.7, 13.8, 43.2, 43.3, 46.0, 46.2, 
62.2, 62.3, 72.1, 72.4, 103.2, 103.3, 123.1, 124.1, 126.30, 126.34, 131.8, 132.0, 140.8, 
141.04, 168.8, 169.3, 174.8, 175.2. HPLC-MS (ESI): tr= 7.3 min, 7.6 min; [M+H]
+= 357.2, 
359.1 m/z, [M+Na]+= 379.1, 381.0 m/z. Anal. Calcd for C13H13BrN2O5 (356.00): C, 43.72; 
H, 3.67; N, 7.84. Found: C, 43.71; H, 3.68; N, 7.81. CSP-HPLC: IC 85:15 n-Hex/IPA for 15 
min, then up to 80:20 in 10 min, 80:20 for 10 min, then up to 70:30 in 10 min, 70:30 up 
Chapter 4 
114 
 
to 70 min; flow rate = 0.5 mL/min at 14°C. λ=214 nm. tr(isomer A) = 48.4 min (major), 
50.7 min (minor); tr(isomer B) = 57.4 min (major), 66.1 min (minor). 
Tert-butyl 3-((R)-1-ethoxy-3-nitro-1-oxopropan-2-yl)-5-methoxy-2-oxoindoline-1-
carboxylate (3h): mixture of two diastereoisomers. 89% yield (36 mg), oil. 1H NMR 
(400 MHz, CDCl3) δ = 7.79 (d, J = 2.9 Hz, 1H), 7.77 (d, J = 2.9 Hz, 1H), 6.90 – 6.84 (m, 
2H), 6.80 (dd, J = 2.6, 1.1 Hz, 1H), 6.77 (dd, J = 2.6, 1.2 Hz, 1H), 4.97 (dd, J = 14.5, 9.1 
Hz, 1H), 4.84 (dd, J = 14.8, 8.1 Hz, 1H), 4.64 (dd, J = 14.8, 5.8 Hz, 1H), 4.35 (dd, J = 14.5, 
4.6 Hz, 1H), 4.25 – 4.01 (m, 7H), 3.96 (d, J = 2.8 Hz, 1H), 3.81 (s, 3H), 3.80 (s, 3H), 1.64 
(s, 18H), 1.22 –1.13 (m, 6H). 13C NMR (50 MHz, CDCl3) δ = 13.7, 13.8, 28.1, 43.7, 43.9, 
45.3, 45.7, 55.6, 55.7, 62.2, 62.3, 72.1, 72.5, 84.66, 84.74, 110.0, 110.2, 113.8, 113.9, 
116.3, 116.4, 124.5, 125.0, 133.6, 133.8, 148.8, 156.97, 157.01, 168.7, 169.1, 172.6, 
173.4. HPLC-MS (ESI): tr= 9.9 min, 10.2 min; [M+Na]
+= 431.3 m/z, [2M+Na]+ = 839.6 
m/z. Anal. Calcd for C19H24N2O8 (408.15): C, 55.88; H, 5.92; N, 6.86. Found: C, 55.77; H, 
5.93; N, 6.87.  
3-((R)-1-ethoxy-3-nitro-1-oxopropan-2-yl)-5-methoxy-2-oxoindoline: mixture of two 
diastereoisomers, gum. 1H NMR (400 MHz, CDCl3) δ = 8.45 (bs, 2H), 6.90 – 6.73 (m, 
6H), 4.96 (dd, J = 14.5, 9.3 Hz, 1H), 4.76 (dd, J = 14.8, 8.9 Hz, 1H), 4.49 – 4.35 (m, 2H), 
4.29 – 4.15 (m, 4H), 4.10 (ddd, J = 8.6, 4.8, 3.3 Hz, 1H), 4.04 – 3.92 (m, 3H), 3.79 (s, 3H), 
3.78 (s, 3H), 1.25 (t, J = 7.1 Hz, 3H), 1.20 (t, J = 7.1 Hz, 3H). 13C NMR (50 MHz, CDCl3) δ = 
13.8, 13.9, 43.0, 43.3, 45.5, 45.6, 55.78, 55.84, 62.1, 62.2, 72.0, 72.1, 110.8, 111.6, 
111.7, 113.7, 113.8, 126.1, 126.4, 134.6, 134.8, 156.09, 156.14, 169.1, 169.8, 176.5, 
176.8. HPLC-MS (ESI): tr= 5.9 min, 6.2 min; [M+H]
+= 309.2 m/z, [M+Na]+= 331.2, 
[2M+Na]+= 639.3 m/z. Anal. Calcd for C14H16N2O6 (308.10): C, 54.54; H, 5.23; N, 9.09. 
Found: C, 54.42; H, 5.24; N, 9.12. CSP-HPLC: OD-H 85:15 n-Hex/IPA for 15 min, then up 
to 80:20 in 10 min, 80:20 for 10 min, then up to 70:30 in 10 min, 70:30 up to 41 min; 
flow rate = 0.5 mL/min at rt. λ=214 nm. tr(isomer A) = 24.9 min (major), 33.4 min 
(minor); tr(isomer B) = 31.3 min (minor), 36.3 min (major). 
Tert-butyl 3-((R)-1-(benzyloxy)-3-nitro-1-oxopropan-2-yl)-2-oxoindoline-1-
carboxylate (3i): mixture of two diastereoisomers. 72% yield (32 mg), oil. 1H NMR (200 
MHz, CDCl3) δ = 7.80 (d, J = 8.2 Hz, 2H), 7.41 – 6.95 (m, 16H), 5.15 (s, 2H), 5.10 (s, 2H), 
5.02 (dd, J = 14.4, 9.3 Hz, 1H), 4.81 (dd, J = 14.8, 8.3 Hz, 1H), 4.58 (dd, J = 14.9, 5.5 Hz, 
1H), 4.39 (dd, J = 14.5, 4.6 Hz, 1H), 4.27 – 3.93 (m, 4H), 1.64 (s, 9H), 1.63 (s, 9H). 13C 
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NMR (50 MHz, CDCl3) δ = 28.0, 43.6, 43.7, 45.0, 45.4, 67.97, 68.02, 72.2, 84.9, 115.4, 
115.5, 123.1, 123.3, 123.5, 124.6, 124.7, 128.4, 128.5, 128.6, 128.7, 129.2, 129.4, 
134.4, 134.5, 140.2, 140.5, 148.6, 168.7, 169.1, 172.5, 173.2. HPLC-MS (ESI): tr= 11.0 
min, 11.2 min; [M+Na]+= 463.3 m/z, [2M+Na]+= 903.5 m/z. Anal. Calcd for C23H24N2O7 
(440.16): C, 62.72; H, 5.49; N, 6.36. Found: C, 62.71; H, 5.48; N, 6.35.  
3-((R)-1-(benzyloxy)-3-nitro-1-oxopropan-2-yl)-2-oxoindoline: mixture of two 
diastereoisomers, gum. 1H NMR (400 MHz, CDCl3) δ = 8.42 (bs, 2H), 7.39 – 7.30 (m, 
6H), 7.30 – 7.20 (m, 7H), 7.18 (d, J = 7.5 Hz, 1H), 7.08 – 6.91 (m, 3H), 6.85 (t, J = 8.4 Hz, 
1H), 5.26 – 5.08 (m, 4H), 5.01 (dd, J = 14.6, 9.5 Hz, 1H), 4.76 (dd, J = 14.8, 9.0 Hz, 1H), 
4.51 – 4.38 (m, 2H), 4.16 (m, 1H), 4.10 (m, 1H), 3.98 – 3.91 (m, 2H). 13C NMR (50 MHz, 
CDCl3) δ = 43.0, 43.3, 44.98, 45.03, 67.8, 67.9, 71.9, 72.3, 110.3, 110.4, 122.96, 122.99, 
124.3, 124.4, 124.6, 124.8, 128.4, 128.51, 128.54, 128.6, 128.7, 129.1, 129.3, 134.6, 
134.7, 141.2, 141.5, 169.1, 169.7, 176.3, 176.5. HPLC-MS (ESI): tr= 8.4 min, 8.7 min; 
[M+H]+= 341.1 m/z, [M+Na]+ = 363.2 m/z. Anal. Calcd for C18H16N2O5 (340.11): C, 63.52; 
H, 4.74; N, 8.23. Found: C, 63.42; H, 4.73; N, 8.22. CSP-HPLC: OJ 90:10 n-Hex/IPA for 10 
min, then up to 80:20 in 20 min, 80:20 up to 105 min; flow rate = 0.5 mL/min at rt. 
λ=214 nm. tr(isomer A) = 77.1 min (minor), 90.9 min (major); tr(isomer B) = 84.8 min 
(major), 100.9 min (minor).  
Tert-butyl 3-((R)-1-(tert-butoxy)-3-nitro-1-oxopropan-2-yl)-2-oxoindoline-1-
carboxylate (3j): mixture of two diastereoisomers. 99% yield (40 mg), oil. 1H NMR (400 
MHz, CDCl3) δ = 7.90 (d, J = 8.1 Hz, 1H), 7.86 (d, J = 8.1 Hz, 1H), 7.40 – 7.32 (m, 2H), 
7.28 – 7.14 (m, 4H), 5.06 (dd, J = 14.2, 9.0 Hz, 1H), 4.88 (dd, J = 14.7, 8.1 Hz, 1H), 4.69 
(dd, J = 14.7, 6.0 Hz, 1H), 4.49 (dd, J = 14.1, 5.6 Hz, 1H), 4.15 (ddd, J = 8.9, 5.7, 2.9 Hz, 
1H), 4.00 (ddd, J = 8.1, 6.0, 3.3 Hz, 1H), 3.93 (d, J = 3.2 Hz, 1H), 3.82 (d, J = 2.8 Hz, 1H), 
1.65 (s, 9H), 1.64 (s, 9H), 1.30 (s, 9H), 1.19 (s, 9H). 13C NMR (50 MHz, CDCl3) δ = 27.3, 
27.5, 28.1, 44.5, 44.9, 45.1, 45.5, 72.9, 73.3, 83.5, 84.8, 115.2, 115.3, 123.5, 123.6, 
123.7, 124.3, 124.6, 129.0, 129.3, 140.3, 140.7, 148.9, 167.4, 167.9, 172.8, 173.4. 
HPLC-MS (ESI): tr= 10.8 min, 11.1 min; [M+Na]
+= 429.4 m/z, [2M+Na]+ = 835.5 m/z. 
Anal. Calcd for C20H26N2O7 (406.17): C, 59.10; H, 6.45; N, 6.89. Found: C, 58.95; H, 6.44; 
N, 6.91.  
3-((R)-1-(tert-butoxy)-3-nitro-1-oxopropan-2-yl)-2-oxoindoline: mixture of two 
diastereoisomers, syrup. 1H NMR (400 MHz, CDCl3) δ = 8.06 (bs, 2H), 7.32 – 7.25 (m, 
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2H), 7.25 – 7.19 (m, 2H), 7.11 – 7.03 (m, 2H), 6.95 – 6.88 (m, 2H), 5.00 (dd, J = 14.2, 9.3 
Hz, 1H), 4.80 (dd, J = 14.7, 9.1 Hz, 1H), 4.46 (ddd, J = 14.2, 12.1, 5.0 Hz, 2H), 4.08 – 3.96 
(m, 2H), 3.91 (d, J = 3.5 Hz, 1H), 3.81 (d, J = 3.6 Hz, 1H). 13C NMR (100 MHz, CDCl3) δ = 
43.9, 44.0, 45.00, 45.2, 72.3, 73.1, 109.9, 110.0, 122.9, 122.8, 124.4, 124.5, 125.2, 
125.4, 129.0, 129.2, 141.1, 141.6, 167.8, 168.7, 176.2, 176.3. HPLC-MS (ESI): tr= 7.3 
min, 7.9 min; [M+H]+= 251.1 m/z. Anal. Calcd for C11H10N2O5 (250.06): C, 52.80; H, 4.03; 
N, 11.20. Found: C, 52.74; H, 4.01; N, 11.23. CSP-HPLC: OJ 90:10 n-Hex/IPA for 10 min, 
then up to 80:20 in 20 min, 80:20 up to 56 min; flow rate = 0.5 mL/min at rt. λ=214 nm. 
tr(isomer A) = 27.6 min (major), 38.4 min (minor); tr(isomer B) = 33.0 min (major), 52.2 
min (minor). 
Tert-butyl 3-((S)-2-nitro-1-phenylethyl)-2-oxoindoline-1-carboxylate (3k): mixture of 
two diastereoisomers. 52% yield (20 mg), gum. 1H NMR (400 MHz, CDCl3) δ = 7.72 (d, J 
= 8.2 Hz, 1H), 7.57 (d, J = 8.0 Hz, 1H), 7.35 – 7.08 (m, 10H), 7.08 – 6.95 (m, 5H), 6.63 (d, 
J = 7.5 Hz, 1H), 5.43 – 5.29 (m, 2H), 5.12 (dd, J = 13.9, 7.9 Hz, 1H), 4.92 (dd, J = 13.1, 9.0 
Hz, 1H), 4.25 (td, J = 7.6, 3.8 Hz, 1H), 4.03 (m, 1H), 3.92 (d, J = 3.7 Hz, 1H), 3.80 (d, J = 
7.8 Hz, 1H), 1.65 (s, 18H). 13C NMR (100 MHz, CDCl3) δ = 27.99, 28.01, 45.5, 46.0, 48.2, 
48.7, 75.7, 77.1, 84.5, 84.6, 114.9, 115.0, 123.9, 124.1, 124.3, 124.4, 124.6, 124.8, 
128.0, 128.2, 128.4, 128.48, 128.53, 128.7, 128.8, 129.0, 134.1, 135.2, 140.2, 140.4, 
148.5, 148.6, 173.5, 173.9. HPLC-MS (ESI): tr= 10.6 min; [M+Na]
+= 405.2 m/z. Anal. 
Calcd for C21H22N2O5 (382.15): C, 65.96; H, 5.80; N, 7.33. Found: C, 65.87; H, 5.81; N, 
7.32.  
3-((S)-2-nitro-1-phenylethyl)-2-oxoindoline: mixture of two diastereoisomers, 
amorphous solid. 1H NMR (400 MHz, CDCl3) δ = 7.33 – 7.00 (m, 14H), 6.93 – 6.85 (m, 
1H), 6.80 (d, J = 7.8 Hz, 1H), 6.67 (d, J = 7.7 Hz, 1H), 6.57 (d, J = 7.6 Hz, 1H), 5.48 (dd, J = 
13.1, 6.7 Hz, 1H), 5.35 (dd, J = 13.7, 7.3 Hz, 1H), 5.14 (dd, J = 13.7, 8.0 Hz, 1H), 4.92 (dd, 
J = 13.1, 9.1 Hz, 1H), 4.29 (dt, J = 7.7, 4.0 Hz, 1H), 4.01 (m, 1H), 3.84 (d, J = 3.9 Hz, 1H), 
3.73 (d, J = 8.3 Hz, 1H). 13C NMR (50 MHz, CDCl3) δ = 44.5, 45.3, 47.9, 48.6, 75.8, 77.5, 
109.8, 110.0, 122.4, 122.5, 124.4, 125.4, 126.26, 126.32, 128.0, 128.1, 128.40, 128.45, 
128.50, 128.53, 128.8, 134.9, 136.0, 141.2, 141.5, 177.4, 177.5. HPLC-MS (ESI): tr= 7.6 
min; [M+H]+= 283.3 m/z, [M+Na]+= 305.3 m/z. Anal. Calcd for C16H14N2O3 (282.10): C, 
68.07; H, 5.00; N, 9.92. Found: C, 67.94; H, 5.00; N, 9.96. CSP-HPLC: IC 90:10 n-Hex/IPA 
for 10 min, then up to 80:20 in 5 min, 80:20 for 15 min, then up to 70:30 in 5 min, 
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70:30 up to 36 min; flow rate = 0.5 mL/min at rt. λ=230 nm. tr(isomer A) = 25.0 min 
(minor), 26.8 min (major); tr(isomer B) = 29.7 min (major), 31.7 min (minor). 
Tert-butyl 3-((S)-2-nitro-1-(4-nitrophenyl)ethyl)-2-oxoindoline-1-carboxylate (3l): 
mixture of two diastereoisomers. 98% yield (42 mg), gum. 1H NMR (400 MHz, CDCl3) δ 
= 8.12 (d, J = 8.5 Hz, 2H), 8.00 (d, J = 8.8 Hz, 2H), 7.73 (d, J = 8.2 Hz, 1H), 7.57 (d, J = 8.1 
Hz, 1H), 7.40 – 7.30 (m, 2H), 7.30 – 7.17 (m, 6H), 7.16 – 7.07 (m, 1H), 6.85 (d, J = 7.6 Hz, 
1H), 5.42 – 5.22 (m, 3H), 4.97 (dd, J = 13.4, 9.5 Hz, 1H), 4.37 (ddd, J = 8.5, 6.8, 3.9 Hz, 
1H), 4.32 – 4.23 (m, 1H), 3.98 (d, J = 3.8 Hz, 1H), 3.88 (d, J = 6.7 Hz, 1H), 1.58 (s, 18H). 
13C NMR (50 MHz, CDCl3) δ = 27.97, 28.00, 45.1, 45.5, 48.1, 48.5, 75.4, 85.1, 115.2, 
115.4, 123.3, 123.6, 123.7, 123.8, 124.4, 124.5, 124.7, 129.2, 129.3, 129.5, 129.6, 
140.0, 140.5, 141.5, 142.4, 147.7, 147.9, 148.2, 148.3, 172.8, 173.4. HPLC-MS (ESI): tr= 
10.7 min; [M+Na]+= 450.2 m/z, [2M+Na]+= 877.7 m/z. Anal. Calcd for C21H21N3O7 
(427.14): C, 59.01; H, 4.95; N, 9.83. Found: C, 58.85; H, 4.94; N, 9.81. 
3-((S)-2-nitro-1-(4-nitrophenyl)ethyl)-2-oxoindoline: mixture of two diastereoisomers, 
amorphous solid. 1H NMR (400 MHz, CDCl3) δ = 8.12 (d, J = 8.9 Hz, 2H), 8.01 (d, J = 8.8 
Hz, 2H), 7.91 (bs, 1H), 7.38 – 7.23 (m, 6H), 7.19 (t, J = 7.2 Hz, 1H), 7.09 (t, J = 7.6 Hz, 
1H), 7.01 (t, J = 7.6 Hz, 1H), 6.87 – 6.80 (m, 2H), 6.70 (d, J = 7.8 Hz, 1H), 5.41 – 5.26 (m, 
3H), 4.97 (dd, J = 13.3, 9.4 Hz, 1H), 4.41 (ddd, J = 8.3, 6.9, 4.0 Hz, 1H), 4.27 (dt, J = 9.4, 
6.7 Hz, 1H), 3.90 (d, J = 3.9 Hz, 1H), 3.81 (d, J = 6.9 Hz, 1H). 13C NMR (50 MHz, CDCl3) δ 
= 44.3, 44.9, 47.8, 48.3, 75.4, 76.6, 110.2, 110.4, 122.9, 123.0, 123.6, 123.9, 124.3, 
125.0, 125.4, 129.1, 129.2, 129.4, 129.5, 140.8, 141.3, 142.1, 142.9, 147.6, 147.9, 
176.4, 176.7. HPLC-MS (ESI): tr= 7.5 min, 7.6 min; [M+H]
+= 328.3 m/z, [M+Na]+= 350.1 
m/z. Anal. Calcd for C16H13N3O5 (327.09): C, 58.72; H, 4.00; N, 12.84. Found: C, 58.52; 
H, 4.01; N, 12.85. CSP-HPLC: IC 85:15 n-Hex/IPA for 20 min, then up to 80:20 in 20 min, 
80:20 up to 52 min; flow rate = 0.5 mL/min at rt. λ=214 nm. tr(isomer A) = 39.0 min 
(minor), 46.8 min (major); tr(isomer B) = 43.0 min (major), 45.5 min (minor). 
Tert-butyl 3-((S)-3,3-dimethyl-1-nitrobutan-2-yl)-2-oxoindoline-1-carboxylate (3m): 
mixture of two diastereoisomers. 62% yield (22 mg), gum. 1H NMR (400 MHz, CDCl3) δ 
= 7.88 (d, J = 8.3 Hz, 1H), 7.79 (d, J = 8.2 Hz, 1H), 7.38 – 7.11 (m, 6H), 4.71 – 4.47 (m, 
4H), 3.82 (s, 1H), 3.74 (s, 1H), 3.05 (ddd, J = 10.4, 4.7, 1.7 Hz, 1H), 2.86 (m, 1H), 1.65 (s, 
18H), 1.13 (s, 18H). 13C NMR (50 MHz, CDCl3) δ = 28.1, 28.3, 28.6, 33.7, 34.1, 45.3, 45.4, 
48.0, 49.7, 73.7, 74.1, 84.4, 84.5, 115.0, 115.6, 123.3, 124.0, 124.4, 124.5, 127.4, 128.4, 
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128.8, 139.8, 140.8, 149.0, 149.1, 174.0, 175.7. HPLC-MS (ESI): tr= 10.8 min, 11.2 min; 
[M+Na]+= 385.2 m/z, [2M+Na]+= 747.7 m/z. Anal. Calcd for C19H26N2O5 (362.18): C, 
62.97; H, 7.23; N, 7.73. Found: C, 62.95; H, 7.24; N, 7.74.  
3-((S)-3,3-dimethyl-1-nitrobutan-2-yl)-2-oxoindoline: mixture of two 
diastereoisomers, amorphous solid. 1H NMR (400 MHz, CDCl3) δ = 8.32 (bs, 1H), 8.22 
(bs, 1H), 7.31 – 7.16 (m, 4H), 7.13 – 6.98 (m, 2H), 6.95 – 6.81 (m, 2H), 4.74 – 4.47 (m, 
4H), 3.72 (s, 1H), 3.66 (s, 1H), 3.06 (ddd, J = 9.9, 4.9, 1.7 Hz, 1H), 2.90 (ddd, J = 8.6, 5.1, 
1.8 Hz, 1H), 1.14 (s, 18H). 13C NMR (50 MHz, CDCl3) δ = 28.4, 28.5, 33.7, 34.1, 45.4, 
47.1, 48.8, 74.2, 74.6, 109.8, 110.3, 122.3, 122.7, 123.9, 125.1, 126.1, 128.3, 128.6, 
129.1, 140.8, 141.8, 177.6, 179.5. HPLC-MS (ESI): tr= 7.8 min, 8.4 min; [M+H]
+= 263.1 
m/z, [M+Na]+= 285.2 m/z, [2M+H]+= 525.3 m/z. Anal. Calcd for C14H18N2O3 (262.13): C, 
64.10; H, 6.92; N, 10.68. Found: C, 63.88; H, 6.94; N, 10.70. CSP-HPLC: IC 90:10 n-
Hex/IPA for 15 min, then up to 80:20 in 10 min, 80:20 for 10 min, then up to 70:30 in 5 
min, 70:30 for 5 min, then up to 1:1 in 1 min, 1:1 up to 53 min; flow rate = 0.5 mL/min 
at rt. λ=254 nm. tr(isomer A) = 31.5 min (major), 39.2 min (minor); tr(isomer B) = 45.9 
min (major), 47.7 min (minor). 
Tert-butyl 3-((R)-1-ethoxy-2-methyl-3-nitro-1-oxopropan-2-yl)-2-oxoindoline-1-
carboxylate (3n): mixture of two diastereoisomers. 57% yield (22 mg), oil. 1H NMR 
(400 MHz, CDCl3) δ = 7.92 – 7.78 (m, 2H), 7.59 (d, J = 7.6 Hz, 1H), 7.41 – 7.29 (m, 2H), 
7.22 – 7.12 (m, 2H), 7.04 (d, J = 7.6 Hz, 1H), 5.38 (d, J = 13.2 Hz, 1H), 5.15 (d, J = 13.2 
Hz, 2H), 4.97 (d, J = 12.4 Hz, 1H), 4.46 – 4.33 (m, 4H), 3.95 (s, 1H), 3.94 (s, 1H), 1.65 (s, 
9H), 1.64 (s, 9H), 1.38 (t, J = 7.2 Hz, 3H), 1.35 (t, J = 6.8 Hz, 3H), 1.13 (s, 6H). 13C NMR 
(50 MHz, CDCl3) (major isomer) δ = 13.9, 14.6, 28.1, 49.1, 49.9, 62.2, 80.0, 85.1, 115.0, 
122.6, 124.6, 125.1, 129.4, 140.8, 148.6, 171.6, 172.8. HPLC-MS (ESI): tr = 10.8 min; 
[M+Na]+ = 415.4 m/z, [2M+Na]+ = 807.5 m/z. Anal. Calcd for C19H24N2O7 (392.16): C, 
58.16; H, 6.16; N, 7.14. Found: C, 58.08; H, 6.18; N, 7.15.  
3-((R)-1-ethoxy-2-methyl-3-nitro-1-oxopropan-2-yl)-2-oxoindoline: mixture of two 
diastereoisomers, gum. 1H NMR (400 MHz, CDCl3) δ = 7.68 (bs, 1H), 7.57 (bs, 1H), 7.40 
– 7.19 (m, 3H), 7.09 – 6.94 (m, 3H), 6.88 (d, J = 7.6 Hz, 1H), 6.82 (d, J = 8.2 Hz, 1H), 5.46 
(d, J = 13.2 Hz, 1H), 5.17 (d, J = 12.8 Hz, 1H), 5.15 (d, J = 13.2 Hz, 1H), 4.93 (d, J = 12.8 
Hz, 1H), 4.48 – 4.34 (m, 4H), 3.85 (s, 2H), 1.41 (t, J = 7.2 Hz, 3H), 1.37 (t, J = 7.2 Hz, 3H), 
1.13 (s, 6H). 13C NMR (100 MHz, CDCl3) (major isomer) δ = 14.1, 14.3, 48.4, 49.5, 62.2, 
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79.8, 109.8, 122.9, 124.3, 125.2, 129.2, 141.4, 171.9, 175.7. HPLC-MS (ESI): tr = 6.7 min, 
7.4 min; [M+H]+= 293.3 m/z, [M+Na]+ = 315.2 m/z, [2M+Na]+ = 607.4 m/z. Anal. Calcd 
for C14H16N2O5 (292.11): C, 57.53; H, 5.52; N, 9.58. Found: C, 57.51; H, 5.54; N, 9.56. 
CSP-HPLC: IC 90:10 n-Hex/IPA for 10 min, then up to 80:20 in 5 min, 80:20 for 15 min, 
then up to 70:30 in 15 min, 70:30 up to 47 min; flow rate = 0.5 mL/min at rt. λ=214 nm. 
tr(isomer A) = 23.2 min (major), 29.0 min (minor); tr(isomer B) = 35.3 min (minor), 41.6 
min (major). 
Tert-butyl 3-((2R,3S)-1-ethoxy-3-nitro-1-oxobutan-2-yl)-2-oxoindoline-1-carboxylate 
(anti-4b): mixture of two diastereoisomers. 71% yield (28 mg), gum. 1H NMR (400 
MHz, CDCl3) δ = 7.84 (t, J = 8.6 Hz, 2H), 7.39 – 7.29 (m, 4H), 7.17 (t, J = 7.7 Hz, 2H), 5.67 
(dq, J = 9.9, 6.8 Hz, 1H), 5.30 (dq, J = 9.2, 6.3 Hz, 1H), 3.99 – 3.91 (m, 4H), 3.91 – 3.84 
(m, 1H), 3.80 (dd, J = 9.3, 4.1 Hz, 1H), 3.74 (d, J = 4.3 Hz, 1H), 3.62 (d, J = 4.0 Hz, 1H), 
1.78 (d, J = 6.5 Hz, 3H), 1.64 (m, 21H), 0.99 (t, J = 7.2 Hz, 3H), 0.98 (t, J = 7.2 Hz, 3H). 13C 
NMR (100 MHz, CDCl3) δ = 13.5, 13.6, 18.1, 18.9, 28.0, 28.1, 44.1, 45.3, 50.6, 51.5, 61.8, 
61.8, 79.5, 81.8, 84.5, 84.7, 115.1, 115.2, 123.4, 123.7, 124.0, 124.4, 124.5, 124.6, 
129.1, 129.3, 140.4, 140.5, 148.9, 149.1, 167.9, 168.1, 172.8, 172.9. HPLC-MS (ESI): tr= 
10.3 min, 10.4 min; [M+Na]+= 415.3 m/z. Anal. Calcd for C19H24N2O7 (392.16): C, 58.16; 
H, 6.16; N, 7.14. Found: C, 57.98; H, 6.18; N, 7.14.  
3-((2R,3S)-1-ethoxy-3-nitro-1-oxobutan-2-yl)-2-oxoindoline: mixture of two 
diastereoisomers, amorphous solid. 1H NMR (400 MHz, CDCl3) δ = 8.10 (bs, 1H), 8.01 
(bs, 1H), 7.34 – 7.19 (m, 4H), 7.12 – 7.01 (m, 2H), 6.94 – 6.83 (m, 2H), 5.62 (dq, J = 9.6, 
6.9 Hz, 1H), 5.36 (dq, J = 8.6, 6.6 Hz, 1H), 4.08 – 3.96 (m, 4H), 3.90 (dd, J = 9.6, 4.4 Hz, 
1H), 3.77 (dd, J = 8.5, 5.2 Hz, 1H), 3.70 (d, J = 4.4 Hz, 1H), 3.60 (d, J = 5.2 Hz, 1H), 1.77 
(d, J = 6.6 Hz, 3H), 1.62 (d, J = 6.9 Hz, 3H), 1.02, (t, J = 7.1 Hz, 6H). 13C NMR (100 MHz, 
CDCl3) δ = 13.67, 13.72, 17.4, 18.7, 44.0, 44.8, 49.8, 50.4, 61.68, 61.73, 79.5, 81.6, 
109.8, 109.9, 122.5, 122.8, 124.6, 125.2, 125.3, 125.4, 128.9, 129.0, 141.2, 141.4, 
168.3, 168.7, 176.3. HPLC-MS (ESI): tr= 6.9 min, 7.0 min; [M+H]
+= 293.3 m/z, [M+Na]+= 
315.2 m/z, [2M+Na]+= 607.4 m/z. Anal. Calcd for C14H16N2O5 (292.11): C, 57.53; H, 5.52; 
N, 9.58. Found: C, 57.39; H, 5.51; N, 9.55. CSP-HPLC: IC 90:10 n-Hex/IPA for 10 min, 
then up to 80:20 in 5 min, 80:20 for 20 min, then up to 75:25 in 15 min, 75:25 up to 53 
min; flow rate = 0.5 mL/min at rt. λ=214 nm. tr(isomer A) = 24.4 min (major), 31.5 min 
(minor); tr(isomer B) = 39.8 min (minor), 47.0 min (major). 
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Tert-butyl 3-((2R,3S)-1-ethoxy-3-nitro-1-oxopentan-2-yl)-2-oxoindoline-1-carboxylate 
(anti-4c): mixture of two diastereoisomers. 76% yield (31 mg), gum. 1H NMR (400 MHz, 
CDCl3) δ = 7.84 (t, J = 8.0 Hz, 2H), 7.40 – 7.22 (m, 4H), 7.20 – 7.12 (m, 2H), 5.62 (ddd, J = 
10.8, 7.3, 5.8 Hz, 1H), 5.16 (ddd, J = 10.3, 8.3, 5.0 Hz, 1H), 3.92 (q, J = 7.1 Hz, 2H), 3.89 – 
3.81 (m, 3H), 3.77 (dd, J = 10.3, 3.0 Hz, 1H), 3.62 (d, J = 4.3 Hz, 1H), 3.54 – 3.47 (m, 1H), 
2.19 – 2.05 (m, 2H), 2.00 – 1.89 (m, 2H), 1.65 (s, 18H), 1.08 (t, J = 7.3 Hz, 3H), 1.03 (t, J 
= 7.3 Hz, 3H), 0.95 (t, J = 7.3 Hz, 3H), 0.92 (t, J = 7.3 Hz, 3H). 13C NMR (100 MHz, CDCl3) 
δ = 9.6, 10.5, 13.4, 13.5, 26.3, 26.6, 28.0, 28.1, 44.0, 45.6, 49.9, 50.8, 61.76, 61.78, 
84.5, 84.6, 85.4, 88.9, 115.0, 115.1, 123.1, 123.6, 123.9, 124.4, 124.6, 124.7, 129.1, 
129.2, 140.4, 140.5, 148.9, 149.1, 167.9, 168.1, 172.6, 172.9. HPLC-MS (ESI): tr= 10.9 
min, 11.0 min; [M+Na]+= 429.2 m/z. Anal. Calcd for C20H26N2O7 (406.17): C, 59.10; H, 
6.45; N, 6.89. Found: C, 59.04; H, 6.43; N, 6.92.  
3-((2R,3S)-1-ethoxy-3-nitro-1-oxopentan-2-yl)-2-oxoindoline: mixture of two 
diastereoisomers, gum. 1H NMR (400 MHz, CDCl3) δ = 8.14 (bs, 2H), 7.39 – 7.17 (m, 
4H), 7.14 – 6.98 (m, 2H), 6.95 – 6.81 (m, 2H), 5.60 (ddd, J = 10.6, 8.4, 4.7 Hz, 1H), 5.25 – 
5.12 (m, 1H), 4.00 – 3.80 (m, 5H), 3.73 (dd, J = 9.9, 3.7 Hz, 1H), 3.56 (d, J = 4.4 Hz, 1H), 
3.45 (d, J = 3.7 Hz, 1H), 2.24 – 2.05 (m, 2H), 2.05 – 1.87 (m, 2H), 1.11 – 1.05 (m, 3H), 
1.02 (t, J = 7.3 Hz, 3H), 0.99 – 0.91 (m, 6H). 13C NMR (50 MHz, CDCl3) δ = 9.7, 10.5, 13.5, 
13.6, 26.2, 26.3, 44.1, 45.4, 49.3, 49.7, 61.6, 61.7, 85.5, 88.9, 109.9, 110.0, 122.5, 
122.7, 124.4, 124.9, 125.3, 125.4, 128.9, 129.0, 141.6, 141.7, 168.2, 168.7, 176.7, 
177.0. HPLC-MS (ESI): tr= 7.8 min, 7.9 min; [M+H]
+= 307.3 m/z, [M+Na]+= 329.1 m/z, 
[2M+Na]+= 635.5 m/z. Anal. Calcd for C15H18N2O5 (306.12): C, 58.82; H, 5.92; N, 9.15. 
Found: C, 58.65; H, 5.91; N, 9.17. CSP-HPLC: IC 90:10 n-Hex/IPA for 10 min, then up to 
80:20 in 5 min, 80:20 for 20 min, then up to 75:25 in 15 min, 75:25 up to 58 min; flow 
rate = 0.5 mL/min at rt. λ=230 nm. tr(isomer A) = 21.9 min (major), 27.9 min (minor); 
tr(isomer B) = 32.6 min (minor), 51.0 min (major). 
(2R,3S)-1-ethyl 6-methyl 2-(1-(tert-butoxycarbonyl)-2-oxoindolin-3-yl)-3-
nitrohexanedioate (anti-4d): mixture of two diastereoisomers. 83% yield (39 mg), oil. 
1H NMR (400 MHz, CDCl3) δ = 7.91 – 7.79 (m, 2H), 7.40 – 7.28 (m, 4H), 7.22 – 7.13 (m, 
2H), 5.70 - 5.60 (m, 1H), 5.41 – 5.26 (m, 1H), 4.06 – 3.92 (m, 3H), 3.92 - 3.77 (m, 1H), 
3.72 (s, 3H), 3.70 (s, 3H), 3.65 (d, J = 4.0 Hz, 1H), 3.53 (d, J = 2.4 Hz, 1H), 2.60 – 2.19 (m, 
8H), 1.65 (s, 18H), 0.98 (t, J = 7.2 Hz, 3H), 0.93 (t, J = 7.2 Hz, 3H). 13C NMR (100 MHz, 
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CDCl3) δ = 13.4, 13.5, 27.8, 27.9, 28.0, 28.1, 29.8, 30.3, 44.0, 45.4, 49.9, 50.7, 51.9, 
61.9, 62.0, 83.5, 84.5, 84.7, 86.3, 115.1, 115.2, 123.6, 123.7, 124.4, 124.5, 124.6, 124.7, 
129.1, 129.3, 140.4, 140.5, 148.9, 149.0, 167.7, 167.8, 171.8, 172.5, 172.8. HPLC-MS 
(ESI): tr= 11.2 min; [M+Na]
+= 487.3 m/z. Anal. Calcd for C22H28N2O9 (464.18): C, 56.86; 
H, 6.08; N, 6.03. Found: C, 56.69; H, 6.08; N, 6.05.  
(2R,3S)-1-ethyl 6-methyl 3-nitro-2-(2-oxoindolin-3-yl)hexanedioate: mixture of two 
diastereoisomers, gum. 1H NMR (400 MHz, CDCl3) δ = 7.71 – 7.50 (bs, 2H), 7.34 – 7.20 
(m, 4H), 7.05 (t, J = 8.0 Hz, 2H), 6.90 – 6.81 (m, 2H), 5.68 - 5.59 (m, 1H), 5.41 – 5.29 (m, 
1H), 4.05 – 3.92 (m, 4H), 3.86 (dd, J = 10.0, 4.4 Hz, 1H), 3.74 (dd, J = 9.2, 4.4 Hz, 1H), 
3.72 (s, 3H), 3.69 (s, 3H), 3.59 (d, J = 4.4 Hz, 1H), 3.51 (d, J = 4.4 Hz, 1H), 2.54 – 2.39 (m, 
6H), 2.28 – 2.20 (m, 2H), 1.03 – 0.94 (m, 6H). 13C NMR (100 MHz, CDCl3) δ = 13.6, 13.7, 
27.4, 27.7, 29.9, 30.4, 43.9, 44.9, 49.4, 49.7, 51.9, 61.8, 61.9, 83.5, 86.1, 109.6, 109.7, 
122.6, 122.9, 124.5, 124.9, 125.2, 125.3, 129.0, 129.1, 141.2, 141.4, 168.0, 168.4, 
171.9, 171.9, 175.7, 175.9. HPLC-MS (ESI): tr= 7.3 min; [M+H]
+= 365.3 m/z, [M+Na]+= 
387.2 m/z, [2M+Na]+= 751.5 m/z. Anal. Calcd for C17H20N2O7 (364.13): C, 56.04; H, 5.53; 
N, 7.69. Found: C, 55.83; H, 5.53; N, 7.68. CSP-HPLC: IC 80:20 n-Hex/IPA for 10 min, 
then up to 75:25 in 5 min, 75:25 for 25 min, then up to 65:35 in 15 min, 65:35 up to 67 
min; flow rate = 0.5 mL/min at rt. λ=254 nm. tr(isomer A) = 26.8 min (major), 33.3 min 
(minor); tr(isomer B) = 34.5 min (minor), 63.1 min (major). 
Tert-butyl 3-((2R,3S)-1-ethoxy-3-nitro-1-oxo-4-phenylbutan-2-yl)-2-oxoindoline-1-
carboxylate (anti-4e): mixture of two diastereoisomers. 72% yield (34 mg), amorphous 
solid. 1H NMR (400 MHz, CDCl3) δ = 7.88 – 7.78 (m, 2H), 7.39 – 7.24 (m, 12H), 7.22 – 
7.13 (m, 4H), 5.86 (ddd, J = 4.4, 8.4, 10.4 Hz, 1H), 5.46 (dt, J = 2.8, 10.4 Hz, 1H), 3.98 – 
3.84 (m, 6H), 3.67 (d, J = 4.0 Hz, 1H), 3.53 (d, J = 2.8 Hz, 1H), 3.45 (dd, J = 2.8, 14.4 Hz, 
1H), 3.32 (dd, J = 10.8, 14.4 Hz, 1H), 3.28 – 3.16 (m, 2H), 1.66 (s, 9H), 1.65 (s, 9H), 0.97 
(t, J = 7.2 Hz, 3H), 0.95 (t, J = 7.6 Hz, 3H). 13C NMR (100 MHz, CDCl3) δ = 13.4, 13.5, 28.0, 
28.1, 39.0, 39.1, 44.2, 45.6, 49.8, 50.7, 61.9, 62.0, 84.6, 84.7, 85.7, 89.2, 115.1, 115.2, 
123.0, 123.7, 123.8, 124.4, 124.6, 124.7, 127.7, 127.8, 128.8, 128.8, 128.9, 128.9, 
129.0, 129.1, 129.3, 134.1, 135.1, 140.4, 140.5, 148.9, 168.0, 168.0, 172.4, 172.9. 
HPLC-MS (ESI): tr= 12.1 min, 12.4 min; [M+Na]
+= 491.3 m/z, [2M+Na]+= 959.6 m/z. 
Anal. Calcd for C25H28N2O7 (468.19): C, 64.09; H, 6.02; N, 5.98. Found: C, 64.02; H, 6.00; 
N, 6.00.  
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3-((2R,3S)-1-ethoxy-3-nitro-1-oxo-4-phenylbutan-2-yl)-2-oxoindoline: mixture of two 
diastereoisomers, amorphous solid. 1H NMR (400 MHz, CDCl3) δ = 8.12 – 7.89 (bs, 2H), 
7.40 – 7.21 (m, 13H), 7.17 (d, J = 7.6 Hz, 1H), 7.13 – 7.00 (m, 2H), 6.96 – 6.82 (m, 2H), 
5.88 – 5.79 (m, 1H), 5.53 (dt, J = 2.8, 10.0 Hz, 1H), 4.08 – 3.92 (m, 4H), 3.90 (dd, J = 2.0, 
9.6 Hz, 1H), 3.82 (dd, J = 4.0, 9.2 Hz, 1H), 3.63 (d, J = 4.0 Hz, 1H), 3.52 (d, J = 4.0 Hz, 1H), 
3.43 (dd, J = 3.6, 14.8 Hz, 1H), 3.35 (dd, J = 10.0, 14.4 Hz, 1H), 3.27 – 3.10 (m, 2H), 1.06 
(t, J = 7.6 Hz, 3H), 0.99 (t, J = 7.2 Hz, 3H). 13C NMR (100 MHz, CDCl3) δ = 13.6, 13.7, 38.5, 
39.0, 44.3, 45.3, 49.3, 49.7, 61.8, 61.9, 85.8, 89.1, 110.0, 110.2, 122.6, 122.9, 124.5, 
124.7, 124.8, 125.3, 127.6, 127.7, 128.8, 128.8, 128.9, 128.9, 129.0, 129.1, 134.4, 
135.3, 141.4, 141.6, 168.3, 168.6, 176.3, 176.6. HPLC-MS (ESI): tr= 9.1 min, 9.2 min; 
[M+H]+= 369.4 m/z, [M+Na]+= 391.2 m/z, [2M+Na]+= 759.5 m/z. Anal. Calcd for 
C20H20N2O5 (368.14): C, 65.21; H, 5.47; N, 7.60. Found: C, 65.15; H, 5.48; N, 7.59. CSP-
HPLC: IC 90:10 n-Hex/IPA for 15 min, then up to 80:20 in 10 min, 80:20 for 15 min, 
then up to 70:30 in 10 min, 70:30 for 5 min, then up to 1:1 in 5 min, 1:1 up to 76 min; 
flow rate = 0.5 mL/min at rt. λ=214 nm. tr(isomer A) = 27.2 min (major), 45.7 min 
(minor); tr(isomer B) = 39.8 min (minor), 70.0 min (major). 
Tert-butyl 3-((2R,3S)-1-ethoxy-2-methyl-3-nitro-1-oxobutan-2-yl)-2-oxoindoline-1-
carboxylate (5): major diastereoisomer. 72% yield (29 mg), syrup. 1H NMR (400 MHz, 
CDCl3) δ = 7.83 (d, J = 8.0 Hz, 1H), 7.35 (t, J = 8.0 Hz, 1H), 7.13 (t, J = 8.0 Hz, 1H), 7.0 (d, J 
= 6.8 Hz, 1H), 5.50 (q, J = 6.8 Hz, 1H), 4.41 – 4.30 (m, 2H), 4.23 (s, 1H), 1.96 (d, J = 7.2 
Hz, 3H), 1.65 (s, 9H), 1.36 (t, J = 6.8 Hz, 3H), 1.05 (s, 3H). 13C NMR (100 MHz, CDCl3) δ = 
13.9, 15.8, 15.8, 28.1, 48.9, 51.4, 62.2, 85.1, 88.5, 115.0, 124.1, 124.7, 129.2, 129.7, 
140.7, 148.7, 170.6, 172.7. HPLC-MS (ESI): tr= 11.6 min; [M+Na]
+= 429.4 m/z. *α+D
25 = 
19 (c = 0.48, CH2Cl2). Anal. Calcd for C20H26N2O7 (406.17): C, 59.10; H, 6.45; N, 6.89. 
Found: C, 59.04; H, 6.45; N, 6.91.  
3-((2R,3S)-1-ethoxy-2-methyl-3-nitro-1-oxobutan-2-yl)-2-oxoindoline: major 
diastereoisomer, syrup. 1H NMR (400 MHz, CDCl3) δ = 7.68 (bs, 1H), 7.05 – 6.97 (m, 
2H), 6.90 – 6.84 (m, 2H), 5.59 (q, J = 6.4 Hz, 1H), 4.40 – 4.31 (m, 2H), 4.12 (s, 1H), 1.95 
(d, J = 6.4 Hz, 3H), 1.37 (t, J = 7.2 Hz, 3H), 1.08 (s, 3H). 13C NMR (100 MHz, CDCl3) δ = 
13.9, 15.7, 15.8, 48.6, 50.7, 62.0, 88.2, 109.7, 123.0, 124.8, 129.0, 129.1, 141.3, 175.6, 
178.5. HPLC-MS (ESI): tr= 8.2 min; [M+H]
+= 307.3 m/z, [M+Na]+= 329.1 m/z. *α+D
25 = 13 
(c = 0.13, CH2Cl2). Anal. Calcd for C15H18N2O5 (306.12): C, 58.82; H, 5.92; N, 9.15. Found: 
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C, 58.58; H, 5.92; N, 9.16. CSP-HPLC: IC 90:10 n-Hex/IPA for 10 min, then up to 80:20 in 
5 min, 80:20 up to 25 min; flow rate = 0.5 mL/min at rt. λ=214 nm. tr(major isomer) = 
14.5 min (major), 17.8 min (minor). 
Synthesis of (S)-tert-butyl 3-((R)-2,5-dioxo-1-phenylpyrrolidin-3-yl)-3-((2R,3S)-1-
ethoxy-3-nitro-1-oxobutan-2-yl)-2-oxoindoline-1-carboxylate (6): (E)-tert-butyl 3-(2-
ethoxy-2-oxoethylidene)-2-oxoindoline-1-carboxylate 2c (0.1 mmol, 31.7 mg) was 
added to a solution of VI (10 mol %) in DCM (0.15 mL), then nitroethane 1b (0.5 mmol) 
was added at 0°C. The mixture was stirred at the same temperature till complete 
conversion (about 4.5 h). The solvent and the excess of 1b were quickly removed 
under vacuum (without heating), DCM (0.3 mL) was added and N-phenylmaleimide 
(0.2 mmol) was lastly added at 0°C. The conversion was monitored by TLC and 1H-NMR 
till full conversion (1.5 h). The crude reaction mixture was directly purified by flash 
chromatography on silica gel (cyclohexane/ethyl acetate 9/1). 81% yield (46 mg), gum. 
1H NMR (400 MHz, CDCl3) δ = 7.88 (d, J = 8.4 Hz, 1H), 7.48 – 7.37 (m, 4H), 7.27 – 7.25 
(m, 1H), 7.20 – 7.13 (m, 3H), 5.95 – 5.85 (m, 1H), 4.89 (d, J = 4.8 Hz, 1H), 3.87 – 3.81 
(m, 3H), 2.92 (dd, J = 9.2, 18.0 Hz, 1H), 2.11 (dd, J = 5.2, 18.0 Hz, 1H), 1.69 (s, 9H), 1.64 
(d, J = 7.2 Hz, 3H), 0.94 (t, J = 7.6 Hz, 3H). 13C NMR (100 MHz, CDCl3) δ = 13.6, 18.6, 
28.1, 30.7, 42.0, 52.0, 52.8, 61.6, 79.0, 85.4, 115.7, 123.8, 124.4, 125.1, 126.4, 129.0, 
129.2, 130.7, 131.1, 140.7, 144.6, 148.4, 168.2, 173.1, 174.4, 174.7. HPLC-MS (ESI): tr= 
10.9 min; [M-Boc+H]+= 466.4 m/z, [M+H2O]
+= 583.4 m/z. *α+D
25 = 107 (c = 0.71, CH2Cl2). 
Anal. Calcd for C29H31N3O9 (565.21): C, 61.59; H, 5.52; N, 7.43. Found: C, 61.49; H, 5.54; 
N, 7.40. The absolute configuration of the stereocenters generated in the addition of 
N-phenylmaleimide was not experimentally determined, but it was indicated on the 
basis of that obtained with the same catalyst promoting the same reaction on similar 
substrates.
20 
Synthesis of (R)-tert-butyl 3-(2,2-bis(phenylsulfonyl)ethyl)-3-((2R,3S)-1-ethoxy-3-
nitro-1-oxobutan-2-yl)-2-oxoindoline-1-carboxylate (7): (E)-tert-butyl 3-(2-ethoxy-2-
oxoethylidene)-2-oxoindoline-1-carboxylate 2c (0.1 mmol, 31.7 mg) was added to a 
solution of VI (10 mol %) in DCM (0.15 mL), then nitroethane 1b (0.5 mmol) was added 
at 0°C. The mixture was stirred at the same temperature till complete conversion 
(about 4.5 h). The solvent and the excess of 1b were quickly removed under vacuum 
(without heating), toluene (0.6 mL) was added and 1,1-bis(benzenesulfonyl)-ethylene 
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(0.2 mmol) was lastly added at -10°C. The conversion was monitored by TLC and 1H-
NMR till full conversion (overnight). The reaction was quenched with 2 mL of HCl (1N) 
at 0°C and extracted with ethyl acetate (3 X 3 mL). The organic phases were collected 
and dried over Na2SO4. The solvent was evaporated under reduced pressure and the 
product was purified by flash-chromatography on silica gel (cyclohexane/ethyl acetate 
8/2). 68% yield (48 mg), syrup. 1H NMR (400 MHz, CDCl3) δ = 7.99 – 7.93(m, 3H), 7.79 
(d, J = 7.2 Hz, 2H), 7.73 – 7.66 (m, 2H), 7.61 – 7.50 (m, 5H), 7.44 (t, J = 7.6 Hz, 1H), 7.27 
– 7.24 (m, 1H), 5.16 – 5.09 (m, 1H), 4.41 (dd, J = 3.2, 6.0 Hz, 1H), 4.13 (d, J = 5.2 Hz, 1H), 
4.01 (q, J = 7.2 Hz, 2H), 2.94 (dd, J = 5.6, 16.0 Hz, 1H), 2.85 (dd, J = 2.8, 16.0 Hz, 1H), 
1.64 (s, 9H), 1.38 (d, J = 6.8 Hz, 3H), 1.07 (t, J = 7.2 Hz, 3H). 13C NMR (100 MHz, CDCl3) δ 
= 13.6, 17.4, 28.1, 29.6, 50.9, 55.9, 61.8, 79.2, 79.4, 84.8, 116.0, 124.7, 125.6, 126.2, 
128.9, 129.0, 129.7, 130.1, 131.0, 134.5, 134.9, 135.6, 137.7, 140.7, 148.8, 168.0, 
174.3. HPLC-MS (ESI): tr= 11.9 min; [M-Boc+H]
+= 601.3 m/z, [M+H2O]
+= 718.4 m/z. 
*α+D
25 = 8 (c = 0.54, CH2Cl2). Anal. Calcd for C33H36N2O11S2 (700.18): C, 56.56; H, 5.18; N, 
4.00. Found: C, 56.38; H, 5.17; N, 4.01. The absolute configuration of the stereocenter 
generated in the addition of 1,1-bis(benzenesulfonyl)-ethylene was not experimentally 
determined, but it was indicated on the basis of that obtained with the same catalyst 
promoting the same reaction on similar substrates.21b 
Synthesis of (R)-tert-butyl 3-((2R,3S)-1-ethoxy-3-nitro-1-oxobutan-2-yl)-3-((S)-2-nitro-
1-phenylethyl)-2-oxoindoline-1-carboxylate (8): (E)-tert-butyl 3-(2-ethoxy-2-
oxoethylidene)-2-oxoindoline-1-carboxylate 2c (0.1 mmol, 31.7 mg) was added to a 
solution of VI (10 mol %) in DCM (0.15 mL), then nitroethane 1b (0.5 mmol) was added 
at 0°C. The mixture was stirred at the same temperature till complete conversion 
(about 4.5 h). The solvent and the excess of 1b were quickly removed under vacuum 
(without heating), DCM (0.3 mL) was added and trans-β-nitrostyrene (0.2 mmol) was 
lastly added at -40°C. The conversion was monitored by TLC and 1H-NMR (90% of 
conversion after 24 hours). The reaction was quenched with 2 mL of HCl (1N) and 
extracted with ethyl acetate (3 X 2 mL). The organic phases were collected and dried 
over Na2SO4. The solvent was evaporated under reduced pressure and the product was 
purified by flash-chromatography on silica gel (cyclohexane/ethyl acetate 9/1). 76% 
yield (41 mg), syrup. Major diastereoisomer: 1H NMR (400 MHz, CDCl3) δ = 7.88 – 7.82 
(m, 1H), 7.65 – 7.41 (m, 3H), 7.23 – 7.15 (m, 2H), 7.10 – 6.97 (m, 2H), 6.86 (d, J = 7.6 
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Hz, 1H), 5.37 – 5.23 (m, 2H), 4.52 – 4.36 (m, 3H), 4.17 (dd, J = 3.2, 10.4 Hz, 1H), 4.13 (d, 
J = 6.8 Hz, 1H), 1.64 (d, J = 7.2 Hz, 3H), 1.63 (s, 9H), 1.39 (t, J = 7.2 Hz, 3H). 13C NMR 
(100 MHz, CDCl3) δ = 14.0, 17.8, 28.0, 50.0, 51.9, 55.8, 62.9, 75.1, 81.6, 85.1, 114.8, 
115.2, 123.7, 124.4, 124.6, 126.3, 127.9, 128.4, 129.1, 129.8, 132.8, 139.8, 147.8, 
168.9, 174.2. HPLC-MS (ESI): tr= 12.1 min; [M+Na]
+= 564.3 m/z, [2M+Na]+= 1105.7 m/z. 
*α+D
25 = 16 (c = 0.91, CH2Cl2). Anal. Calcd for C27H31N3O9 (541.21): C, 59.88; H, 5.77; N, 
7.76. Found: C, 59.65; H, 5.77; N, 7.77. The absolute configuration of the stereocenters 
generated in the addition of trans-β-nitrostyrene was not experimentally determined, 
but it was indicated on the basis of that obtained with the same catalyst promoting the 
same reaction on similar substrates.22b 
Synthesis of (S)-tert-butyl 3-((2R,3S)-1-ethoxy-3-nitro-1-oxobutan-2-yl)-2-oxo-3-((R)-
3-oxocyclohexyl)indoline-1-carboxylate (9): (E)-tert-butyl 3-(2-ethoxy-2-
oxoethylidene)-2-oxoindoline-1-carboxylate 2c (0.1 mmol, 31.7 mg) was added to a 
solution of VI (10 mol %) in DCM (0.15 mL), then nitroethane 1b (0.5 mmol) was added 
at 0°C. The mixture was stirred at the same temperature till complete conversion 
(about 4.5 hours). The reaction was quenched with 2 mL of HCl (1N) at 0°C and 
extracted with DCM (3 X 2 mL). The organic phases were collected and dried over 
Na2SO4. The solvent was evaporated under reduced pressure (without heating) and the 
crude mixture was directly used in the next transformation. Catalyst X·3HCl (10 mol %), 
triethylamine (30 mol %) and benzoic acid (20 mol %) were dissolved in toluene (0.3 
mL). After stirring at room temperature for 10 min, 2-cyclohexen-1-one (0.12 mmol) 
was added followed by the addition of crude 4b dissolved in toluene (0.3 mL). The 
mixture was stirred at room temperature for 48 hours. The crude reaction was directly 
purified by flash chromatography on silica gel (cyclohexane/ethyl acetate 85/15). 65% 
yield (32 mg), gum. 1H NMR (400 MHz, CDCl3) δ = 7.85 (d, J = 8.4 Hz, 1H), 7.41 (d, J = 7.6 
Hz, 1H), 7.37 (t, J = 6.4 Hz, 1H), 7.20 (t, J = 6.8 Hz, 1H), 5.46 – 5.39 (m, 1H), 4.16 (d, J = 
5.2 Hz, 1H), 3.95 – 3.87 (m, 2H), 2.45 – 2.33 (m, 3H), 2.10 – 2.03 (m, 2H), 1.90 – 1.78 
(m, 2H), 1.66 (s, 9H), 1.58 – 1.46 (m, 2H), 1.49 (d, J = 6.8 Hz, 3H), 1.03 (t, J = 7.2 Hz, 3H). 
13C NMR (100 MHz, CDCl3) δ = 13.6, 18.2, 24.0, 25.6, 28.1, 40.7, 42.3, 43.1, 52.7, 54.8, 
61.7, 79.4, 85.0, 115.1, 124.4, 124.8, 126.1, 129.6, 140.7, 148.6, 168.2, 175.1, 208.7. 
HPLC-MS (ESI): tr= 10.7 min; [M-Boc+H]
+= 389.3 m/z, [M+H2O]
+= 506.5 m/z, [2M+Na]+= 
999.8 m/z. *α+D
25 = -13 (c = 1.02, CH2Cl2). Anal. Calcd for C25H32N2O8 (488.22): C, 61.46; 
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H, 6.60; N, 5.73. Found: C, 61.35; H, 6.59; N, 5.75. The absolute configuration of the 
stereocenters generated in the addition of 2-cyclohexen-1-one was not experimentally 
determined, but it was indicated on the basis of that obtained with the same catalyst 
promoting the same reaction on similar substrates.10p 
Synthesis of (S)-tert-butyl 3-((2R,3S)-1-ethoxy-3-nitro-1-oxobutan-2-yl)-2-oxo-3-((R)-
4-oxobutan-2-yl)indoline-1-carboxylate (10): To a solution of catalyst XI (20 mol %) 
and crude product 4b (0.1 mmol, prepared as described for product 9) in DCM (1 mL) 
at -40°C, benzoic acid (20 mol %) and then crotonaldehyde (0.15 mmol) were added. 
After stirring at the same temperature for 24 h, the reaction was quenched with 2 mL 
of HCl (1N) at 0°C and extracted with DCM (3 X 2 mL). The organic phases were 
collected and dried over Na2SO4. The solvent was evaporated under reduced pressure 
and the crude mixture was purified by flash chromatography on silica gel 
(cyclohexane/ethyl acetate 9/1). 71% yield (33 mg), gum. Mixture of two 
diastereoisomers. 1H NMR (400 MHz, CDCl3) δ = 9.62 (d, J = 2.0 Hz, 1H), 9.61 (d, J = 2.4 
Hz, 1H), 7.85 (d, J = 8.4 Hz, 2H), 7.43 – 7.32 (m, 4H), 7.20 (t, J = 7.6 Hz, 2H), 5.50 – 5.43 
(m, 1H), 5.30 – 5.23 (m, 1H), 4.13 (d, J = 5.6 Hz, 1H), 4.12 (d, J = 5.6 Hz, 1H), 3.99 – 3.88 
(m, 4H), 2.86 – 2.77 (m, 2H), 2.65 (d, J = 16.4 Hz, 1H), 2.53 (d, J = 17.6 Hz, 1H), 2.23 
(ddd, J = 2.8, 10.8, 14.0 Hz, 1H), 2.08 (ddd, J = 2.4, 10.4, 12.4 Hz, 1H), 1.66 (s, 18H), 1.53 
(d, J = 6.8 Hz, 3H), 1.51 (d, J = 6.8 Hz, 3H), 1.06 (t, J = 7.2 Hz, 3H), 1.02 (t, J = 7.2 Hz, 3H), 
0.96 (d, J = 6.8 Hz, 3H), 0.78 (d, J = 6.8 Hz, 3H). 13C NMR (100 MHz, CDCl3) δ = 13.6, 
13.7, 15.0, 18.1, 28.1, 32.6, 33.2, 45.4, 45.7, 53.0, 53.0, 54.7, 61.7, 61.8, 79.3, 79.9, 
84.8, 84.9, 115.0, 115.1, 124.3, 124.4, 124.5, 124.7, 126.3, 126.3, 129.5, 140.3, 140.6, 
148.6, 148.7, 168.1, 168.3, 175.5, 175.7, 199.5, 200.0. HPLC-MS (ESI): tr= 10.7 min; [M-
Boc+H]+= 363.4 m/z, [M+H2O]
+= 480.4 m/z, [M+Na]+= 485.3 m/z, [2M+Na]+= 947.8 
m/z. Anal. Calcd for C23H30N2O8 (462.20): C, 59.73; H, 6.54; N, 6.06. Found: C, 59.68; H, 
6.52; N, 6.08. The absolute configuration of the stereocenters generated in the 
addition of crotonaldehyde was not experimentally determined, but it was indicated on 
the basis of that obtained with the same catalyst promoting the same reaction on 
similar substrates.8c 
Synthesis of tert-butyl 3-((2R,3S)-3-amino-1-ethoxy-1-oxobutan-2-yl)-2-oxoindoline-
1-carboxylate (11a + 11b): Compound 4b (0.38 mmol, 149 mg) was dissolved in EtOH 
(5.5 mL), Raney Nickel (6 drops of the commercially available suspension in water) was 
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added and the reaction mixture was stirred at rt under H2 balloon overnight. Then it 
was filtered and washed with ethyl acetate and DCM. The solvent was removed under 
reduced pressure and the diastereomeric mixture of 11a and 11b (dr = 54:46) was 
obtained pure. 95% yield (131 mg), oil. Mixture of two diastereoisomers. 1H NMR (400 
MHz, CDCl3) δ = 7.73 (bs, 2H), 7.31 – 7.22 (m, 4H), 7.18 (d, J = 6.8 Hz, 1H), 7.14 – 7.09 
(m, 2H), 7.04 (t, J = 7.2 Hz, 1H), 6.43 (bs, 2H), 4.29 (d, J = 10.8 Hz, 2H), 4.24 – 4.16 (m, 
2H), 3.98 – 3.84 (m, 2H), 3.28 (dd, J = 8.8, 10.0 Hz, 1H), 3.09 (dd, J = 8.8, 10.0 Hz, 1H), 
1.53 (s, 9H), 1.52 (s, 9H), 1.44 (d, J = 6.0 Hz, 3H), 1.39 (d, J = 6.0 Hz, 3H), 1.25 (t, J = 7.2 
Hz, 3H), 0.96 (t, J = 7.2 Hz, 3H). 13C NMR (50 MHz, CDCl3) δ = 13.6, 14.1, 21.3, 21.6, 
28.4, 45.2, 47.4, 50.4, 51.0, 52.6, 54.4, 61.3, 61.8, 80.1, 80.3, 124.5, 124.7, 125.0, 
126.7, 127.7, 128.1, 128.2, 137.1, 137.2, 151.0, 153.8, 169.5, 170.0, 171.8, 175.2. 
HPLC-MS (ESI): tr= 7.4 min, 8.0 min; [M-Boc+H]
+= 263.3 m/z, [M+H]+= 363.4 m/z, 
[2M+Na]+= 747.7 m/z. Anal. Calcd for C19H26N2O5 (362.18): C, 62.97; H, 7.23; N, 7.73. 
Found: C, 62.84; H, 7.22; N, 7.72. 
Procedure for the stereoconvergent epimerization to (R)-tert-butyl 3-((2R,3S)-3-
amino-1-ethoxy-1-oxobutan-2-yl)-2-oxoindoline-1-carboxylate (11a): The 
diastereomeric mixture of 11a and 11b (dr = 54:46) (0.1 mmol, 36.2 mg) was dissolved 
in acetone (0.6 mL) and K2CO3 (0.2 mmol) was added. The reaction mixture was stirred 
at 50°C for 24 h and the conversion was monitored by 1H-NMR. After completion, the 
solvent was removed, the residue was dissolved in water (3 mL) and extracted with 
DCM (3 X 3 mL). The organic phases were collected and dried over Na2SO4. The solvent 
was evaporated under reduced pressure and compound 11a was obtained pure. 95% 
yield, 34 mg, oil. 1H NMR (400 MHz, CDCl3) δ = 7.71 (bs, 1H), 7.31 – 7.27 (m, 2H), 7.18 
(d, J = 6.8 Hz, 1H), 7.12 (t, J = 7.2 Hz, 1H), 6.22 (bs, 1H), 4.28 (d, J = 10.4 Hz, 1H), 4.24 – 
4.16 (m, 2H), 3.97 – 3.90 (m, 1H), 3.09 (dd, J = 10.8, 8.0 Hz, 1H), 1.52 (s, 9H), 1.44 (d, J = 
6.0 Hz, 3H), 1.25 (t, J = 7.2 Hz, 3H). 13C NMR (100 MHz, CDCl3) δ = 14.1, 21.6, 28.4, 47.4, 
51.0, 54.3, 61.8, 80.1, 124.6, 125.0, 127.6, 128.2, 128.4, 137.2, 153.7, 171.8, 175.2. 
HPLC-MS (ESI): tr= 8.0 min; [M-Boc+H]
+= 263.1 m/z, [M+H]+= 363.2 m/z, [2M+Na]+= 
747.2 m/z. *α+D
25 = 34 (c = 0.99, CH2Cl2). Anal. Calcd for C19H26N2O5 (362.18): C, 62.97; 
H, 7.23; N, 7.73. Found: C, 62.77; H, 7.24; N, 7.76.  
Synthesis of 12a + 12b: Compound 4b (0.2 mmol, 78.5 mg) was dissolved in MeOH (3.5 
mL) and Pd on C (20 % w/w) was added. The reaction mixture was stirred at rt under 
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H2 balloon overnight. Then it was filtered and washed with ethyl acetate and DCM. The 
solvent was evaporated under reduced pressure and the crude mixture was purified by 
flash chromatography on silica gel (cyclohexane/ethyl acetate 1/1). 90% yield, 68 mg, 
oil.  
(R)-tert-butyl 3-((2R,3S)-1-ethoxy-3-(hydroxyamino)-1-oxobutan-2-yl)-2-oxoindoline-
1-carboxylate (12a): 1H NMR (400 MHz, CDCl3) δ = 7.64 (bs, 1H), 7.28 – 7.23 (m, 1H), 
7.15 – 7.06 (m, 1H), 7.02 – 6.97 (m, 2H), 4.44 – 4.37 (m, 1H), 4.27 (d, J = 9.6 Hz, 1H), 
3.94 – 3.76 (m, 2H), 3.20 (dd, J = 10.0, 8.4 Hz, 1H), 1.54 (s, 9H), 1.44 (d, J = 5.6 Hz, 3H), 
0.92 (t, J = 7.2 Hz, 3H). 13C NMR (50 MHz, CDCl3) δ = 13.5, 18.3, 28.4, 42.2, 48.8, 55.7, 
61.5, 80.5, 118.9, 125.0, 127.3, 128.5, 129.7, 136.9, 153.4, 168.3, 169.4. HPLC-MS (ESI): 
tr= 7.0 min; [M-Boc+H]
+= 279.4 m/z, [2M+Na]+= 779.6 m/z. *α+D
25 = -5 (c = 0.67, CH2Cl2). 
Anal. Calcd for C19H26N2O6 (378.18): C, 60.30; H, 6.93; N, 7.40. Found: C, 60.28; H, 6.91; 
N, 7.39.  
(S)-tert-butyl 3-((2R,3S)-1-ethoxy-3-(hydroxyamino)-1-oxobutan-2-yl)-2-oxoindoline-
1-carboxylate (12b): 1H NMR (400 MHz, CDCl3) δ = 7.74 (bs, 1H), 7.32 – 7.27 (m, 1H), 
7.18 – 6.99 (m, 3H), 4.31 – 4.18 (m, 3H), 3.97 – 3.91 (m, 1H), 2.87 (t, J = 8.4 Hz, 1H), 
1.53 (s, 9H), 1.47 (d, J = 5.6 Hz, 3H), 1.27 (t, J = 7.2 Hz, 3H). 13C NMR (100 MHz, CDCl3) δ 
= 14.1, 19.0, 28.4, 50.5, 51.3, 56.6, 62.1, 80.3, 118.6, 124.6, 128.2, 128.4, 129.7, 137.2, 
153.7, 169.3, 171.4. HPLC-MS (ESI): tr= 7.6 min; [M-Boc+H]
+= 279.2 m/z, [2M+Na]+= 
779.6 m/z. [α+D
25 = 8 (c = 0.93, CH2Cl2). Anal. Calcd for C19H26N2O6 (378.18): C, 60.30; H, 
6.93; N, 7.40. Found: C, 60.10; H, 6.94; N, 7.39.  
Procedure for the stereoconvergent epimerization to 12a: The diastereomeric 
mixture of 12a and 12b (dr = 60:40) (0.1 mmol, 37.8 mg) was dissolved in EtOH (0.7 
mL) and NaHCO3 (10 drops of a saturated solution) was added. The reaction mixture 
was stirred at rt for 48 h and the conversion was monitored by 1H-NMR. After 
completion, water (3 mL) was added to the mixture and it was extracted with ethyl 
acetate (3 X 3 mL). The organic phases were collected and dried over Na2SO4. The 
solvent was evaporated under reduced pressure and compound 12a was obtained 
pure (90% yield, 34 mg, oil).  
Synthesis of ((2S,3R,3aR)-2,8-dimethyl-2,3,3a,8-tetrahydropyrrolo[2,3-b]indol-3-
yl)methanol (13): Compound anti-4b (0.2 mmol, 78.5 mg) was dissolved in EtOH (3 
mL), Raney Nickel (4 drops of the commercially available suspension in water) was 
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added and the reaction mixture was stirred at rt under H2 balloon overnight. Then it 
was filtered and washed with ethyl acetate and DCM. The solvent was removed under 
reduced pressure and the diastereomeric mixture of 11a and 11b (dr = 54:46) was 
obtained pure. The crude mixture was dissolved in acetone (1.5 mL) and K2CO3 (0.4 
mmol) was added. The reaction mixture was stirred at 50°C for 24 h and the 
conversion was monitored by 1H-NMR. After completion, the solvent was removed, 
the residue was dissolved in water (5 mL) and extracted with DCM (3 X 6 mL). The 
organic phases were collected and dried over Na2SO4. The solvent was evaporated 
under reduced pressure and the crude product 11a was dissolved in THF (5 mL). LiAlH4 
(2 mmol) was added and the mixture was heated at 75°C for 2 h. It was cooled to room 
temperature, quenched with ethyl acetate (6 mL) and then H2O (1.2 mL). The resulting 
mixture was filtered through celite and washed with ethyl acetate and MeOH. The 
filtrates were concentrated under reduced pressure and the residue was purified by 
flash chromatography on silica gel (DCM/MeOH 20/1) providing compound 13. 72% 
yield over 3 steps, 31 mg, amorphous solid. 1H NMR (400 MHz, CD3OD) δ = 7.14 (t, J = 
8.0 Hz, 1H), 7.01 (d, J = 7.2 Hz, 1H), 6.70 – 6.66 (m, 2H), 3.72 (d, J = 8.0 Hz, 1H), 3.64 
(dd, J = 12.0, 4.0 Hz, 1H) 3.60 (dd, J = 12.0, 4.0 Hz, 1H), 3.59 – 3.53 (m, 1H), 2.80 (s, 3H), 
2.10 – 2.04 (m, 1H), 1.26 (d, J = 6.0 Hz, 3H). 13C NMR (100 MHz, CD3OD) δ = 21.8, 30.8, 
47.2, 52.6, 54.6, 62.4, 111.7, 118.1, 125.3, 128.8, 129.2, 149.3, 179.7. HPLC-MS (ESI): 
tr= 2.2 min; [M+H]
+= 217.1 m/z, [M+H2O+H]
+= 235.3 m/z, [M+Na]+= 239.1 m/z. *α+D
25 = 
-14 (c = 0.45, MeOH). Anal. Calcd for C13H16N2O (216.13): C, 72.19; H, 7.46; N, 12.95. 
Found: C, 72.16; H, 7.43; N, 12.99.  
Synthesis of tert-butyl 3-((2R,3R)-1-ethoxy-3-nitro-1-oxobutan-2-yl)-2-oxoindoline-1-
carboxylate (syn-4b): Compound anti-4b (0.1 mmol, 39 mg) was dissolved in DCM (0.4 
mL) and DBU (1,5-diazabiciclo[5.4.0]undec-5-ene, 30 mol %) was added. The reaction 
mixture was stirred at rt for 24 h and the conversion was monitored by 1H-NMR. The 
solvent was evaporated under reduced pressure and the crude reaction mixture was 
directly purified by flash chromatography on silica gel (cyclohexane/ethyl acetate 9/1). 
70% yield, 27.5 mg, gum. Mixture of two diastereoisomers (dr = 70:30). 1H NMR (400 
MHz, CDCl3) δ = 7.89 – 7.82 (m, 2H), 7.38 – 7.27 (m, 3H), 7.21 – 7.12 (m, 3H), 5.33 – 
5.23 (m, 2H), 4.13 (dd, J = 2.4, 10.0 Hz, 1H), 4.05 (q, J = 6.8 Hz, 2H), 3.96 – 3.85 (m, 4H), 
3.81 (s, 1H), 1.75 (d, J = 7.2 Hz, 3H), 1.67 – 1.64 (m, 21H), 1.08 (t, J = 7.2 Hz, 3H), 0.91 (t, 
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J = 7.2 Hz, 3H). 13C NMR (100 MHz, CDCl3) δ = 13.4, 13.6, 17.9, 18.4, 28.1, 44.4, 44.6, 
49.1, 49.4, 61.8, 62.0, 80.9, 81.6, 84.8, 84.9, 115.3, 115.4, 123.5, 123.6, 123.7, 124.6, 
124.6, 129.2, 129.4, 140.2, 140.5, 148.9, 168.6, 169.6, 173.0, 173.2. HPLC-MS (ESI): tr= 
10.3 min, 10.4 min; [M-Boc+H]+= 293.3 m/z, [M +H2O]
+= 410.3 m/z, [M+Na]+= 415.3 
m/z. Anal. Calcd for C19H24N2O7 (392.16): C, 58.16; H, 6.16; N, 7.14. Found: C, 58.06; H, 
6.18; N, 7.15. To check the optical purity of compound syn-4b, it was deprotected as 
previously described and injected in CSP-HPLC.  
3-((2R,3R)-1-ethoxy-3-nitro-1-oxobutan-2-yl)-2-oxoindoline: amorphous solid, 
mixture of two diastereoisomers (dr = 76:24), the signals of the major one have been 
described. 1H NMR (400 MHz, CDCl3) δ = 7.82 (bs, 1H), 7.30 – 7.25 (m, 2H), 7.08 (t, J = 
7.2 Hz, 1H), 6.90 (d, J = 8.0 Hz, 1H), 5.25 – 5.17 (m, 1H), 4.11 (q, J = 6.8 Hz, 2H), 3.91 
(dd, J = 2.8, 10.0 Hz, 1H), 3.87 (d, J = 2.8 Hz, 1H), 1.59 (d, J = 6.4 Hz, 3H), 1.13, (t, J = 7.2 
Hz, 3H). ). 13C NMR (100 MHz, CDCl3) δ = 13.8, 17.8, 44.3, 48.4, 61.9, 81.5, 110.0, 122.9, 
124.7, 124.9, 129.1, 140.9, 170.3, 176.0. HPLC-MS (ESI): tr= 7.0 min; [M+H]
+= 293.3 
m/z, [M+Na]+= 315.2 m/z, [2M+Na]+= 607.4 m/z. Anal. Calcd for C14H16N2O5 (292.11): 
C, 57.53; H, 5.52; N, 9.58. Found: C, 57.35; H, 5.51; N, 9.62. CSP-HPLC: IC 90:10 n-
Hex/IPA for 10 min, then up to 80:20 in 5 min, 80:20 for 20 min, then up to 75:25 in 15 
min, 75:25 up to 47 min; flow rate = 0.5 mL/min at rt. λ=214 nm. tr(major isomer) = 
25.4 min (minor), 34.0 min (major); tr(minor isomer) = 28.6 min (major), 42.7 min 
(minor). 
Synthesis of ((2R,3R,3aS)-2,8-dimethyl-2,3,3a,8-tetrahydropyrrolo[2,3-b]indol-3-
yl)methanol (14): Compound syn-4b (0.1 mmol, 39 mg) was dissolved in EtOH (2 mL), 
Raney Nickel (3 drops of the commercially available suspension in water) was added 
and the reaction mixture was stirred at rt under H2 balloon overnight. Then it was 
filtered and washed with ethyl acetate and DCM. The solvent was removed under 
reduced pressure and the β-amino oxindole 14a was obtained pure as an oil. The crude 
14a was dissolved in THF (3 mL), LiAlH4 (1 mmol) was added and the mixture was 
heated at 75°C for 2 h. It was cooled to room temperature, quenched with ethyl 
acetate (4 mL) and then H2O (0.8 mL). The resulting mixture was filtered through celite 
and washed with ethyl acetate and MeOH. The filtrates were concentrated under 
reduced pressure and the residue was purified by flash chromatography on silica gel 
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(DCM/MeOH 20/1) providing compound 14. 76% yield over 2 steps, 16.5 mg, 
amorphous solid.  
(S)-Tert-butyl 3-((2R,3R)-3-amino-1-ethoxy-1-oxobutan-2-yl)-2-oxoindoline-1-
carboxylate (14a): 1H NMR (400 MHz, CDCl3) δ = 7.73 (bs, 1H), 7.32 – 7.23 (m, 2H), 7.15 
– 7.08 (m, 2H), 5.88 (bs, 1H), 4.32 (d, J = 10.0 Hz, 1H), 4.28 – 4.13 (m, 3H), 3.64 (dd, J = 
8.8, 9.2 Hz, 1H), 1.54 (s, 9H), 1.30 – 1.26 (m, 6H). 13C NMR (100 MHz, CDCl3) δ = 14.1, 
18.0, 28.4, 43.5, 49.0, 51.7, 61.6, 80.0, 124.6, 127.6, 128.0, 128.1, 128.5, 137.4, 153.7, 
171.2, 176.2. HPLC-MS (ESI): tr= 7.7 min; [M-Boc+H]
+= 263.3 m/z, [M+H]+= 363.4 m/z. 
*α+D
25 = 19 (c = 1.69, CH2Cl2). Anal. Calcd for C19H26N2O5 (362.18): C, 62.97; H, 7.23; N, 
7.73. Found: C, 62.77; H, 7.21; N, 7.72.  
((2R,3R,3aS)-2,8-dimethyl-2,3,3a,8-tetrahydropyrrolo[2,3-b]indol-3-yl)methanol (14): 
1H NMR (400 MHz, CD3OD) δ = 7.14 (t, J = 7.6 Hz, 1H), 6.97 (d, J = 7.2 Hz, 1H), 6.72 – 
6.65 (m, 2H), 3.95 – 3.88 (m, 1H), 3.75 (dd, J = 7.6, 10.8 Hz, 1H) 3.66 (d, J = 6.4 Hz, 1H), 
3.56 (dd, J = 7.6, 10.4 Hz, 1H), 2.81 (s, 3H), 2.54 – 2.47 (m, 1H), 1.22 (d, J = 6.8 Hz, 3H). 
13C NMR (50 MHz, CD3OD) δ = 16.0, 30.8, 47.0, 51.3, 60.8, 111.6, 117.9, 124.0, 128.0, 
129.2, 149.3, 180.1. HPLC-MS (ESI): tr= 2.1 min; [M+H2O+H]
+= 235.3 m/z, [2M+Na]+= 
455.5 m/z. *α+D
25 = 15 (c = 0.15, MeOH). Anal. Calcd for C13H16N2O (216.13): C, 72.19; H, 
7.46; N, 12.95. Found: C, 72.16; H, 7.45; N, 13.00. 
General procedure for the organocatalysed spirocyclization. 
The 3-ylidene oxindole (0.1 mmol) was added to a solution of catalyst (10 or 20 mol%) 
in DCM (0.15 mL), then the nitrocompound (0.12 or 0.2 mmol) was added at room 
temperature. The mixture was stirred at the same temperature and the conversion 
was monitored by TLC and 1H NMR. The crude mixture was directly purified by flash 
chromatography on silica gel (cyclohexane/diethyl ether 9:1).  
Ethyl 1'-benzyl-6-(2-ethoxy-2-oxoethyl)-3-nitro-2'-oxospiro[cyclohexane-1,3'-
indoline]-2-carboxylate (16b,a): 1H NMR (400 MHz, CDCl3) δ 7.49 – 7.39 (m, 2H), 7.38 
– 7.21 (m, 5H), 7.04 (t, J = 7.7 Hz, 1H), 6.87 (d, J = 7.9 Hz, 1H), 5.26 (dt, J = 12.2, 4.7 Hz, 
1H), 5.09 (d, J = 15.3 Hz, 1H), 4.79 (d, J = 15.0 Hz, 1H), 4.10 – 3.98 (m, 2H), 3.94 (d, J = 
11.7 Hz, 1H), 3.67 (q, J = 7.1 Hz, 2H), 2.79 – 2.59 (m, 2H), 2.25 – 2.02 (m, 2H), 1.87 (dd, J 
= 16.0, 2.8 Hz, 1H), 1.80 – 1.63 (m, 1H), 1.55 – 1.45 (m, 1H), 1.19 (t, J = 7.2 Hz, 3H), 0.67 
(t, J = 7.1 Hz, 3H). 13C NMR (100 MHz, CDCl3) δ 176.8, 171.0, 168.3, 143.4, 135.6, 129.4, 
128.8, 128.1, 127.9, 125.9, 125.2, 122.6, 109.6, 82.3, 61.4, 60.7, 53.9, 49.9, 44.7, 40.1, 
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34.7, 30.7, 25.8, 14.1, 13.4. HPLC-MS (ESI) tr = 10.7 min; [M+H]
+ = 495.4 m/z, [2M+Na]+ 
= 1011.7 m/z. CSP-HPLC: IC 90:10 n-hexane/IPA for 15 min, then up to 80:20 in 20 min; 
flow rate 0.7 mL/min at 40°C; λ 210 nm; tr = 63.3 min (minor), tr = 65.2 min (major). 
1'-(tert-butyl) 2-ethyl 6-(2-ethoxy-2-oxoethyl)-3-nitro-2'-oxospiro[cyclohexane-1,3'-
indoline]-1',2-dicarboxylate (16c,a): 1H NMR (400 MHz, CDCl3) δ 7.93 (d, J = 8.2 Hz, 
1H), 7.39 (t, J = 7.8, 1H), 7.25 (d, J = 6.3 Hz, 1H), 7.18 (t, J = 7.5, 1H), 5.23 (dt, J = 12.3, 
4.7 Hz, 1H), 4.13 – 3.99 (m, 2H), 3.95 (d, J = 11.7 Hz, 1H), 3.76 (q, J = 7.2, 2H), 2.78 – 
2.66 (m, 1H), 2.67 – 2.57 (m, 1H), 2.23 – 2.02 (m, 2H), 1.97 (dd, J = 16.1, 3.0 Hz, 1H), 
1.68 (s, 9H), 1.56 – 1.46 (m, 2H), 1.20 (t, J = 7.1, 3H), 0.87 (t, J =7.2 Hz, 3H). 13C NMR (50 
MHz, CDCl3) δ 175.5, 170.7, 168.2, 148.8, 140.1, 129.7, 125.0, 124.61, 124.58, 115.6, 
85.0, 81.9, 61.7, 60.8, 54.4, 50.3, 40.6, 35.1, 30.6, 28.1, 25.3, 14.1, 13.3. HPLC-MS (ESI) 
tr = 11.0 min; [M+Na]
+ = 527.5 m/z, [2M+Na]+ = 1031.8 m/z. CSP-HPLC: IC 90:10 n-
hexane/IPA for 15 min, then up to 80:20 in 10 min, 80:20 for 15 min, then up to 70:30 
in 10 min; flow rate 0.5 mL/min at 40°C; λ 254 nm; tr = 57.5 min (minor), tr = 78.7 min 
(major). 
Ethyl 1'-acetyl-6-(2-ethoxy-2-oxoethyl)-3-nitro-2'-oxospiro[cyclohexane-1,3'-
indoline]-2-carboxylate (16o,a): 1H NMR (400 MHz, CDCl3) δ 8.32 (d, J = 8.0 Hz, 1H), 
7.49 – 7.34 (m, 1H), 7.34 – 7.15 (m, 2H), 5.24 (dt, J = 12.3, 4.7 Hz, 1H), 4.05 (q, J = 7.2 
Hz, 2H), 3.93 (d, J = 11.7 Hz, 1H), 3.82 – 3.67 (m, 2H), 2.77 (s, 3H), 2.74 – 2.58 (m, 2H), 
2.26 – 2.07 (m, 2H), 1.86 (dd, J = 16.0, 3.2 Hz, 1H), 1.63 – 1.50 (m, 2H), 1.19 (t, J = 7.1 
Hz, 3H), 0.80 (t, J = 7.2 Hz, 3H). CSP-HPLC: IC 90:10 n-hexane/IPA for 15 min, then up to 
80:20 in 10 min, 80:20 for 15 min, then up to 70:30 in 10 min; flow rate 0.5 mL/min at 
40°C; λ 214 nm; tr = 31.2 min (major), tr = 41.5 min (minor). 
1'-(tert-butyl) 2-ethyl 5'-chloro-6-(2-ethoxy-2-oxoethyl)-3-nitro-2'-
oxospiro[cyclohexane-1,3'-indoline]-1',2-dicarboxylate (16d,a): 1H NMR (400 MHz, 
CDCl3) δ 7.92 (d, J = 8.8 Hz, 1H), 7.37 (dd, J = 8.8, 2.1 Hz, 1H), 7.20 (d, J = 2.1 Hz, 1H), 
5.23 – 5.10 (m, 1H), 4.07 (q, J = 7.2 Hz, 2H), 3.94 (d, J = 11.8 Hz, 1H), 3.87 – 3.72 (m, 
2H), 2.80 – 2.68 (m, 1H), 2.69 – 2.56 (m, 1H), 2.24 – 2.01 (m, 2H), 1.95 (dd, J = 16.1, 3.1 
Hz, 1H), 1.67 (s, 9H), 1.61 – 1.48 (m, 2H), 1.21 (t, J = 7.1 Hz, 3H), 0.89 (t, J = 7.2 Hz, 3H). 
13C NMR (100 MHz, CDCl3) δ 174.9, 170.4, 168.0, 148.6, 138.7, 130.1, 129.8, 126.9, 
124.7, 116.8, 85.5, 81.6, 61.9, 60.9, 54.4, 50.1, 40.6, 35.0, 30.5, 28.1, 25.3, 14.1, 13.3.  
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HPLC-MS (ESI) tr = 11.5 min; [M+Na]
+ = 561.0 m/z, [2M+Na]+ = 1099.2 m/z. CSP-HPLC: 
IC 90:10 n-hexane/IPA for 8 min, then up to 80:20 in 8 min, 80:20 for 8 min, then up to 
70:30 in 8 min; flow rate 0.5 mL/min at 40°C; λ 210 nm; tr = 47.5 min (minor), tr = 50.2 
min (major). 
1'-(tert-butyl) 2-ethyl 6'-chloro-6-(2-ethoxy-2-oxoethyl)-3-nitro-2'-
oxospiro[cyclohexane-1,3'-indoline]-1',2-dicarboxylate (16f,a): 1H NMR (400 MHz, 
CDCl3) δ 8.06 – 7.98 (m, 1H), 7.22 – 7.13 (m, 2H), 5.23 – 5.10 (m, 1H), 4.13 – 4.01 (m, 
2H), 3.93 (d, J = 11.6 Hz, 1H), 3.80 (q, J = 7.3 Hz, 2H), 2.77 – 2.66 (m, 1H), 2.67 – 2.56 
(m, 1H), 2.22 – 2.00 (m, 2H), 1.94 (dd, J = 15.9, 2.4 Hz, 1H), 1.68 (s, 9H), 1.63 – 1.47 (m, 
2H), 1.20 (t, J = 7.2 Hz, 3H), 0.92 (t, J = 7.1 Hz, 3H). 13C NMR (100 MHz, CDCl3) δ 175.1, 
170.5, 168.1, 148.5, 141.1, 135.8, 125.4, 124.6, 123.4, 116.4, 85.6, 81.7, 61.9, 60.9, 
54.2, 50.2, 40.6, 35.0, 30.5, 28.0, 25.3, 14.1, 13.4. HPLC-MS (ESI) tr = 12.1 min; [M+Na]
+ 
= 561.2 m/z, [2M+Na]+ = 1099.7 m/z. CSP-HPLC: IC 90:10 n-hexane/IPA for 15 min, then 
up to 80:20 in 10 min, 80:20 for 15 min, then up to 70:30 in 10 min; flow rate 0.5 
mL/min at 40°C; λ 230 nm; tr = 41.5 min (minor), tr = 57.2 min (major). 
1'-(tert-butyl) 2-ethyl 7'-chloro-6-(2-ethoxy-2-oxoethyl)-3-nitro-2'-
oxospiro[cyclohexane-1,3'-indoline]-1',2-dicarboxylate (16p,a): 1H NMR (400 MHz, 
CDCl3) δ 7.38 (d, J = 7.0 Hz, 1H), 7.23 – 7.04 (m, 2H), 5.20 (dt, J = 12.3, 4.7 Hz, 1H), 4.15 
– 3.99 (m, 2H), 3.93 (d, J = 11.7 Hz, 1H), 3.87 (q, J = 7.2 Hz, 2H), 2.78 – 2.66 (m, 1H), 
2.66 – 2.55 (m, 1H), 2.39 – 2.25 (m, 1H), 2.17 – 1.96 (m, 2H), 1.66 (s, 9H), 1.61 – 1.42 
(m, 2H), 1.20 (t, J = 7.1 Hz, 3H), 0.91 (t, J = 7.2 Hz, 3H). CSP-HPLC: IC 90:10 n-
hexane/IPA for 15 min, then up to 80:20 in 10 min, 80:20 for 15 min, then up to 70:30 
in 10 min; flow rate 0.5 mL/min at 40°C; λ 254 nm; tr = 40.0 min (major), tr = 42.8 min 
(minor). 
1'-(tert-butyl) 2-ethyl 6-(2-ethoxy-2-oxoethyl)-5'-methoxy-3-nitro-2'-
oxospiro[cyclohexane-1,3'-indoline]-1',2-dicarboxylate (16h,a): 1H NMR (400 MHz, 
CDCl3) δ 7.86 (d, J = 8.9 Hz, 1H), 6.88 (dd, J = 9.1, 2.6 Hz, 1H), 6.78 (d, J = 2.6 Hz, 1H), 
5.19 (dt, J = 12.3, 4.7 Hz, 1H), 4.06 (q, J = 7.2 Hz, 2H), 3.94 (d, J = 11.7 Hz, 1H), 3.86 – 
3.74 (m, 5H), 2.75 – 2.65 (m, 1H), 2.66 – 2.57 (m, 1H), 2.20 – 2.01 (m, 2H), 1.96 (dd, J = 
16.1, 3.0 Hz, 1H), 1.67 (s, 9H), 1.61 – 1.49 (m, 2H), 1.20 (t, J = 7.1 Hz, 3H), 0.89 (t, J = 7.1 
Hz, 3H). 13C NMR (100 MHz, CDCl3) δ 175.5, 170.7, 168.2, 156.5, 148.8, 133.3, 126.3, 
116.3, 112.9, 112.3, 84.8, 81.8, 61.7, 60.8, 55.7, 54.5, 50.1, 40.5, 35.0, 30.5, 28.1, 25.2, 
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14.1, 13.3. HPLC-MS (ESI) tr = 10.9 min; [M-Boc]
+ = 435.4 m/z. CSP-HPLC: IC 90:10 n-
hexane/IPA for 15 min, then up to 80:20 in 10 min, 80:20 for 15 min, then up to 70:30 
in 10 min; flow rate 0.5 mL/min at 40°C; λ 210 nm; tr = 48.0 min (minor), tr = 77.0 min 
(major). *α+D
20 = +24.3° (c = 0.55, CHCl3). 
1'-(tert-butyl) 2-ethyl 6-(2-ethoxy-2-oxoethyl)-5'-methyl-3-nitro-2'-
oxospiro[cyclohexane-1,3'-indoline]-1',2-dicarboxylate (16q,a): 1H NMR (400 MHz, 
CDCl3) δ 7.80 (d, J = 8.3 Hz, 1H), 7.17 (d, J = 8.3 Hz, 1H), 7.01 (s, 1H), 5.23 (dt, J = 12.3, 
4.7 Hz, 1H), 4.15 – 4.00 (m, 2H), 3.93 (d, J = 11.7 Hz, 1H), 3.77 (q, J = 7.2 Hz, 2H), 2.78 – 
2.66 (m, 1H), 2.67 – 2.55 (m, 1H), 2.37 (s, 3H), 2.20 – 2.01 (m, 2H), 1.96 (dd, J = 16.1, 
3.0 Hz, 1H), 1.67 (s, 9H), 1.59 – 1.46 (m, 2H), 1.20 (t, J = 7.2 Hz, 3H), 0.87 (t, J = 7.1 Hz, 
3H). 13C NMR (100 MHz, CDCl3) δ 175.7, 170.8, 168.3, 148.8, 137.7, 134.3, 130.2, 125.1, 
125.0, 115.3, 84.8, 81.9, 61.7, 60.8, 54.4, 50.2, 40.6, 35.1, 30.6, 28.1, 25.3, 21.3, 14.1, 
13.3. HPLC-MS (ESI) tr = 11.5 min; [M+Na]
+ = 541.4 m/z, [2M+Na]+ = 1059.9 m/z. CSP-
HPLC: IC 90:10 n-hexane/IPA for 15 min, then up to 80:20 in 10 min, 80:20 for 15 min, 
then up to 70:30 in 10 min; flow rate 0.5 mL/min at 40°C; λ 254 nm; tr = 60.1 min 
(minor), tr = 73.8 min (major). *α+D
20 = +19.8° (c = 1.08, CHCl3). 
1'-(tert-butyl) 2-ethyl 6-(2-ethoxy-2-oxoethyl)-3-nitro-2'-oxo-5'-
(trifluoromethoxy)spiro[cyclohexane-1,3'-indoline]-1',2-dicarboxylate (16r,a): 1H 
NMR (400 MHz, CDCl3) δ 8.02 (d, J = 9.0 Hz, 1H), 7.33 – 7.16 (m, 1H), 7.13 – 7.03 (m, 
1H), 5.14 (dt, J = 12.5, 4.8 Hz, 1H), 4.18 – 3.99 (m, 2H), 3.96 (d, J = 11.8 Hz, 1H), 3.79 (q, 
J = 7.1 Hz, 2H), 2.79 – 2.70 (m, 1H), 2.70 – 2.57 (m, 1H), 2.26 – 2.01 (m, 2H), 1.95 (dd, J 
= 16.1, 3.1 Hz, 1H), 1.67 (s, 9H), 1.63 – 1.47 (m, 2H), 1.21 (t, J = 7.1 Hz, 3H), 0.88 (t, J = 
7.2 Hz, 3H). 13C NMR (100 MHz, CDCl3) δ 174.9, 170.4, 167.9, 148.6, 145.5, 138.8, 
126.8, 122.3, 120.4 (q, J = 256 Hz), 118.1, 116.7, 85.6, 81.6, 61.9, 61.0, 54.5, 50.2, 40.5, 
35.0, 30.5, 28.1, 25.4, 14.1, 13.3. HPLC-MS (ESI) tr = 12.0 min; [M+Na]
+ = 611.3 m/z, 
[2M+Na]+ = 1199.7 m/z. CSP-HPLC: IC 90:10 n-hexane/IPA for 15 min, then up to 80:20 
in 10 min, 80:20 for 15 min, then up to 70:30 in 10 min; flow rate 0.5 mL/min at 40°C; λ 
230 nm; tr = 25.9 min (minor), tr = 48.8 min (major). *α+D
20 = +15.5° (c = 0.88, CHCl3). 
2-benzyl 1'-(tert-butyl) 6-(2-ethoxy-2-oxoethyl)-3-nitro-2'-oxospiro[cyclohexane-1,3'-
indoline]-1',2-dicarboxylate (16i,a): 1H NMR (400 MHz, CDCl3) δ 7.71 (d, J = 8.4 Hz, 
1H), 7.32 – 7.16 (m, 6H), 7.11 (t, J = 7.2 Hz, 1H), 6.97 – 6.90 (m, 1H), 5.25 (dt, J = 12.4, 
4.8 Hz, 1H), 4.84 – 4.67 (m, 2H), 4.16 – 3.93 (m, 3H), 2.79 – 2.66 (m, 1H), 2.66 – 2.54 
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(m, 1H), 2.21 – 1.99 (m, 2H), 1.91 (dd, J = 16.1, 3.1 Hz, 1H), 1.73 – 1.44 (m, 11H), 1.18 
(t, J = 7.2 Hz, 3H). 13C NMR (100 MHz, CDCl3) δ 175.3, 170.7, 168.3, 148.5, 139.9, 134.3, 
129.6, 128.5, 128.33, 128.30, 124.6, 124.38, 124.36, 115.7, 84.8, 81.9, 67.4, 60.8, 54.3, 
50.1, 40.8, 34.9, 30.6, 28.1, 25.3, 14.1. HPLC-MS (ESI) tr = 12.0 min; [M+Na]
+ = 589.4 
m/z. CSP-HPLC: IC 90:10 n-hexane/IPA for 15 min, then up to 80:20 in 10 min, 80:20 for 
15 min, then up to 70:30 in 10 min; flow rate 0.5 mL/min at 40°C; λ 210 nm; tr = 42.0 
min (minor), tr = 69.6 min (major). *α+D
20 = +11.5° (c = 0.72, CHCl3). 
tert-butyl 2-benzoyl-6-(2-ethoxy-2-oxoethyl)-3-nitro-2'-oxospiro[cyclohexane-1,3'-
indoline]-1'-carboxylate (16t,a): 1H NMR (400 MHz, CDCl3) δ 7.76 (d, J = 8.0 Hz, 1H), 
7.66 – 7.18 (m, 8H), 5.51 (dt, J = 12.1, 4.4 Hz, 1H), 4.74 (d, J = 11.3 Hz, 1H), 4.05 (q, J = 
6.7 Hz, 2H), 2.93 – 2.82 (m, 1H), 2.83 – 2.71 (m, 1H), 2.39 – 2.12 (m, 2H), 1.89 – 1.77 
(m, 1H), 1.63 – 1.50 (m, 11H), 1.19 (t, J = 7.1 Hz, 3H). CSP-HPLC: IC 90:10 n-hexane/IPA 
for 15 min, then up to 80:20 in 10 min, 80:20 for 15 min, then up to 70:30 in 10 min; 
flow rate 0.5 mL/min at 40°C; λ 230 nm; tr = 41.3 min (major), tr = 60.0 min (minor). 
tert-butyl 6-(2-ethoxy-2-oxoethyl)-3-nitro-2-(4-nitrophenyl)-2'-oxospiro[cyclohexane-
1,3'-indoline]-1'-carboxylate (16l,a): 1H NMR (400 MHz, CDCl3) δ 7.85 (bt, J = 6.8 Hz, 
2H), 7.57 (t, J = 6.8 Hz, 2H), 7.43 – 7.26 (m, 2H), 6.88 (bs, 2H), 5.37 (dt, J = 12.2, 4.2 Hz, 
1H), 4.15 – 4.03 (m, 2H), 4.00 (d, J = 12.2 Hz, 1H), 3.01 – 2.85 (m, 1H), 2.80 – 2.67 (m, 
1H), 2.49 – 2.31 (m, 2H), 2.10 – 1.84 (m, 2H), 1.79 – 1.65 (m, 1H), 1.50 (s, 9H), 1.21 (t, J 
= 7.1 Hz, 3H). 13C NMR (50 MHz, CDCl3) δ 174.8, 170.7, 147.63, 147.55, 140.5, 140.1, 
129.9, 124.8, 124.7, 124.6, 123.0, 122.9, 115.7, 85.2, 84.8, 60.8, 57.9, 53.5, 39.1, 36.3, 
31.2, 27.9, 25.8, 14.1. HPLC-MS (ESI) tr = 11.4 min; [M+Na]
+ = 576.3 m/z. CSP-HPLC: IC 
90:10 n-hexane/IPA for 15 min, then up to 80:20 in 10 min, 80:20 for 15 min, then up 
to 70:30 in 10 min; flow rate 0.5 mL/min at 40°C; λ 254 nm; tr = 40.4 min (minor), tr = 
42.1 min (major). 
tert-butyl 2-cyano-6-(2-ethoxy-2-oxoethyl)-3-nitro-2'-oxospiro[cyclohexane-1,3'-
indoline]-1'-carboxylate (16u,a): 1H NMR (400 MHz, CDCl3) δ 8.05 (d, J = 8.3 Hz, 1H), 
7.55 – 7.45 (m, 1H), 7.38 – 7.27 (m, 2H), 5.03 (dt, J = 12.2, 4.4 Hz, 1H), 4.15 – 3.98 (m, 
2H), 3.88 (d, J = 11.9 Hz, 1H), 2.81 – 2.67 (m, 1H), 2.68 – 2.55 (m, 1H), 2.33 – 2.08 (m, 
2H), 1.95 (dd, J = 16.2, 3.2 Hz, 1H), 1.89 – 1.72 (m, 1H), 1.72 – 1.56 (m, 10H), 1.20 (t, J = 
7.1 Hz, 3H). 13C NMR (100 MHz, CDCl3) δ 173.7, 170.2, 148.1, 140.4, 130.7, 125.1, 
124.4, 123.7, 116.5, 114.3, 85.9, 82.1, 61.0, 54.7, 39.7, 38.8, 35.4, 30.3, 28.0, 25.0, 
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14.1. HPLC-MS (ESI) tr = 10.1 min; [M+Na]
+ = 480.0 m/z, [2M+Na]+ = 937.4 m/z. CSP-
HPLC: IC 90:10 n-hexane/IPA for 8 min, then up to 80:20 in 8 min, 80:20 for 8 min, then 
up to 70:30 in 8 min, 80:20 in 8 min, then up to 1:1; flow rate 0.5 mL/min at 40°C; λ 
230 nm; tr = 31.0 min (minor), tr = 36.3 min (major). 
1'-(tert-butyl) 2-ethyl 6-(2-ethoxy-2-oxoethyl)-2-methyl-3-nitro-2'-
oxospiro[cyclohexane-1,3'-indoline]-1',2-dicarboxylate (16n,a): 1H NMR (400 MHz, 
CDCl3) δ 7.94 (d, J = 8.4 Hz, 1H), 7.46 – 7.36 (m, 2H), 7.23 (t, J = 7.4 Hz, 1H), 4.93 (dd, J 
= 13.4, 4.9 Hz, 1H), 4.42 – 4.31 (m, 2H), 4.12 – 3.95 (m, 2H), 3.59 – 3.46 (m, 1H), 3.26 
(dq, J = 13.3, 5.5 Hz, 1H), 2.54 – 2.39 (m, 1H), 1.93 – 1.72 (m, 2H), 1.64 (s, 9H), 1.56 – 
1.43 (m, 2H), 1.38 (t, J = 7.1 Hz, 3H), 1.20 (t, J = 7.2 Hz, 3H), 0.87 (s, 3H). CSP-HPLC: IC 
90:10 n-hexane/IPA for 15 min, then up to 80:20 in 10 min, 80:20 for 15 min, then up 
to 70:30 in 10 min; flow rate 0.5 mL/min at 40°C; λ 230 nm; tr = 22.1 min (major), tr = 
26.8 min (minor). 
1'-(tert-butyl) 2-ethyl 6-(2-ethoxy-2-oxoethyl)-3-nitro-2'-oxospiro[cyclohexane-1,3'-
indoline]-1',2-dicarboxylate (16c,b): 1H NMR (400 MHz, CDCl3) δ 7.80 (d, J = 8.2 Hz, 
1H), 7.39 – 7.20 (m, 3H), 5.63 (dt, J = 11.7, 6.0 Hz, 1H), 4.07 – 3.90 (m, 2H), 3.80 (q, J = 
7.2 Hz, 2H), 3.45 (d, J = 11.4 Hz, 1H), 2.73 – 2.55 (m, 1H), 2.54 – 2.39 (m, 1H), 2.35 – 
2.19 (m, 1H), 2.19 – 1.89 (m, 3H), 1.90 – 1.78 (m, 1H), 1.65 (s, 9H), 1.17 (t, J = 7.1 Hz, 
3H), 0.84 (t, J = 7.2 Hz, 3H). 13C NMR (100 MHz, CDCl3) δ 173.7, 171.3, 168.3, 148.7, 
140.0, 129.4, 127.5, 125.0, 122.6, 115.0, 84.8, 81.8, 61.6, 60.8, 53.8, 53.0, 41.2, 34.6, 
30.6, 28.1, 24.3, 14.0, 13.4. HPLC-MS (ESI) tr = min; [M+]
+ = m/z. CSP-HPLC: IC 90:10 n-
hexane/IPA for 10 min, then up to 80:20 in 10 min, 80:20 for 10 min, then up to 70:30; 
flow rate 0.5 mL/min at 40°C; λ 254 nm; tr = 29.1 min (minor), tr = 30.5 min (major). 
1'-(tert-butyl) 2-ethyl 6-(1-ethoxy-1-oxopropan-2-yl)-3-nitro-2'-
oxospiro[cyclohexane-1,3'-indoline]-1',2-dicarboxylate (16c,c): 1H NMR (400 MHz, 
CDCl3) δ 7.88 – 7.79 (m, 1H), 7.41 – 7.29 (m, 2H), 7.23 – 7.13 (m, 1H), 5.73 (dt, J = 11.9, 
4.4 Hz, 1H), 4.28 – 4.10 (m, 2H), 3.75 (q, J = 7.1 Hz, 1H), 3.74 (q, J = 7.1 Hz, 1H), 3.42 (d, 
J = 11.5 Hz, 1H), 2.75 – 2.59 (m, 2H), 2.45 (dd, J = 12.5, 3.3 Hz, 1H), 2.13 – 1.99 (m, 1H), 
1.64 (s, 9H), 1.61 – 1.45 (m, 2H), 1.29 (t, J = 7.1 Hz, 3H), 0.82 (t, J = 7.2 Hz, 3H), 0.65 (s, 
3H). 13C NMR (100 MHz, CDCl3) δ 175.6, 173.8, 167.9, 149.3, 140.1, 129.4, 128.3, 124.0, 
123.9, 115.7, 84.1, 81.5, 62.4, 61.5, 55.6, 51.9, 51.0, 30.4, 28.2, 26.5, 21.8, 14.1, 13.4. 
CSP-HPLC: IC 90:10 n-hexane/IPA for 15 min, then up to 80:20 in 10 min, 80:20 for 15 
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min, then up to 70:30 in 10 min, 70:3 for 15 min, then up to 1: in 2 min; flow rate 0.5 
mL/min at 40°C; λ 254 nm; tr = 53.7 min (major), tr = 86.4 min (minor). *α+D
20 = +15.8° (c 
= 0.74, CHCl3). 
1'-(tert-butyl) 2-ethyl 6-(2-(benzyloxy)-2-oxoethyl)-3-nitro-2'-oxospiro[cyclohexane-
1,3'-indoline]-1',2-dicarboxylate (16c,f): 1H NMR (400 MHz, CDCl3) δ 7.80 (d, J = 8.1 
Hz, 1H), 7.42 – 7.18 (m, 8H), 5.64 (dt, J = 11.7, 3.9 Hz, 1H), 5.00 (d, J = 13.3 Hz, 1H), 4.94 
(d, J = 12.4 Hz, 1H), 3.80 (q, J = 8.0 Hz, 2H), 3.45 (d, J = 11.4 Hz, 1H), 2.68 – 2.56 (m, 1H), 
2.56 – 2.42 (m, 1H), 2.42 – 1.76 (m, 5H), 1.64 (s, 9H), 0.84 (t, J = 7.0 Hz, 3H). CSP-HPLC: 
IC 90:10 n-hexane/IPA for 15 min, then up to 80:20 in 10 min, 80:20 for 15 min, then 
up to 70:30 in 10 min; flow rate 0.5 mL/min at 40°C; λ 210 nm; tr = 52.4 min (minor), tr 
= 59.6 min (major). 
1'-(tert-butyl) 2-ethyl 6-(2-(benzyloxy)-2-oxoethyl)-3-nitro-2'-oxospiro[cyclohexane-
1,3'-indoline]-1',2-dicarboxylate (16c,g): 1H NMR (400 MHz, CDCl3) δ 7.79 (d, J = 8.4 
Hz, 1H), 7.41 – 7.20 (m, 8H), 5.63 (dt, J = 11.8, 4.3 Hz, 1H), 5.00 (d, J = 12.2 Hz, 1H), 4.94 
(d, J = 12.2 Hz, 1H), 3.80 (q, J = 7.1 Hz, 2H), 3.45 (d, J = 11.5 Hz, 1H), 2.68 – 2.57 (m, 1H), 
2.55 – 2.42 (m, 1H), 2.34 – 2.18 (m, 1H), 2.16 – 2.01 (m, 2H), 1.99 – 1.84 (m, 2H), 1.64 
(s, 9H), 0.84 (t, J = 7.1 Hz, 3H). 13C NMR (50 MHz, CDCl3) δ 173.6, 171.2, 168.3, 148.7, 
140.0, 135.3, 129.5, 128.6, 128.4, 128.2, 127.4, 125.0, 122.6, 115.1, 84.8, 81.8, 66.7, 
61.6, 53.8, 52.9, 41.3, 34.6, 30.5, 28.1, 24.2, 13.4. HPLC-MS (ESI) tr = 12.1 min; [M+Na]
+ 
= 589.0 m/z, [2M+Na]+ = 1155.2 m/z. CSP-HPLC: IC 90:10 n-hexane/IPA for 8 min, then 
up to 80:20 in 8 min, 80:20 for 8 min, then up to 70:30 in 8 min; flow rate 0.5 mL/min 
at 40°C; λ 254 nm; tr = 57.5 min (minor), tr = 78.7 min (major). 
1'-(tert-butyl) 2-ethyl 6-(cyanomethyl)-3-nitro-2'-oxospiro[cyclohexane-1,3'-
indoline]-1',2-dicarboxylate (16c,h): 4 diastereoisomers obtained. 
Isomer A: 1H NMR (400 MHz, CDCl3) δ 7.89 (d, J = 8.1 Hz, 1H), 7.43 (t, J = 8.1 Hz, 1H), 
7.21 (t, J = 7.1 Hz, 1H), 7.14 (d, J = 7.1 Hz, 1H), 5.53 (dt, J = 12.8, 4.8 Hz, 1H), 4.16 (dq, J 
= 10.8, 7.1 Hz, 1H), 4.00 (dq, J = 10.8, 7.2 Hz, 1H), 3.42 (d, J = 5.8 Hz, 1H), 3.13 – 2.99 
(m, 1H), 2.97 – 2.80 (m, 1H), 2.63 – 2.50 (m, 1H), 2.38 – 2.25 (m, 1H), 1.97 – 1.87 (m, 
1H), 1.66 (s, 9H), 1.63 – 1.48 (m, 2H), 1.11 (t, J = 7.2 Hz, 3H). CSP-HPLC: IC 90:10 n-
hexane/IPA for 8 min, then up to 80:20 in 8 min, 80:20 for 8 min, then up to 70:30 in 8 
min, 73: 30 for 8 min, then up to 1:1 in 8 min; flow rate 0.5 mL/min at 40°C; λ 230 nm; 
tr = 37.4 min (major), tr = 42.6 min (minor). 
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Isomer B: 1H NMR (400 MHz, CDCl3) δ 7.97 (d, J = 8.3 Hz, 1H), 7.49 – 7.37 (m, 1H), 7.32 
– 7.18 (m, 2H), 5.24 (dt, J = 12.3, 4.8 Hz, 1H), 3.92 (d, J = 11.7 Hz, 1H), 3.87 – 3.67 (m, 
2H), 2.88 – 2.75 (m, 1H), 2.57 – 2.44 (m, 1H), 2.35 – 2.23 (m, 1H), 2.19 – 2.00 (m, 2H), 
1.84 (ddd, J = 27.1, 13.7, 3.4 Hz, 1H), 1.75 – 1.51 (m, 10H), 0.87 (t, J = 7.1 Hz, 3H). CSP-
HPLC: IC 90:10 n-hexane/IPA for 8 min, then up to 80:20 in 8 min, 80:20 for 8 min, then 
up to 70:30 in 8 min, 73: 30 for 8 min, then up to 1:1 in 8 min; flow rate 0.5 mL/min at 
40°C; λ 230 nm; tr = 56.8 min (major), tr = 65.5 min (minor). 
Isomer C: 1H NMR (400 MHz, CDCl3) δ 7.92 (d, J = 7.6 Hz, 1H), 7.46 – 7.10 (m, 3H), 5.31 
(dt, J = 11.8, 6.1 Hz, 1H), 4.01 (d, J = 11.6 Hz, 1H), 3.76 (q, J = 7.1 Hz, 2H), 2.83 (dd, J = 
17.3, 4.8 Hz, 1H), 2.72 – 2.61 (m, 1H), 2.34 – 2.02 (m, 3H), 1.74 – 1.61 (m, 11H), 0.83 (t, 
J = 7.1 Hz, 3H). CSP-HPLC: IC 90:10 n-hexane/IPA for 8 min, then up to 80:20 in 8 min, 
80:20 for 8 min, then up to 70:30 in 8 min, 73: 30 for 8 min, then up to 1:1 in 8 min; 
flow rate 0.5 mL/min at 40°C; λ 230 nm; tr = 69.4 min (major), tr = 81.5 min (minor). 
Isomer D: 16c,i. 
1'-(tert-butyl) 2-ethyl 6-(cyanomethyl)-3-nitro-2'-oxospiro[cyclohexane-1,3'-
indoline]-1',2-dicarboxylate (16c,i): 1H NMR (400 MHz, CDCl3) δ 7.84 (d, J = 8.2 Hz, 1H), 
7.47 – 7.38 (m, 1H), 7.35 – 7.27 (m, 2H), 5.64 (dt, J = 11.9, 4.4 Hz, 1H), 3.82 (q, J = 7.0 
Hz, 2H), 3.44 (d, J = 11.5 Hz, 1H), 2.80 – 2.67 (m, 1H), 2.49 – 2.33 (m, 1H), 2.33 – 1.91 
(m, 5H), 1.65 (s, 9H), 0.85 (t, J = 7.1 Hz, 3H). 13C NMR (100 MHz, CDCl3) δ 172.8, 167.9, 
148.4, 139.9, 130.1, 126.5, 125.4, 122.2, 117.0, 115.4, 85.3, 81.4, 61.9, 53.5, 52.6, 42.0, 
30.1, 28.1, 24.0, 18.8, 13.4. HPLC-MS (ESI) tr = 9.9 min; [M+Na]
+ = 480.0 m/z, [2M+Na]+ 
= 937.2 m/z. CSP-HPLC: IC 90:10 n-hexane/IPA for 8 min, then up to 80:20 in 8 min, 
80:20 for 8 min, then up to 70:30 in 8 min, 73: 30 for 8 min, then up to 1:1 in 8 min; 
flow rate 0.5 mL/min at 40°C; λ 230 nm; tr = 50.7 min (minor), tr = 53.1 min (major). 
1'-(tert-butyl) 2-ethyl 5-(2-ethoxy-2-oxoethyl)-3-nitro-2'-oxospiro[cyclopentane-1,3'-
indoline]-1',2-dicarboxylate (19A): 1H NMR (400 MHz, CDCl3) δ 7.95 (d, J = 8.2 Hz, 1H), 
7.38 (t, J = 7.9 Hz, 1H), 7.21 – 7.12 (m, 1H), 6.97 (d, J = 7.9 Hz, 1H), 5.68 (ddd, J = 10.8, 
7.6, 3.0 Hz, 1H), 4.44 (d, J = 7.7 Hz, 1H), 4.10 – 3.95 (m, 2H), 3.87 – 3.65 (m, 2H), 3.37 – 
3.20 (m, 1H), 3.03 – 2.92 (m, 1H), 2.54 – 2.42 (m, 1H), 2.01 (dd, J = 16.2, 5.5 Hz, 1H), 
1.90 (dd, J = 16.2, 9.3 Hz, 1H), 1.67 (s, 9H), 1.18 (t, J = 7.2 Hz, 3H), 0.75 (t, J = 7.1 Hz, 
3H). 13C NMR (50 MHz, CDCl3) δ 174.6, 170.3, 167.7, 148.9, 140.3, 129.7, 124.61, 
124.58, 123.4, 115.7, 84.9, 84.3, 61.6, 60.9, 60.4, 57.6, 44.4, 36.4, 34.6, 28.1, 14.0, 
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13.2. HPLC-MS (ESI) tr = 10.7 min; [2M+Na]
+ = 1003.7 m/z. CSP-HPLC: IC 90:10 n-
hexane/IPA for 15 min, then up to 80:20 in 10 min, 80:20 for 15 min, then up to 70:30 
in 10 min; flow rate 0.5 mL/min at 40°C; λ 254 nm; tr = 47.6 min (minor), tr = 60.1 min 
(major). 
1'-(tert-butyl) 2-ethyl 5-(2-ethoxy-2-oxoethyl)-2'-oxospiro[cyclopentane-1,3'-indolin]-
2-ene-1',2-dicarboxylate (19B): 1H NMR (400 MHz, CDCl3) δ 7.88 (d, J = 8.1 Hz, 1H), 
7.31 (t, J = 7.9 Hz, 1H), 7.17 (bt, J = 2.4 Hz, 1H), 7.11 (t, J = 7.6 Hz, 1H), 6.95 (d, J = 7.5 
Hz, 1H), 4.11 – 3.82 (m, 4H), 3.53 – 3.38 (m, 1H), 3.05 (ddd, J = 18.7, 8.5, 3.0 Hz, 1H), 
2.51 (ddd, J = 18.6, 9.5, 2.2 Hz, 1H), 2.25 (dd, J = 16.4, 8.5 Hz, 1H), 2.13 (dd, J = 16.4, 7.3 
Hz, 1H), 1.67 (s, 9H), 1.13 (t, J = 7.1 Hz, 3H), 1.05 (t, J = 7.2 Hz, 3H). 13C NMR (100 MHz, 
CDCl3) δ 177.3, 171.1, 162.2, 149.3, 146.3, 140.0, 138.6, 128.9, 127.4, 124.0, 123.8, 
115.4, 84.0, 62.6, 60.6, 60.5, 45.1, 38.4, 35.7, 28.1, 14.0, 13.6. HPLC-MS (ESI) tr = 10.3 
min; [M+Na]+ = 466.4 m/z, [2M+Na]+ = 909.7 m/z. CSP-HPLC: IC 90:10 n-hexane/IPA for 
15 min, then up to 80:20 in 10 min, 80:20 for 15 min, then up to 70:30 in 10 min; flow 
rate 0.5 mL/min at 40°C; λ 254 nm; tr = 67.2 min (major), tr = 83.1 min (minor). *α+D
20 = 
-32.3° (c = 1.12, CHCl3). 
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Chapter 5 
Photochemical Organocatalytic Atom 
Transfer Radical Addition to Alkenes  
1. Introduction on atom transfer radical addition reactions 
In 1937, during their investigations on the regioselectivity of the addition of HBr to 
unsymmetrical alkenes in the presence of peroxides, Kharasch and co-workers 
observed the formation of the anti-Markovnikov adduct.110 They proposed that such 
products were formed by means of a free radical mechanism in which the peroxides 
acted as free-radical initiators. Subsequent works confirmed the ability of peroxides to 
act as free-radical initiators in this reaction, generating bromine radicals by homolytic 
cleavage of the HBr bond. The addition of a bromine radical to an alkene occurs at the 
least substituted carbon atom producing a more stable alkyl radical, which is 
irreversibly trapped by the hydrogen atom from HBr molecule, giving the anti-
Markovnikov addition product (Scheme 28). 
 
Scheme 28 
After the discovery of the “peroxide effect” it was recognized that a variety of 
substrates could be used in the radical addition to alkenes. In particular, Kharasch 
                                                     
110 Kharasch M. S., Engelmann H., Mayo F. R., J. Org. Chem. 1937, 2, 288-302. 
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investigated the addition of polyhalogenated alkanes to alkenes in the presence of 
free-radical initiators or light.111 This reaction is today known as the Kharasch addition 
or atom transfer radical addition (ATRA). Very high yields of the monoadduct were 
obtained in the case of simple 1-olefins, but were significantly decreased for more 
reactive alkenes (styrene, methyl acrylate and methyl methacrylate), that were highly 
active in free-radical polymerization. In this case the reaction was called atom transfer 
radical polymerization (ATRP) and was mostly the result of radical-radical termination 
reactions and multiple radical additions to alkene generating oligomers and polymers 
(Scheme 29). Since the ATRA reaction competes with radical mediated olefin 
polymerization, it found limited application in organic synthesis. 
 
Scheme 29 
In the middle of the past century, Minisci and co-workers noticed, during their 
studies of acrylonitrile polymerization in halogenated solvents (CCl4 and CHCl3), the 
formation of considerable amounts of the addition product of the halomethane to the 
olefin.112 They realized that iron species, originated from corrosion in the reactor, were 
responsible for the catalytic process and they therefore proposed a mechanism in 
which iron chlorides increased the addition rate.113 These seminal findings can be 
considered as the beginning of the transition-metal-catalysed (TMC) Kharasch reaction 
or TMC-ATRA.114 
                                                     
111 (a) Kharasch M. S., Jensen E. V., Urry W. H., Science 1945, 102, 128-128; (b) Kharasch M. S., Jensen E. V., Urry 
W. H., J. Am. Chem. Soc. 1945, 67, 1626-1626. 
112 De Malde M., Minisci F., Pallini U., Volterra E., Quilico A., Chim. Ind. (Milan, Italy) 1956, 38, 371-382. 
113 (a) Minisci F., Gazz. Chim. Ital. 1961, 91, 386-389; (b) Minisci F., Pallini U., Gazz. Chim. Ital. 1961, 91, 1030-
1036; (c) Minisci F., Galli R., Tetrahedron Lett. 1962, 3, 533-538; (d) Minisci F., Galli R., Chim. Ind. (Milan, Italy) 
1963, 45, 1400-1401; (e) Minisci F., Cecere M., Galli R., Gazz. Chim. Ital. 1963, 93, 1288-1294. 
114 Muñoz-Molina J. M., Belderrain T. B., Pérez P. J., Eur. J. Inorg. Chem. 2011, 3155-3164. 
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The TMC-ATRA reaction (Scheme 30) begins with the activation step in which the 
carbon–halogen (C-X) bond is homolytically dissociated by the metal catalyst (LnM), 
yielding a carbon-centered radical and a metal halide. The former species interacts 
with the olefin affording another radical, which provides the halogen abstraction from 
the metal halide in the deactivation step. The metal is reduced to the initial oxidation 
state and the desired addition product is formed. 
 
Scheme 30 
The principal drawback of this synthetic method was the large amount of catalyst 
(typically 10-30 mol%) required to achieve high selectivity towards the desired 
compound, which causes serious problems for product separation and catalyst 
recycling. Additionally, these relatively large catalyst loadings make the process 
environmentally unfriendly and expensive. One of the main reasons for high catalyst 
loading was the accumulation of the metal complex in the higher oxidation state, as a 
result of radical termination reactions. Different methodologies were developed to 
overcome these drawbacks, like for example the design of solid supported catalysts, 
the use of biphasic systems such as fluorous solvents, or the use of highly active metal 
complexes based on ligand design.115 Perhaps, the most significant solution to the 
problem of catalyst recycling and regeneration in ATRA relies on the use of reducing 
agents116 such as radical initiator AIBN (azobisisobutyronitrile).117 In this case the 
                                                     
115 Clark A. J., Chem. Soc. Rev. 2002, 31, 1-11. 
116 (a) Eckenhoff W. T., Pintauer T., Catalysis Reviews: Science and Engineering 2010, 1-59; (b) Pintauer T., Eur. 
J. Inorg. Chem. 2010, 2449-2460. 
117 (a) Eckenhoff W. T., Garrity S. T., Pintauer T., Eur. J. Inorg. Chem. 2008, 563-571; (b) Eckenhoff W. T., 
Pintauer T., Dalton Trans. 2011, 40, 4909-4917; (c) Quebatte L., Thommes K., Severin K., J. Am. Chem. Soc. 
2006, 128, 7440-7441. 
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decomposition of AIBN provides constant source of radicals which continuously reduce 
the transition metal complex in the higher oxidation state to the lower oxidation state. 
As a result, ATRA reactions can now be conducted using metal catalysts at ppm level. 
The recent developments in this area could have important industrial implications on 
the synthesis of small organic molecules, natural products and pharmaceutical drugs. 
Great progress was made not only in controlling product selectivity, but also in 
utilizing a variety of halogenated compounds (alkyl and aryl halides, N-chloroamines, 
alkylsulfonyl halides and polyhalogenated compounds). Furthermore, it was also 
demonstrated that different alkenes such as styrene, alkyl acrylates and acrylonitrile 
could be used in the reaction. Therefore, TMC-ATRA became a broadly applicable 
synthetic tool. 
Transition metal complexes of Ru, Fe, Ni and Cu are typically used as catalysts for 
atom transfer radical addition (ATRA) and cyclization (ATRC) providing the formation of 
carbon-carbon bonds. 
The ATRC (Scheme 31) has found a number of synthetic applications constituting a 
useful tool for the synthesis of valuable cyclic compounds.  
 
Scheme 31 
The most successful catalysts for ATRC reactions are copper complexes115 that 
induce the formation of an array of ring sizes from 4 to 18. Furthermore, the halide 
functionality in the resulting product can be very beneficial because it can be easily 
reduced, eliminated, displaced, converted to a Grignard reagent, or can serve as a 
further radical precursor. Recently, copper-catalysed ATRA and ATRC reactions were 
utilized in cascade or sequential additions118 in the synthesis of natural products and 
pharmaceutical drugs.  
In 1995, a new class of radical polymerization methods was reported independently 
by the groups of Matyjaszewski119 and Sawamoto.120 This new process named atom 
                                                     
118  tevens C.  .,  an Meenen E., Masschelein K. G. R., Eeckhout Y., Hooghe W., D’hondt B., Nemykinb  . N., 
Zhdankin V. V., Tetrahedron Lett. 2007, 48, 7108-7111. 
119  Wang J., Matyjaszewski K., J. Am. Chem. Soc. 1995, 117, 5614-5615. 
120 Kato M., Kamigaito M., Sawamoto M., Higashimura T., Macromolecules 1995, 28, 1721-1723. 
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transfer radical polymerization (ATRP),121 had a tremendous impact on the synthesis of 
macromolecules with well-defined compositions, architectures and functionalities. 
ATRP was successfully mediated by a variety of metals (Ti, Mo, Re, Fe, Ru, Os, Rh, Co, 
Ni, Pd and Cu), but copper complexes were found to be the most efficient catalysts.122 
ATRP is mechanistically similar to ATRA with the exception that more than one 
addition step occurs (Scheme 29). ATRP reactions became one of the most powerful 
synthetic methods to obtain polymers and copolymers because they were able to 
provide them with predetermined and narrow molecular weight distribution. 
The use of photoredox catalysts, such as Ru-(bpy)3Cl2, to initiate organic 
transformations has recently gained a lot of interest.123 Stephenson et al. realized the 
goal of performing ATRA between activated halides and alkenes utilizing visible light 
photocatalysis124 (Scheme 32).  
 
Scheme 32 
Both reductive quenching, which can be achieved in the presence of an external 
electron donor, and oxidative quenching of photocatalysts can effectively be used for 
                                                     
121 (a) Matyjaszewski K., Xia J., Chem. Rev. 2001, 101, 2921-2990; (b) Patten T. E, Matyjaszewski K., Acc. Chem. 
Res. 1999, 32,895-903; (c) Tsarevsky N. V, Matyjaszewski K., Chem. Rev. 2007, 107, 2270-2299. 
122 Pintauer T., Matyjaszewski K., Chem. Soc. Rev. 2008, 37, 1087-1097. 
123 (a) Prier C. K., Rankic D. A., MacMillan D. W. C., Chem. Rev. 2013, 113, 5322-5363; (b) Xi Y., Yia H., Lei A., Org. 
Biomol. Chem. 2013, 11, 2387-2403; (c) Narayanam J. M. R., Stephenson C. R. J., Chem. Soc. Rev. 2011,40, 102-
113; (d) Yoon T. P., Ischay M. A., Du J., Nat. Chem. 2010, 2, 527-532. 
124 (a) Nguyen J. D., Tucker J. W., Konieczynska M. D., Stephenson C. R. J., J. Am. Chem. Soc. 2011, 133, 4160-
4163; (b) Wallentin C., Nguyen J. D., Finkbeiner P., Stephenson C. R. J., J. Am. Chem. Soc. 2012, 134, 8875-8884. 
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ATRA transformations. This ATRA protocol provided high yields under mild reaction 
conditions, with a simple reaction setup, minimal side reactions, optimal catalytic 
efficiency and straightforward purification. 
2. Origin of the project 
Melchiorre and co-workers found out that the photochemical activity of a key 
donor–acceptor complex can drive a stereoselective catalytic α-alkylation of 
aldehydes125 (Scheme 33). In this process the electron donor-acceptor (EDA) complex 
formed is able to absorb visible light and to give a single electron transfer (SET) from 
the enamine donor to the acceptor, as for example 2,4-dinitrobenzyl bromide, thus 
forming a chiral radical ion pair. Then the living group on the radical anion is released 
and the in cage radical coupling takes place providing the final α-alkylation of the 
aldehyde. The light source can be a 23 W compact fluorescent light (CFL) bulb or, even 
better, the sun. 
 
Scheme 33 
Even if not via EDA complex, in these reaction conditions, also α-bromomalonates 
were able to provide the α-alkylation of aldehydes. 
                                                     
125 Arceo E., Jurberg I. D., Álvarez-Fernández A., Melchiorre P., Nat. Chem. 2013, 5, 750-756. 
Chapter 5 
147 
 
During the mechanistic study of the reaction, one of the attempts made to trap the 
radical intermediates was the addition of olefin 2 to the reaction mixture (Scheme 34). 
This brought to the formation of the expected product 4 and also of 5a given by the 
trapping of the diethyl-methylmalonate radical by the olefin. 
 
Scheme 34 
In order to prove that the enamine formation was essential for the generation of 
the radical, the same reaction shown in Scheme 34 was carried out without the 
catalyst. In this case the enamine, which is a good electron donor, could not be 
formed, hence no electron transfer and radical generation were expected and an 
absence of reactivity was anticipated. However, while product 4 was not detected as 
expected, product 5a was surprisingly still yielded. Since enols are also known to be 
good electron donors,126 the reaction in the absence of the catalyst was also 
performed with a non enolizable aldehyde like pivalaldehyde, but again product 5a 
was formed thus demonstrating that the possible formation of the enol was not 
responsible for the reaction. 
The discovery that the ATRA reaction could be promoted by an aldehyde, in the 
presence of a base, performing the reaction in front of an house bulb (23 W CFL) as 
shown in Scheme 35, prompted us to deeply study this new process. 
 
Scheme 35 
                                                     
126 (a) Russell G. A., Janzen E. G., Strom E. T., J. Am. Chem. Soc. 1964, 86, 1807-1814; (b) Kornblum N., Angew. 
Chem. Int. Ed. 1975, 14, 734-745; (c) Bunnett J. F., Singh P., J. Org. Chem. 1981, 46, 5022-5025; (d) Russell G. A., 
Mudryk B., Jawdosiuk M., J. Am. Chem. Soc. 1981, 103, 4611-4613; (e) Ashby E. C., Argyropoulos J. N., Richard 
Meyer G., Goel A. G., J. Am. Chem. Soc. 1982, 104, 6788-6789; (f) Ashby E. C., Park W., Tetrahedron Let. 1983, 
24, 1667-1670; (g) Ashby E. C., Argyropoulos J. N., J. Org. Chem. 1985, 50, 3274-3283; (h) Gassman P. G., 
Bottorff K. J., J. Org. Chem. 1988, 53, 1097-1100. 
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3. Study of the reaction 
The study of this photochemical organocatalytic atom transfer radical addition 
started from the observation that this reaction between an alkyl halide and an olefin 
could be mediated by an aldehyde when the reaction was irradiated with a normal 23 
W CFL house bulb in the absence of oxygen. 
The preliminary exploratory reactions set up in this study are shown in Table 28.  
Table 28: Preliminary reactions for the photochemical organocatalysed ATRA between 1a and 2.
a
 
 
Entry Aldehyde Time (h) Conv. (%)b 
1 Butanal (3 eq.) 
18 
42 
16 
34 
2 Pivalaldehyde (3 eq.) 
18 
42 
28 
60 
3 2,6-dichlorobenzaldehyde (3 eq.) 
20 
44 
68 
64 
84 
>99 
4 2,6-dichlorobenzaldehyde (0.2 eq.) 21 23 
a
 Reaction conditions: 1a (0.1 mmol), 2 (0.2 mmol), aldehyde, 2,6-lutidine (0.1 
mmol), acetonitrile (0.2 mL), rt, irradiation with a 23 W CFL bulb placed around 
10 cm far from the reaction, freeze-pump-thaw repeated three times. 
b
 
Determined by 
1
H NMR of the crude mixture from the relative amounts of 1a and 
5a. 
The first reaction was carried out in the same conditions used when the product 
was initially observed i.e. using 3 equivalents of  butanal (entry 1); in these conditions 
the conversion of 1a was only 34% after 42 hours. As previously described we 
performed the reaction also using pivalaldehyde (entry 2) in order to exclude the 
formation of an enol that might be able to act as electron donor like the enamine in 
electron transfer processes. Using pivalaldehyde the reactivity improved giving a 60% 
of conversion of the alkyl halide in the same reaction time. We decided also to test an 
aromatic aldehyde in this process and we chose 2,6-dichlorobenzaldehyde (entry 3) 
which provided 64% of conversion of the alkyl halide in only 20 hours and attained 
complete conversion in 68 hours. Encouraged by this result we tried to decrease the 
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amount of aldehyde from 3 equivalents to 20 mol% (entry 4) obtaining a 23% 
conversion of 1a in 21 hours.  
Since the aldehydic additives did not appear to be consumed in the reaction, and 
motivated by the interest of a catalytic version of this reaction, we soon after 
examined those additives in sub-stoichiometric amount. A large number of aldehydes 
were tested in catalytic amount in the reaction of olefin 2 and alkyl bromide 1a under 
irradiation in CH3CN (Table 29). The necessity of light irradiation was confirmed by 
performing the experiments under careful exclusion of light. In the absence of 
irradiation the functionalization of olefin 2 with 1a in the presence of the aldehydes 
did not occur. The reaction was very sensitive to small amounts of oxygen, which 
implied the requirement of a process for degassing the reaction mixture prior to 
irradiation. 
Table 29: Aldehydes screening for the photochemical organocatalysed ATRA between 1a and 2.
a
 
 
Entry Aldehyde Time (h) Conv. (%)b 
1 2,6-Dichlorobenzaldehyde 21 23 
2 4-Cyanobenzaldehyde 21 30 
3 4-Bromobenzaldehyde 21 74 
4 4-Anisaldehyde 19 >99 
5 Butanal 19 8 
6 Benzaldehyde 18 77 
7 Salicylaldehyde 18 - 
8 Ethyl Glyoxalate 18 - 
9 Hydrocinnamaldehyde 18 - 
10 Furfural 19 - 
11 2-Bromobenzaldehyde 19 46 
12 4-Methoxycinnamaldehyde 19 - 
13 1-Naphthaldehyde 19 - 
14 Pivalaldehyde 18 9 
15 4-(dimethylamino)benzaldehyde 16 40 
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Entry Aldehyde Time (h) Conv. (%)b 
16 2,4,6-Trimethoxybenzaldehyde 16 >99 
17 2,4-Dimethoxybenzaldehyde 15.5 71 
18 2,3-Dimethoxybenzaldehyde 17 23 
19 3,4,5-Trimethoxybenzaldehyde 18 17 
a
 Reaction conditions: 1a (0.1 mmol), 2 (0.2 mmol), aldehyde (20 mol%), 2,6-
lutidine (0.1 mmol), acetonitrile (0.2 mL), rt, irradiation with a 23 W CFL bulb 
placed around 10 cm far from the reaction, freeze-pump-thaw repeated three 
times. 
b
 Determined by 
1
H NMR of the crude mixture from the relative amounts 
of 1a and 5a. 
We tested aliphatic, aromatic, heteroaromatic and α,β-unsaturated aldehydes as 
additives in the model reaction (entries 1-15) finding that 4-anisaldehyde (entry 4) was 
the one that provided the best result: complete conversion of 1a was achieved in 19 
hours. It was curious to observe such differences in reactivity for example between 
benzaldehyde (77% conversion in 18 hours) and salicylaldehyde (no reaction). All these 
results revealed to be very difficult to rationalize. However, one thing still common in 
all cases was that the aldehyde was not consumed in the process (considering the 
sensitivity of 1H NMR analysis). Since p-anisaldehyde gave impressive results, we 
tested other aldehydes with more methoxy groups in order to see if increasing the 
number of electron-donating groups on the aromatic ring the reactivity improved, but 
again we obtained results difficult to rationalize and effects that differed depending on 
the position of the substituents in the aromatic ring (entries 16-19). While 2,4,6-
trimethoxybenzaldehyde provided an improved reactivity, all the other methoxy 
polysubstituted aromatic aldehydes didn’t equal the performance of p-anisaldehyde. 
Although 2,4,6-trimethoxybenzaldehyde was slightly more reactive we decided to use 
the inexpensive and easily available p-anisaldehyde for further studies and 
optimization. 
Some attempts of using ketones instead of aldehydes as additives to promote this 
ATRA reaction were made, but these carbonyl compounds turned out to be much less 
efficient (Table 30). For example the reaction using acetone as solvent without 
aldehyde didn’t give any product (entry 1), while the reaction using benzophenone 
(entry 4), acetophenone (entry 3) or butanone (entry 2) in stoichiometric or super-
stoichiometric amounts provided much worse results compared to those obtained 
with a catalytic amount of p-anisaldehyde. 
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Table 30: Ketones screening for the photochemical organocatalysed ATRA between 1a and 2.
a 
 
Entry Ketone Solvent Time (h) Conv. (%)b 
1 - Acetone 13 - 
2 Butanone (3 eq.) MeCN 42 23 
3 Acetophenone (3 eq.) MeCN 17 traces 
4 Benzophenone (1 eq.) MeCN 17 40 
a
 Reaction conditions: 1a (0.1 mmol), 2 (0.2 mmol), ketone, 2,6-lutidine (0.1 mmol), 
solvent (0.2 mL), rt, irradiation with a 23 W CFL bulb placed around 10 cm far from 
the reaction, freeze-pump-thaw repeated three times. 
b
 Determined by 
1
H NMR of 
the crude mixture from the relative amounts of 1a and 5a. 
We carried out the reaction with benzophenone (Table 30, entry 4) also adding 1 
equivalent of p-anisaldehyde and we obtained a conversion of 1a of 83% after 18 
hours, while the reaction with 1 equivalent of p-anisaldehyde and without 
benzophenone afforded complete conversion of the alkyl halide after the same time of 
reaction. This may suggest some kind of competition between benzophenone and p-
anisaldehyde when they are both present in the reaction thus reducing the reactivity 
of the latter. 
The model reaction was studied in different solvents, and the process showed a 
relative insensitivity to the nature of the solvent (Table 31). Polar aprotic solvents were 
in general effective (CH3CN, DMF, CH2Cl2, DMSO, 1,4-dioxane, TCE), with acetonitrile 
providing the best reactivity (entry 1). However, acetone and CHCl3 only afforded 
modest values of conversion at the same reaction time. Nevertheless, when using 
apolar solvents such as n-hexane, methyl tert-butyl ether and toluene, similar results 
as those found in polar solvents were obtained. Except of THF that gave traces of by-
products (entry 3), in all the other solvents tested the selectivity of the reaction 
towards product 5a is remarkable, the product mixtures containing neither dimers nor 
dehalogenated products. 
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Table 31: Solvents screening for the photochemical organocatalysed ATRA between 1a and 2.
a
 
 
Entry Solvent Time (h) Conv. (%)b 
1 MeCN 19 >99 
2 Toluene 19 62 
3 THF 19 By-products 
4 1,4-Dioxane 20 92 
5 MTBE 19 84 
6 n-Hexane 19 86 
7 TCE 19 66 
8 CHCl3 19 47 
9 DMF 19 95 
10 DMSO 19 83 
11 DCM 19 85 
12 Acetone 15 54 
a
 Reaction conditions: 1a (0.1 mmol), 2 (0.2 mmol), p-
anisaldehyde (20 mol%), 2,6-lutidine (0.1 mmol), solvent 
(0.2 mL), rt, irradiation with a 23 W CFL bulb placed 
around 10 cm far from the reaction, freeze-pump-thaw 
repeated three times. 
b
 Determined by 
1
H NMR of the 
crude mixture from the relative amounts of 1a and 5a. 
In the same conditions used for the solvent screening, the reaction carried out on-
water gave 95% of NMR yield after 18 hours, while the same reaction on water 
performed without 2,6-lutidine provided 87% of NMR yield in the same reaction time 
(Scheme 36). In the case of the on-water reactions we didn’t determine the conversion 
of the alkyl halide from the 1H NMR of the aliquot taken from the reaction mixture, 
because on-water the reaction was heterogeneous. So we extracted the reaction with 
DCM, we added a known amount of 1,3,5-trimethoxybenzene as internal standard and 
we calculated the NMR yield from the relative amount of the internal standard and the 
product 5a. The results obtained in the on-water conditions are noteworthy because 
the reaction in an organic solvent, like for example acetonitrile, needed the presence 
of 2,6-lutidine when 20 mol% of p-anisaldehyde was used as catalyst, otherwise the 
reaction didn’t take place. Also in the case of the on-water reaction the light irradiation 
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and the exclusion of oxygen were strictly necessary. While a protocol on-water might 
be interesting to develop further in the future, our preliminary experiments in the 
reaction of 2 (2 eq.) and 1a (0.1 mmol) in the presence of catalytic p-anisaldehyde and 
0.2 mL of H2O afforded good but non-reproducible results varying from 60 to 90% yield 
of 5a isolated after 18 hours of irradiation. A plausible explanation for this variation 
might be due to the intrinsic heterogeneity of the mixture and therefore the difficulty 
in achieving consistent irradiation. A drawback of the on-water protocol is the inherent 
limitation to liquid and non-water sensitive reagents. 
 
Scheme 36 
On the other hand, the reaction performed in a mixture of acetonitrile and water 
provided a simple method for the preparation of lactones from simple olefins and α-
bromo esters. When we used a 1:1 mixture of acetonitrile and water as solvent, where 
two phases were still present, longer reaction times were required and while 
monitoring the reaction progress by NMR the disappearance of the ATRA product 
together with the formation of a new compound were observed. This was due to 
further polar reactions on the ATRA product involving first a nucleophilic substitution 
of the bromo by the water and then a lactonization (Scheme 37). This is an interesting 
possibility of one-pot synthesis of a different class of compounds. Using the 1:1 
mixture of acetonitrile and water also solid olefins without hydroxyl group, like 
norbornene, could be used and the base was still not needed. 
 
Scheme 37 
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The presence of 2,6-lutidine revealed to be necessary for the reaction to work in 
organic solvents and for obtaining synthetically useful yields. A standard control 
experiment showed that in the absence of aldehyde, 2,6-lutidine was not able to 
confer any reactivity. In order to have more information on the necessity of the base,  
we carried out the screening of several inorganic and organic bases in the reaction of 
olefin 2 with the alkyl halide 1a catalyzed by p-anisaldehyde under irradiation in 
acetonitrile (Table 32).  
Table 32: Bases screening for the photochemical organocatalysed ATRA between 1a and 2.
a
 
 
Entry Base pKab Time (h) Conv. (%)c 
1 2,6-Lutidine 6.7 19 >99 
2 NaOAc  20 8 
3 Cs2CO3  20 Unselective, by-products 
4 4-Methoxypyridine 6.6 20 12 
5 1-Methylimidazole 6.9 20 - 
6 Pyridine 5.2 18 traces 
7 2,4,6-Collidine 7.5 18 76 
8 2,6-Di-tert-butylpyridine 5.0 20 5 
9 2,3-Lutidine 6.6 18 76 
10 4-Phenylenediamine 6.1 18 25 
11 N,N-diethylaniline 6.6 18 71 
a
 Reaction conditions: 1a (0.1 mmol), 2 (0.2 mmol), p-anisaldehyde (20 mol%), base (0.1 mmol), 
acetonitrile (0.2 mL), rt, irradiation with a 23 W CFL bulb placed around 10 cm far from the 
reaction, freeze-pump-thaw repeated three times. 
b
 Referred to the conjugate acids in water.
127
 
c
 Determined by 
1
H NMR of the crude mixture from the relative amounts of 1a and 5a. 
The reactivity varied significantly depending on the base used and the tests 
confirmed that 2,6-lutidine was the best among the bases screened (entry 1). Inorganic 
bases seemed to be non suitable for this process (entries 2, 3), while the reactivity of 
the organic bases seemed to depend both on the pKa and on the steric hindrance. In 
fact not hindered bases like 4-methoxypyridine (entry 4), 1-methylimidazole (entry 5), 
pyridine (entry 6) and 4-phenylenediamine (entry 10) didn’t provide good results, 
                                                     
127 http://research.chem.psu.edu/brpgroup/pKa_compilation.pdf 
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while better results were obtained when sterically hindered bases with a pKa similar to 
2,6-lutidine were used. 2,4,6-collidine (entry 7), 2,3-lutidine (entry 9) and N,N-
diethylaniline (entry 11) provided a reactivity comparable to the one obtained with 
2,6-lutidine. In particular N,N-diethylaniline, that has a completely different structure 
respect to 2,6-lutidine, gave good results having comparable basicity and steric effects 
around the nitrogen. 2,6-Di-tert-butylpyridine (entry 8) was probably not basic enough 
to allow the reaction to take place. Hence the base had to be moderately strong and 
non-nucleophilic owning substituents which provide steric hindrance near the nitrogen 
avoiding the possibility of coordination or creation of adducts. 
The role of the base in the reaction is still unclear; in fact apparently there is no 
obvious need for deprotonation or neutralization of acids generated during the 
reaction. Since the reaction on water, as mentioned above, worked well also in the 
absence of 2,6-lutidine, it suggests that the role of 2,6-lutidine should also be able to 
be played by water and that makes us think that the role might be that of simple acid 
removal. 
Seeing that the on-water protocol provided the ATRA product efficiently even 
without the addition of base, we decided to perform some experiments and check the 
pH of the media after reaction. When the reaction was performed with the light 
irradiation on water or in acetonitrile, without 2,6-lutidine, at 16 hours of reaction the 
pH was acidic, while the experiment in acetonitrile but with 2,6-lutidine had a slightly 
basic pH after overnight reaction. When we irradiated only solutions of the aldehyde 
or the malonate in on-water conditions overnight the pH of the solution after that time 
was neutral, but when we irradiated a 1:1 mixture of aldehyde and malonate on water 
for the same time we had acidic pH with the formation of diethyl 2-methylmalonate 
and 4-methoxybenzoic anhydride in 2:1 ratio and with less than 10% conversion of the 
malonate. This was not observed when an equivalent mixture was stirred in similar 
conditions but not irradiated (performed in the dark): in this case the pH was neutral 
and both the reagents remained unreacted. So this indicates that these two species 
are probably the ones involved in the initiation step and that this process can involve 
the generation of an acid, but only when irradiated with light.  
We observed the formation of diethyl 2-methylmalonate and 4-methoxybenzoic 
anhydride in 2:1 ratio (traces formed after 18 hours) also when the reaction was 
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performed in the exact conditions as the model reaction but in the absence of the 
olefin (Scheme 38). 
 
Scheme 38 
Since 2,6-lutidine in the reaction performed in an organic solvent should play the 
same role as the water in the on-water protocol (assuming the same mechanism for 
both the reaction in organic solvent and on water) and the reaction in acetonitrile 
doesn’t work without 2,6,-lutidine, probably the formation of a small amount of acid 
takes place at an early stage and this acid is somehow detrimental for the ATRA 
reaction. So we decided to set up some reactions adding p-methoxybenzoic acid to see 
if we were able to shut down the reactivity and have some evidence that this was the 
acid being generated in the reaction. The results are reported in Table 33. 
Table 33: Effect of p-methoxybenzoic acid on the photochemical organocatalysed ATRA between 1a and 2.
a 
 
Entry 2,6-lutidine p-methoxybenzoic acid Solvent Time (h) Conv. (%)b 
1 - 5 mol % H2O 14 74 
2 1 eq. 5 mol % MeCN 14 85 
3 1 eq. 20 mol % MeCN 14 64 
4 1 eq. 1 eq. MeCN 20 49 
a
 Reaction conditions: 1a (0.1 mmol), 2 (0.2 mmol), p-anisaldehyde (20 mol%), 2,6-lutidine, p-
methoxybenzoic acid, solvent (0.2 mL), rt, irradiation with a 23 W CFL bulb placed around 10 cm far from 
the reaction, freeze-pump-thaw repeated three times. 
b
 Determined by 
1
H NMR of the crude mixture 
from the relative amounts of 1a and 5a. 
As we can see in the table, when increasing the amount of acid the reaction rate 
decreased, but we were not able to completely shut down the reactivity even when 
using 1 equivalent of p-methoxybenzoic acid. This indicates that p-methoxybenzoic 
acid could not be the acid generated because it should derive from the p-anisaldehyde 
that was present in the reaction in catalytic amount (20 mol %).  
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Looking at the result reported in Scheme 38 we hypothesised that the acid formed 
could be hydrobromic acid produced together with diethyl 2-methylmalonate and 4-
methoxybenzoic anhydride. Since the reaction is able to reach complete conversion of 
the alkyl halide and give a very high isolated yield of the ATRA product incorporating 
the bromo atom, obviously the amount of hydrobromic acid produced should be very 
low, although maybe enough to prevent the reaction from taking place in the absence 
of 2,6-lutidine. Unfortunately we still don’t have reliable experimental data to prove, 
without any doubt, the formation of HBr and so to attribute with certainty the role of 
2,6-lutidine; studies on the role of the base are still in progress. 
In addition to studying the effects of different aldehydes on the reaction and the 
effect of solvents and bases of diverse nature, both alkene and halide amounts and 
concentrations were varied to determine the effects on the reaction time and 
conversion. A study varying the stoichiometry of the reactants in the reaction is 
presented in Table 34. 
Table 34: Study of the stoichiometry of the photochemical organocatalysed ATRA between 1a and 2.
a 
 
Entry 
1a 
(eq.) 
2 
(eq.) 
p-anisaldehyde 
(eq.) 
2,6-lutidine 
(eq.) 
MeCN 
[1a]0 
Time 
(h) 
Conv. 
(%)b 
1 1 2 0.2 1 0.5M 21 >99 
2 1 1 0.2 1 0.5M 
20 
51 
50 
78 
3 1 1 1 1 0.5M 21 62 
4c 2 1 0.2 1 0.5M 20 40 
5 1 2 0.1 1 0.5M 17 72 
6 1 2 0.05 0.2 0.5M 63 70 
7 1 2 0.05 0.05 0.5M 63 42 
8d 1 2 0.2 1 0.1M 20 44 
9e 1 2 0.2 1 2.5M 17 90 
10e 1 2 0.2 - 2.5M 15d 20 
a
 Reaction conditions: 1a (0.1 mmol), 2, p-anisaldehyde, 2,6-lutidine, acetonitrile (0.2 mL), rt, irradiation with a 23 W 
CFL bulb placed around 10 cm far from the reaction, freeze-pump-thaw repeated three times. 
b
 Determined by 
1
H 
NMR of the crude mixture from the relative amounts of 1a and 5a. 
c
 1a (0.2 mmol), 2 (0.1 mmol). 
d 
acetonitrile (1 
mL).
 e 
1a (0.5 mmol). 
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Comparing the results reported in entries 1 and 2 the importance of an excess of 
olefin is evident. Furthermore the use of 2 equivalents of olefin (entry 1) provided 
better results than the use of stoichiometric amount of p-anisaldehyde (entry 3) or of 
the use of an excess of alkyl bromide (entry 4). 
We tried to lower the amount of p-anisaldehyde (entry 5) to 10 mol% obtaining only 
a small decrease of reactivity, so we lowered both the amount of p-anisaldehyde and 
2,6-lutidine (entries 6, 7) and we still observed reactivity with an increase of the 
reaction times. 
We examined also the dilution noting that a decrease in the concentration (entry 8) 
provided a slower reaction, while an increase in the concentration (entry 9) didn’t 
improve the reactivity. The reaction with higher concentration was also performed 
without 2,6-lutidine (entry 10); this result together with the one reported in entry 9 
implies that the efficiency of the reaction on water was not due to an effect of 
concentration.  
Having optimized the reaction conditions for the model reaction, we studied the 
scope of the reaction in order to establish the viability and limitations of this method. 
First, we tested different alkyl halides as partners in the reaction with olefin 2, as 
reported in Table 35. 
Table 35: Scope of the alkyl halides for the photochemical organocatalysed ATRA.
a
 
 
Entry Product Time (h) Conv. (%)b Yield (%)c 
1  
(5a) 
19 >99 88 
2  
(5b) 
15 >99 98 
3  
(5c) 
74 >99 78 
4  
(5d) 
40 >99 71 
Chapter 5 
159 
 
Entry Product Time (h) Conv. (%)b Yield (%)c 
5  
(5e) 
48 >99 60 
6  
(5f) 
20 >99 94 
7d  
(5g) 
20 95 85 
8e  
(5h) 
42 >99 79 
9f  
(5i) 
23 >99 94 
10  
(5j) 
40 92 
65 
(YNMR=92%) 
11  
(5k) 
20.5 >99 94 
a
 Reaction conditions: 1 (0.1 mmol), 2 (0.2 mmol), p-anisaldehyde (20 mol%), 2,6-
lutidine (0.1 mmol), acetonitrile (0.2 mL), rt, irradiation with a 23 W CFL bulb placed 
around 10 cm far from the reaction, freeze-pump-thaw repeated three times. 
b
 
Determined by 
1
H NMR of the crude mixture from the relative amounts of 1 (or 2) 
and 5. 
c
 Yield of isolated product after flash-chromatography. 
d
 Reaction set up on 
doubled scale. 
e
 1h (0.5 mmol), 2 (0.1 mmol). 
f
 Reaction conditions: 1i (0.2 mmol), 2 
(0.1 mmol), p-anisaldehyde (20 mol%), water (0.2 mL), rt, 23 W CFL, freeze-pump-
thaw repeated three times. 
The scope for the alkyl halide is quite broad. The diethyl bromomalonate was 
slightly more reactive than the methyl-substituted diethyl 2-bromo-2-methylmalonate 
(entries 1, 2), while the monoester ethyl 2-bromopropionate (entry 3) revealed to be 
less reactive. We tested also ethyl bromoacetate, but the reaction was very slow and 
never reached synthetically useful yields. In the cases with polybrominated 
compounds reported in entries 4 and 6 the reactions provided high yields of products 
5d and 5f exclusively, without proceeding further to give a second ATRA reaction 
between the product and the excess of olefin. We performed the reaction also with 
ethyl 2-bromo-2-fluoroacetate (entry 5) affording the particularly valuable fluorinated 
compound 5e in good yield, in which the bromo was the halogen atom transferred. 
The use of bromoacetonitrile in this simple protocol allowed the direct introduction of 
a nitrile group, reacting in 20 hours with almost complete conversion and affording 
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high yields (entry 7). Noteworthy is the result obtained with carbon tetrachloride 
(entry 8). In fact this substrate is very difficult to reduce, but slightly modifying the 
reaction conditions we were able to obtain complete conversion of olefin 2 in 42 hours 
and good yields of the corresponding polychlorinated product. Except for some specific 
examples, the isolation of the product in these reactions was relatively simple by 
column chromatography, due to the high selectivity of the reaction and subsequently 
the absence of byproducts. However visualization of the thin layer chromatography 
plates was not always easy using the common stain solutions. Moreover we carried 
out the reaction with perfluorohexyl iodide (entry 9) achieving excellent results also 
performing the reaction on water; in these reaction we used an excess of alkyl halide 
to avoid the difficult separation of the product from the olefin in this specific case. 
During the series of control experiments performed for all the substrates under study, 
for this particular substrate we recorded a background reaction. Indeed the ATRA took 
place also in the absence of aldehyde, because the perfluorohexyl iodide can suffer 
homolytic cleavage of the carbon-iodine bond under irradiation in our conditions. 
While without aldehyde the reaction gave a conversion of the perfluorinated iodo 
compound of less then 30% overnight, addition of 20 mol% of p-anisaldehyde to the 
reaction in acetonitrile resulted in complete conversion in the same reaction time; so 
even in the presence of a background reaction our protocol provided a major 
improvement of the reactivity. Background reactions were detected as well for carbon 
tertrabromide and bromotrichloromethane (entries 10, 11), but in these cases the 
background reactions afforded very high reaction rates, and no substantial 
improvement was observed in the presence of the aldehydic catalyst. 
We tried to exploit the homolytic cleavage of perfluorohexyl iodide to initiate the 
ATRA reaction of other compounds, like for example diethyl 2-bromo-2-
methylmalonate, in the absence of p-anisaldehyde, with the idea of providing a 
protocol in which this easily cleavable halide compound would serve as initiator of the 
ATRA reaction of a second alkyl halide. However, the reaction provided only the ATRA 
product of the perfluoroalkyl iodide even when the bromomalonate was used as the 
solvent (Scheme 39).  
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Scheme 39 
So we inferred that the aldehyde is strictly necessary for the reaction with diethyl 2-
bromo-2-methylmalonate to take place. Furthermore, it was not possible to initiate 
the reaction of alkyl halides that didn’t show reactivity using our protocol (for example 
the chloro-analogue diethyl chloromalonate) using a small amount of other halides 
able to work in this process (for example bromo diethyl malonate in catalytic amount 
or carbon tetrachloride as solvent). The reaction of diethyl chloromalonate was never 
initiated in those attempts. 
After our success in finding halide partners applicable to our ATRA protocol, we 
investigated the behaviour of different olefins under the optimized reaction condition 
(Table 36). Since diethyl bromomalonate was among the most reactive alkyl halides 
tested, we decided to use it for this study.   
Table 36: Scope of the olefins for the photochemical organocatalysed ATRA.
a 
 
Entry Product Time (h) Conv. (%)b Yield (%)c 
1d  
(7a) 
12 >99 86 
Chapter 5 
162 
 
Entry Product Time (h) Conv. (%)b Yield (%)c 
2  
(7b) 
16 96 92 
3 
 
(7c) 
15 >99 89 
4  
(7d) 
23 97 70 
5 
 
(7e) 
12 97 89 
6 
 
(7f) 
95 78 75 
7e 
 
(7g) 
14 >99 97 
8  
(7h) 
88 >99 92 
9 
 
(7i) 
16 >99 88 
10  
(7j) 
19 95 89 
11  
(7k) 
111 84 78 
12  
(7l) 
16 94 78 
13 
 
(7m) 
26 98 85 
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Entry Product Time (h) Conv. (%)b Yield (%)c 
14 
 
(7n) 
12 >99 97 
15f  
(7o) 
85 60 42 
16  
(7p) 
13 >99 87 
17  
(7q) 
96 70 60 
18 
 
(7r) 
15 >99 82 
a
 Reaction conditions: 1b (0.1 mmol), 6 (0.2 mmol), p-anisaldehyde (20 mol%), 2,6-lutidine (0.1 
mmol), acetonitrile (0.2 mL), rt, irradiation with a 23 W CFL bulb placed around 10 cm far from 
the reaction, freeze-pump-thaw repeated three times. 
b
 Determined by 
1
H NMR of the crude 
mixture from the relative amounts of 1b and 7. 
c
 Yield of isolated product after flash-
chromatography.
 d
 Reaction set up on doubled scale. 
e
 Starting from cis-cyclooctene. 
f
 6o (0.4 
mmol). 
The reaction worked perfectly for non-polarized terminal aliphatic olefins without 
any functional groups (entries 1-3) and also bearing an aromatic ring (entry 4). The 
transformation showed to be tolerant to the presence of a variety of functional groups 
like bromide (entry 8), ketone (entry 9), alcohol (entry 10), carbamate (entry 11), 
esters (entries 12, 13), epoxide (entry 14) and ether (entry 15). Also α-methyl 
substituted terminal olefins can be used in this process (entry 16) achieving very good 
results. We tested also 3-butyn-1-ol (entry 17); and even if the reaction was much 
slower, it was interesting to see that we can extend this process also to alkynes. Finally 
we tested limonene as a substrate of the reaction obtaining selectively the ATRA 
product on the terminal bond (7r) with 82% yield in 15 hours, without detecting any 
product involving the trisubstituted internal double bond in the reaction. 
Encouraged by the wide scope in both the olefinic and halide partners, and by the 
good results achieved in terms of yield, we decided to test also internal olefins, which 
usually are typically more difficult to react in ATRA reactions. Under the same mild 
reaction conditions the cyclic substrates 2-norbornene, cyclohexene and cyclooctene 
led to the corresponding functionalized compounds with excellent yields (Table 36, 
Chapter 5 
164 
 
entries 5-7). We were pleased to see that in the case of the even more challenging 
linear internal olefin, both cis- and trans-octene afforded the desired transformation 
employing our reaction conditions (Scheme 40). It is noteworthy that the cis isomer 
appeared to be more reactive than the trans. Unfortunately in both cases there were 
not any regio- or stereo-control and both regioisomers were formed in both 
diastereoisomers. 
 
Scheme 40 
Additionally, we performed a scale-up of the reaction (by a factor of 100) between 
diethyl bromomalonate (10 mmol) and 1-hexen-5-ol isolating the product in 98.6% 
yield and recovering 91% of p-anisaldehyde. The reaction time increased to 44 hours 
instead of 15 probably because  the same source of irradiation as for the small scale 
0.1 mmol reaction was used, so only one 23 W CFL bulb. 
In order to explore the possibility of a polar pathway participating in the reaction 
mechanism, we performed the reaction adding to the mixture tetrabutylammoniun 
bromide (Scheme 41). In these conditions if a carbocation is formed during the 
reaction, the bromide should be incorporated to give product 5k, otherwise only 
product 5h would be produced through a pure radical pathway. 
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Scheme 41 
Since only product 5h was observed, we could infer that only a radical mechanism 
was present in this organocatalytic photochemical ATRA reaction. 
We set up different reactions aimed to prove the radical pathway and to further 
study the mechanism. First, we set up the model reaction in the presence of radical 
scavengers such as 2,6-bis(1,1-dimethylethyl)-4-methylphenol (BHT), and (2,2,6,6-
tetramethyl-piperidin-1-yl)oxyl (TEMPO) or in the presence of the good electron-
acceptor 1,4-dinitrobenzene (Table 37); in all the cases the reaction was strongly 
inhibited, confirming the radical nature of the process. Unfortunately, the addition of 
radical scavengers didn’t lead to the trapping of any intermediate. 
Table 37: Study of the formation of radicals in the presence of radical and electron transfer inhibitors.
a
 
 
Entry Inhibitor Time (h) Conv. (%)b 
1 - 24 >99 
2 BHT 24 - 
3 TEMPO 24 - 
4 1,4-Dinitrobenzene 24 - 
a  
Reaction conditions: 1a (0.1 mmol), 2 (0.2 mmol), p-anisaldehyde 
(20 mol%), 2,6-lutidine (0.1 mmol), inhibitor (0.1 mmol), acetonitrile 
(0.2 mL), rt, irradiation with a 23 W CFL bulb placed around 10 cm far 
from the reaction, freeze-pump-thaw repeated three times.. 
b
 
Determined by 
1
H NMR of the crude mixture from the relative 
amounts of 1a and 5a. 
Another proof of the presence of a radical pathway was found in the reaction 
carried out with β-pinene. After the addition of the malonate radical to the double 
bond, a ring opening rearrangement of the structure, a process well known for radical 
intermediates, took place followed by the addition of the bromine (Scheme 42). This 
reaction also provides evidence against the involvement of concerted mechanism. 
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Scheme 42 
A further demonstration that the reaction is not concerted was gained performing 
the model reaction between olefin 2 and 1a in carbon tetrachloride as solvent, instead 
of acetonitrile (Scheme 43). In these conditions, two carbon-centered secondary 
radical intermediates may be formed as both diethyl 2-bromo-2-methylmalonate and 
carbon tetrachloride are valid substrates for this reaction. These intermediates can 
abstract both a bromine or a chlorine atom forming four possible products. In fact, this 
crossover experiment afforded the four possible products excluding the possibility of a 
concerted mechanism. 
 
Scheme 43 
The use of 1,6-heptadien-4-ol as the olefin might give the formation of different 
products: the single addition to one double bond, the addition to both the double 
bonds or the cyclization. The intermediate formed can be imagined to cyclize by 
intramolecular addition to the second double bond to form a 5-membered ring or a 6-
membered ring. Usually 5-exo cyclizations are highly favoured in radical mechanisms; 
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conversely 6-endo cyclizations are typical in polar mechanisms where 5-exo 
cyclizations cannot occur. When performing the reaction with bromomalonate, we 
obtained the 5-membered cyclized product as reported in Scheme 44, consistent with 
ring closure of a radical. 
 
Scheme 44 
In order to have additional information on the mechanism, the requirement of light 
irradiation throughout the reaction progress and on the probable contribution of a 
radical chain, we carried out the reaction alternating periods of irradiation with dark 
periods (Scheme 45).  
 
Scheme 45 
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In our experiments, the reactions stopped immediately when light was excluded 
during the dark periods, initiating again when irradiation was restored. These 
observations tell us that the light is essential for the reaction to proceed and suggests 
that if a radical chain mechanism is present, it would have very short propagating 
chains. The proper way to establish the presence, absence or the extent of a radical 
chain is the determination of the quantum yield; these mesurements will be done in 
the near future during the mechanistic studies that are still in progress. 
All the data reported in the lines of Scheme 45 were produced by different parallel 
and identical reactions. The reason is that taking an aliquot from one reaction requires 
the opening of the Schlenk tube and, even if taking care of excluding oxygen during the 
sampling, there is the risk of interrupting a chain if present. So, for example, the data 
reported before and after a dark period come from two different reactions set up in 
exactly the same conditions. 
From the results obtained we could also infer that there is not an induction period 
since the reaction gave conversion from the first few hours. 
To be sure of the absence of metal impurities that could catalyse the reaction we 
performed it in the presence of EDTA sodium salt able to chelate metals (Scheme 46). 
The reaction proceeded thus excluding the hypothesis of the catalytic metal impurity. 
Additionally, the model reaction was performed with freshly distilled reagents, alkyl 
halide, olefin, aldehyde, base and solvent, in new glassware, with the same excellent 
results. The reproducibility of the protocol, the fact that not all the aldehydes were 
able to catalyse the process and that the reaction without aldehyde didn’t occur, 
together with the other experimental information make us be certain that an impurity 
could not be responsible for the reactivity under study. 
 
Scheme 46 
Even if the reaction was not coloured (only sometimes yellowish after many hours) 
we measured the absorption spectra of the reaction components in order to 
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investigate the possibility of the formation of an EDA complex able to promote the 
reaction. We recorded the absorption spectra of all the possible mixtures of the 
reagents in many different concentrations but none of them absorbed in the visible. In 
the UV region, the interpretation of the results was complicated because the 
concentrations used in the reaction were too high for recording a UV absorption 
spectra without saturating the detector of the spectrophotometer, while decreasing 
too much the concentration in order to allow a proper analysis could eliminate the 
possibility of formation of weak complexes that are usually very sensitive to 
concentration. 
The light is very important for this reaction as the transformation does not occur at 
all in the dark even if heated at 100°C in DMF or at reflux in toluene for several hours. 
The model reaction was set up on the roof of the institute using illumination by the 
sun, instead of the 23 W CFL bulb used in the laboratory set-up, providing 91% of 
conversion in 9 hours using only 5 mol% of p-anisaldehyde. We rationalized this 
increased reactivity based on the much higher light intensity of the sun compared to 
that of a household bulb and maybe also on a plausible increase of the temperature of 
the mixture.  
With the aim of understanding which was the useful wavelength able to promote 
reactivity we set up a series of experiments using a Xenon lamp equipped with 
different light filters (Scheme 47). 
 
Scheme 47 
First we set up the reaction using a 385 nm cut-off filter excluding completely the 
UV and near UV wavelengths; the power of the lamp was set to 12% in order to be 
closer to the light intensity of a 23 W CFL bulb at 15 cm far from the reaction. In these 
conditions the reaction did not proceed. We carried out the same reaction using a 360 
nm band-pass filter which allows irradiation from 355 to 365 nm to get through, 
obtaining 27% of conversion of the alkyl halide in 2 hours and 15 minutes, thus 
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demonstrating that these near UV wavelengths were the ones able to promote the 
process. 
In fact all the CFL bulbs have a residual UV emission peak centred at 360 nm and 
probably this near-UV light is the one able to promote the reaction under study. The 
emission spectrum of one of the lamps that were used in the laboratory is shown in 
Figure 21 in which the peak responsible of this organocatalytic photochemical ATRA 
reaction to alkenes is highlighted. 
 
Figure 21 
4. Conclusions 
We developed the first organocatalytic photochemical ATRA reaction. This 
photochemical transformation offers a new synthetic methodology for the rapid 
construction of highly functionalized complex molecules in a single step by 
introduction of two functional groups in adjacent carbons of a simple olefin. This 
process has a broad scope that includes mono- and di- substituted olefins both 
terminal and internal. Also alkynes are able to react smoothly in these conditions. 
Furthermore the presence of many functional groups is tolerated in the olefinic 
partner. The direct introduction of several functional groups such as fluorinated 
fragments, alcohol, nitrile, ester and halide, which are excellent synthetic targets for 
further functionalization, into a simple olefin is allowed by the very mild and extremely 
selective reaction developed. 
We were able to scale up the reaction, an achievement not common for 
organocatalytic processes which usually show poor ability to adjust to scales higher 
than those used for reaction development (usually less than 1 mmol). This established 
its potential for a synthetic practical use. 
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The absence of pricey transition-metal catalysts, toxic reagents, or harsh reaction 
conditions makes this reaction attractive from economic, environmental and safety 
perspectives. 
Although the most obvious mechanism for this transformation is the classical ATRA 
pathway, given the novelty of the reaction, further studies on the mechanism of the 
photochemical event are still in progress. 
5. Experimental section 
General Information 
The 1H and 13C NMR spectra were recorded at 400 MHz and 500 MHz for 1H or at 100 
MHz and 125 MHz for 13C, respectively. The chemical shifts (δ) for 1H and 13C are given 
in ppm relative to residual signals of the solvents (CHCl3 @ 7.26 ppm 
1H NMR, 77.16 
ppm 13C NMR). Coupling constants are given in Hz. The following abbreviations are 
used to indicate the multiplicity: s, singlet; d, doublet; t, triplet; q, quartet; m, 
multiplet; bs, broad signal.  
High-resolution mass spectra (HRMS) were obtained from the ICIQ High Resolution 
Mass Spectrometry Unit on Waters GCT gas chromatograph coupled time-of-flight 
mass spectrometer (GC/MS-TOF) with electron ionization (EI).  
General Procedures 
All reactions were set up under an argon or nitrogen atmosphere in oven-dried 
glassware using standard Schlenk techniques, unless otherwise stated. Synthesis grade 
solvents were used as purchased and the reaction mixtures were degassed by three 
cycles of freeze-pump-thaw. Chromatographic purification of products was 
accomplished using force-flow chromatography (FC) on silica gel (35-70 mesh). For thin 
layer chromatography (TLC) analysis throughout this work, Merck precoated TLC plates 
(silica gel 60 GF254, 0.25 mm) were employed, using UV light as the visualizing agent 
and basic aqueous potassium permanganate (KMnO4) stain solutions, and heat as 
developing agents. Organic solutions were concentrated under reduced pressure on a 
Büchi rotary evaporator. 
Materials. Reagents were purchased at the highest commercial quality from Sigma 
Aldrich, Fluka, and Alfa Aesar and used as received, without further purification, unless 
otherwise stated. All the reagents used within this study are commercially available 
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except of tert-butyl allylcarbamate obtained from the Boc-protection of allylamine. 
General Procedures for the Photochemical Organocatalytic Atom Transfer Radical 
Addition to Alkenes 
1. General Procedure for the Photochemical Organocatalytic Atom Transfer Radical 
Addition to Alkenes 
A 10 mL Schlenk tube was charged with the solvent (CH3CN, 0.5 M referring to the alkyl 
halide), olefin (2 eq.), 2,6-lutidine (1 eq.), the alkyl halide (1 eq.) and p-anisaldehyde 
(20 mol%). The reaction mixture was degassed via freeze pump thaw (x 3 times), and 
the vessel refilled with argon or nitrogen. After the reaction mixture was thoroughly 
degassed, the vial was sealed and positioned approximately 10 cm away from the light 
source. A household full spectrum 23 W compact fluorescent light (CFL) bulb was used 
for irradiating the reaction mixture. The reaction can be monitored by analysis (1H 
NMR spectroscopy) of an aliquot taken from the reaction mixture under inert 
atmosphere. After stirring for the indicated time, the crude mixture was loaded 
directly into the silica gel column. Purification by flash column chromatography affords 
the functionalized compound in the stated yield. 
2. On Water-Procedure for the Photochemical Organocatalytic Atom Transfer Radical 
Addition to Alkenes  
A 10 mL Schlenk tube was charged with the solvent (H2O, 0.5 M referring to the alkyl 
halide), olefin (2 eq.), the alkyl halide (1 eq.) and p-anisaldehyde (20 mol%). The 
reaction mixture was degassed via freeze pump thaw (x 3 times), and the vessel 
refilled with argon or nitrogen. After the reaction mixture was thoroughly degassed, 
the vial was sealed and positioned approximately 10 cm away from the light source. A 
household full spectrum 23 W compact fluorescent light (CFL) bulb was used for 
irradiating the reaction mixture. After stirring for the indicated time, the crude mixture 
was extracted with DCM (x3), the solvent was removed under pressure and the crude 
was loaded into the silica gel column. Purification by flash column chromatography 
affords the functionalized compound in the stated yield. 
Diethyl 2-methyl-2-(2-bromo-6-hydroxyhexyl)malonate (5a) 
The general procedure was followed using diethyl 2-bromo-2-methylmalonate (0.1 
mmol, 19 μL, 1 eq.), MeCN (200 L), 5-hexen-1-ol (0.2 mmol, 24 L, 2 eq.), 2,6-lutidine 
(0.1 mmol, 12 L, 1 eq.) and p-anisaldehyde (0.02 mmol, 2.4 L, 20 mol%). After 19 h 
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the reaction showed complete conversion of the alkyl halide. Purification by flash 
column chromatography (gradient eluent from hexane to 20:1 hexane:AcOEt) afforded 
the title compound (30.9 mg, 88% yield) as a colourless oil. 
1H NMR (CDCl3, 500 MHz): δ 4.20-4.16 (m, 4H), 4.10-4.05 (m, 1H),  3.67-3.65 (t, J = 6.2 
Hz 2H), 2.60-2.50 (m, 2H), 1.90-1.83 (m, 2H), 1.67-1.51 (m, 4H), 1.49 (s, 3H), 1.27-1.24 
2x (t, J = 7.0 Hz, 3H). 13C NMR (CDCl3, 100 MHz): δ 171.8, 171.7, 62.7, 61.7, 61.5, 53.1, 
51.6, 44.5, 40.2, 31.9, 23.7, 20.0, 14.0, 13.9. HRMS (-ve CI): calculated for C14H25BrNaO5 
(M+Na): 375.0778, found: 375.0790. 
Diethyl 2-(2-bromo-6-hydroxyhexyl)malonate (5b) 
The general procedure was followed using diethyl bromomalonate (0.1 mmol, 17 μL, 1 
eq.), MeCN (200 L), 5-hexen-1-ol (0.2 mmol, 24 L, 2 eq.), 2,6-lutidine (0.1 mmol, 12 
L, 1 eq.) and p-anisaldehyde (0.02 mmol, 2.4 L, 20 mol%). After 15 h the reaction 
showed complete conversion of the bromo malonate. Purification by flash column 
chromatography (gradient eluent from hexane to 19:1 hexane:AcOEt) afforded the 
title compound (33.4 mg, 98% yield) as a colourless oil. 
1H NMR (500 MHz, CDCl3) δ 4.31 – 4.19 (m, 4H), 4.09 – 3.99 (m, 1H), 3.81 (dd, J = 10.2, 
4.2 Hz, 1H), 3.69 (t, J = 6.0 Hz, 2H), 2.49 (ddd, J = 14.8, 10.2, 3.1 Hz, 1H), 2.28 (ddd, J = 
14.8, 10.7, 4.2 Hz, 1H), 1.97 – 1.86 (m, 2H), 1.72 – 1.51 (m, 4H), 1.34 – 1.25 2x(t, J = 7.1 
Hz, 3H). 13C NMR (100 MHz, CDCl3) δ 169.0, 168.8, 62.6, 61.7, 61.6, 54.6, 50.6, 39.1, 
37.8, 31.9, 23.8, 14.1, 14.0. HRMS (+ve ESI): calculated for C13H23BrNaO5 (M+Na): 
361.0627, found: 361.0621. 
Ethyl 4-bromo-8-hydroxy-2-methyloctanoate (5c) 
The general procedure was followed using ethyl-2-bromopropionate (0.1 mmol, 13 
μL), MeCN (200 L), 5-hexen-1-ol (0.2 mmol, 24 L, 2 eq.), 2,6-lutidine (0.1 mmol, 12 
L, 1 eq.) and p-anisaldehyde (0.02 mmol, 2.4 L, 20 mol%). After 74 h the reaction 
showed complete conversion of the alkyl halide. Purification by flash column 
chromatography (gradient eluent from hexane to 9:1 hexane:AcOEt) afforded the title 
compound (22 mg, 78% yield) as a colourless oil. 
1H NMR (400 MHz, CDCl3) δ 4.23 – 4.09 (m, 4H), 4.10 – 3.99 (m, 2H), 3.73 – 3.62 (m, 
4H), 2.94 – 2.80 (m, 1H), 2.83 – 2.70 (m, 1H), 2.36 – 2.14 (m, 2H), 1.93 – 1.75 (m, 6H), 
1.69 – 1.50 (m, 10H), 1.33 – 1.24 2x(t, J = 7.1 Hz, 3H), 1.22 (d, J = 7.2 Hz, 3H), 1.18 (d, J 
= 7.0 Hz, 3H). 13C NMR (100 MHz, CDCl3) δ 176.1, 176.0, 62.63, 62.61, 60.6, 60.5, 56.1, 
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54.9, 43.1, 42.1, 39.4, 39.0, 38.1, 37.9, 32.0, 23.9, 23.7, 18.2, 16.1, 14.23, 14.21. HRMS 
(+ve ESI): calculated for C11H21BrNaO3 (M+Na): 303.0559, found: 303.0566. 
Diethyl 2-bromo-2-(2-bromo-6-hydroxyhexyl)malonate (5d) 
The general procedure was followed using diethyl dibromomalonate (0.1 mmol, 19 L, 
1 eq.), MeCN (200 L), 1-hexen-5-ol (0.2 mmol, 24 L, 2 eq.), 2,6-lutidine (0.1 mmol, 12 
L, 1 eq.) and p-anisaldehyde (0.02 mmol, 2.4 L, 20 mol%). After 40 h the reaction 
showed complete conversion of the alkyl halide. Purification by flash column 
chromatography (gradient eluent from hexane to 15:1 hexane:AcOEt) afforded the 
title compound (29.5 mg, 71% yield) as a colourless oil. 
1H NMR (500 MHz, CDCl3) δ 4.42 – 4.18 (m, 5H), 3.69 (t, J = 5.9 Hz, 2H), 2.98 (dd, J = 
16.0, 8.5 Hz, 1H), 2.88 (dd, J = 16.0, 3.4 Hz, 1H), 2.03 – 1.81 (m, 2H), 1.71 – 1.53 (m, 
4H), 1.37 – 1.27 (m, 6H). 13C NMR (125 MHz, CDCl3) δ 166.9, 165.8, 63.5, 63.3, 62.6, 
61.8, 51.2, 46.4, 39.5, 31.9, 23.6, 13.8, 13.7. HRMS (+ve ESI): calculated for 
C13H22Br2NaO5 (M+Na): 438.9726, found: 438.9740. 
Ethyl 4-bromo-2-fluoro-8-hydroxyoctanoate (5e) 
The general procedure was followed using ethyl bromofluoroacetate (0.1 mmol, 11.8 
L, 1 eq.), MeCN (200 L), 1-hexen-5-ol (0.2 mmol, 24 L, 2 eq.), 2,6-lutidine (0.1 
mmol, 12 L, 1 eq.) and p-anisaldehyde (0.02 mmol, 2.4 L, 20 mol%). After 48 h the 
reaction showed complete conversion of the alkyl halide. Purification by flash column 
chromatography (gradient eluent from hexane to 20:1 hexane:AcOEt) afforded the 
title compound (17.1 mg, 60% yield) as a colourless oil. 
1H NMR (500 MHz, CDCl3) δ 5.34 – 5.04 (m, 1H), 4.38 – 4.25 (m, 2H), 4.27 – 4.14 (m, 
1H), 3.69 (t, J = 6.0 Hz, 2H), 2.58 – 2.42 (m, 1H), 2.41 – 2.22 (m, 1H), 2.04 – 1.81 (m, 
2H), 1.77 – 1.49 (m, 5H), 1.39 – 1.27 (m, 3H). 13C NMR (125 MHz, CDCl3) δ 169.5, 169.3, 
169.2, 169.0, 88.0, 87.8, 86.6, 86.3, 62.5, 61.9, 61.8, 51.68, 51.66, 50.7, 50.6, 41.8, 
41.6, 41.4, 41.2, 39.0, 38.1, 31.9, 31.8, 23.8, 23.7, 14.12, 14.10. HRMS (+ve ESI): 
calculated for C10H18BrFNaO3 (M+Na): 307.0316, found: 307.0314. 
2,2,4-Tribromooctane-1,8-diol (5f) 
The general procedure was followed using 2,2,2-tribromoethanol (0.1 mmol, 28.2 mg, 
1 eq.), MeCN (200 L), 1-hexen-5-ol (0.2 mmol, 24 L, 2 eq.), 2,6-lutidine (0.1 mmol, 12 
L, 1 eq.) and p-anisaldehyde (0.02 mmol, 2.4 L, 20 mol%). After 20 h the reaction 
showed complete conversion of the alkyl halide. Purification by flash column 
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chromatography (gradient eluent from hexane to 15:1 hexane:AcOEt) afforded the 
title compound (36.1 mg, 94% yield) as a colourless oil. 
1H NMR (400 MHz, CDCl3) δ 4.36 – 4.21 (m, 1H), 4.19 (d, J = 12.9 Hz, 1H), 4.05 (d, J = 
12.9 Hz, 1H), 3.71 (t, J = 6.0 Hz, 2H), 3.24 (dd, J = 16.3, 6.6 Hz, 1H), 3.00 (dd, J = 16.3, 
3.7 Hz, 1H), 2.18 (s, 2H), 2.08 – 1.91 (m, 2H), 1.75 – 1.53 (m, 4H). 13C NMR (100 MHz, 
CDCl3) δ 73.1, 72.9, 62.6, 54.2, 52.0, 39.8, 31.8, 23.6. HRMS (+ve ESI): calculated for 
C8H15O2
79Br2  (M+Na): 300.9433, found: 300.9443.  
4-Bromo-8-hydroxyoctanenitrile (5g) 
The general procedure was followed using bromoacetonitrile (0.2 mmol, 13 L, 1 eq.), 
MeCN (400 L), 1-hexen-5-ol (0.4 mmol, 48 L, 2 eq.), 2,6-lutidine (0.2 mmol, 24 L, 1 
eq.) and p-anisaldehyde (0.04 mmol, 4.8 L, 20 mol%). After 20 h the reaction showed 
95% conversion of the alkyl halide. Purification by flash column chromatography 
(gradient eluent from hexane to 15:1 hexane:AcOEt) afforded the title compound (37.5 
mg, 85% yield) as a colourless oil. 
1H NMR (500 MHz, CDCl3) δ 4.13 – 4.02 (m, 1H), 3.67 (t, J = 6.0 Hz, 2H), 2.70 – 2.57 (m, 
2H), 2.26 – 2.15 (m, 1H), 2.15 – 2.00 (m, 1H), 2.00 – 1.80 (m, 2H), 1.71 – 1.52 (m, 5H). 
13C NMR (125 MHz, CDCl3) δ 118.8, 62.4, 54.7, 38.6, 34.5, 31.8, 23.8, 16.0.  HRMS (+ve 
ESI): calculated for C8H15BrNO (M+H): 220.0332, found: 220.0321. 
5,7,7,7-Tetrachloroheptan-1-ol (5h) 
The general procedure was followed using CCl4 (0.5 mmol, 48 μL, 5 eq.), MeCN (200 
L), 5-hexen-1-ol (0.1 mmol, 12 L, 1 eq.), 2,6-lutidine (0.1 mmol, 12 L, 1 eq.) and p-
anisaldehyde (0.02 mmol, 2.4 L, 20 mol%). After 42 h the reaction showed complete 
conversion of the olefin. Purification by flash column chromatography (gradient eluent 
from hexane to 9:1 hexane:AcOEt) afforded the title compound (20.1 mg, 79% yield) as 
a colourless oil. 
1H NMR (300 MHz, CDCl3) δ 4.37 – 4.22 (m, 1H), 3.78 – 3.62 (m, 2H), 3.30 (dd, J = 15.7, 
5.7 Hz, 1H), 3.15 (dd, J = 15.7, 4.3 Hz, 1H), 2.08 – 1.81 (m, 2H), 1.77 – 1.50 (m, 4H), 1.36 
(bs, 1H). 13C NMR (100 MHz, CDCl3) δ 96.9, 62.6, 62.2, 57.6, 38.8, 31.9, 22.4. HRMS 
(APCI): calculated for (M-2HCl-OH)+: 163.0076, found: 163.0074. 
7,7,8,8,9,9,10,10,11,11,12,12,12-Tridecafluoro-5-iodododecan-1-ol (5i) 
The on water-procedure was followed using perfluorohexyl iodide (0.2 mmol, 44 μL, 2 
eq.) H2O (200 L), 5-hexen-1-ol (0.1 mmol, 12 L, 1 eq.) and p-anisaldehyde (0.02 
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mmol, 2.4 L, 20 mol%). After 23 h the reaction showed complete NMR yield (1,3,5-
trimethoxy benzene as internal standard). Purification by flash column 
chromatography (gradient eluent from hexane to 19:1 hexane:AcOEt) afforded the 
title compound (51.2 mg, 94% yield) as a colourless oil. 
1H NMR (400 MHz, CDCl3) δ 4.43 – 4.31 (m, 1H), 3.71 (t, J = 5.9 Hz, 2H), 3.05 – 2.71 (m, 
2H), 1.97 – 1.76 (m, 2H), 1.76 – 1.46 (m, 4H). 13C NMR (100 MHz, CDCl3) δ 62.5 , 41.6 (t, 
J = 20.9 Hz), 40.0 (d, J = 2.1 Hz), 31.5 , 26.0 , 20.4. 19F NMR (376 MHz, CDCl3) δ -80.9 (t, J 
= 10.0 Hz, 3F), -111.3 – -112.3 (m, 1F), -114.2 – -115.2 (m, 1F), -121.7 – -122.0 (m, 2F), -
122.8 – -123.1 (m, 2F), -123.6 – -123.9 (m, 2F), -126.1 – -126.4 (m, 2F). HRMS (+ve 
APCI): calculated for C12H11F13I (M-H2O): 528.9698, found: 528.9692. 
Diethyl 2-(2-bromodecyl)malonate (7a) 
The general procedure was followed using diethyl bromomalonate (0.2 mmol, 17 μL, 1 
eq.), MeCN (400 L), 1-decene (0.4 mmol, 76 L, 2 eq.), 2,6-lutidine (0.2 mmol, 24 L, 
1 eq.) and p-anisaldehyde (0.04 mmol, 4.8 L, 20 mol%). After 12 h the reaction 
showed complete conversion of the alkyl halide. Purification by flash column 
chromatography (gradient eluent from hexane to 20:1 hexane:AcOEt) afforded the 
title compound (65.4 mg, 86% yield) as a colourless oil. 
1H NMR (500 MHz, CDCl3) δ 4.27 – 4.17 (m, 4H), 4.09 – 3.94 (m, 1H), 3.80 (dd, J = 10.2, 
4.2 Hz, 1H), 2.48 (ddd, J = 14.8, 10.3, 3.1 Hz, 1H), 2.26 (ddd, J = 14.9, 10.7, 4.2 Hz, 1H), 
1.91 – 1.82 (m, 2H), 1.62 – 1.50 (m, 1H), 1.50 – 1.38 (m, 1H), 1.34 – 1.23 (m, 11H), 0.92 
– 0.86 (m, 3H). 13C NMR (125 MHz, CDCl3) δ 169.0, 168.8, 61.7, 61.6, 55.0, 50.6, 39.4, 
37.9, 31.8, 29.4, 29.2, 28.9, 27.4, 22.6, 14.1, 14.06, 14.02. HRMS (+ve ESI): calculated 
for C17H31BrNaO4 (M+Na): 401.1298, found: 401.1309. 
Diethyl 2-(2-bromo-3-cyclopentylpropyl)malonate (7b) 
The general procedure was followed using diethyl bromomalonate (0.1 mmol, 17 μL, 1 
eq.), MeCN (200 L), allylcyclopentane (0.2 mmol, 29 L, 2 eq.), 2,6-lutidine (0.1 mmol, 
12 L, 1 eq.) and p-anisaldehyde (0.02 mmol, 2.4 L, 20 mol%). After 16 h the reaction 
showed 96% conversion of the alkyl halide. Purification by flash column 
chromatography (gradient eluent from hexane to 19:1 hexane:AcOEt) afforded the 
title compound (32.3 mg, 92% yield) as a colourless oil. 
1H NMR (500 MHz, CDCl3) δ 4.33 – 4.18 (m, 4H), 4.10 – 3.98 (m, 1H), 3.83 (dd, J = 10.3, 
4.2 Hz, 1H), 2.52 (ddd, J = 14.8, 10.2, 3.1 Hz, 1H), 2.25 (ddd, J = 14.8, 10.6, 4.2 Hz, 1H), 
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2.16 – 2.05 (m, 1H), 2.01 (ddd, J = 14.6, 8.8, 6.0 Hz, 1H), 1.89 – 1.74 (m, 3H), 1.68 – 1.51 
(m, 4H), 1.33 – 1.24 2x(t, J = 7.2 Hz, 3H), 1.19 – 1.01 (m, 2H). 13C NMR (125 MHz, CDCl3) 
δ 169.0, 168.8, 61.7, 61.6, 54.3, 50.6, 45.9, 38.2, 38.1, 32.5, 31.9, 25.0, 25.0, 14.1, 14.0. 
HRMS (+ve ESI): calculated for C15H25BrNaO4 (M+Na): 371.0834, found: 371.0828. 
Diethyl 2-(2-bromo-2-cyclohexylethyl)malonate (7c) 
The general procedure was followed using diethyl bromomalonate (0.1 mmol, 17 μL, 1 
eq.), MeCN (200 L), vinylcyclohexane (0.2 mmol, 27 L, 2 eq.), 2,6-lutidine (0.1 mmol, 
12 L, 1 eq.) and p-anisaldehyde (0.02 mmol, 2.4 L, 20 mol%). After 15 h the reaction 
showed complete conversion of the alkyl halide. Purification by flash column 
chromatography (gradient eluent from hexane to 20:1 hexane:AcOEt) afforded the 
title compound (30.9 mg, 89% yield) as a colourless oil. 
1H NMR (500 MHz, CDCl3) δ 4.42 – 4.09 (m, 4H), 3.96 (ddd, J = 11.3, 4.2, 2.6 Hz, 1H), 
3.80 (dd, J = 10.7, 3.8 Hz, 1H), 2.47 (ddd, J = 14.8, 10.7, 2.6 Hz, 1H), 2.28 (ddd, J = 15.0, 
11.3, 3.8 Hz, 1H), 1.89 – 1.75 (m, 4H), 1.74 – 1.62 (m, 1H), 1.62 – 1.56 (m, 1H), 1.37 – 
1.21 (m, 11H). 13C NMR (125 MHz, CDCl3) δ 169.1, 168.9, 61.8, 61.7, 61.6, 50.8, 44.9, 
35.2, 30.6, 29.2, 26.2, 26.1, 26.0, 14.1, 14.0. . HRMS (+ve ESI): calculated for 
C15H25BrNaO4 (M+Na): 371.0828, found: 371.0830. 
Diethyl 2-(2-bromo-4-phenylbutyl)malonate (7d) 
The general procedure was followed using diethyl bromomalonate (0.1 mmol, 17 μL, 1 
eq.), MeCN (200 L), 4-phenyl-1-butene (0.2 mmol, 30 L, 2 eq.), 2,6-lutidine (0.1 
mmol, 12 L, 1 eq.) and p-anisaldehyde (0.02 mmol, 2.4 L, 20 mol%). After 23 h the 
reaction showed 97% conversion of the alkyl halide. Purification by flash column 
chromatography (gradient eluent from hexane to 19:1 hexane:AcOEt) afforded the 
title compound (25.9 mg, 70% yield) as a colourless oil. 
1H NMR (500 MHz, CDCl3) δ 7.35 – 7.29 (m, 2H), 7.26 – 7.19 (m, 3H), 4.28 – 4.14 (m, 
4H), 4.04 – 3.94 (m, 1H), 3.81 (dd, J = 10.0, 4.4 Hz, 1H), 2.98 – 2.89 (m, 1H), 2.84 – 2.74 
(m, 1H), 2.51 (ddd, J = 14.8, 10.0, 3.2 Hz, 1H), 2.35 (ddd, J = 14.9, 10.5, 4.4 Hz, 1H), 2.25 
– 2.12 (m, 2H), 1.29 (t, J = 7.1 Hz, 3H), 1.26 (t, J = 7.1 Hz, 3H). 13C NMR (125 MHz, CDCl3) 
δ 168.9, 168.7, 140.6, 128.51, 128.48, 126.2, 61.7, 61.6, 54.0, 50.6, 41.0, 37.9, 33.6, 
14.0. HRMS (+ve ESI): calculated for C17H23BrNaO4 (M+Na): 393.0677, found: 393.0672. 
Diethyl 2-(3-bromobicyclo[2.2.1]heptan-2-yl)malonate (7e) 
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The general procedure was followed using diethyl bromomalonate (0.1 mmol, 17 μL, 1 
eq.), MeCN (200 L), norbornene (0.2 mmol, 18.8 mg, 2 eq.), 2,6-lutidine (0.1 mmol, 12 
L, 1 eq.) and p-anisaldehyde (0.02 mmol, 2.4 L, 20 mol%). After 12 h the reaction 
showed 97% conversion of the alkyl halide. Purification by flash column 
chromatography (gradient eluent from hexane to 19:1 hexane:AcOEt) afforded the 
title compound (29.6 mg, 89% yield) as a colourless oil in a mixture of two 
diastereoisomers. 
1H NMR (400 MHz, CDCl3) δ 4.38 (dd, J = 7.0, 1.9 Hz, 1H), 4.33 – 4.12 (m, 8H), 4.11 – 
4.03 (m, 1H), 3.61 (d, J = 12.1 Hz, 1H), 3.15 (d, J = 11.0 Hz, 1H), 2.64 – 2.53 (m, 2H), 2.51 
– 2.43 (m, 1H), 2.38 – 2.29 (m, 1H), 2.10 – 1.98 (m, 3H), 1.98 – 1.89 (m, 1H), 1.76 – 1.43 
(m, 6H), 1.39 – 1.23 (m, 16H). 13C NMR (100 MHz, CDCl3) δ 169.0, 168.4, 168.1, 167.7, 
61.8, 61.62, 61.60, 61.5, 60.8, 57.8, 55.7, 55.5, 52.3, 48.0, 47.0, 44.6, 41.4, 40.0, 34.7, 
34.2, 30.0, 29.6, 26.8, 23.6, 14.12, 14.05, 13.9. HRMS (+ve ESI): calculated for 
C14H21BrNaO4 (M+Na): 355.0521, found: 355.0515. 
Diethyl 2-(2-bromocyclohexyl)malonate (7f) 
The general procedure was followed using diethyl bromomalonate (0.1 mmol, 17 μL, 1 
eq.), MeCN (200 L), cyclohexene (0.2 mmol, 20 L, 2 eq.), 2,6-lutidine (0.1 mmol, 12 
L, 1 eq.) and p-anisaldehyde (0.02 mmol, 2.4 L, 20 mol%). After 95 h the reaction 
showed 78% conversion of the alkyl halide. Purification by flash column 
chromatography (gradient eluent from hexane to 30:1 hexane:AcOEt) afforded the 
title compound as a mixture of two diastereomers (24.1 mg, 75% yield) as a colourless 
oil. 
1H NMR (400 MHz, CDCl3) δ 4.81 – 4.72 (m, 1H), 4.33 – 4.16 (m, 9H), 4.14 (d, J = 3.7 Hz, 
1H), 3.51 (d, J = 10.8 Hz, 1H), 2.49 – 2.40 (m, 1H), 2.40 – 2.30 (m, 1H), 2.28 – 2.13 (m, 
2H), 2.05 – 1.86 (m, 4H), 1.84 – 1.72 (m, 4H), 1.58 – 1.39 (m, 6H), 1.32 – 1.26 (m, 12H). 
13C NMR (100 MHz, CDCl3) δ 169.1, 168.4, 168.1, 167.9, 61.54, 61.51, 61.4, 61.1, 58.4, 
57.4, 56.4, 54.3, 46.3, 42.0, 38.8, 34.8, 28.5, 27.2, 25.4, 25.3, 24.7, 20.2, 14.15, 14.09, 
14.07, 14.06. HRMS (+ve ESI): calculated for C13H21BrNaO4 (M+Na): 343.0515, found: 
343.0521. 
Diethyl 2-(2-bromocyclooctyl)malonate (7g) 
The general procedure was followed using diethyl bromomalonate (0.1 mmol, 17 μL, 1 
eq.), MeCN (200 L), cis-cyclooctene (0.2 mmol, 26 L, 2 eq.), 2,6-lutidine (0.1 mmol, 
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12 L, 1 eq.) and p-anisaldehyde (0.02 mmol, 2.4 L, 20 mol%). After 14 h the reaction 
showed complete conversion of the alkyl halide. Purification by flash column 
chromatography (gradient eluent from hexane to 30:1 hexane:AcOEt) afforded the 
title compound (mixture of two diastereomers) (33.8 mg, 97% yield) as a colourless oil. 
1H NMR (500 MHz, CDCl3) δ 4.52 – 4.44 (m, 1H), 4.43 – 4.34 (m, 1H), 4.28 – 4.14 (m, 
8H), 3.26 (dd, J = 8.5, 3.1 Hz, 2H), 2.48 – 2.16 (m, 8H), 2.14 – 2.02 (m, 2H), 1.95 – 1.60 
(m, 10H), 1.53 – 1.36 (m, 6H), 1.31 – 1.28 (m, 12H).13C NMR (101 MHz, CDCl3) δ 168.8, 
168.74, 168.72, 61.3, 61.29, 61.25, 58.8, 58.7, 56.6, 56.2, 37.8, 37.7, 36.5, 36.0, 34.7, 
34.0, 29.12, 29.05, 28.3, 28.2, 26.7, 26.2, 25.3, 24.0, 14.1. HRMS (+ve ESI): calculated 
for C15H25BrNaO4 (M+Na): 371.0828, found: 371.0833. 
Diethyl 2-(2,7-dibromoheptyl)malonate (7h) 
The general procedure was followed using diethyl bromomalonate (0.1 mmol, 17 μL, 1 
eq.), MeCN (200 L), 7-Bromo-1-heptene (0.2 mmol, 30.5 L, 2 eq.), 2,6-lutidine (0.1 
mmol, 12 L, 1 eq.) and p-anisaldehyde (0.02 mmol, 2.4 L, 20 mol%). After 88 h the 
reaction showed complete conversion of the alkyl halide. Purification by flash column 
chromatography (gradient eluent from hexane to 19:1 hexane:AcOEt) afforded the 
title compound (38.5 mg, 92% yield) as a colourless oil. 
1H NMR (500 MHz, CDCl3) δ 4.31 – 4.19 (m, 4H), 4.06 – 3.98 (m, 1H), 3.81 (dd, J = 10.3, 
4.2 Hz, 1H), 3.44 (t, J = 6.7 Hz, 2H), 2.48 (ddd, J = 14.9, 10.3, 3.1 Hz, 1H), 2.28 (ddd, J = 
14.9, 10.7, 4.2 Hz, 1H), 1.94 – 1.85 (m, 4H), 1.67 – 1.57 (m, 1H), 1.56 – 1.43 (m, 3H), 
1.35 – 1.25 2x(t, J = 7.1 Hz, 3H). 13C NMR (125 MHz, CDCl3) δ 168.9, 168.8, 61.7, 61.6, 
54.6, 50.6, 39.2, 37.9, 33.6, 32.5, 27.5, 26.6, 14.1, 14.0. HRMS (+ve ESI): calculated for 
C14H24Br2NaO4 (M+Na): 436.9939, found: 436.9934. 
Diethyl 2-(2-bromo-5-oxohexyl)malonate (7i) 
The general procedure was followed using diethyl bromomalonate (0.1 mmol, 17 μL, 1 
eq.), MeCN (200 L), 5-hexen-2-one (0.2 mmol, 23 L, 2 eq.), 2,6-lutidine (0.1 mmol, 
12 L, 1 eq.) and p-anisaldehyde (0.02 mmol, 2.4 L, 20 mol%). After 16 h the reaction 
showed complete conversion of the alkyl halide. Purification by flash column 
chromatography (gradient eluent from hexane to 20:1 hexane:AcOEt) afforded the 
title compound (29.5 mg, 88% yield) as a colourless oil. 
1H NMR (500 MHz, CDCl3) δ 4.29 – 4.16 (m, 4H), 4.13 – 3.97 (m, 1H), 3.77 (dd, J = 10.0, 
4.5 Hz, 1H), 2.82 – 2.61 (m, 2H), 2.48 (ddd, J = 14.8, 9.9, 3.3 Hz, 1H), 2.31 (ddd, J = 14.9, 
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10.4, 4.5 Hz, 1H), 2.26 – 2.19 (m, 1H), 2.18 (s, 3H), 2.10 – 1.98 (m, 1H), 1.34 – 1.25 (m, 
6H). 13C NMR (125 MHz, CDCl3) δ 207.0, 168.8, 168.6, 61.75, 61.69, 53.9, 50.5, 41.3, 
38.0, 32.8, 30.1, 14.04, 14.01. HRMS (+ve ESI): calculated for C13H21BrNaO5 (M+Na): 
359.0465, found: 359.0463. 
Diethyl 2-(2-bromo-4-hydroxy-4-methylhexyl)malonate (7j) 
The general procedure was followed using diethyl bromomalonate (0.1 mmol, 17 μL, 1 
eq.), MeCN (200 L), 3-methyl-5-hexen-3-ol (0.2 mmol, 27 L, 2 eq.), 2,6-lutidine (0.1 
mmol, 12 L, 1 eq.) and p-anisaldehyde (0.02 mmol, 2.4 L, 20 mol%). After 19 h the 
reaction showed 95% conversion of the alkyl halide. Purification by flash column 
chromatography (gradient eluent from hexane to 19:1 hexane:AcOEt) afforded the 
title compound (31.6 mg, 89% yield) as a colourless oil in a mixture of the two 
diastereoisomers. 
1H NMR (400 MHz, CDCl3) δ 4.34 – 4.18 (m, 10H), 3.81 (dd, J = 10.3, 4.0 Hz, 2H), 2.77 – 
2.59 (m, 2H), 2.37 – 2.20 (m, 4H), 2.16 – 2.04 (m, 2H), 1.91 (bs, 1H), 1.76 (bs, 1H), 1.63 
– 1.50 (m, 4H), 1.35 – 1.24 (m, 12H), 1.25 (s, 3H), 1.23 (s, 3H), 0.98 – 0.89 2x(t, J = 7.5 
Hz, 3H). 13C NMR (100 MHz, CDCl3) δ 169.01, 168.95, 168.88, 168.84, 72.92, 72.88, 
61.73, 61.71, 61.70, 61.68, 50.64, 50.56, 50.03, 50.01, 49.9, 49.8, 39.3, 39.2, 35.5, 34.8, 
26.6, 26.0, 14.1, 14.0, 8.2, 8.1. HRMS (+ve ESI): calculated for C14H25BrNaO5 (M+Na): 
375.0783, found: 375.0778. 
Diethyl 2-(2-bromo-3-((tert-butoxycarbonyl)amino)propyl)malonate (7k) 
The general procedure was followed using diethyl bromomalonate (0.1 mmol, 17 μL, 1 
eq.), MeCN (200 L), Boc-allylamine (0.2 mmol, 31.4 mL, 2 eq.), 2,6-lutidine (0.1 mmol, 
12 L, 1 eq.) and p-anisaldehyde (0.02 mmol, 2.4 L, 20 mol%). After 111 h the 
reaction showed 84% conversion of the alkyl halide. Purification by flash column 
chromatography (gradient eluent from hexane to 19:1 hexane:AcOEt) afforded the 
title compound (31.0 mg, 78% yield) as a colourless oil. 
1H NMR (500 MHz, CDCl3) δ 4.99 (bs, 1H), 4.32 – 4.18 (m, 4H), 4.19 – 4.05 (m, 1H), 3.76 
(dd, J = 9.5, 5.0 Hz, 1H), 3.62 – 3.45 (m, 2H), 2.50 (ddd, J = 14.9, 9.5, 3.7 Hz, 1H), 2.29 
(ddd, J = 15.0, 10.1, 5.1 Hz, 1H), 1.47 (s, 9H), 1.37 – 1.23 2x(t, J = 7.1 Hz, 3H). 13C NMR 
(125 MHz, CDCl3) δ 168.8, 168.5, 155.6, 79.9, 61.8, 61.7, 53.3, 50.2, 47.1, 34.6, 28.3, 
14.04, 14.01. HRMS (+ve ESI): calculated for C15H26BrNNaO6 (M+Na): 418.0841, found: 
418.0836. 
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1,1-Diethyl 11-methyl 3-bromoundecane-1,1,11-tricarboxylate (7l) 
The general procedure was followed using diethyl bromomalonate (0.1 mmol, 17 μL, 1 
eq.), MeCN (200 L), methyl undec-10-enoate (0.2 mmol, 47 L, 2 eq.), 2,6-lutidine 
(0.1 mmol, 12 L, 1 eq.) and p-anisaldehyde (0.02 mmol, 2.4 L, 20 mol%). After 16 h 
the reaction showed 94% conversion of the alkyl halide. Purification by flash column 
chromatography (gradient eluent from hexane to 19:1 hexane:AcOEt) afforded the 
title compound (33.9 mg, 78% yield) as a colourless oil. 
1H NMR (500 MHz, CDCl3) δ 4.31 – 4.17 (m, 4H), 4.07 – 3.97 (m, 1H), 3.81 (dd, J = 10.3, 
4.2 Hz, 1H), 3.69 (s, 3H), 2.48 (ddd, J = 14.9, 10.3, 3.1 Hz, 1H), 2.33 (t, J = 7.5 Hz, 2H), 
2.27 (ddd, J = 14.8, 10.7, 4.2 Hz, 1H), 1.93 – 1.81 (m, 2H), 1.69 – 1.59 (m, 2H), 1.60 – 
1.51 (m, 1H), 1.51 – 1.40 (m, 1H), 1.36 – 1.27 (m, 14H). 13C NMR (125 MHz, CDCl3) δ 
174.3, 169.0, 168.8, 61.7, 61.6, 55.0, 51.4, 50.6, 39.4, 37.9, 34.1, 29.2, 29.12, 29.08, 
28.9, 27.4, 24.9, 14.1, 14.0. HRMS (+ve ESI): calculated for C19H33BrNaO6 (M+Na): 
459.1358, found: 459.1353. 
Diethyl 2-(6-acetoxy-2-bromohexyl)malonate (7m) 
The general procedure was followed using diethyl bromomalonate (0.1 mmol, 17 μL, 1 
eq.), MeCN (200 L), 5-hexenyl acetate (0.2 mmol, 32 L, 2 eq.), 2,6-lutidine (0.1 
mmol, 12 L, 1 eq.) and p-anisaldehyde (0.02 mmol, 2.4 L, 20 mol%). After 26 h the 
reaction showed 98% conversion of the alkyl halide. Purification by flash column 
chromatography (gradient eluent from hexane to 19:1 hexane:AcOEt) afforded the 
title compound (32.5 mg, 85% yield) as a colourless oil. 
1H NMR (500 MHz, CDCl3) δ 4.31 – 4.17 (m, 4H), 4.09 (t, J = 6.3 Hz, 2H), 4.07 – 3.97 (m, 
1H), 3.80 (dd, J = 10.3, 4.2 Hz, 1H), 2.48 (ddd, J = 14.7, 10.3, 3.1 Hz, 1H), 2.27 (ddd, J = 
14.8, 10.7, 4.2 Hz, 1H), 2.07 (s, 3H), 1.94 – 1.86 (m, 2H), 1.72 – 1.60 (m, 3H), 1.60 – 1.47 
(m, 1H), 1.34 – 1.24 (m, 6H). 13C NMR (125 MHz, CDCl3) δ 171.1, 168.9, 168.8, 64.1, 
61.7, 61.6, 54.4, 50.5, 39.0, 37.9, 27.9, 24.0, 21.0, 14.1, 14.0. HRMS (+ve ESI): 
calculated C15H25BrNaO6 (M+Na): 403.0732, found: 403.0727. 
Diethyl 2-(2-bromo-4-(oxiran-2-yl)butyl)malonate (7n) 
The general procedure was followed using diethyl bromomalonate (0.1 mmol, 17 μL, 1 
eq.), MeCN (200 L), 1,2-epoxy-5-hexene (0.2 mmol, 23 L, 2 eq.), 2,6-lutidine (0.1 
mmol, 12 L, 1 eq.) and p-anisaldehyde (0.02 mmol, 2.4 L, 20 mol%). After 12 h the 
reaction showed complete conversion of the alkyl halide. Purification by flash column 
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chromatography (gradient eluent from hexane to 20:1 hexane:AcOEt) afforded the 
title compound (32.8 mg, 97% yield) as a colourless oil. 
1H NMR (400 MHz, CDCl3) δ 4.33 – 4.16 (m, 4H), 4.15 – 3.97 (m, 1H), 3.83 – 3.77 (m, 
1H), 3.01 – 2.89 (m, 1H), 2.79 (dd, J = 4.9, 3.9 Hz, 1H), 2.59 – 2.41 (m, 2H), 2.37 – 2.22 
(m, 1H), 2.11 – 1.92 (m, 2H), 1.88 – 1.72 (m, 1H), 1.70 – 1.49 (m, 1H), 1.33 – 1.26 2x (t, J 
= 7.1 Hz, 3H). 13C NMR (125 MHz, CDCl3) δ 168.8, 168.7, 61.73, 61.66, 54.1, 53.8, 51.5, 
51.2, 50.5, 46.93, 46.90, 37.9, 37.8, 35.9, 35.4, 30.6, 30.2, 14.04, 14.01. HRMS (+ve 
ESI): calculated for C13H21BrNaO5 (M+Na): 359.0465, found: 359.0467. 
Diethyl 2-(2-bromo-3-methoxypropyl)malonate (7o) 
The general procedure was followed using diethyl bromomalonate (0.1 mmol, 17 μL, 1 
eq.), MeCN (200 L), allyl methyl ether (0.4 mmol, 37.6 L, 4 eq.), 2,6-lutidine (0.1 
mmol, 12 L, 1 eq.) and p-anisaldehyde (0.02 mmol, 2.4 L, 20 mol%). After 85 h the 
reaction showed 60% conversion of the alkyl halide. Purification by flash column 
chromatography (gradient eluent from hexane to 19:1 hexane:AcOEt) afforded the 
title compound (13.2 mg, 42% yield) as a colourless oil. 
1H NMR (500 MHz, CDCl3) δ 4.32 – 4.19 (m, 4H), 4.20 – 4.11 (m, 1H), 3.78 (dd, J = 10.1, 
4.5 Hz, 1H), 3.73 – 3.61 (m, 2H), 3.42 (s, 3H), 2.62 (ddd, J = 14.8, 10.1, 3.5 Hz, 1H), 2.27 
(ddd, J = 15.0, 10.5, 4.6 Hz, 1H), 1.34 – 1.28 2x(t, J = 7.1 Hz, 3H). 13C NMR (125 MHz, 
CDCl3) δ 168.9, 168.7, 76.7, 61.7, 61.7, 58.9, 50.2, 49.9, 34.4, 14.1, 14.0. HRMS (+ve 
ESI): calculated for C11H19BrNaO5 (M+Na): 333.0308, found: 333.0309. 
Diethyl 2-(2-bromo-2-methylundecyl)malonate (7p) 
The general procedure was followed using diethyl bromomalonate (0.1 mmol, 17 μL, 1 
eq.), MeCN (200 L), 2-methyl-1-undecene (0.2 mmol, 44 L, 2 eq.), 2,6-lutidine (0.1 
mmol, 12 L, 1 eq.) and p-anisaldehyde (0.02 mmol, 2.4 L,  20 mol%). After 13 h the 
reaction showed complete conversion of the alkyl halide. Purification by flash column 
chromatography (gradient eluent from hexane to 30:1 hexane:AcOEt) afforded the 
title compound (35.4 mg, 87% yield) as a colourless oil. 
1H NMR (500 MHz, CDCl3) δ 4.29 – 4.16 (m, 4H), 3.75 (dd, J = 6.3, 5.2 Hz, 1H), 2.60 (dd, 
J = 15.3, 5.2 Hz, 1H), 2.49 (dd, J = 15.2, 6.3 Hz, 1H), 1.87 (ddd, J = 14.2, 11.3, 5.1 Hz, 
1H), 1.76 (ddd, J = 14.2, 11.0, 5.3 Hz, 1H), 1.68 (s, 3H), 1.59 – 1.44 (m, 2H), 1.34 – 1.24 
(m, 18H), 0.90 (t, J = 6.8 Hz, 3H). 13C NMR (100 MHz, CDCl3) δ 169.6, 169.4, 71.2, 61.7, 
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50.1, 45.8, 43.4, 31.9, 31.0, 29.6, 29.52, 29.45, 29.3, 25.7, 22.7, 14.1, 14.0. HRMS (+ve 
ESI): calculated for C19H35BrNaO4  (M+Na): 429.1611, found: 429.1608. 
Diethyl 2-(2-bromo-4-hydroxybut-1-en-1-yl)-2-methylmalonate (7q) 
The general procedure was followed using diethyl 2-bromo-2-methylmalonate (0.1 
mmol, 19 μL, 1 eq.), MeCN (200 L), 3-butyn-1-ol (0.2 mmol, 15 L, 2 eq.), 2,6-lutidine 
(0.1 mmol, 12 L, 1 eq.) and p-anisaldehyde (0.02 mmol, 2.4 L,  20 mol%). After 96 h 
the reaction showed 70% conversion of the alkyl halide. Purification by flash column 
chromatography (gradient eluent from hexane to 30:1 hexane:AcOEt) afforded the 
title compound (19.4 mg, 60% yield) as a colourless oil. 
1H NMR (400 MHz, CDCl3) δ 6.61 (s, 1H), 4.39 – 4.11 (m, 4H), 3.95 – 3.77 (m, 1H), 2.75 – 
2.57 (m, 2H), 1.76 (t, J = 6.1 Hz, 1H), 1.65 (s, 3H), 1.29 (t, J = 7.1 Hz, 6H). 13C NMR (126 
MHz, CDCl3) δ 170.6, 132.8, 127.8, 62.2, 60.5, 55.6, 39.3, 23.1, 13.9. HRMS (+ve ESI): 
calculated for C12H19BrNaO5 (M+Na): 345.0308, found: 345.0305. 
Diethyl 2-(2-bromo-2-(4-methylcyclohex-3-en-1-yl)propyl)malonate (7r) 
The general procedure was followed using diethyl bromomalonate (0.1 mmol, 17 μL, 1 
eq.), MeCN (200 L), R (+)-limonene (0.2 mmol, 32 L, 2 eq.), 2,6-lutidine (0.1 mmol, 
12 L, 1 eq.) and p-anisaldehyde (0.02 mmol, 2.4 L, 20 mol%). After 15 h the reaction 
showed complete conversion of the alkyl halide. Purification by flash column 
chromatography (gradient eluent from hexane to 20:1 hexane:AcOEt) afforded the 
title compound (30.7 mg, 82% yield) as a colourless oil. 
1H NMR (400 MHz, CDCl3) δ 5.47 – 5.28 (m, 1H), 4.32 – 4.16 (m, 4H), 3.84 – 3.72 (m, 
1H), 2.70 (ddd, J = 20.4, 15.3, 4.5 Hz, 1H), 2.52 (ddd, J = 16.0, 15.3, 6.9 Hz, 1H), 2.32 – 
1.93 (m, 5H), 1.82 – 1.72 (m, 1H), 1.71 – 1.59 (m, 6H), 1.54 – 1.38 (m, 1H), 1.34 – 1.22 
(m, 6H). 13C NMR (100 MHz, CDCl3) δ 169.74, 169.71, 169.4, 134.2, 133.9, 120.0, 119.7, 
76.3, 76.2, 61.81, 61.77, 61.7, 50.0, 49.9, 46.5, 46.3, 41.4, 40.7, 30.9, 28.41, 28.38, 
27.9, 27.8, 26.0, 25.6, 23.1, 14.0.  HRMS (+ve ESI): calculated for C17H27BrNaO4 (M+Na): 
397.0985, found: 397.0985. 
Diethyl 2-((4-(2-bromopropan-2-yl)cyclohex-1-en-1-yl)methyl)malonate (8) 
The general procedure was followed using diethyl bromomalonate (0.1 mmol, 17 μL, 1 
eq.), MeCN (200 L), (-)-β-pinene (0.2 mmol, 31 L, 2 eq.), 2,6-lutidine (0.1 mmol, 12 
L, 1 eq.) and p-anisaldehyde (0.02 mmol, 2.4 L, 20 mol%). After 15 h the reaction 
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showed full conversion. Purification by flash column chromatography (gradient eluent 
from hexane to 20:1 hexane:AcOEt) afforded the title compound as a colourless oil. 
Diethyl 2-(2-(bromomethyl)-4-hydroxycyclopentyl)malonate (10) 
The general procedure was followed using diethyl bromomalonate (0.1 mmol, 17 μL, 1 
eq.), MeCN (200 L), 3-butyn-1-ol (0.2 mmol, 15 L, 2 eq.), 2,6-lutidine (0.1 mmol, 12 
L, 1 eq.) and p-anisaldehyde (0.02 mmol, 2.4 L,  20 mol%). After 60 h the reaction 
showed 95% conversion of the alkyl halide. Purification by flash column 
chromatography (gradient eluent from hexane to 30:1 hexane:AcOEt) afforded the 
title compound (31.5 mg, 90% yield) as a colourless oil. 
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List of Abbreviations 
Ac   Acetyl 
ACDC   Asymmetric Counteranion-Directed Catalysis 
AIBN   Azobisisobutyronitrile 
Ar   Aryl 
ATRA   Atom Transfer Radical Addition 
ATRC   Atom Transfer Radical Cyclization 
ATRP   Atom Transfer Radical Polymerization 
BF4   Tetrafluoroborate 
BHT   2,6-Bis(1,1-dimethylethyl)-4-methylphenol 
BINOL   1,1'-Bi-2-naphthol 
bmim   1-Butyl-3-methylimidazolium 
Bn   Benzyl 
Boc   tert-butoxycarbonyl 
CA   Chloroacetic acid 
Cbz   Benzyloxycarbonyl 
CFL   Compact Fluorescent Light 
CSP   Chiral Stationary Phase 
DBU   1,5-Diazabiciclo[5.4.0]undec-5-ene 
DCM   Dichloromethane 
DEAD   Diethyl azodicarboxylate 
DFPA   α,α-Difluorophenylacetic acid 
DFT   Density Functional Theory  
DMAP   N-dimethylamino pyridine 
DMF   Dimethylformamide 
DMSO   Dimethyl sulfoxide 
dr   Diastereomeric ratio 
E+   Electrophile 
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ECD   Electronic Circular Dichroism 
EDA   Electron Donor-Acceptor 
ee   Enantiomeric excess 
EI   Electron Ionization 
ESI   Electrospray Ionization 
Et   Ethyl 
EWG   Electron Withdrawing Group  
GC   Gas Chromatography 
HOMO   Highest Occupied Molecular Orbital 
HPLC   High Performance Liquid Chromatography 
HPLC-MS  High Performance Liquid Chromatography – Mass Spectrometry 
HRMS   High-Resolution Mass Spectrometry 
IPA   Isopropyl alcohol 
i-Pr   Isopropyl 
IL   Ionic Liquid 
LUMO   Lowest Unoccupied Molecular Orbital 
KHMDS  Potassium hexamethyldisilazane 
Me   Methyl 
mlc-SILP  Multilayered covalently bonded Supported Ionic Liquids Phases 
MNBA   4-Methyl-2-nitrobenzoic acid 
MS-TOF   Mass Spectrometry – Time-of-flight  
MTBE   Methyl tert-butyl ether 
NMR   Nuclear Magnetic Resonance 
NTf2    Bis(trifluoromethane)sulfonimide or bistriflimide 
Nu:   Nucleophile 
OFBA   o-Fluorobenzoic acid 
OR   Optical Rotation 
Ox   Oxidant 
PF6   Hexafluorophosphate 
Ph   Phenyl 
PTC   Phase-Transfer Catalysis 
R   Alkyl 
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Ra-Ni   Raney Nickel 
rt   Room temperature 
SET   Single Electron Transfer 
SILP   Supported Ionic Liquid Phases 
So:   SOMOphile 
SOMO   Singly Occupied Molecular Orbital 
t-Bu   tert-butyl 
TADDOL  α,α,α,α-Tetraaryl-1,3-dioxolane-4,5- dimethanol 
TCE   Tetrachloroethylene 
TEA   Triethylamine 
TEMPO  2,2,6,6-Tetramethylpiperidine-1-oxyl 
TES   Triethylsilyl 
TFA   Trifluoroacetic acid 
THF   Tetrahydrofuran 
TLC   Thin-Layer Chromatography 
TMC   Transition Metal Catalysed 
TMS   Trimethylsilyl 
TUC   Takemoto's thiourea catalyst 
UV   Ultraviolet 
 
